<SEC-DOCUMENT>0001144204-16-115210.txt : 20160729
<SEC-HEADER>0001144204-16-115210.hdr.sgml : 20160729
<ACCEPTANCE-DATETIME>20160729133424
ACCESSION NUMBER:		0001144204-16-115210
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20160914
FILED AS OF DATE:		20160729
DATE AS OF CHANGE:		20160729
EFFECTIVENESS DATE:		20160729

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		161793283

	BUSINESS ADDRESS:	
		STREET 1:		450 NORTH BRAND BLVD.,
		STREET 2:		SUITE 600
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203
		BUSINESS PHONE:		818-396-8050

	MAIL ADDRESS:	
		STREET 1:		700 NORTH BRAND BLVD.,
		STREET 2:		SUITE 1400
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>v445127_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Proxy Statement Pursuant to Section 14(a)
of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;
)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Filed by the Registrant <FONT STYLE="font-family: Wingdings">x</FONT></FONT></TD>
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Filed by a Party other than the Registrant <FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: -.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: -.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Confidential, for Use of
the Commission Only&nbsp;(as permitted by Rule 14a-6(e)(2))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting Material Pursuant
to &sect;240.14a-12</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Apollo Medical Holdings, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name of Registrant as Specified In Its
Charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">Payment of Filing Fee (Check
the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: -.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">No fee required.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee computed on table below
per Exchange Act Rules 14a-6(i)(4) and 0-11.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title of each class
of securities to which transaction applies:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-left: 0.75in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Aggregate number of
securities to which transaction applies:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-left: 0.75in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Per unit price or other
underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated
and state how it was determined):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-left: 0.75in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Proposed maximum aggregate
value of transaction:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-left: 0.75in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(5)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Total fee paid:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-left: 0.75in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee paid previously with
preliminary materials.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Check box if any part of
the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Amount Previously Paid:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-left: 0.75in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form, Schedule or Registration
Statement No.:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-left: 0.75in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Filing Party:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-left: 0.75in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Date Filed:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-left: 0.75in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.05pt; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="tlogo.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>700 North Brand Boulevard, Suite 1400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Glendale, California 91203</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF 2016 ANNUAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TO BE HELD ON SEPTEMBER 14, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To Our Common and Preferred Stockholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You are cordially
invited to attend the 2016 Annual Meeting of Stockholders (the &ldquo;2016 Annual Meeting&rdquo;) of Apollo Medical Holdings, Inc.
(the &ldquo;company&rdquo;, &ldquo;we&rdquo;, &ldquo;our&rdquo; or &ldquo;us&rdquo;), which will be held at the company&rsquo;s
offices located at 700 North Brand Boulevard, Suite 1440, Glendale, California 91203, at 10:00 a.m. on Wednesday, September 14,
2016 for the following purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.8pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: .5in"></TD><TD STYLE="width: 18pt">1.</TD><TD STYLE="text-align: justify">To elect seven directors to our Board of Directors (the &ldquo;Board&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.8pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: .5in"></TD><TD STYLE="width: 18pt">2.</TD><TD STYLE="text-align: justify">To adopt the Apollo Medical Holdings, Inc. 2015 Equity Incentive Plan (the &ldquo;2015 Plan&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.8pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: .5in"></TD><TD STYLE="width: 18pt">3.</TD><TD>To hold an advisory vote on named executive officer compensation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.8pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: .5in"></TD><TD STYLE="width: 18pt">4.</TD><TD>To hold an advisory vote on the frequency of future advisory votes on named executive officer compensation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These matters
are described more fully in the proxy statement accompanying this notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our stockholders
will also act upon such other business as may properly come before the meeting or any adjournment or postponement thereof. The
Board is not aware of any other business to be presented to a vote of the stockholders at the 2016 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has
fixed the close of business on July 21, 2016 as the record date (the &ldquo;Record Date&rdquo;) for determining those stockholders
who will be entitled to notice of and to vote at the 2016 Annual Meeting. The stock transfer books will remain open between the
Record Date and the date of the 2016 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Representation
of at least a majority in voting interest of our common stock and our Series A and Series B preferred stock either in person or
by proxy is required to constitute a quorum for purposes of voting on each proposal to be voted on at the 2016 Annual Meeting.
Accordingly, it is important that your shares be represented at the 2016 Annual Meeting. <B>WHETHER OR NOT YOU PLAN TO ATTEND THE
2016 ANNUAL MEETING, PLEASE COMPLETE, DATE AND SIGN THE ENCLOSED PROXY CARD AND RETURN IT IN THE ENCLOSED ENVELOPE.</B> Your proxy
may be revoked at any time prior to the time it is voted at the 2016 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please read the
accompanying proxy material carefully. Your vote is important and we appreciate your cooperation in considering and acting on the
matters presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">By Order of the Board of Directors,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><IMG SRC="tsig.jpg" ALT=""></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Warren Hosseinion, M.D.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><I>Chief Executive Officer</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">July 29, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Glendale, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE </B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>STOCKHOLDER MEETING TO BE HELD ON SEPTEMBER 14, 2016: </B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>THIS PROXY STATEMENT AND THE ANNUAL REPORT ARE AVAILABLE AT</B> </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-left: black 1pt solid; padding-bottom: 1pt; text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>https://materials.proxyvote.com/03763A</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-decoration: none; text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Stockholders Should Read the Entire Proxy
Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Carefully Prior to Returning Their Proxies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FOR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>2016 ANNUAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>APOLLO MEDICAL HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>To Be Held on September 14, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This proxy statement
is furnished in connection with the solicitation by our Board of Directors (the &ldquo;Board&rdquo;) of proxies to be voted at
the 2016 Annual Meeting of Stockholders (the &ldquo;2016 Annual Meeting&rdquo;), which will be held at 10:00 a.m. on September
14, 2016 at 700 North Brand Boulevard, Suite 1440, Glendale, California 91203, or at any adjournments or postponements thereof,
for the purposes set forth in the accompanying Notice of 2016 Annual Meeting of Stockholders (the &ldquo;Notice&rdquo;). This proxy
statement and the proxy card are first being delivered or mailed to stockholders on or about August 4, 2016. In addition, stockholders
may obtain additional copies of our Annual Report to Stockholders and this proxy statement, without charge, by writing to us at
our principal executive offices at 700 North Brand Boulevard, Suite 1400, Glendale, California 91203, Attention:&nbsp;Secretary,
or from our website at http://irdirect.net/AMEH/sec_filings. Our Annual Report to Stockholders for the year ended March 31, 2016
(the &ldquo;Annual Report&rdquo;), which incorporates our Annual Report on Form 10-K (the &ldquo;10-K&rdquo;), is being mailed
to stockholders concurrently with this proxy statement. The Annual Report is not to be regarded as proxy soliciting material or
as a communication by means of which any solicitation of proxies is to be made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING RIGHTS AND SOLICITATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The close of business
on July 21, 2016 was the record date (the &ldquo;Record Date&rdquo;) for stockholders entitled to notice of and to vote at the
2016 Annual Meeting. As of the Record Date, we had 5,745,036 shares of common stock, par value $0.001 per share, 1,111,111 shares
of Series A preferred stock, par value $0.001 per share, and 555,555 shares of Series B preferred stock, par value $0.001 per share,
issued and outstanding, according to the records maintained by our transfer agent. All of the shares of our common stock, Series
A preferred stock and Series B preferred stock outstanding on the Record Date, and only those shares (collectively, the &ldquo;Voting
Shares&rdquo;), are entitled to vote together as one class on each of the proposals to be voted upon at the 2016 Annual Meeting.
Holders of Voting Shares will have one vote for each such share so held with regard to each matter to be voted upon.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All votes will
be tabulated by the inspector of elections appointed for the 2016 Annual Meeting, who will separately tabulate affirmative and
negative votes, abstentions and broker non-votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of
a majority of the Voting Shares shall constitute a quorum for the transaction of business at the 2016 Annual Meeting. Voting Shares
represented in person or by proxy at the 2016 Annual Meeting will be counted for purposes of determining whether a quorum is present
at the meeting. Voting Shares which abstain from voting as to a particular matter will be treated as shares that are present and
entitled to vote for purposes of determining the voting interest present and entitled to vote with respect to any particular matter,
but will not be counted as votes cast on such matter. If a broker or nominee holding stock in &ldquo;street name&rdquo; indicates
on a proxy that it does not have discretionary authority to vote as to a particular matter, those shares will not be considered
as present and entitled to vote with respect to such matter and will not be counted as a vote cast on such matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In voting with
regard to the proposal to elect directors (Proposal 1), stockholders may vote in favor of all the nominees, withhold their votes
as to all nominees or withhold their votes as to one or more specific nominees. The vote required by Proposal 1 is governed by
Delaware law and is a plurality of the votes cast by the holders of shares entitled to vote, provided that a quorum is present.
As a result, in accordance with Delaware law, votes that are withheld and broker non-votes will not be counted and will have no
effect on the voting for election of directors. Brokers do not have discretionary authority to vote on this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In voting with
regard to the proposal to adopt the 2015 Plan (Proposal 2), stockholders may vote in favor of such proposal or against such proposal
or may abstain from voting. The vote required to approve Proposal 2 is governed by Delaware law, and the minimum vote required
is a majority of the total votes cast on such proposal, provided that a quorum is present. As a result, in accordance with Delaware
law, abstentions and broker non-votes will not be counted and will have no effect on the outcome of the vote on this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In voting with regard
to the advisory vote on named executive officer compensation (Proposal 3), stockholders may vote in favor of such proposal or against
such proposal or may abstain from voting. The vote required to approve Proposal 4 is the affirmative vote of a majority of the
shares present or represented by proxy at the Annual Meeting and entitled to vote on the matter. Abstentions will have the same
effect as votes &ldquo;against&rdquo; the proposal. Brokers do not have discretionary authority to vote on this proposal. Broker
non-votes, therefore, will have no effect on the proposal as brokers are not entitled to vote on such proposals in the absence
of voting instructions from the beneficial owner.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In voting with
regard to the proposal on the frequency of having an advisory vote on named executive compensation (Proposal 4), stockholders may
vote to have such vote every one year, two years, three years or abstain. The vote required to approve Proposal 4 is a majority
of the total votes cast on such proposal, provided a quorum is present. Abstentions will have no effect on the proposal. Brokers
do not have discretionary authority to vote on this proposal. Broker non-votes, therefore, will have no effect on the stockholder
proposal as brokers are not entitled to vote on such proposals in the absence of voting instructions from the beneficial owner.
If none of the frequency alternatives (one year, two years or three years) receives a majority of the shares present or represented
by proxy and entitled to vote, we will consider the highest number of votes cast by stockholders to be the frequency that has been
selected by our stockholders. Consistent with current rules of the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) promulgated
under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), our proxies will have discretionary authority
to vote in accordance with the Board&rsquo;s frequency vote recommendation for proxy cards that are returned with no selection
made relating to the frequency vote. Because the frequency vote is advisory and not binding on us or the Board in any way, the
Board may decide that it is in our and our stockholders&rsquo; best interests to hold an advisory vote on executive compensation
more or less frequently than the option selected by our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the rules
of The New York Stock Exchange (the &ldquo;NYSE&rdquo;) that govern most domestic stock brokerage firms, member brokerage firms
that hold shares in &ldquo;street name&rdquo; for beneficial owners may, to the extent that such beneficial owners do not furnish
voting instructions with respect to any or all proposals submitted for stockholder action, vote in their discretion upon proposals
which are considered &ldquo;discretionary&rdquo; proposals under the rules of the NYSE. Member brokerage firms that have received
no instructions from their clients as to &ldquo;non-discretionary&rdquo; proposals do not have discretion to vote on these proposals.
Such broker non-votes will not be considered in determining whether a quorum exists at the 2016 Annual Meeting and will not be
considered as votes cast in determining the outcome of any proposal.&nbsp;&nbsp;Under the rules of the NYSE as currently in effect,
voting on directors by member broker firms is &ldquo;non-discretionary&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Voting Shares
represented by proxies in the accompanying form which are properly executed and returned to us will be voted at the 2016 Annual
Meeting in accordance with the stockholders&rsquo; instructions contained therein. In the absence of contrary instructions, shares
represented by such proxies will be voted FOR the election of each of the director nominees named in this proxy statement in Proposal
1, FOR Proposals 2 and 3, and for the &ldquo;three years&rdquo; alternative in Proposal 4. Management does not know of any matters
to be presented at the 2016 Annual Meeting other than those set forth in this proxy statement and in the Notice accompanying this
proxy statement. If other matters should properly come before the 2016 Annual Meeting, the proxyholders will vote on such matters
in accordance with their best judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any stockholder
has the right to revoke his, her or its proxy at any time before it is voted at the 2016 Annual Meeting by giving written notice
to our Secretary, and by executing and delivering to the Secretary a duly executed proxy card bearing a later date, or by appearing
at the 2016 Annual Meeting and voting in person; <I>provided, however</I>, that under the rules of the NYSE, any beneficial owner
whose shares are held in &ldquo;street name&rdquo; by a member brokerage firm may revoke his, her or its proxy and vote his, her
or its shares in person at the 2016 Annual Meeting only in accordance with the applicable rules and procedures of the NYSE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The entire cost
of soliciting proxies will be borne by the company. Proxies will be solicited principally through the use of the mails, but, if
deemed desirable, may be solicited personally or by telephone, or special letter by our officers and regular employees for no additional
compensation. Arrangements may be made with brokerage houses and other custodians, nominees and fiduciaries to send proxies and
proxy material to the beneficial owners of our common stock, and such persons may be reimbursed for their expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ELECTION OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Composition of Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As currently in
effect, our bylaws provide that the authorized number of directors shall be fixed from time to time by the Board, provided that
the authorized number of directors shall not be less than one. The Board currently consists of seven members. The Board has nominated
seven individuals for election as directors at the 2016 Annual Meeting and has set the number of directors at seven.&nbsp;&nbsp;Subject
to vacancies on the Board, which may be filled in accordance with our Bylaws, all our directors are elected by our stockholders
at each annual meeting of stockholders and will serve until their successors are elected and qualified, or until their earlier
resignation or removal. There are no family relationships among any of our current directors, the nominees for directors and our
executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The proxyholders
named on the proxy card intend to vote all proxies received by them in the accompanying form FOR the election of each of the director
nominees listed below, unless instructions to the contrary are marked on the proxy. Each nominee has been nominated by the Board,
acting upon the recommendation of the Board&rsquo;s Nominating/Corporate Governance Committee. All of the nominees are currently
members of the Board. If elected, each nominee will serve until the annual meeting of stockholders to be held in 2017 or until
a successor has been duly elected and qualified, or until their earlier resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that
a nominee is unable or declines to serve as a director at the time of the 2016 Annual Meeting, the proxies will be voted for any
nominee who shall be designated by the present Board to fill such a vacancy. In the event that additional persons are nominated
for election as directors, the proxyholders intend to vote all proxies received by them for each of the nominees listed below,
unless instructions are given to the contrary. As of the date of this proxy statement, the Board is not aware of any nominee who
is unable or will decline to serve as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nominees for Election as Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following
is certain information as of July 21, 2016 regarding the nominees for election as directors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 43%; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Position</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Age</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Warren Hosseinion, M.D.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Gary Augusta</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Executive Chairman</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">49</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mark Fawcett</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">49</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Thomas S. Lam, M.D.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">67</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Suresh Nihalani</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">63</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">David Schmidt</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">68</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Ted Schreck</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">70</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Biographical Information Regarding Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Warren Hosseinion,
M.D. </I>Dr. Hosseinion has been our Company&rsquo;s Chief Executive Officer and a member of our Board of Directors since July
2008. In 2001, Dr. Hosseinion co-founded ApolloMed Hospitalists in Los Angeles with Dr. Adrian Vazquez. Dr. Hosseinion received
his B.S. in biology from the University of San Francisco, his M.S. in physiology and biophysics from Georgetown University Graduate
School, his medical degree from the Georgetown University School of Medicine, and his residency in internal medicine from the Los
Angeles County-University of Southern California Medical Center.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Gary Augusta.</I>
Mr. Augusta has been a member of our Board of Directors since March 2012 and has been Executive Chairman since October 2013. In
addition to Board responsibilities, Mr. Augusta focuses on strategic planning, corporate development, capital raising and population
health technology for the company. Mr. Augusta also serves as President of Flacane Advisors focusing on healthcare and technology
advisory and investments. From January 2010 to December 2014, Mr. Augusta was President of SpaGus Ventures and SpaGus Capital
Partners focusing on healthcare and technology investments and advisory services. From March 2004 to December 2009, Mr. Augusta
was President and CEO of OCTANe, an innovation development company. From March 2001 to January 2004, Mr. Augusta was a Corporate
Officer at Fluor, Inc., a Fortune 500 company, focusing on Corporate Development and M&amp;A. From June 1994 to Mach 2000, Mr.
Augusta was a Consultant and Principal with AT Kearney, a leading global consulting firm. He earned a BS in Mechanical Engineering
from the University of Rhode Island and a Master of Science and Management (MSM) from Georgia Institute of Technology (Georgia
Tech).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Mark Fawcett. </I>Mr.
Fawcett has been a member of our Board of Directors since January 2016. Since 2002, Mr. Fawcett has served as Senior Vice President
and Treasurer of Fresenius Medical Care Holdings, Inc. (&ldquo;FMCH&rdquo;) and its subsidiaries. FMCH is a wholly-owned subsidiary
of Fresenius Medical Care AG&nbsp;&amp; Co. KGaA&nbsp;(NYSE: FMS) (collectively with FMCH and their respective subsidiaries, &ldquo;FMS&rdquo;).
FMS is the world&rsquo;s leading provider of chronic kidney failure products and services. Prior to his joining FMS, Mr. Fawcett
was Director in Corporate Finance at BankBoston beginning in 1997. Mr. Fawcett had various positions of increasing responsibility
beginning in 1988 with Merrill Lynch in New York and London then at The Bank of New York. Mr. Fawcett graduated with a B.A. in
psychology from Wesleyan University and a M.B.A. from Columbia University Business School. Mr. Fawcett serves as the nominee of
NNA of Nevada, Inc. (&ldquo;NNA&rdquo;), an affiliate of FMCH.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Thomas S. Lam,
M.D. </I>Dr. Lam has been a member of our Board of Directors since January 2016. Dr. Lam has served as Chief Executive Officer
of Network Medical Management, Inc. (&ldquo;NMM&rdquo;), a management service organization in the healthcare field that provides
medical services to patients and healthcare management, since January 2006. From January 2006 to September 2014, Dr. Lam was the
Chairman and CEO of Allied Physicians of California IPA. Since October 2014, he has served as the Chief Administrative and Financial
Officer of Allied Pacific of California IPA. Dr. Lam was the recipient of the Corporate Citizens of the Year Award from the Board
of Directors of East Los Angeles College Foundation in April 2014. In February 2015, YMCA Board of Directors of West San Gabriel
Valley honored Dr. Lam as the recipient of Heart of the Community Award. Dr. Lam received his medical training from New York Medical
College and gastroenterology training from Georgetown University. Dr. Lam serves as the nominee of NMM.<I> </I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I> </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Suresh Nihalani</I>.
Mr. Nihalani has been a member of our Board of Directors since October 2008. Mr. Nihalani has served as a business consultant and
advisor since 2008, and is currently involved with many early stage ventures in the area of cloud computing, data centers, next
generation storage and 4G backhaul wireless radios, assisting them in technology direction, business development and strategic
business planning. Mr. Nihalani was President and CEO of ClearMesh Network from 2005 to 2007. He also co-founded Nevis Networks,
where he served as CEO from 2002 through 2005. From 1996 to 2001, he co-founded and served as CEO of Accelerated Networks. Prior
to that he co-founded ACT Networks where he held various executive level positions. Mr. Nihalani holds a BS in Electrical Engineering
from ITT Bombay and MSEE and MBA degrees from the Florida Institute of Technology.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>David Schmidt.</I>
Mr. Schmidt has been a member of our Board of Directors since May 2013. He has served since January 2011 as Principal of Schmidt
&amp; Associates, a consultancy practice that focuses on strategic planning and implementation in the healthcare industry. Since
April 2015 Mr. Schmidt has also served as the CEO of the TPG-International Health Academy, a company that organizes trade missions
to expose Senior Health Plan and Health System executives from the United States to other country's health systems. From August
2002 to December 2010, he served as the CEO and Member of the Board of SCAN Health Plan, a provider of Medicare Advantage plans.
From 2000 to 2002 he served as CEO of Medicheck, a firm that provided Internet-based financial service management to healthcare
organizations, which was sold to Passport Health Communications. He served on Passport&rsquo;s Board from 2002 to 2006. From 1992
to 1998 he was the Senior Vice President of Sales and Customer Services for Care America/Blue Shield Health Plan and Regional Vice
President for FHP Healthcare. He received a BA in Economics from UCLA and a MBA from The Anderson School of Management at UCLA.
Prior to his healthcare experience he held senior management roles in manufacturing companies including Avery Dennison. He also
serves on the board of Beacon Healthcare Systems and was a founding board member of the SCAN Foundation, a 501(c)(3) corporation
focused on long term care in the United States.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Ted Schreck.</I>
Mr. Schreck has been a member of Board of our Directors since February 2012. Other than serving on our Board of Director and various
other non-full time engagements, since 2009 Mr. Schreck has been retired. From 2006 to 2008 he served as a consultant for the Legacy
Health System, based in Portland, Oregon, which operates six hospitals, a research institute, and a network of clinics. From 1998
to 2006, he served as an executive with Tenet Healthcare including as CEO of USC University Hospital and USC/Norris Cancer Hospital,
Regional Vice President of Operations for Los Angeles-area hospitals, and finally as Senior Vice President. From 1973 to 1988 he
served with St. Joseph Health System, as CEO of Santa Rosa General Hospital and Senior Vice President of Santa Rosa Memorial Hospital.
Schreck also served as the CEO of the Eden Township District Hospitals from 1992 to 1998, and CEO of Delta Memorial Hospital from
1988 to 1992. He holds a BA degree from UCLA and Doctorate from USC.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CORPORATE GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a
corporate governance page on our corporate website at <I><U>www.apollomed.net,</U> </I>which includes information regarding the
company&rsquo;s corporate governance practices. Our Code of Ethics for Directors, Executive Officers and Other Senior Personnel
(which, among others, covers our CEO, CFO and controller), Audit Committee Pre-Approval Policy, Related Person Transaction Policy,
Board committee charters and Insider Trading Policy are available on that page of our website. Any changes to these documents and
any waivers granted with respect to our code of ethics will be posted on our website. In addition, we will provide a copy of any
of these documents without charge to any stockholder upon written request made to Apollo Medical Holdings, Inc. at 700 North Brand
Boulevard, Suite 1400, Glendale, California 91203, Attention:&nbsp;&nbsp;Secretary. The information on our website is not, and
shall not be deemed to be, a part of this proxy statement or incorporated by reference into this or any other filing we make with
the Securities and Exchange Commission (the &ldquo;SEC&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.9pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.9pt"><B><I>Director Independence</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board currently
consists of seven members, a majority of whom meet the independence requirements of the NASDAQ Stock Market (&ldquo;NASDAQ&rdquo;),
as currently in effect. The Board has made independence determinations in accordance with the NASDAQ listing standards, which state
that a director will not be independent if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: .5in">(i) the
director, or an immediate family member of the director, is, or within the last three years was, employed by the company or any
of its subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: .5in">(ii) the
director, or an immediate family member of the director, has received, during any twelve-month period within the last three years,
more than $120,000 in direct compensation from the company, other than director and committee fees, and pension or other forms
of deferred compensation for prior service (provided such compensation is not contingent on continued service);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: .5in">(iii)
the director, or an immediate family member of the director, is a current partner of a firm that is the company&rsquo;s (or any
of its subsidiaries) internal or external auditor; or is a current employee of such a firm; or who was, within the last three years
(but is no longer), a partner or employee of such firm and personally worked on the company&rsquo;s audit within that time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: .5in">(iv) the
director, or an immediate family member of the director, is, or has been within the last three years, employed as an executive
officer of another company where any of the company&rsquo;s present executive officers at the same time serve or served on that
company&rsquo;s compensation committee; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: .5in">(v) the
director is a current employee, or an immediate family member of such director is a current executive officer, of a company that
has made payments to, or received payments from, the company for property or services in an amount, which, in any of the last three
fiscal years, exceeds the greater of $1 million or two percent (2%) of such other company&rsquo;s consolidated gross revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to
any relationship not covered above, the determination of whether the relationship is material, and therefore whether a director
would be independent, will be made by those directors who satisfy the independence criteria set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to
the forgoing, the Board also makes such independence determinations with respect to its audit committee and compensation committee
members after taking into account the additional independence and financial literacy standards for members of each such committee,
as applicable, in accordance with and pursuant to the rules and regulations of the SEC and NASDAQ listing rules as currently in
effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has
affirmatively determined that each of Messrs. Fawcett, Nihalani, Schmidt and Schreck are independent.&nbsp;&nbsp;In addition, the
Board has affirmatively determined that none of our independent directors has a material relationship with the company other than
as a director, in accordance with these categorical standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.9pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"><B><I>Meetings of the Board</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board held
four meetings and acted by written consent 13 times during fiscal year 2016. Each of our incumbent directors attended 75% or more
of the aggregate number of meetings of the Board and the committees on which such director served in fiscal year 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The company&rsquo;s
non-management directors meet periodically in executive session without management present to discuss certain Board policies, processes
and practices, and other matters relating to the company and the functioning of the Board. These discussions are informal, in keeping
with the company&rsquo;s size, and we do not have an official presiding or &ldquo;lead&rdquo; independent director for such meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We attempt to schedule
our annual meeting of stockholders at a time and date to accommodate attendance by directors, taking into account the directors'
schedules. Directors are encouraged to attend our annual meeting of stockholders, but the Board has not adopted a formal policy
with respect to such attendance. All of our incumbent directors attended our 2014 annual meeting of stockholders, except for Mr.
Fawcett and Dr. Lam, who were not directors at the time of our 2014 annual meeting of stockholders, and Mr. Schmidt, who was unable
to attend the 2014 annual meeting. We did not hold an annual meeting of stockholders in 2015.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Board Leadership</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our company is
led by Warren Hosseinion, M.D., who has served as our Chief Executive Officer since July 2008, and Gary Augusta, who has served
as our Executive Chairman since October 2013. We do not formally have an independent lead director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board leadership
structure is commonly utilized by many other public companies in the United States, and we believe that this leadership structure
has been effective for our company. We believe that having a Chief Executive Officer who can focus on the broad executive and operational
issues facing the company, and a separate Executive Chairman who can focus on Board and oversight functions, independent chairs
for each of our Board committees and only independent directors serving on these committees allocates responsibility and creates
checks and balances for our company. This structure provides us with leadership for our company to ensure continuity of our operational,
executive and Board functions by individuals playing to their strongest qualities, combined with oversight of the company by experienced
independent directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"><B><I>Risk Management
Oversight Function of the Board</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has
allocated responsibilities for overseeing risk associated with the company&rsquo;s business among the Board as a whole and the
committees of the Board. In performing its risk oversight function, the Board oversees management&rsquo;s development and execution
of appropriate business strategies to mitigate the risk that such strategies will fail to generate long-term value for the company
and its stockholders or that such strategies will motivate management to take excessive risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board also regularly
reviews information regarding the company&rsquo;s financial, operational and strategic risks. Each of the Board&rsquo;s committees
also oversees the management of company risks that fall within the committee&rsquo;s areas of responsibility, including identifying,
quantifying and assisting management in mitigating risks. In performing this function, each committee has full access to management,
as well as the ability to engage advisors. As set forth in its charter, the Audit Committee is responsible for discussing with
management the company&rsquo;s major financial risk exposures and the steps management has taken to monitor and control those exposures.
The Audit Committee gives updates to the Board at its regular meetings, including updates on financial risks. The Audit Committee
also meets privately with the company&rsquo;s independent registered public accounting firms and our Chief Financial Officer at
least quarterly. The Compensation Committee oversees the company&rsquo;s risk management related to employee compensation plans
and arrangements. While each committee is responsible for overseeing the management of those risk areas, the entire Board is also
regularly informed through committee reports.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.9pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.9pt"><B><I>Communications with the Board</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following
procedures have been established by the Board in order to facilitate communications between our stockholders and the Board:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Stockholders and any
interested parties may send correspondence to the Board or to any individual director, by mail to Corporate Secretary, Apollo
Medical Holdings, Inc. at 700 North Brand Boulevard, Suite 1400, Glendale, California 91203, or by e-mail to investors@apollomed.net.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Our Corporate Secretary
is responsible for the first review and logging of this correspondence and forwards the communication to the director or directors
to whom it is addressed unless it is a type of correspondence which the Board has identified as correspondence which may be retained
in our files and not sent to directors. The Board has authorized the Secretary to retain and not send to directors communications
that: (a) are advertising or promotional in nature (offering goods or services), (b) solely relate to complaints by clients with
respect to ordinary course of business customer service and satisfaction issues or (c) clearly are unrelated to our business,
industry, management or Board or committee matters. These types of communications will be logged and filed but not circulated
to directors. Except as set forth in the preceding sentence, the Secretary does not screen communications sent to directors.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The log of stockholder
correspondence is available to members of the Board for inspection. At least once each year, the Corporate Secretary provides
to the Board a summary of the communications received from stockholders, including the communications not sent to directors in
accordance with the procedures set forth above.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our stockholders
may also communicate directly with our non-management directors as a group, by mail addressed to Independent Directors, c/o Corporate
Secretary, Apollo Medical Holdings, Inc. at 700 North Brand Boulevard, Suite 1400, Glendale, California 91203, or by e-mail to
investors@apollomed.net.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit
Committee has established procedures for the receipt, retention and treatment of complaints regarding questionable
accounting, internal controls, financial improprieties or auditing matters. Any of the company&rsquo;s employees may
confidentially communicate concerns about any of these matters by calling our corporate offices at (818) 396-8050. All of the
reporting mechanisms are also posted on our website. Upon receipt of a complaint or concern, a determination will be made
whether it pertains to accounting, internal controls or auditing matters and, if it does, it will be handled in accordance
with the procedures established by the Audit Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Committees of the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Board has
a standing Audit Committee, Compensation Committee and Nominating/Corporate Governance Committee.&nbsp;&nbsp;The composition, functions
and general responsibilities of each committee are summarized below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.9pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"><B><I>Audit Committee</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Audit Committee
consists of Messrs. Schmidt (chairman), Nihalani and Schreck.&nbsp;&nbsp;The Board has determined that Mr. Schmidt is an audit
committee financial expert, as that term is defined in Item 401(h) of Regulation S-K of the Exchange Act, and is independent within
the meaning of Item 7(d)(3)(iv) of Schedule 14A of the Exchange Act. The Board also believes that all members of the Audit Committee
meet the independence and knowledge requirements of NASDAQ as currently in effect. For information about Messrs. Schmidt&rsquo;s,
Nihalani&rsquo;s and Schreck&rsquo;s experience, please see &ldquo;Biographical Information Regarding Directors&rdquo; above. The
Audit Committee held four meetings during fiscal year 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Consistent with
the company&rsquo;s Audit Committee Charter, no member of the Audit Committee may serve on the audit committees of more than two
other public companies (in addition to ours). Currently, no member of the Audit Committee serves on more than two other public
company audit committees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee operates under a written charter, a copy
of which is available on our website. The Audit Committee&rsquo;s duties include (a) monitoring and ensuring (i) the integrity
of our financial statements, (ii) compliance with legal and regulatory requirements, (iii) the qualifications and independence
of our independent auditors, and (iv) the performance of our internal audit function and external auditors; (b) preparing the report
required to be prepared by the Audit Committee under the rules of the SEC for inclusion in our proxy statement; and (c) overseeing
our accounting and financial reporting processes the audits of our financial statements. In addition, the Audit Committee has responsibility
for reviewing complaints about, and investigating allegations of, financial impropriety or misconduct. Please see &ldquo;Report
of Audit Committee&rdquo; below, which provides further details of many of the duties and responsibilities of the Audit Committee.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">As part of its
responsibility, the Audit Committee is responsible for engaging our independent registered public accounting firm, as well as pre-approving
audit and non-audit services performed by our independent registered public accounting firm in order to assure that the provision
of such services does not impair their independence. The Audit Committee has adopted, and the Board has ratified, an Audit Committee
Pre-Approval Policy, which is also available on our website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.9pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"><B><I>Compensation Committee, Compensation
Committee Interlocks and Insider Participation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Compensation
Committee consists of Messrs. Nihalani (chairman), Schmidt and Schreck. The Board has determined that all members of the Compensation
Committee qualify as &ldquo;independent&rdquo; directors as defined under NASDAQ rules, as a &ldquo;non-employee director&rdquo;
as defined in Rule 16b-3(b)(3) under the Exchange Act and as an &ldquo;outside director&rdquo; within the meaning of Section 162(m)(4)(C)(i)
of the Internal Revenue Code of 1986, as amended (the &ldquo;IRS Code&rdquo;). No member of the Compensation Committee was at any
time during fiscal year 2016 an officer or employee of the company. The Compensation Committee acted by unanimous written consent
two times during fiscal year 2016. None of our executive officers served on the compensation committee of another entity or on
any other committee of the board of directors of another entity performing similar functions during fiscal year 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Compensation
Committee operates under a written charter, a copy of which is available on our website. The Compensation Committee establishes
the compensation and benefits of our executive officers. The compensation committee also administers our employee benefit plans,
including our equity incentive plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.9pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"><B><I>Nominating/Corporate Governance Committee</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating/Corporate
Governance Committee consists of Messrs. Schreck (chairman), Nihalani and Schmidt. All members of the Nominating/Corporate Governance
Committee meet the independence requirements of NASDAQ as currently in effect. The Nominating/Corporate Governance Committee acted
by unanimous written consent two times during fiscal year 2016.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Nominating/Corporate
Governance Committee operates under a written charter, a copy of which is available on our website. The Nominating/Corporate Governance
Committee has the primary responsibility for overseeing the company&rsquo;s corporate governance compliance practices, as well
as supervising the affairs of the company as they relate to the nomination of directors. The principal ongoing functions of the
Nominating/Corporate Governance Committee include developing criteria for selecting new directors, establishing and monitoring
procedures for the receipt and consideration of director nominations by stockholders and others, considering and examining director
candidates, recommending director nominations to the Board, developing and recommending corporate governance principles for the
company and monitoring the company&rsquo;s compliance with those principles and establishing and monitoring procedures for the
receipt of stockholder communications directed to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Nominating/Corporate
Governance Committee is also responsible for conducting an annual evaluation of the Board to determine whether the Board and its
committees are functioning effectively, and began reporting annually to the Board with the results of this evaluation beginning
in 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Director Nominations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Nominating/Corporate
Governance Committee has the responsibility to identify appropriate candidates to serve as directors of the company, and interviews
director candidates and makes recommendations to the Board regarding candidate selection. In considering candidates to serve as
directors, the Nominating/Corporate Governance Committee evaluates various minimum individual qualifications, including strength
of character, maturity of judgment, relevant technical skills or financial acumen, diversity of viewpoint and industry knowledge,
as well as the extent to which the candidate would fill a present need on the Board.&nbsp;&nbsp;The Nominating/Corporate Governance
Committee also considers additional factors which may provide a range of experiences, skills and perspective to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">In recommending
the nominees who are standing for election as directors at the 2016 Annual Meeting, the Nominating/Corporate Governance Committee
considered the foregoing factors and each nominee&rsquo;s previous service on the Board, which provides continuity in its deliberations.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The
Nominating/Corporate Governance Committee also considered specific qualifications, attributes and skills that each nominee
possesses and contributes to the work of the Board. Dr. Hosseinion is a pioneer in the &quot;hospitalist movement&rdquo; and
is the co-founder of our company and serves as our CEO; he has extensive experience in managing medical groups and is an
innovator in using population health data to improve patient care and clinical outcomes, all of which makes him a valued
board member, as well as providing continuity between management and the Board. In addition, Dr. Hosseinion is currently a
practicing hospitalist physician and brings to our Board of Directors and our Company a depth of understanding of physician
culture and strong knowledge of the healthcare market. Mr. Augusta&rsquo;s background in engineering and finance and his
successful career in business development, particularly in capitalizing new ventures, make him a strong candidate to continue
to serve as a director, especially given our focus on capital raising and related growth activities. Mr. Fawcett is currently
a senior finance officer with FMCH and brings a broad knowledge of the health care industry and finances to the Board, with a
special understanding of the managed care market and health care contracting. Dr. Lam is a prominent physician and the CEO of
NMM; he has managed medical groups and has experience with capitation and at risk contracting, both unique perspectives that
add to our Board&rsquo;s knowledge base. Mr. Nihalani is an engineer and successful entrepreneur, founding companies which
have later gone public; his assistance and advice in guiding our development as a public company has been invaluable and
makes him a valuable candidate to continue to serve on our Board. Additionally, Mr. Nihalani&rsquo;s qualifications to serve
on our Board of Directors include over 35 years of corporate experience working as a senior executive and director with both
public and private organizations. Mr. Schmidt has a background in finance and is the past President of SCAN, one of the
nation&rsquo;s largest Medicare Senior Advantage insurers; his extensive knowledge of the insurance industry with a special
focus on Medicare, enables him to provide a unique perspective to us, as a regulated business, and to serve as chair of our
Audit Committee. Additionally, Mr. Schmidt&rsquo;s qualifications to serve on our Board of Directors include 20 years of
experience working as a senior executive in the healthcare industry. Mr. Schreck is a former healthcare executive, having
worked with the St. Joseph Health System and Tenet Healthcare; his broad knowledge of the hospital industry and health care
finances brings a crucial perspective to the Board. Additionally, Mr. Schreck&rsquo;s qualifications to serve on our Board of
Directors include over 30 years of corporate experience working as a senior executive in the healthcare industry.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Nominating/Corporate
Governance Committee will also consider stockholder nominations for director. Any nominations for director submitted to this committee
by stockholders will be evaluated according to the company&rsquo;s overall needs, the director qualification standards set forth
above, and the nominee&rsquo;s overall knowledge, experience and background. A nominating stockholder must give appropriate notice
to the company of the nomination not less than 90 days prior to the first anniversary of the preceding year&rsquo;s annual meeting.
In the event that the date of the annual meeting is advanced by more than 30 days or delayed by more than 60 days from the anniversary
date of the preceding year&rsquo;s annual meeting, the notice by the stockholder must be delivered not later than the close of
business on the later of the 60th day prior to such annual meeting or the tenth day following the day on which public announcement
of the date of such annual meeting is first made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The stockholders&rsquo;
notice shall set forth, as to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each person whom the stockholder proposes to nominate for election as a director:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the name, age, business address and residence address of such person,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the principal occupation or employment of the person,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the class and number of shares of the company&rsquo;s stock which are beneficially owned by such person, if any, and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any other information relating to such person which is required to be disclosed in solicitations for proxies for election of directors pursuant to Regulation 14A under the Exchange Act and the rules thereunder; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the stockholder giving the notice:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the name and record address of the stockholder and the class and number of shares of the company&rsquo;s stock which are beneficially owned by the stockholder,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a description of all arrangements or understandings between such stockholder and each proposed nominee and any other person or persons (including their names) pursuant to which nomination(s) are to be made by such stockholder,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a representation that such stockholder intends to appear in person or by proxy at the meeting to nominate the persons named in its notice,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any other information relating to such person which is required to be disclosed in solicitations for proxies for election of directors pursuant to Regulation 14A under the Exchange Act and the rules thereunder.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The notice must
be accompanied by a written consent of the proposed nominee to be named as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Recommendation of the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"><B>The Board unanimously
recommends that stockholders vote FOR the election of each of the director nominees identified above.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPROVAL OF 2015 EQUITY COMPENSATION
PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 15,
2015, the Board adopted the Apollo Medical Holdings, Inc. Equity Incentive Plan (the &ldquo;2015 Plan&rdquo;). At the 2016 Annual
Meeting our stockholders are being asked to approve the 2015 Plan. The following is only a summary of the 2015 Plan and is qualified
in its entirety by reference to the full text of the 2015 Plan, a copy of which is attached as <I>Appendix A</I> to this proxy
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Purpose </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that
our ability to award incentive compensation based on equity in the company is critical to our continued success in remaining competitive
and attracting, motivating and retaining key personnel. Approval of this proposal would provide 1,500,000 shares to be used for
grants under the 2015 Plan. In addition, shares that are subject to outstanding grants under the company&rsquo;s 2010 Equity Incentive
Plan (the &ldquo;2010 Plan&rdquo;) and 2013 Equity Incentive Plan (the &ldquo;2013 Plan&rdquo;) but that ordinarily would have
been restored to such plans reserve due to award forfeitures and terminations will roll into and become available for awards under
the 2015 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The creativity
and entrepreneurial drive of our employees and other personnel who provide services to the company are important factors in the
growth and success of our business. We believe that our broad-based equity incentive program is an effective means of motivating
and rewarding the efforts of our employees and other valuable personnel. By giving our employees, consultants and directors an
opportunity to share in the growth of our equity, we align their interests with those of our stockholders. Our employees, consultants
and directors understand that their stake in our company will have value only if, working together, we create value for our stockholders.
Awards under our equity incentive plans generally vest over a period of time (for example, stock options generally vest over a
three-year period), giving the recipient an additional incentive to provide services over a number of years and build on past performance.
We believe that our option program has helped us to build a team of high achievers who have demonstrated long-term dedication and
productivity and who, in turn, help us to attract like-minded individuals to our company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We remain committed
to the goals of managing dilution from options and enhancing stockholder value. We have never repriced options, and the 2015 Plan
specifically prohibits the repricing of options. In addition, the 2015 Plan prohibits the grant of &ldquo;discount&rdquo; options
(i.e. options with an exercise price below fair market value).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to continue
to remain competitive in attracting, motivating and retaining our key personnel, additional shares will be needed for us to continue
our equity incentive compensation program. In light of the fact that we have been making awards under the 2013 Plan during a very
dynamic period of growth and expansion for our company, we had exhausted the available shares for grant under the 2013 Plan during
fiscal 2016. Therefore, if the 2015 Plan is not approved by our stockholders, we will not have a functioning equity incentive plan
for future grants. We currently anticipate that approval of the 2015 Plan will provide us with adequate shares for incentive compensation
awards for approximately six additional years. The visibility and sustainability of the equity incentive compensation program are
important factors in accomplishing our goals of attracting, motivating and retaining key employees, consultants and directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Number of Shares </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2015 Plan
freezes the number of shares available for awards under the 2013 Plan as of the date of the adoption of the 2015 Plan by the Board,
which was December 15, 2015. As a result, as of such date, no new awards have been made under the 2013 Plan. In addition, no awards
have been granted under the 2010 Plan since the adoption of the 2013 Plan. As of December 15, 2015, an aggregate 690,000 shares
of common stock were subject to outstanding awards under the 2010 and 2013 Plans that were subject to potential forfeiture or termination
and that therefore could roll into and become available for awards under the 2015 Plan (the &ldquo;Rollover Shares&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the 2015
Plan, 1,500,000 new shares of our common stock, plus the Rollover Shares, are reserved for issuance under awards. Any shares that
are represented by awards under the 2015 Plan that are (i) forfeited, expire, or are canceled or settled in cash without delivery
of shares, (ii) forfeited back to us or reacquired by us after delivery for any reason, or (iii) tendered to us or withheld to
pay the exercise price or related tax withholding obligations in connection with any award under the 2015 Plan, will again be available
for awards under the 2015 Plan. Only shares actually issued under the 2015 Plan will reduce the share reserve. If we acquire another
entity through a merger or similar transaction and issue replacement awards under the 2015 Plan to employees, officers and directors
of the acquired entity, those awards, to the extent permitted under applicable laws and securities exchange rules, will not reduce
the number of shares reserved for the 2015 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2015 Plan
imposes the following additional maximum limitations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The maximum number of
shares that may be issued in connection with incentive stock options intended to qualify under IRS Code Section 422 is 1,500,000
shares.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The maximum number of
shares that may be subject to stock options and/or stock appreciation rights granted to any one person in any calendar year is
500,000 shares, except that options and/or stock appreciation rights granted to a new employee in the calendar year in which his
or her employment commences may not relate to more than 1,000,000 shares.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The maximum number of
shares that may be subject to restricted stock or restricted stock units granted to any one person in any calendar year is 500,000
shares.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The maximum number of
shares that may be subject to performance shares or performance units (if such units are valued in relation to shares) granted
to any one person in any calendar year is 500,000 shares.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The maximum amount payable
under an award of performance units (if such units are not valued in relation to shares) granted to any one person in any calendar
year is $500,000.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation
Committee, in its discretion, may grant awards that exceed the above limits (other than the limits on incentive stock options)
if the Committee determines that such awards will not be considered &ldquo;qualified performance-based compensation&rdquo; within
the meaning of IRS Code Section 162(m), but only if and to the extent that such discretion does not disqualify performance-based
awards from qualifying as such under IRS Code Section 162(m).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The number of
shares reserved for issuance under the 2015 Plan, and the limits on the number of awards that may be granted to any one participant
or of a particular type, as described above, are subject to adjustment to reflect certain subsequent changes to our capital structure,
such as stock splits, stock dividends and recapitalizations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Administration </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Like the 2013
Plan and the 2010 Plan, the 2015 Plan is administered by the Compensation Committee of the Board (the &ldquo;Compensation Committee&rdquo;).
The Compensation Committee will have full power to administer the 2015 Plan and the decisions of the Compensation Committee will
be final and binding upon all the participants. See &ldquo;Corporate Governance &ndash; Committees of the Board &ndash; <I>Compensation
Committee, Compensation Committee Interlocks and Insider Participation&rdquo;.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may
delegate the Compensation Committee&rsquo;s administrative authority to another committee, or the Compensation Committee may delegate
some of its authority to the Chief Executive Officer of the company. Any such delegation may be made only to the extent the law
allows. In addition, the 2015 Plan provides that only the Board, or a committee comprised entirely of non-employee directors, may
approve awards to individuals who are subject to Section 16 of the Exchange Act. As used herein, the term &ldquo;Compensation Committee&rdquo;
also includes the Board or other committee that has authority with respect to the approval of awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Eligibility </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selection
of the participants in the 2015 Plan will generally be determined by the Compensation Committee. Employees and those about to become
employees, including those who are officers or directors of the company or its subsidiaries and affiliates, are eligible to be
selected to receive awards under the 2015 Plan. In addition, non-employee service providers, including non-employee directors,
and employees of unaffiliated entities that provide bona fide services to the company as an independent contractor are eligible
to be selected to receive awards under the 2015 Plan. Non-employee directors of the Board are eligible for and shall receive grants
of options in such amounts and on such terms as determined by the Board as a whole. All other grants must be approved by the Compensation
Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of July 21,
2016, three named executive officers, four non-employee directors and approximately 22 other employees are eligible to be selected
by the Compensation Committee to receive grants under the 2015 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Types of Awards </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2015 Plan
allows for the grant of stock options, stock appreciation rights, performance awards, restricted stock awards, restricted stock
units and dividend equivalent units in any combination, separately or in tandem. Subject to the terms of the 2015 Plan, the Compensation
Committee will determine the terms and conditions of awards, including the times when awards vest or become payable and the effect
of certain events such as termination of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Stock Options.</I>&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee may grant either incentive stock options qualified under IRS Code Section 422 or options not qualified under
any section of the IRS Code (&ldquo;non-qualified options&rdquo;). All stock options granted under the 2015 Plan must have an exercise
price that is at least equal to the fair market value of our underlying common stock on the grant date. As of July 21, 2016, the
fair market value of a share of our common stock, based on the closing price per share on that date as quoted on OTC Pink Market,
was $5.50. No stock option granted under the 2015 Plan may have a term longer than ten years, except that under the 2015 Plan the
term may be extended for six months beyond the date of death in the event that an option recipient dies prior to the option&rsquo;s
termination date. The exercise price of stock options may be paid in cash, or, if the Compensation Committee permits, by tendering
shares of common stock, or by any other means the Compensation Committee approves. Stock options may contain a replenishment provision
under which we issue a new option to an option holder (called a &ldquo;replenishment option&rdquo;), in order to maintain his or
her equity stake in the company, if the option holder surrenders previously-owned shares to us in payment of the exercise price
of an outstanding stock option. The automatic replenishment option grant generally covers only the number of shares surrendered,
and expires at the same time as the option that was exercised would have expired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the 2015
Plan, each non-employee director is eligible to receive stock option grants in such amounts and on such terms as determined by
the Board as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
shows the number of shares subject to option grants made under the 2010 Plan and 2013 Plan to our executive officers and the other
individuals and groups indicated, from the respective dates of inception of those plans to July 21, 2016.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cumulative Option Grant Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2010 and 2013 Equity Incentive Plans</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>Number of</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>shares of</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>common stock</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>remaining</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>Weighted-</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>available for</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>Number of shares of</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>average</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>future issuance</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>common stock</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>exercise price</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>under equity</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>to be issued</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>of outstanding</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>compensation</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>upon exercise of</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>options,</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>plans (excluding</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>outstanding options,</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>warrants, and</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><B>securities</B></TD><TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: justify"><B>Plan Category</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><B>warrants, and rights</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><B>rights</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><B>reflected)</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 61%; text-align: left">Equity compensation plans approved by stockholders</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">690,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">3.35</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,600</FONT></TD><TD STYLE="width: 1%; text-align: left">(1)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Equity compensation plans not approved by stockholders</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Total</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">690,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3.35</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">48,600</TD><TD STYLE="padding-bottom: 1pt; text-align: left">(1)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0.25in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(1) The 2015 Plan provides that no new
awards may be granted under the 2013 Plan. Additionally, no awards have been granted under the 2010 Plan since the adoption of
the 2013 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Stock Appreciation
Rights.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee may grant stock appreciation rights which provide the recipient the
right to receive a payment (in cash, shares or a combination of both) equal to the difference between the fair market value of
a specific number of shares on the grant date and the fair market value of such shares on the date of exercise. Stock appreciation
rights must expire no later than ten years after their grant date, except that under the 2015 Plan the term may be extended for
six months beyond the date of death in the event that a recipient dies prior to the SAR&rsquo;s termination date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Performance-Based
Awards.</I>&nbsp;&nbsp;&nbsp;&nbsp;In order to enable the company to avail itself of the tax deductibility of &ldquo;qualified
performance-based compensation,&rdquo; within the meaning of IRS Code Section 162(m), paid to certain of its senior officers, the
2015 Plan provides for performance-based awards, the grant or vesting of which is dependent upon the attainment of objective performance
targets relative to certain performance measures. Performance targets may include minimum, maximum and target levels of performance,
with the size of the award or vesting based on the level attained. Performance measures are criteria established by the Compensation
Committee relating to any of the following, as it may apply to an individual, one or more business units, divisions or subsidiaries,
or on a company-wide basis, and either in absolute terms or relative to the performance of one or more comparable companies or
an index covering multiple companies: income from operations; revenue; earnings before interest, taxes, depreciation and amortization
(EBITDA); income before income taxes and minority interests; operating income; pre- or after-tax income; average accounts receivable;
cash flow; cash flow per share; net earnings; earnings per share; return on equity; return on invested capital; return on assets;
growth in assets; economic value added; share price performance; total stockholder return; improvement in or attainment of expense
levels; market penetration; or business expansion and/or acquisitions or divestitures. The Compensation Committee can select other
goals not listed here for awards that are not intended to meet the requirements of &ldquo;qualified performance-based compensation.&rdquo;
The Compensation Committee may specify that the performance-based awards will become payable in whole or in part in the event of
the recipient&rsquo;s termination of employment as a result of death, disability or retirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Performance-based
awards may be paid in cash, shares or a combination of both, as determined by the Compensation Committee at the time of making
an award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Restricted
Stock and Restricted Stock Unit Awards.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee may grant shares of restricted common
stock with or without payment of consideration by the recipient, or may grant restricted stock units. The Compensation Committee
will determine whether restricted stock units will be paid in cash, our common stock or a combination thereof. All or part of any
restricted stock or restricted stock unit award may be subject to conditions and restrictions, which the Compensation Committee
will specify. There will be a restriction period of at least three years&rsquo; duration on stock and unit awards, unless the vesting
of such awards is contingent on the attainment of performance goals, in which case the restriction period must be at least one
year. The Compensation Committee may specify that the restriction period will lapse in the event of the recipient&rsquo;s termination
of employment as a result of death, disability or retirement. In addition, the Compensation Committee may provide for a shorter
restriction period if it determines in its sole discretion that an award of restricted stock or restricted stock units is made
in lieu of cash compensation (including without limitation cash bonus compensation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Dividend Equivalent
Unit Awards.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee may grant awards of dividend equivalent units, either alone
or in tandem with other awards, but only if the Board of Directors has declared a dividend on our common stock. A dividend equivalent
unit gives the recipient the right to receive a current or deferred payment equal to the dividends paid on one or more shares of
our common stock as the Compensation Committee specifies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Payment of
Directors&rsquo; Fees in Securities.</I>&nbsp;&nbsp;&nbsp;&nbsp;Subject to any restrictions the Board imposes, a non-employee director
may elect to receive stock options in lieu of all or any portion of the director&rsquo;s annual retainer payment from the company.
These options will be issued under and subject to the terms of the 2015 Plan. The number of options to be issued in connection
with such an election by a director will be four times the amount of the cash compensation divided by the closing price of our
common stock on the date the cash compensation would otherwise have been paid to the director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Recoupment</I>.
Any awards granted pursuant to the 2015 Plan, and any stock issued or cash paid pursuant to an award, is subject to (A) any recoupment,
clawback, equity holding, stock ownership or similar policies adopted by the company from time to time and (B) any recoupment,
clawback, equity holding, stock ownership or similar requirements made applicable by law, regulation or listing standards to the
company from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Use of Shares
to Satisfy Tax Withholding</I>. A participant may satisfy all or a portion of the federal, state and local withholding tax obligations
arising in connection with an award by electing to (i) have the company withhold shares otherwise issuable under the award, (ii)
tender back shares received in connection with such award or (iii) deliver other previously owned shares, in each case having a
fair market value equal to the amount to be withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Adjustment of Awards
for Certain Corporate Events</I>. In the event of a stock dividend, stock split or reverse stock split, merger, consolidation,
or similar corporate transaction, the Compensation Committee may adjust the number and type of securities subject to awards, and
the grant, purchase or exercise price of awards to prevent the dilution or enlargement in benefits under outstanding awards. The
Compensation Committee may also (or in lieu of the foregoing) make provision for a cash payment to the holder of an outstanding
award in exchange for the cancellation of all or a portion of the award (without the consent of the holder of an award), but in
the event of a change of control, the amount of such payment must be at least as favorable to the holder as the amount the holder
could have received in respect of such award after the change of control. In addition, in the event of any reorganization, merger,
consolidation, combination or other similar corporate transaction, whether or not constituting a change of control (other than
any such transaction in which the company is the continuing corporation and in which the company&rsquo;s common stock is not being
converted into or exchanged for different securities, cash or other property, or any combination thereof), the Compensation Committee
may substitute, on an equitable basis as the Committee determines, for each share then subject to an award, the number and kind
of shares of stock, other securities, cash or other property to which holders of our common stock are or will be entitled in respect
of each share pursuant to the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Change of Control </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation
Committee may determine, in its discretion, whether an award issued under the 2015 Plan will become vested or payable, either in
whole or in part, upon a change of control of the company (as defined in the 2015 Plan). In addition, each holder of an option
or stock appreciation right, and each holder of shares received under a restricted stock award, restricted stock unit award, performance
award or dividend equivalent award, if any, that vested or became payable as a result of the change of control, may, under certain
conditions, have the right for a period of 30 days following the change of control to surrender the award or shares for a cash
payment equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.2in; text-align: left"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">in the case of an option
or stock appreciation right, the difference between the higher of the fair market value of a share of our common stock on the
date of surrender or the date of the change of control, and the grant or exercise price of the award; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.2in; text-align: left"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">in the case of shares,
the higher of the fair market value of a share of our common stock on the date of surrender or the date of the change of control.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation
Committee may also cancel any options or stock appreciation rights that are not exercised or surrendered during the 30-day period
described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provisions
of the 2015 Plan governing the ability of participants to surrender awards upon a change of control for a cash payment will also
apply to awards made under the 2010 Plan and 2013 Plan. Accordingly, upon approval of the 2015 Plan, the 2010 and Plan 2013 Plan
will be deemed amended to incorporate these change of control provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Transferability of Awards </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Awards granted
under the 2015 Plan are not transferable, other than by will or pursuant to state intestate laws, unless the Committee otherwise
approves a transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Foreign Participation </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation
Committee may provide for such special terms as it may consider necessary or appropriate to accommodate differences in local law,
tax policy or custom regarding awards granted to participants employed in foreign countries. In addition, the Compensation Committee
may approve such supplements to, or amendments, restatements or alternative versions of, the 2015 Plan as it determines is necessary
or appropriate for such purposes. Any such amendment, restatement or alternative versions that the Compensation Committee approves
for purposes of using the 2015 Plan in a foreign country will not affect the terms of the 2015 Plan for use in any other country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Outstanding Awards </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 15,
2016, the Compensation Committee granted stock options to various persons under the 2015 Plan. On the same date, the Board of Directors
granted stock options to the Board&rsquo;s independent directors. The grant of any future awards will be subject to the discretion
of the Compensation Committee, except for options issued in payment for director fees at the election of a director, and, accordingly,
the number of shares that will be covered by any awards or the individuals to whom awards will be made in the future cannot be
determined at this time. To date, no director has elected to receive options in payment for director fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following
table sets forth information about awards made under the 2015 Plan to date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 24.5pt"><B>NEW PLAN BENEFITS
UNDER 2015 PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 24.5pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 95%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid; text-align: justify">Name and Position</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid; text-align: center">Dollar Value (1)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid; text-align: center">No. of Units (2)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Warren Hosseinion, M.D.<BR> Chief Executive Officer</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">595,502</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">93,500</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Gary Augusta<BR> Executive Chairman</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">541,365</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">93,500</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Adrian Vazquez<BR> Chief Medical Officer</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">149,035</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,400</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">William R. Abbott<BR> Former Acting Chief Financial Officer(3)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">173,700</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">All Executive Officers as a Group</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,285,902</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">210,400</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">All Directors who are not Executive Officers</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">434,250</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">All Employees who are not Executive Officers</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">224,363</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,750</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0.25in; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Based on the aggregate exercise price of the stock
options.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Represents the number of shares underlying stock options
granted under the 2015 Plan. No other awards have been granted under the 2015 Plan. All awards granted to date under the 2015
Plan are subject to stockholder approval of the 2015 Plan on or before December 15, 2016. If such approval is not obtained by
such date, all awards made under the 2015 Plan shall be null and void.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Mr. Abbott served as Acting Chief Financial Officer
from September 21, 2015 through March 21, 2016, having previously served as the company&rsquo;s Controller.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Amendments </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board or Compensation
Committee may alter, amend, suspend or discontinue the 2015 Plan at any time, but no such action may be taken without stockholder
approval if such approval is required by law or listing requirements, or if such action materially increases the number of shares
that may be issued under the 2015 Plan or the annual award limits, or eliminates the prohibition on stock option repricing. The
Compensation Committee may alter or amend awards under the 2015 Plan, but no such action may be taken without the consent of the
participant if it would materially adversely affect an outstanding award, and no such action may be taken without prior stockholder
approval if it would result in repricing a stock option to a lower exercise price other than to reflect a capital adjustment of
our stock, such as a stock split. The company has never repriced options in the past.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Term of 2015 Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our stockholders
approve Proposal 2, the 2015 Plan will become effective as of December 15, 2015, and will remain in effect until December 15,
2025, unless it is terminated earlier by the Board or the Compensation Committee. As mentioned previously, no new awards will
be made under the 2010 Plan or the 2013 Plan if our stockholders approve the 2015 Plan, although the 2010 Plan and 2013 Plan will
continue in effect for purposes of administering awards outstanding under such plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Federal Income Tax Consequences </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following
summary is intended only as a general guide to the United States federal income tax consequences under current law of incentive
stock options and non-qualified stock options, which are authorized for grant under the 2015 Plan. It does not attempt to describe
all possible federal or other tax consequences of participation in the 2015 Plan or tax consequences based on particular circumstances.
The tax consequences may vary if options are granted outside the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Incentive Stock
Options.</I>&nbsp;&nbsp;&nbsp;&nbsp;An option holder recognizes no taxable income for regular income tax purposes as a result of
the grant or exercise of an incentive stock option qualifying under IRC Section 422. Option holders who dispose of the shares acquired
under an incentive stock option after two years following the date the option was granted and after one year following the exercise
of the option will normally recognize a capital gain or loss upon a sale of the shares equal to the difference, if any, between
the sale price and the purchase price of the shares. If an option holder satisfies such holding periods upon a sale of the shares,
the company will not be entitled to any deduction for federal income tax purposes. If an option holder disposes of shares within
two years after the date of grant or within one year after the date of exercise (a &ldquo;disqualifying disposition&rdquo;), the
difference between the fair market value of the shares on the exercise date and the option exercise price (not to exceed the gain
realized on the sale if the disposition is a transaction with respect to which a loss, if sustained, would be recognized) will
be taxed as ordinary income at the time of disposition. Any gain in excess of that amount will be a capital gain. If a loss is
recognized, there will be no ordinary income, and such loss will be a capital loss. Any ordinary income recognized by the option
holder upon the disqualifying disposition of the shares generally will result in a deduction by the company for federal income
tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Non-Qualified
Stock Options.</I>&nbsp;&nbsp;&nbsp;&nbsp;Options not designated or qualifying as incentive stock options will be non-qualified
stock options having no special tax status. An optionee generally recognizes no taxable income as the result of the grant of such
an option. Upon exercise of a non-qualified stock option, the optionee normally recognizes ordinary income in the amount of the
difference between the option exercise price and the fair market value of the shares on the exercise date. If the optionee is an
employee, such ordinary income generally is subject to withholding of income and employment taxes. Upon the sale of stock acquired
by the exercise of a non-qualified stock option, any gain or loss, based on the difference between the sale price and the fair
market value on the exercise date, will be taxed as a capital gain or loss. No tax deduction is available to the company with respect
to the grant of a non-qualified stock option or the sale of the stock acquired pursuant to such grant. The company generally should
be entitled to a deduction equal to the amount of ordinary income recognized by the optionee as a result of the exercise of a non-qualified
stock option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Other Considerations.</I>&nbsp;&nbsp;&nbsp;&nbsp;The
IRS Code allows publicly-held corporations to deduct compensation in excess of $1 million paid to the corporation&rsquo;s chief
executive officer and its four other most highly compensated executive officers in office at the end of the tax year if the compensation
is payable solely based on the attainment of one or more performance goals and certain statutory requirements are satisfied. We
intend for compensation arising from grants of awards under the 2015 Plan which are based on performance goals, including stock
options and stock appreciation rights granted at fair market value, to be deductible by us as performance-based compensation not
subject to the $1 million limitation on deductibility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2015 Plan provides
that, except as may be set forth in a written agreement by and between the company and the holder of an award, if the company&rsquo;s
auditors determine that any payment or transfer by the company under the 2015 Plan to or for the benefit of a participant would
be nondeductible by the company for federal income tax purposes because of the provisions concerning &ldquo;excess parachute payments&rdquo;
in IRS Code Section 280G, then the aggregate present value of all such payments shall be reduced (but not below zero) to a present
value amount that would not be nondeductible by the company because of IRS Code Section 280G.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The company does not
guarantee to any participant or any other person with an interest in an award that (i) any award intended to be exempt from Code
Section 409A shall be so exempt, (ii) any Award intended to comply with Code Section 409A or Code Section 422 shall so comply or
(iii) any Award shall otherwise receive a specific tax treatment under any other applicable tax law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Effect of &ldquo;No&rdquo; Vote on Previously-Granted
Awards under 2015 Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 15, 2016,
the Compensation Committee granted stock options to various persons under the 2015 Plan. On the same date, the Board of Directors
granted stock options to the Board&rsquo;s independent directors. None of the stock options granted on February 15, 2016 may be
exercised, in whole or in part, unless and until our stockholders approve the 2015 Plan, which approval must be obtained on or
before December 15, 2016. Should our stockholders not approve the 2015 Plan at the 2016 Annual Meeting or by December 15, 2016,
all such options shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recommendation of the Board </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>The Board unanimously recommends
that stockholders vote FOR the proposal to adopt the 2015 Plan. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL 3 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under Section&nbsp;14A
of the Exchange Act, which was added under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the company&rsquo;s
stockholders are entitled to vote at the Annual Meeting to approve, on an advisory basis, the compensation of our named executive
officers, as disclosed in this proxy statement pursuant to the SEC&rsquo;s compensation disclosure rules. This proposal, commonly
known as a &ldquo;say-on-pay&rdquo; proposal, gives stockholders the opportunity to express their views on our named executive
officers&rsquo; compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation
of our named executive officers and the philosophy, policies and practices described in this proxy statement. This vote is advisory,
which means that the vote is not binding on the company, the Board or the Compensation Committee. However, we value the concerns
of our stockholders, and the Compensation Committee will evaluate whether any actions are necessary to address those concerns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are asking
our stockholders to indicate their support for our named executive officer compensation as described in this proxy statement. Accordingly,
we will ask our stockholders to vote &ldquo;FOR&rdquo; the following resolution at the 2016 Annual Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;RESOLVED, that the Company&rsquo;s
stockholders approve, on an advisory basis, the compensation of the named executive officers, as disclosed pursuant to Item&nbsp;402
of Regulation S-K, including the Compensation Discussion and Analysis, the Summary Compensation Table, the other compensation tables
and narrative discussion in the Proxy Statement for the Company&rsquo;s 2016 Annual Meeting of Stockholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Recommendation of the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>The Board unanimously
recommends that stockholders vote FOR the proposal to approve the compensation of the named executive officers, as disclosed in
this proxy statement. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL 4 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADVISORY VOTE ON THE FREQUENCY OF FUTURE
ADVISORY VOTES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ON EXECUTIVE COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;14A
of the Exchange Act also provides for stockholders to vote on whether future advisory votes on executive compensation for our named
executive officers should be held every year, every two years or every three years.&nbsp;This proposal, commonly known as a &ldquo;say-on-frequency&rdquo;
proposal, gives stockholders the opportunity to express their views on our how often future advisory votes should be held regarding
named executive officers&rsquo; compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board initially
recommended, and our stockholders approved at the 2014 Annual Meeting, such a &ldquo;say-on-pay&rdquo; vote to be held annually.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After careful consideration
of various factors, including how other smaller public company are addressing &ldquo;say-on-frequency&rdquo; and the fact that
our executive compensation is typically determined pursuant to multi-year employment agreements and therefore does not vary significantly
from one year to the next, the Board has determined that an advisory vote on executive compensation that occurs once every three
years is the most appropriate alternative for the company. Accordingly, the Board recommends that you vote that future advisory
votes on executive compensation occur every three years rather than every year.&nbsp;We believe that an advisory vote on executive
compensation that occurs every three years will provide our stockholders with sufficient time to evaluate the effectiveness of
our overall compensation philosophy, policies and practices in the context of our long-term business results, while avoiding over-emphasis
on short-term variations in compensation and business results.&nbsp;We emphasize long-term performance in the design of our executive
compensation program, including the multi-year employment agreements we have with our named executive officers and equity incentive
grants, because by doing so our compensation structure is more closely aligned with the long-term strategic plan for the company
and the interests of our stockholders. We believe that compensation decisions, company performance and potential increases in stockholder
value should be evaluated over a long-term horizon, rather than simply on a year-to-year, short-term basis, and accordingly, we
believe that a vote that occurs once every three years will allow our stockholders to better evaluate our executive compensation
programs.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also believe
that an advisory vote once every three years is an appropriate frequency to provide sufficient time for us to thoughtfully consider
the views of our stockholders and, to the extent possible in light of existing contractual obligations, implement any appropriate
changes to our executive compensation program.&nbsp;An advisory vote once every three years also will permit our stockholders to
observe and evaluate the impact of any changes to our executive compensation policies and practices that have occurred since the
last advisory vote on executive compensation, including any changes made in response to the outcome of the prior advisory vote
on executive compensation. We also point out that since our named executive officers have multi-year employment agreements, only
certain aspects of their compensation is set annually and amendments to such agreements require the consent of the applicable officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The proxy card
provides stockholders with the opportunity to choose from among four options, holding the vote every one year, two years, three
years, or abstaining from voting and, therefore, stockholders will not be voting to approve or disapprove the recommendation of
the Board. The Board will consider the frequency that receives the highest number of votes to be the frequency selected by our
stockholders, regardless of whether that frequency receives a majority of the votes cast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This vote is advisory,
which means that the vote is not binding on the company or the Board.&nbsp;Because this vote is advisory and not binding in any
way, the Board may decide that it is in the best interest of the company and our stockholders to hold an advisory vote on executive
compensation more or less frequently than the option selected by our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Recommendation of the Board </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>The Board unanimously
recommends that you vote FOR the alternative of once every three years as the preferred frequency for future advisory votes on
executive compensation for our named executive officers.&nbsp;Properly submitted proxies will be so voted unless the stockholder
specifies otherwise. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The following
sets forth the names, positions and ages of our executive officers as of July 21, 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 43%; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Position</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Age</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Warren Hosseinion, M.D.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer and Secretary</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Gary Augusta</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Executive Chairman</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">49</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mihir Shah</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Adrian Vazquez, M.D.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Medical Officer</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">46</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Background</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"><I>Warren Hosseinion,
M.D.</I>&nbsp;&nbsp;&nbsp;Dr. Hosseinion has been our Chief Executive Officer since the inception of the company in July 2008
and our Corporate Secretary since September 2015. <I>See</I> &ldquo;Proposal 1&mdash;Election of Directors&rdquo; for additional
biographical information about Dr. Hosseinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Gary Augusta</I>.
Mr. Augusta has been our Executive Chairman since October 2013. <I>See</I> &ldquo;Proposal 1&mdash;Election of Directors&rdquo;
for additional biographical information about Mr. Augusta.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Mihir Shah.</I>
Mr. Shah, CPA, became our Chief Financial Officer on July 21, 2016, having served as our accounting consultant from March 2016
through July 20, 2016. From April 2015 to February 2016, Mr. Shah served as Chief Financial Officer of Unitek Information Systems,
Inc., a private equity-backed company that offers nursing, allied health and information technology training programs.&nbsp; From
April 2013 to March 2015, he was Vice President and Controller of Health Essentials, LLC, a private equity-backed healthcare organization
that provides post-acute care and hospice/palliative care services to the frail and elderly population in California. Mr. Shah
was employed at Arcadian Health Plan from December 2005 through March 2013, serving as its Vice President Finance and Analytics
from January 2010 through March 2013, Senior Director of Finance and Analytics from January 2008 through December 2009, and Senior
Financial Analyst from December 2005 through December 2007. He is a Certified Public Accountant and received a Master of Commerce-Cost
Accounting from Gujarat University in Ahmedabad, India.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"><I>Adrian Vazquez,
M.D.</I> Dr. Vazquez, has served as our Chief Medical Officer since March 2014, having previously served as the Company&rsquo;s
President and Chairman of the Board of Directors from 2008 to 2011. Dr. Vazquez co-founded ApolloMed Hospitalists in 2001. He received
his B.S. in biology from the University of California, Irvine, his medical degree from the UC Irvine School of Medicine and his
residency in internal medicine from the Los Angeles County-University of Southern California Medical Center. He is a Diplomate
of the American Board of Internal Medicine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITY OWNERSHIP OF CERTAIN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BENEFICIAL OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The following
tables set forth information, as of July 21, 2016, concerning, except as indicated by the footnotes below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each person whom we
know beneficially owns more than 5% of any class of our Voting Shares;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each of our directors
and nominees for the board of directors;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">each named executive officer listed in the Summary Compensation Table below; and</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">all of our directors
and executive officers as a group.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Unless otherwise
noted below, the address of each beneficial owner listed in the table is c/o Apollo Medical Holdings, Inc. at 700 North Brand Boulevard,
Suite 1400, Glendale, California 91203.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">We have determined
beneficial ownership in accordance with the rules of the SEC.&nbsp;&nbsp;Except as indicated by the footnotes below, we believe,
based on the information furnished to us, that the persons and entities named in the table below have sole voting and investment
power with respect to all shares of common stock that they beneficially own, subject to applicable community property laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Applicable percentage
ownership is based on 5,745,036 shares of common stock, 1,111,111 shares of Series A preferred stock and 555,555 shares of Series
B preferred stock issued and outstanding, according to the records maintained by our transfer agent. Each share of Series A preferred
stock and Series B preferred stock is entitled to one vote for each share of common stock into which such preferred stock is convertible,
which is currently on a one-for-one basis. The holders of Series A preferred stock and Series B preferred stock vote together with
the holders of common stock on all matters set forth in the Notice. In computing the number of shares of stock beneficially owned
by a person and the percentage ownership of that person, we deemed to be outstanding all shares of stock subject to options, warrants,
and convertible securities held by that person or entity that are currently exercisable or convertible or that will become exercisable
or convertible within sixty days following July 21, 2016. We did not deem these shares outstanding, however, for the purpose of
computing the percentage ownership of any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The information
provided in the tables is based on our records, information filed with the SEC, and information provided to us by the applicable
holder of the stock, except where otherwise noted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Series A and Series B Preferred Stock</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Series A Preferred Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Series B Preferred Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Name and Address of Beneficial Owner</B></P></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Percent</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of Class</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Shares</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Percent</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of Class</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">Network Medical Management, Inc.<BR> 1668 S. Garfield Ave.<BR> Alhambra, California 91801</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,111,111</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">100</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">555,555</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">100</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Common Stock</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Beneficial Owner</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
                                         Beneficially Owned</B></FONT></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percent
                                         </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
                                         Class</B></FONT></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5%
    Stockholders:</B></FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; font-weight: bold; text-align: left; padding-bottom: 1pt"><P STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-weight: normal; font-style: normal">Network Medical Management, Inc.</FONT><BR><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">
1668 Garfield Avenue, 2<SUP>nd</SUP> Floor</FONT><BR><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">
Alhambra, California 91801</FONT></P></TD><TD STYLE="width: 1%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,333,332</FONT></P></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.7</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NNA
    of Nevada, Inc.<BR> 920 Winter Street<BR> Waltham, Massachusetts 02451</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.9</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    and Named Executive Officers</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warren
    Hosseinion, M.D.</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,137,826</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.4</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
    Vazquez, M.D.</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">969,981</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.7</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Augusta</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">261,433</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    Fawcett</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.2</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
    Lam, M.D. </FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suresh
    Nihalani</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,331</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward
    Schreck</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">113,333</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Schmidt</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,333</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.9</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Executive Officers and Directors as a Group (8&nbsp;&nbsp;persons)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,639,237</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.5</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) Includes 1,111,111 shares of common
stock issuable on conversion of 1,111,111 shares of Series A Preferred Stock, 555,555 shares of common stock issuable on conversion
of 555,555 shares of Series B Preferred Stock, and 1,666,666 shares of common stock subject to warrants that are exercisable within
60 days of July 21, 2016.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) Includes 125,488 shares subject to options that are exercisable
within 60 days of July 21, 2016, and assumes that the 2015 Plan is approved by the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3) Includes 57,643 shares subject to options that are exercisable
within 60 days of July 21, 2016, and assumes that the 2015 Plan is approved by the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(4) Includes 95,488 shares subject to options that are exercisable
within 60 days of July 21, 2016, and assumes that the 2015 Plan is approved by the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(5) Includes 10,000 shares subject to options
that are exercisable within 60 days of July 21, 2016, and assumes that the 2015 Plan is approved by the stockholders. Does not
include shares held by NNA. Mr. Fawcett is the Senior Vice President and Treasurer of FMCH, the parent corporation of NNA.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(6) Does not include shares held by NMM. Dr. Lam is the Chief
Executive Officer, a director and a stockholder of NMM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(7) Includes 40,000 shares held by a trust of which Mr. Nihalani
is trustee and beneficiary, and 13,333 shares subject to options that are exercisable within 60 days of July 21, 2016, and assumes
that the 2015 Plan is approved by the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(8) Includes 113,333 shares subject to options that are exercisable
within 60 days of July 21, 2016, and assumes that the 2015 Plan is approved by the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(9) Includes 53,333 shares subject to options that are exercisable
within 60 days of July 21, 2016, and assumes that the 2015 Plan is approved by the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(10) Includes all of the shares identified in Notes 2 through
5 and 7 through 9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING
COMPLIANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 16(a) of the
Exchange Act requires our directors, executive officers and holders of more than 10% of a registered class of our equity securities
to file with the SEC initial reports of ownership and reports of changes in ownership of our Class A common stock and our other
equity securities. Directors, executive officers and greater than 10% stockholders are required by SEC regulation to furnish us
with copies of all Section 16(a) reports they file. Based solely on our review of the copies of such forms received by us, or
written representation from certain reporting persons that no Form 5s were required for those persons, we believe that all reporting
requirements under Section 16(a) for the 2016 fiscal year were met in a timely manner by our directors, executive officers and
greater than 10% beneficial owners, except that (i) Mr. Augusta was late in reporting the disposition of common stock held by
him indirectly on December 31, 2014 in connection with the disposition by him of his interest in the entity that is the holder
of such shares; and (ii) NNA was late in filing its Form 3. Both of these reports have been filed as of the date of this proxy
statement.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: yellow"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXECUTIVE COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table discloses the compensation
awarded to, earned by, or paid to our named executive officers for the fiscal years ended March 31, 2016 and 2015, respectively:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name and</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All
    Other</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
    Position</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bonus</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Awards
    (1)</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 22%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warren
    Hosseinion</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                         394,998 </FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000
</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">485,000
</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">$<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">117,193
</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,191</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">390,385
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,083
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">127,641
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">720,109</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary Augusta</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">487,000
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">817,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Chairman</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">228,000
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,083
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,083</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian Vazquez</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">394,292
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">121,000
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">117,847
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">648,139</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Medical Officer</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">435,385
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,041
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,216
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">619,642</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) The amount shown in this column reflects
the aggregate grant date fair value computed in accordance with FASB ASC 718 &ldquo;Compensation &ndash; Stock Compensation&rdquo;.
&nbsp;Please see the notes below for discussions of the assumptions and methodologies used to calculate the valuations of the stock
and option awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) Dr. Hosseinion's salary is for both
patient care and non-clinical work in his role as the Company's Chief Executive Officer.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3) Reflects personal benefits payments
to Dr. Hosseinion for health, life, disability insurance premiums aggregating $31,423 (2016) and $27,026 (2015); allowance for
vehicle, cell phone and computer expenses of $55,000 (2016) and $55,000 (2015); payments of $30,770 (2016) and $32,917 (2015) for
unused paid time off; and other compensation related adjustment of $12,698 in 2015.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(4) In February 2016, the Company&rsquo;s
Board of Directors authorized the issuance of options for 93,500 shares of common stock with an exercise price of $6.369 per share
to Dr. Hosseinion. Two-thirds of the options vested immediately and the remaining one-third vest monthly in equal amounts over
a twelve-month period. The options expire on the fifth anniversary of issuance. The fair value of the 93,500 stock options was
$485,000, and was determined using the Black-Scholes option pricing model. The calculation was based on the Company&rsquo;s closing
stock price on the date of grant and the following weighted-average inputs:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 77%; text-align: left">Expected term (in years)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">6.0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Volatility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">132.91</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Dividends</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Discount rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.31</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(5) In February 2016, the Company&rsquo;s
Board of Directors authorized the issuance of options for 23,400 shares of common stock with an exercise price of $6.369 per share
to Dr. Vazquez. Two-thirds of the options vested immediately and the remaining one-third vest monthly in equal amounts over a twelve-month
period. The options expire on the fifth anniversary of issuance. The fair value of the 23,400 stock options was $121,000, and was
determined using the Black-Scholes option pricing model. The calculation was based on the Company&rsquo;s closing stock price on
the date of grant and the following weighted-average inputs:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 77%; text-align: left">Expected term (in years)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">6.0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Volatility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">132.91</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Dividends</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Discount rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.31</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(6) Reflects personal benefits payments
to Dr. Vazquez for health, life and disability insurance premiums aggregating $25,347 (2016) and $28,392 (2015); allowance for
vehicle, cell phone and computer expenses of $55,000 (2016) and $55,000 (2015); earned, but not yet paid, unused paid time-off
(PTO) in the amount of $37,500 (2016) and PTO payment of $37,500 (2015); and other compensation related adjustment of $7,324 in
2015.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(7) On July 10, 2014, the Company&rsquo;s
Board of Directors authorized the issuance of 10,000 stock options to Dr. Vazquez. The options vest evenly over 3 years, have an
exercise price of $10.00 and expire on the tenth anniversary of issuance. The fair value of the stock options of $26,041 was determined
under the Black-Scholes option pricing model. The calculation was based on the Company&rsquo;s closing stock price on the date
of grant and the following weighted-average inputs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 77%; text-align: left">Expected term (in years)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">6.0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Volatility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63.7</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Dividends</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Discount rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.63</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(8) On July 10, 2014, the Company&rsquo;s
Board of Directors authorized the issuance of 20,000 stock options to Dr. Hosseinion. The options vest evenly over 3 years, have
an exercise price of $10.00 and expire on the tenth anniversary of issuance. The fair value of the stock options of $52,083 was
determined under the Black-Scholes option pricing model. The calculation was based on the Company&rsquo;s closing stock price on
the date of grant and the following weighted-average inputs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 77%; text-align: left">Expected term (in years)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">6.0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Volatility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63.7</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Dividends</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Discount rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.63</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(9) Dr. Hosseinion received an incentive
bonus of $30,000 in 2016 and a bonus payment of $150,000 in 2015 relating to ACO achievement under Medicare Shared Savings Program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(10) Dr. Vazquez has earned, but yet to
be paid, an incentive bonus of $15,000 in 2016. A bonus of $30,000 was paid in 2015 to reflect ACO achievement under Medicare Shared
Savings Program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(11) Dr. Vazquez&rsquo;s salary is for
both patient care and non-clinical work in his role as the Company&rsquo;s Chief Medical Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(12) Mr. Augusta received compensation
for providing business and strategic services to the Company and for his role as the Company&rsquo;s Executive Chairman.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(13) Mr. Augusta received an incentive
bonus of $30,000 in 2016 and a bonus payment of $50,000 in 2015 for providing business and strategic services, and for his role
as Executive Chairman on the Company&rsquo;s Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(14) In February 2016, the Company&rsquo;s
Board of Directors authorized the issuance of options for 93,500 shares of common stock with an exercise price of $5.79 per share
to Mr. Augusta. Two-thirds of the options vested immediately and the remaining one-third vest monthly in equal amounts over a twelve-month
period. The options expire on the tenth anniversary of issuance. The fair value of the 93,500 stock options was $487,000, and was
determined using the Black-Scholes option pricing model. The calculation was based on the Company&rsquo;s closing stock price on
the date of grant and the following weighted-average inputs:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 77%; text-align: left">Expected term (in years)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">6.0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Volatility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">132.91</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Dividends</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Discount rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.31</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(15) On July 10, 2014, the Company&rsquo;s
Board of Directors authorized the issuance of 20,000 stock options to Mr. Augusta. The options vest evenly over 3 years, have an
exercise price of $10.00 and expire on the tenth anniversary of issuance. The fair value of the stock options of $52,083 was determined
under the Black-Scholes option pricing model. The calculation was based on the Company&rsquo;s closing stock price on the date
of grant and the following weighted-average inputs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 77%; text-align: left">Expected term (in years)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">6.0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Volatility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63.7</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Dividends</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Discount rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.63</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Employment and Consulting Agreements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Agreements with
Warren Hosseinion, M.D.</I> On March 28, 2014, our wholly-owned subsidiary Apollo Medical Management, Inc. (&ldquo;AMM&rdquo;)
entered into an employment agreement with Warren Hosseinion, M.D., our Chief Executive Officer (the &ldquo;Hosseinion Employment
Agreement&rdquo;) pursuant to which Dr. Hosseinion has agreed to serve as a senior executive of AMM. The Hosseinion Employment
Agreement provides for (i) base salary of $200,000 per year; (ii) participation in any incentive compensation plans and stock plans
of AMM that are available to other similarly positioned employees of AMM; and (iii) reimbursement of expenses incurred on behalf
of AMM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AMM has the right under
the Hosseinion Employment Agreement to terminate Dr. Hosseinion for cause if, among other things, there is a material and uncured
breach by Dr. Hosseinion, of any of the following agreements: (i) the Hosseinion Hospitalist Participation Agreement (defined below)
or other employment agreement with our affiliate, ApolloMed Hospitalists (&ldquo;AMH&rdquo;); (ii) that certain Stockholder Agreement
dated as of March 28, 2014, by and among Dr. Hosseinion, Adrian Vazquez, M.D., NNA, AMM and us (the &ldquo;Stockholder Agreement&rdquo;);
or (iii) any Physician Shareholders Agreements in favor of AMM or us, for the account of certain of our affiliates. If Dr. Hosseinion&rsquo;s
employment is terminated by AMM without cause, or Dr. Hosseinion terminates his employment for good reason, or AMM provides notice
of intent not to renew, Dr. Hosseinion is entitled, subject to entering into a binding release, to be paid severance of an amount
equal to four weeks of his most recent base salary for every full year of his active employment by AMM, but such amount is to be
no less than six months&rsquo; worth and no more than one year&rsquo;s worth of his most recent base salary. The Hosseinion Employment
Agreement replaced, and thereby terminated, the prior employment agreement between AMM and Dr. Hosseinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 12, 2016,
AMM entered into a First Amendment to Employment Agreement with Dr. Hosseinion (the &ldquo;Hosseinion Amendment&rdquo;). The Hosseinion
Amendment amended the Hosseinion Employment Agreement and provides (i) for the payment of an incentive bonus in the amount of $30,000
to Dr. Hosseinion; and (ii) that unused paid time off (up to 20 days per year) will be paid in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 28, 2014,
AMH also entered into a Hospitalist Participation Service Agreements with Dr. Hosseinion (the &ldquo;Hosseinion Hospitalist Participation
Agreement&rdquo;), pursuant to which Dr. Hosseinion provides physician services for AMH. The Hosseinion Hospitalist Participation
Agreement provides for (i) base salary of $195,000 per year; (ii) a $55,000 annual car and communications allowance; and (iii)
reimbursement of reasonable business expenses. The Hosseinion Hospitalist Participation Agreement replaced, and thereby terminated,
the prior hospitalist participation service agreement between AMH and Dr. Hosseinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a condition of our
causing our affiliates to enter into the Hosseinion Employment Agreement and the Hosseinion Hospitalist Participation Agreement,
also on March 28, 2014 we entered into a stock option agreement with Dr. Hosseinion (the &ldquo;Hosseinion Stock Option Agreement&rdquo;).
The Hosseinion Stock Option Agreement provides that Dr. Hosseinion grants us the option to purchase (at fair market value) all
equity interests in the company held by Dr. Hosseinion, in the event that (i) the Hosseinion Hospitalist Participation Agreement
or the Hosseinion Employment Agreement is terminated by us for cause due to a willful or intentional breach by Dr. Hosseinion;
(ii) Dr. Hosseinion commits fraud or any felony against us or any of our affiliates; (iii) Dr. Hosseinion directly or indirectly
solicits any patients, customers, clients, employees, agents or independent contractors of our or any of our affiliates for competitive
purposes; or (iv) Dr. Hosseinion directly or indirectly &ldquo;competes&rdquo; (as such term is defined in the Hosseinion Stock
Option Agreement) with us or any of our affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We entered into restated
and amended employment agreements dated as of June 29, 2016 with Dr. Hosseinion. The purpose of the amended and restated employment
agreements is to align payment and benefit provisions, and make other technical changes, to the employment agreements that were
previously in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the amended and
restated employment agreement with AMM, Dr. Hosseinion will be paid a base salary of $450,000, which is the same aggregate base
salary as had previously been provided under his agreements with AMM and AMH, including a certain guaranteed expense reimbursement
under the AMH agreement. Conversely, there is no base salary provided under the amended and restated employment agreement with
AMH and the certain guaranteed expense reimbursement has been eliminated from the AMH agreement. In the amended and restated AMH
agreement, the base salary provision has been replaced with an hourly rate if and to the extent that Dr. Hosseinion provides physician
services, which is not guaranteed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All other benefits
that were previously contained in the AMH agreement have been moved to the amended and restated agreements with AMM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The calculation of
severance payment in the event of a termination without Cause (as defined in the amended and restated agreement with AMM) has been
changed. Under the amended and restated agreements with AMM, Dr. Hosseinion will continue to be paid severance in the amount of
four weeks&rsquo; pay of his most recent base salary for each year he is employed. However, in the amended and restated employment
agreement the definition of base salary has been changed to include aggregate base salary paid from AMM and all its entities, to
reflect that Dr. Hosseinion&rsquo;s services are, in some cases, shared among more than one of our affiliates but provide a common
benefit to our company. Additionally, Dr. Hosseinion will receive year-of-service credit for the longest period of time he has
been employed by any of our affiliates, to reflect that, as a co-founder of our company, Dr. Hosseinion has provided continuous
service since our founding notwithstanding the fact that we have reorganized the company to create AMM more recently than our founding.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain other technical
changes have been made to the amended and restated employment agreements. All other material provisions of the original AMH agreements
and the original AMM agreements, as amended, remain as they were in those agreements.&emsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Agreements with
Adrian Vazquez, M.D.</I> On March 28, 2014, AMM entered into an employment agreement with Adrian Vazquez, M.D., our Chief Medical
Officer (the &ldquo;Vazquez Employment Agreement&rdquo;) pursuant to which Dr. Vazquez has agreed to serve as a senior executive
of AMM. The Vazquez Employment Agreement provides for (i) base salary of $200,000 per year; (ii) participation in any incentive
compensation plans and stock plans of AMM that are available to other similarly positioned employees of AMM; and (iii) reimbursement
of expenses incurred on behalf of AMM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AMM has the right under
the Vazquez Employment Agreement to terminate Dr. Vazquez for cause if, among other things, there is a material and uncured breach
by Dr. Vazquez, of any of the following agreements: (i) the Vazquez Hospitalist Participation Agreement (defined below) or other
employment agreement with AMH; (ii) the Stockholder Agreement; or (iii) any Physician Shareholders Agreements in favor of AMM or
us, for the account of certain of our affiliates. If Dr. Vazquez&rsquo;s employment is terminated by AMM without cause, or Dr.
Vazquez terminates his employment for good reason, or AMM provides notice of intent not to renew, Dr. Vazquez is entitled, subject
to entering into a binding release, to be paid severance of an amount equal to four weeks of his most recent base salary for every
full year of his active employment by AMM, but such amount is to be no less than six months&rsquo; worth and no more than one year&rsquo;s
worth of his most recent base salary. The Vazquez Employment Agreement replaced, and thereby terminated, the prior employment agreement
between AMM and Dr. Vazquez.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 12, 2016,
AMM entered into a First Amendment to Employment Agreement with Dr. Vazquez (the &ldquo;Vazquez Amendment&rdquo;). The Vazquez
Amendment amended the Vazquez Employment Agreement and provides (i) for the payment of an incentive bonus in the amount of $15,000
to Dr. Vazquez; and (ii) that unused paid time off (up to 20 days per year) will be paid in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 28, 2014,
AMH also entered into a Hospitalist Participation Service Agreements with Dr. Vazquez (the &ldquo;Vazquez Hospitalist Participation
Agreement&rdquo;), pursuant to which Dr. Vazquez provides physician services for AMH. The Vazquez Hospitalist Participation Agreement
provides for (i) base salary of $195,000 per year; (ii) a $55,000 annual car and communications allowance; and (iii) reimbursement
of reasonable business expenses. The Vazquez Hospitalist Participation Agreement replaced, and thereby terminated, the prior hospitalist
participation service agreement between AMH and Dr. Vazquez.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a condition of our
causing our affiliates to enter into the Vazquez Employment Agreement and the Vazquez Hospitalist Participation Agreement, also
on March 28, 2014 we entered into a stock option agreement with Dr. Vazquez (the &ldquo;Vazquez Stock Option Agreement&rdquo;).
The Vazquez Stock Option Agreement provides that Dr. Vazquez grants us the option to purchase (at fair market value) all equity
interests in the company held by Dr. Vazquez, in the event that (i) the Vazquez Hospitalist Participation Agreement or the Vazquez
Employment Agreement is terminated by us for cause due to a willful or intentional breach by Dr. Vazquez; (ii) Dr. Vazquez commits
fraud or any felony against us or any of our affiliates; (iii) Dr. Vazquez directly or indirectly solicits any patients, customers,
clients, employees, agents or independent contractors of our or any of our affiliates for competitive purposes; or (iv) Dr. Vazquez
directly or indirectly &ldquo;competes&rdquo; (as such term is defined in the Vazquez Stock Option Agreement) with us or any of
our affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We entered into restated
and amended employment agreements dated as of June 29, 2016 with Dr. Vazquez. The purpose of the amended and restated employment
agreements is to align payment and benefit provisions, and make other technical changes, to the employment agreements that were
previously in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the amended and
restated employment agreement with AMM, Dr. Vazquez will be paid a base salary of $450,000, which is the same aggregate base salary
as had previously been provided under his agreements with AMM and AMH, including a certain guaranteed expense reimbursement under
the AMH agreement. Conversely, there is no base salary provided under the amended and restated employment agreement with AMH and
the certain guaranteed expense reimbursement has been eliminated from the AMH agreement. In the amended and restated AMH agreement,
the base salary provision has been replaced with an hourly rate if and to the extent that Dr. Vazquez provides physician services,
which is not guaranteed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All other benefits
that were previously contained in the AMH agreement have been moved to the amended and restated agreements with AMM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The calculation of
severance payment in the event of a termination without Cause (as defined in the amended and restated agreement with AMM) has
been changed. Under the amended and restated agreements with AMM, Dr. Vazquez will continue to be paid severance in the amount
of four weeks&rsquo; pay of his most recent base salary for each year he is employed. However, in the amended and restated employment
agreement the definition of base salary has been changed to include aggregate base salary paid from AMM and all its entities,
to reflect that Dr. Vazquez&rsquo;s services are, in some cases, shared among more than one of our affiliates but provide a common
benefit to our company. Additionally, Dr. Vazquez will receive year-of-service credit for the longest period of time he has been
employed by any of our affiliates, to reflect that, as a co-founder of our company, Dr. Vazquez has provided continuous service
since our founding notwithstanding the fact that we have reorganized the company to create AMM more recently than our founding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain other technical
changes have been made to the amended and restated employment agreements. All other material provisions of the original AMH agreements
and the original AMM agreements, as amended, remain as they were in those agreements.&emsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Agreements with
Gary Augusta.</I> On January 15, 2015, we entered into a Consulting and Representation Agreement (the &ldquo;2015 Augusta Consulting
Agreement&rdquo;) with Flacane Advisors, Inc. (&ldquo;Flacane&rdquo;), which was effective from January 15, 2015, superseded the
prior agreement with Flacane, remained in effect until March 31, 2015 and then was extended until December 31, 2015 unless sooner
replaced by a new agreement. Under the Augusta Consulting Agreement, Flacane was paid $25,000 per month and Mr. Augusta was eligible
to receive options to purchase shares of our common stock as determined by our Board of Directors. Flacane, through the services
of Mr. Augusta, provides business and strategic services and made Mr. Augusta available to serve as our Executive Chairman of the
Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 12, 2016,
we entered into a Consulting Agreement with Flacane (the &ldquo;2016 Augusta Consulting Agreement&rdquo;) to replace the substantially
similar 2015 Augusta Consulting that expired by its terms on December 31, 2015. Under the 2016 Augusta Consulting Agreement, Flacane
received to a signing bonus of $30,000 and is paid $25,000 per month, and Mr. Augusta is eligible to receive options to purchase
shares of our common stock as determined by our Board of Directors. Flacane, through the services of Mr. Augusta, continues to
provide business and strategic services and makes Mr. Augusta available to serve as our Executive Chairman of the Board of DIrectors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective as of March
7, 2012, Mr. Augusta was first appointed to our Board of Directors. In connection with his service as a director, Mr. Augusta entered
into a director agreement, which provides for Mr. Augusta to be a director and entitled Mr. Augusta to acquire 40,000 shares of
our common stock at a price of $0.01 per share. We had the right, but not the obligation, to repurchase those shares, which right
lapsed monthly at a rate of 1/36 per month over a three-year period and has now fully lapsed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.9pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.9pt"><B><I>Equity Awards</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 15, 2016,
we granted stock options to each of our named executive officers on record as of such date.&nbsp;&nbsp;The stock options&nbsp;were
awarded under the 2015 Plan, and entitle the recipient to purchase the stated numbers of share of the company&rsquo;s common stock
at the stated exercise price when the applicable vesting requirements are satisfied. The options have exercise prices ranging
from $5.79 - $6.37 and vesting terms between immediately and twelve months. The Company determined the weighted average fair value
of the options of $5.21 per share using the Black Scholes option pricing model with the following assumptions: term of six years,
risk free rate of 1.31% - 1.94%, no dividends, average volatility of 133% and a share price $5.79 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None of the options
granted on February 15, 2016 may be exercised, in whole or in part, unless and until the stockholders approve the 2015 Plan, which
approval must be obtained on or before December 15, 2016. Should the stockholders not approve the 2015 Plan at the 2016 Annual
Meeting or by December 15, 2016, all such options shall be null and void. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The specific grants to our named executive
officers were as follows:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 65%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Stock Option <BR>
Grants</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>for&nbsp;Fiscal&nbsp;Year&nbsp;2016 </B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%; text-align: left">Warren Hosseinion</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">93,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gary Augusta</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">93,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adrian Vazquez</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,400</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes the outstanding
equity option awards held by each of our named executive officers as of March 31, 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="15" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>OPTION AWARDS</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Number of</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Number of</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Securities</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Securities</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Underlying</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Underlying</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><B>Name and</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Unexercised</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Unexercised</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Option</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>Option</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><B>Principal</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Options-</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Options-</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>Exercise</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>Expiration</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"><B>Position</B></TD><TD STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Grant Date</B></TD><TD STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Exercisable</B></TD><TD STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Unexercisable</B></TD><TD STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Price (1)</B></TD><TD STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1pt; text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Date</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 29%; text-align: left">Warren Hosseinion, M.D.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: right">12/9/2010</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">30,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">1.50</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: center">12/8/2020</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><I>Chief Executive Officer</I></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7/10/2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/8/2024</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2/15/2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,229</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,271</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6.37</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2/14/2021</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gary Augusta</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7/10/2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/8/2024</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><I>Executive Chairman</I></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2/15/2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,229</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,271</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5.79</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2/14/2026</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adrian Vazquez, M.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">12/9/2010</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12/8/2020</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><I>Chief Medical Officer</I></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7/10/2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,833</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,167</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/8/2024</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2/15/2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,575</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,825</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6.37</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2/14/2021</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) All options have been issued with
an exercise price equal to the closing price of our common stock on the date of grant except 93,500 and 23,400 options granted
to Drs. Hosseinion and Vazquez at an exercise price of $6.37 per share, or 110% of the closing price of our common stock on the
date of grant. The weighted average closing stock price for the 93,500 and 23,400 options on the dates of grant was $5.79 per
share. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of our named executive officers exercised
any options or had stock awards that were subject to vesting during the fiscal year ended March 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Potential Payments upon Termination
or Change-In-Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During fiscal year
2016, all of our named executive officers had provisions in their then-current employment or consulting agreements providing for
payments upon certain types of termination of employment, including, in the case of Drs. Hosseinion and Vazquez, upon a change
of control of the company resulting in a termination without cause (as that term is defined in their respective employment agreements,
which are substantially similar to each other).&nbsp;&nbsp;For a description of those provisions, please see &ldquo;Employment
Agreements&rdquo; above. In addition, upon the occurrence of a change of control, the Compensation Committee is authorized to take
certain actions with respect to awards outstanding under the 2015 Plan, the 2013 Plan and the 2010 Plan. See &ldquo;Proposal 2
&ndash; Approval of 2015 Equity Incentive Compensation Plan &ndash; Change of Control&rdquo;.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Director Compensation for Fiscal Year
2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our independent directors are paid director
fees in the amount of $1,000 per month. <FONT STYLE="font-family: Times New Roman, Times, Serif">Directors who are employees of
the Company receive no additional compensation for serving as directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Fees&nbsp;Earned&nbsp;or</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Paid&nbsp;in&nbsp;Cash</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Stock&nbsp;Awards</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Option&nbsp;Awards</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($) (1)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Non-Equity</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Incentive Plan</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Compensation</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Change</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>in Pension</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Value and</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nonqualified</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Deferred</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Compensation</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Earnings</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>All Other</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Compensation</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Total</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="width: 23%">Mark Fawcett(2)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">5,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">78,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="text-align: left">Lance Jon Kimmel(3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">52,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP><P STYLE="margin: 0pt 0">Thomas Lam, M.D.(4)</P>


</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="text-align: left">Suresh Nihalani</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">104,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="text-align: left">David Schmidt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">104,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="text-align: left">Ted Schreck</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">104,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">For a discussion of the assumptions used in the valuation
of awards (estimated forfeitures are not considered for purposes of these computations and the full fair value is recognized in
the year of grant), see the notes to the consolidated financial statements included in our Annual Report on Form 10-K, as filed
with the Securities and Exchange Commission on June 29, 2016.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Mr. Fawcett became a director on January 12, 2016</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Mr. Kimmel served as a director from April 9, 2015 through
September 21, 2015, whereupon he resigned in order to become the company&rsquo;s outside general counsel.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: justify">Dr. Lam became a director on January 19, 2016. Dr. Lam
is not considered an independent director and does not receive director fees.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REVIEW AND APPROVAL OF RELATED PARTY
TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Our Board has
adopted a Related Party Transaction Policy that provides for the review and approval of all related party transactions, which are
generally defined under the policy as any transaction required to be disclosed under Item 404(a) of Regulation S-K. This written
policy is supplemented by other written policies including our Code of Ethics for Directors, Executive Officers and Other Senior
Personnel, and the Audit Committee&rsquo;s charter, as well as certain provisions of the Delaware General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Under our Related
Party Transaction Policy, the Audit Committee or such other committee as may be appointed by the Board (collectively, the &ldquo;Committee&rdquo;)
reviews the material facts relating to all related party transactions that require the Committee&rsquo;s approval and considers
whether to approve of our entry into the related party transaction, subject to certain exceptions. In determining whether to approve
a related party transaction, the Committee shall take into account, among other factors it deems appropriate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the related person&rsquo;s interest and involvement in the interested transaction;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the approximate dollar value of the amount involved in the interested transaction;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the approximate dollar value of the amount of the related person&rsquo;s interest in the interested transaction without regard to the amount of any profit or loss;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">whether the interested transaction was undertaken in the ordinary course of business of the company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">whether the interested transaction with the related person is proposed to be, or was, entered into on terms no less favorable to the company than terms that could have been reached with an unrelated third party;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the purpose of, and the potential benefits to the Company of, the interested transaction; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any other information regarding the interested transaction or the related person in the context of the proposed transaction that would be material to investors in light of the circumstances of the particular transaction.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">No one of the
foregoing factors is dispositive but should be considered qualitatively as the facts and circumstances of a particular transaction
warrant, in the judgment of the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Our Related Party
Transaction Policy also provides that no director shall participate in any approval of a related party transaction for which he
or she is a related party, and that the director shall provide all material information concerning the transaction to the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Under our Related
Party Transaction Policy, certain transactions are deemed to be pre-approved by the Audit Committee, even if the aggregate amount
involved exceeds $120,000.&nbsp; These transactions include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45.8pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">employment of executive officers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45.8pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">director compensation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45.8pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">transactions where all stockholders receive proportional benefits;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45.8pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">certain transactions involving the purchase of advertising from us at market rates and on such
other terms as are consistent with those obtainable in arms-length transactions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45.8pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">transactions involving competitive bids; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45.8pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">transactions that, as a result of corporate practice of medicine or similar laws, require a physician
to serve as nominee shareholder on our behalf.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Committee
may establish such other categories of transactions that shall be deemed pre-approved or ratified (as applicable) and the Committee
shall identify such transactions in connection with this Policy or otherwise in its deliberations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a transaction with
a related party will be ongoing, the Committee may establish guidelines for the Company&rsquo;s management to follow in its ongoing
dealings with the related party. Thereafter, on a schedule as determined in the discretion of the Committee, the Committee shall
review and assess ongoing relationships with the related party to see that they are in compliance with the Committee&rsquo;s guidelines
and that the related party transaction remains appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">On an annual basis,
each director and executive officer of the company must complete a Director and Officer Questionnaire that requires disclosure
of any transaction, arrangement or relationship with us during the last fiscal year in which the director or executive officer,
or any member of his or her immediate family, had a direct or indirect material interest. Any transaction, arrangement or relationship
disclosed in the Director and Officer Questionnaire submitted by a director or executive officer is reviewed and considered by
the Board in making independence determinations with respect to directors and resolving any conflicts of interest that may arise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Primarily because of
laws prohibiting the corporate practice of medicine, we have entered into long-term management service agreements, loan agreements
and other similar arrangements with affiliated physician entities. These physician entities must have only physician owners and
therefore our Chief Executive Officer, Warren Hosseinion, M.D., serves as our nominee owner in such entities, as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Each of AMH, ApolloMed
Care Clinic</FONT> <FONT STYLE="font-size: 10pt">(&ldquo;ACC&rdquo;), Maverick Medical Group, Inc. (&ldquo;MMG&rdquo;), AKM Medical
Group, Inc. (&ldquo;AKM&rdquo;) and Southern California Heart Centers (&ldquo;SCHC&rdquo;) has entered into a Management Agreement
with AMM under which AMM has exclusive authority to manage each of the affiliated entities and is obligated to provide all non-physician
personnel. AMM is entitled to management fees as set forth in each Management Agreement. The term of each Management Agreement
is 20 years from its effective date, and automatically renews for successive 5-year periods, unless terminated earlier for cause
or because of a party&rsquo;s breach.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the Managements Agreements, Dr. Hosseinion has entered into Physician Shareholder Agreements in favor of the company, in his capacity
as a stockholder of, and for the account of, each of the affiliated entities that have entered into Management Agreements with
AMM. The purpose of the Physician Shareholder Agreements is to memorialize the agreement of Dr. Hosseinion to act in accordance
with the Management Agreements, and to the extent of Dr. Hosseinion&rsquo;s personal authority, to refrain from any action or inaction
that would result in a breach by any affiliated entity of its obligations under its Management Agreement. To that end, each Physician
Shareholder Agreement contains covenants which obligate Dr. Hosseinion to comply with the applicable Management Agreement and restrict
Dr. Hosseinion&rsquo;s ability to transfer equity held by Dr. Hosseinion in the applicable affiliated entity or to issue new equity
in the applicable affiliated entity. Each Management Agreement also provides the company with the right to designate a third party
to acquire all (or such amount such that the transferee would acquire a 51% interest) of Dr. Hosseinion&rsquo;s equity in the applicable
affiliated entity for $100, subject to a fair market value adjustment, if applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each of AMH, ACC, MMG,
AKM and SCHC has additionally entered into an Intercompany Loan Agreement with AMM under which AMM has agreed to provide a revolving
loan commitment to each of the affiliated entities in an amount set forth in each Intercompany Loan Agreement. Each Intercompany
Loan Agreement provides that AMM&rsquo;s obligation to make any advances automatically terminates concurrently with the termination
of the Management Agreement with the applicable affiliated entity. In addition, each Intercompany Loan Agreement provides that
(i) any material breach by Dr. Hosseinion of the applicable Physician Shareholder Agreement or (ii) the termination of the Management
Agreement with the applicable affiliated entity constitutes an event of default under the Intercompany Loan Agreement. The Intercompany
Loan Agreement with AMH provides for a maximum advance of $10 million and terminates on September 30, 2018. The Intercompany Loan
Agreement with ACC provides for a maximum advance of $1 million and terminates on July 31, 2018. The Intercompany Loan Agreement,
as amended, with MMG provides for a maximum advance of $2 million and terminates on February 1, 2018. The Intercompany Loan Agreement
with AKM provides for a maximum advance of $5 million and terminates on May 30, 2019. The Intercompany Loan Agreement with SCHC
provides for a maximum advance of $5 million and terminates on July 21, 2019. Outstanding principal under each of the Intercompany
Loan Agreements bears interest at the greater of 10% per annum or the LIBOR rate described in each Intercompany Loan Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into
Stock Option Agreements with each of Dr. Hosseinion and Dr. Vazquez. The Stock Option Agreements provide that each of Dr. Hosseinion
and Dr. Vazquez grant the Company the option to purchase (at fair market value) all equity interests in the Company held by Dr.
Hosseinion or Dr. Vazquez, as applicable, in the event that (i) either the Hosseinion Hospitalist Participation Agreement or the
Vazquez Hospitalist Participation Agreement, respectively, or the Hosseinion Employment Agreement or the Vazquez Employment Agreement,
respectively, is terminated by the Company for cause due to a willful or intentional breach by Dr. Hosseinion or Dr. Vazquez, as
applicable, (ii) Dr. Hosseinion or Dr. Vazquez, as applicable, commits fraud or any felony against the company or any of its affiliates,
(iii) Dr. Hosseinion or Dr. Vazquez, as applicable, directly or indirectly solicits away from the company any patients, customers,
clients, employees, agents or independent contractors of the company or any of its affiliates for competitive purposes or (iv)
Dr. Hosseinion or Dr. Vazquez, as applicable, directly or indirectly &ldquo;competes&rdquo; (as such term is defined in the Stock
Option Agreements) with the Company or any of its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE COMPANY&rsquo;S AUDITORS AND AUDIT
FEES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is the current intention
of the Company&rsquo;s Audit Committee to select and retain BDO USA, LLP as independent auditors of the Company for the current
fiscal year ending March 31, 2017. BDO USA, LLP conducted the audit for the fiscal year ended March 31, 2016. A representative
of BDO USA, LLP will be present at the Meeting and will have an opportunity to make statements if he so desires and will be available
to respond to appropriate questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The following
table summarizes the fees charged by BDO USA, LLP for the services rendered to the company and its subsidiaries in fiscal years
2015 and 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount Billed and Paid</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">Type of Fee</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Fiscal<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT>Year&nbsp;2015</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fiscal&nbsp;Year&nbsp;2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-size: 10pt">Audit (1)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 15%; font-size: 10pt; text-align: right">599,527</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 15%; font-size: 10pt; text-align: right">533,905</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Audit Related</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">Tax</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">All Other Fees</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 13.7pt">Total</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">599,527</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">533,905</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-left: 0; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; padding-top: 2pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents aggregate fees charged by BDO for annual audits, including quarterly reviews and&nbsp;services&nbsp;that&nbsp;are normally&nbsp;provided&nbsp;in&nbsp;connection&nbsp;with&nbsp;statutory&nbsp;or&nbsp;regulatory&nbsp;filings.&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee
has determined that all services performed by BDO USA,&nbsp;LLP are compatible with maintaining the independence of BDO USA,&nbsp;LLP.
The Audit Committee's policy is to pre-approve all audit and permissible non-audit services provided by our independent registered
public accounting firm. These services may include audit services, audit-related services, tax services and other services. Pre-approval
is generally provided for up to one year and any pre-approval is detailed as to the particular service or category of services.
The independent registered public accounting firm and management are required to periodically report to the Audit Committee regarding
the extent of services provided by the independent registered public accounting firm in accordance with this pre-approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AUDIT COMMITTEE REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in"><I>The following
Audit Committee Report does not constitute soliciting material and should not be deemed filed or incorporated by reference into
any of our other filings under the Securities Act or the Exchange Act, except to the extent that we specifically incorporate this
report by reference therein, and shall not be deemed to be soliciting material or otherwise deemed filed under either such Act.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Audit Committee
is currently comprised of three independent directors, all of whom are independent under the rules of the SEC and NASDAQ. The duties
and responsibilities of a member of the Audit Committee are in addition to his or her duties as a member of the Board. The Audit
Committee operates under a written charter, a copy of which is available on the company&rsquo;s corporate website. The Audit Committee
met four times during fiscal 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">The Audit Committee&rsquo;s
primary duties and responsibilities are to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">engage the company&rsquo;s independent registered public accounting firm,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">monitor the independent registered public accounting firm&rsquo;s independence, qualifications and performance,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">pre-approve all audit and non-audit services,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">monitor the integrity of the company&rsquo;s financial reporting process and internal control systems,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">provide an open avenue of communication among the independent registered public accounting firm, financial and senior management of the company and the Board,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">monitor the company&rsquo;s compliance with legal and regulatory requirements, contingent liabilities, risk assessment and risk management; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">review and approve all related party transactions under our Related Party Transactions Policy.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Management is
responsible for the company&rsquo;s internal controls and the financial reporting process. The company&rsquo;s independent registered
public accounting firm is responsible for performing an independent audit of the company&rsquo;s consolidated financial statements
in accordance with the standards of the Public Company Accounting Oversight Board (the &ldquo;PCAOB&rdquo;) and issuing a report
thereon. The Audit Committee&rsquo;s responsibility is to monitor and oversee these processes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">In carrying out
these responsibilities, the Audit Committee monitored the scope and staffing of the company&rsquo;s internal management group that
was previously established by the company regarding the progress and completion of the implementation of the company&rsquo;s internal
controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">In overseeing
the preparation of the company&rsquo;s financial statements, the Audit Committee held meetings with the company&rsquo;s independent
registered public accounting firm, both in the presence of management and privately, to review and discuss all financial statements
prior to their issuance and to discuss the overall scope and plans for their respective audits, the evaluation of the company&rsquo;s
internal controls and significant accounting issues. Management advised the Audit Committee that all financial statements were
prepared in accordance with accounting principles generally accepted in the United States of America, and the Audit Committee discussed
the audited statements with both management and the company&rsquo;s independent registered public accounting firm. The Audit Committee
has discussed with the company&rsquo;s independent registered public accounting firm all matters required to be discussed under
Auditing Standard No. 16 &ldquo;Communications with Audit Committees&rdquo;, as issued by the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">With respect to
the company&rsquo;s independent registered public accounting firm, the Audit Committee received the written disclosures and the
letter from BDO USA, LLP, as required by applicable requirements of the PCAOB, regarding the independent registered public accounting
firm&rsquo;s communications with the Audit Committee concerning independence and have discussed with BDO USA, LLP, among other
things, its independence. The Audit Committee also reviewed and approved the audit and non-audit fees of that firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">On the basis of
these reviews and discussions, the Audit Committee recommended to the Board that the Board approve the inclusion of the company&rsquo;s
audited financial statements in the 10-K for filing with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Submitted by the
Audit Committee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 50%"><FONT STYLE="font-size: 10pt">David Schmidt, Chair</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Suresh Nihalnai </FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Ted Schreck </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STOCKHOLDER PROPOSALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time stockholders
present proposals that may be proper subjects for inclusion in a proxy statement and for consideration at an annual meeting. In
accordance with SEC Rule 14a-8, since we did not hold an annual meeting in 2015, to be included in the proxy statement for our
2017 annual meeting of stockholders, stockholder proposals must be received by us a reasonable time before we&nbsp;print and send
our proxy materials to stockholders for the 2017 annual meeting.&nbsp; We intend to report the date of our next annual meeting
of stockholders and the deadlines for the submission of proposals by stockholders in a quarterly report on Form 10-Q, annual report
on Form 10-K or another report, to be filed with the SEC.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANNUAL REPORT ON FORM 10-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">We filed the 10-K
for the year ended March 31, 2016 with the SEC on June 29, 2016. A copy of our Annual Report to Stockholders (the &ldquo;Annual
Report&rdquo;), which incorporates the 10-K without exhibits, has been mailed to all stockholders along with this proxy statement.
Stockholders may obtain additional copies of the Annual Report and/or the 10-K and the exhibits thereto, without charge, by writing
to us at our principal executive offices at 2425 Olympic Boulevard, Suite 6000 West, Santa Monica, California 90404, Attention:&nbsp;&nbsp;Secretary.
Copies of the 10-K may also be obtained from our website at http://irdirect.net/AMEH/sec_filings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OTHER MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">Management does
not know of any matters to be presented at the 2016 Annual Meeting other than those set forth herein and in the Notice accompanying
this proxy statement. If a stockholder vote is necessary to transact any other business at the 2016 Annual Meeting, the proxyholders
intend to vote their proxies in accordance with their best judgment related to such business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: .5in">It is important
that your shares be represented at the 2016 Annual Meeting, regardless of the number of shares that you hold. <B>YOU ARE, THEREFORE,
URGED TO EXECUTE PROMPTLY AND RETURN THE ACCOMPANYING PROXY IN THE ENVELOPE THAT HAS BEEN ENCLOSED FOR YOUR CONVENIENCE.</B> Stockholders
who are present at the 2016 Annual Meeting may revoke their proxies and vote in person or, if they prefer, may abstain from voting
in person and allow their proxies to be voted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">By Order of the Board of Directors,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><IMG SRC="tsig.jpg" ALT=""></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Warren Hosseinion</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><I>Chief Executive Officer</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: -.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">July
29, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">Glendale, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: right; text-indent: -.5in"><B><I>Appendix
A</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APOLLO MEDICAL HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2015 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. <U>Purpose, History and Effective Date</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) <U>Purpose</U>. The Apollo Medical Holdings,
Inc. 2015 Equity Incentive Plan has two complementary purposes: (i) to attract and retain outstanding individuals to serve as officers,
employees, directors or consultants and (ii) to increase stockholder value. The Plan will provide participants incentives to increase
stockholder value by offering the opportunity to acquire shares of the Company&rsquo;s common stock or receive monetary payments
based on the value of such common stock on the potentially favorable terms that this Plan provides.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) <U>History</U>. Prior to the effective
date of this Plan, the Company had in effect the 2010 Plan and the 2013 Plan, which were originally effective March 4, 2010 and
April 30, 2013, respectively. Upon adoption of this Plan by the Board, no new awards will be granted under the 2013 Plan. No awards
have been granted under the 2010 Plan since the effectiveness of the 2013 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) <U>Effective Date</U>. This Plan will
become effective, and Awards may be granted under this Plan, on and after the Effective Date; provided, however, that prior to
approval of this Plan by the Company's stockholders, but after adoption by the Board, Incentive Stock Options may be granted under
this Plan subject to obtaining the stockholders' approval of this Plan; and provided, further, that such stockholder approval must
occur no later than 12 months after the date of adoption of this Plan by the Board. This Plan will terminate as provided in Section
14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2. <U>Definitions</U>. Capitalized terms used in this Plan have
the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) &ldquo;2010&rdquo; Plan means the Apollo
Medical Holdings, Inc. 2010 Equity Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) &ldquo;2013 Plan&rdquo; means the Apollo
Medical Holdings, Inc. 2013 Equity Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) &ldquo;Affiliate&rdquo; has the meaning
ascribed to such term in Rule 12b-2 promulgated under the Exchange Act or any successor rule or regulation thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) &ldquo;Award&rdquo; means a grant of
Options, Stock Appreciation Rights, Performance Shares, Performance Units, Restricted Stock, Restricted Stock Units or Dividend
Equivalent Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e) &ldquo;Award Agreement&rdquo; means
a written agreement, contract, or other instrument or document evidencing the grant of an Award in such form as the Committee determines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f) &ldquo;Board&rdquo; means the Board
of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g) &ldquo;Change of Control&rdquo; means
the occurrence of any one of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) the consummation of a merger
or consolidation of the Company with or into another entity or any other corporate reorganization, if more than fifty percent (50%)
of the combined voting power of the continuing or surviving entity&rsquo;s securities outstanding immediately after such merger,
consolidation or other reorganization is owned by Persons who were not stockholders of the Company immediately prior to such merger,
consolidation or other reorganization;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) the sale, transfer or other
disposition of all or substantially all of the Company&rsquo;s assets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) a change in the composition
of the Board, as a result of which fewer than fifty percent (50%) of the incumbent directors are directors who either (A) had been
directors of the Company on the date twenty-four (24) months prior to the date of the event that may constitute a Change of Control
(the &ldquo;original directors&rdquo;) or (B) were elected, or nominated for election, to the Board with the affirmative votes
of at least a majority of the aggregate of the original directors who were still in office at the time of the election or nomination
and the directors whose election or nomination was previously so approved; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iv) any transaction as a result
of which any Person is the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly,
of securities of the Company representing at least fifty percent (50%) of the total voting power represented by the Company&rsquo;s
then outstanding voting securities. For purposes of this paragraph (iv), the term &ldquo;Person&rdquo; shall exclude (A) a trustee
or other fiduciary holding securities under an employee benefit plan of the Company or a Subsidiary and (B) a corporation owned
directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common
stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A transaction shall not constitute a Change
of Control if its sole purpose is to change the state of the Company&rsquo;s incorporation or to create a holding company that
will be owned in substantially the same proportions by the persons who held the Company&rsquo;s securities immediately before such
transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding anything herein contained
to the contrary, with respect to an Award that is or may be considered deferred compensation subject to Code Section 409A, the
definition of &ldquo;Change of Control&rdquo; herein shall be amended and interpreted in a manner that allows the definition to
satisfy the requirements of a change of control under Code Section 409A solely for purposes of complying with the requirements
of Code Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(h) &ldquo;Code&rdquo; means the Internal
Revenue Code of 1986, as amended. Any reference to a specific provision of the Code includes any successor provision and the regulations
promulgated under such provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(i) &ldquo;Committee&rdquo; means the Compensation
Committee of the Board (or a successor committee with the same or similar authority), except as otherwise provided in Section 3(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(j) &ldquo;Company&rdquo; means Apollo Medical
Holdings, Inc., a Delaware corporation, or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(k) &ldquo;Director&rdquo; means a member
of the Board, and &ldquo;Non-Employee Director&rdquo; means a Director who is not also an employee of the Company or its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(l) &ldquo;Disability&rdquo; has the meaning
ascribed to the term in Code Section 22(e)(3), as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(m) &ldquo;Disinterested Persons&rdquo;
means the &ldquo;non-employee directors&rdquo; of the Company as such term is defined in Rule 16b-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(n) &ldquo;Dividend Equivalent Unit&rdquo;
means the right to receive a payment equal to the cash dividends paid with respect to a Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(o) &ldquo;Effective Date&rdquo; means the
earlier to occur of the date this Plan is (i) adopted by the Board or (ii) approved by the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(p) &ldquo;Exchange Act&rdquo; means the
Securities Exchange Act of 1934, as amended. Any reference to a specific provision of the Exchange Act includes any successor provision
and the regulations and rules promulgated under such provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(q) &ldquo;Fair Market Value&rdquo; means,
per Share on a particular date, (i) if the Stock is listed for trading on the New York Stock Exchange, the last reported sales
price on the date in question as reported in The Wall Street Journal, or if no sales of Stock occur on the date in question, on
the last preceding date on which there was a sale on such exchange; or (ii) if the Stock is not listed or admitted to trading on
the New York Stock Exchange, the last reported sales price on the date in question on the principal national securities exchange
on which the Stock is listed or admitted to trading, or if no sales of Stock occur on the date in question, on the last preceding
date on which there was a sale on such exchange; or (iii) if the Stock is not listed or admitted to trading on any national securities
exchange, the last sales price on the date in question in the over-the-counter market reported by such reporting system as is then
in use, or if no sales of Stock occur on the date in question, on the last preceding date on which there was a sale; or (iv) if
on any such date the Stock is not reported on any such system, the last sales price on the date in question as furnished by a professional
market making a market in the Stock selected by the Board for the date in question, or if no sales of Stock occur on the date in
question, on the last preceding date on which there was a sale; or (v) if on any such date no market maker is making a market in
the Stock, the price as determined in good faith by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(r) &ldquo;Incentive Stock Option&rdquo;
means an Option that meets the requirements of Code Section 422.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(s) &ldquo;Option&rdquo; means the right
to purchase Shares at a specified price during a specified period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(t) &ldquo;Participant&rdquo; means an individual
selected by the Committee to receive an Award, and includes any individual who holds an Award after the death of the original recipient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(u) &ldquo;Performance Goals&rdquo; means
any goals the Committee establishes that relate to one or more of the following for such period as the Committee specifies:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) Revenue;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) Earnings before interest,
taxes, depreciation and amortization, as adjusted (EBITDA as adjusted);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) Income before income taxes and minority
interests;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iv) Operating income;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(v) Pre- or after-tax income;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(vi) Average accounts receivable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(vii) Cash flow;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(viii) Cash flow per share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ix) Net earnings;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(x) Basic or diluted earnings per share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xi) Return on equity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xii) Return on assets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xiii) Return on capital;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xiv) Growth in assets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xv) Economic value added;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xvi) Share price performance;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xvii) Total stockholder return;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xviii) Improvement or attainment of expense
levels;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xix) Market share or market penetration;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xx) Business expansion, and/or acquisitions
or divestitures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Committee may specify at the time an
Award is made that the Performance Goals are to be measured for an individual, the Company, for the Company on a consolidated basis,
for any one or more Affiliates or divisions of the Company and/or for any other business unit or units of the Company, and/or that
the Performance Goals are to be measured either in absolute terms or relative to the performance of one or more comparable companies
or an index covering multiple companies. In the case of Awards that the Committee determines will not be considered &ldquo;performance
based compensation&rdquo; under Code Section 162(m), the Committee may establish other Performance Goals not listed in this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(v) &ldquo;Performance Shares&rdquo; means
the right to receive Shares to the extent Performance Goals are achieved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(w) &ldquo;Performance Units&rdquo; means
the right to receive a payment, based on a number of units with a specified value, to the extent Performance Goals are achieved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(x) &ldquo;Person&rdquo; has the meaning
given in Section 3(a)(9) of the Exchange Act, as modified and used in Sections 14(d) and 15(d) thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(y) &ldquo;Plan&rdquo; means this Apollo
Medical Holdings, Inc. 2015 Equity Incentive Plan, as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(z) &ldquo;Restricted Stock&rdquo; means
Shares that are subject to a risk of forfeiture and/or restrictions on transfer, which may lapse upon the achievement or partial
achievement of Performance Goals and/or upon the completion of a period of service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(aa) &ldquo;Restricted Stock Unit&rdquo;
means the right to receive a payment which right may vest upon the achievement or partial achievement of Performance Goals and/or
upon the completion of a period of service, with each unit having a value equal to the Fair Market Value of one or more Shares,
or the average of the Fair Market Value of one or more Shares over such period as the Committee specifies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(bb) &ldquo;Retirement&rdquo; means, unless
the Committee determines otherwise in an Award Agreement, termination of employment from the Company and its Affiliates on or after
age 65 with five (5) years of continuous service with the Company and its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(cc) &ldquo;Rule 16b-3&rdquo; means Rule
16b-3 as promulgated by the United States Securities and Exchange Commission under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(dd) &ldquo;Section 16 Participants&rdquo;
means Participants who are subject to the provisions of Section 16 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(ee) &ldquo;Share&rdquo; means a share of
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(ff) &ldquo;Stock&rdquo; means the Class
A common stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(gg) &ldquo;Stock Appreciation Right&rdquo;
or &ldquo;SAR&rdquo; means the right to receive a payment equal to the appreciation of the Fair Market Value of a Share during
a specified period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(hh) &ldquo;Subsidiary&rdquo; means any
corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if each such corporation owns
stock possessing fifty percent (50%) or more of the total combined voting power in one of the other corporations in the chain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3. <U>Administration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) <U>Committee Administration</U>. In
addition to the authority specifically granted to the Committee in this Plan, the Committee has full discretionary authority to
administer this Plan, including but not limited to the authority to (i) interpret the provisions of this Plan, (ii) prescribe,
amend and rescind rules and regulations relating to this Plan, (iii) correct any defect, supply any omission, or reconcile any
inconsistency in the Plan, any Award or Award Agreement in the manner and to the extent it deems desirable to carry this Plan,
such Award or such Award Agreement into effect and (iv) make all other determinations necessary or advisable for the administration
of this Plan. All decisions, interpretations and other actions of the Committee shall be final and binding on all Participants
and any other individual with a right under the Plan or under any Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) <U>Delegation to Other Committees or
CEO</U>. To the extent applicable law permits, the Board may delegate to another committee of the Board, or the Committee may delegate
to a subcommittee or to the Chief Executive Officer of the Company, any or all of the authority and responsibility of the Committee;
provided, however, that no such delegation shall be permitted with respect to Awards made to Section 16 Participants. The Board
may retain any or all of the authority and responsibility of the Committee, or may delegate to another committee or subcommittee
of the Board consisting solely of two or more Disinterested Persons any or all of the authority and responsibility of the Committee,
with respect to Section 16 Participants. If the Board or Committee has retained such authority or made such a delegation, then
all references to the Committee in this Plan include the Board, such other committee, subcommittee or the Chief Executive Officer
to the extent of such retained authority or delegation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) <U>Indemnification</U>. In addition
to such other rights of indemnification as they may have as members of the Board or the Committee, the members of the Board and
the Committee shall be indemnified by the Company against all costs and expenses reasonably incurred by them in connection with
any action, suit or proceeding to which they or any of them may be party by reason of any action taken or failure to act under
or in connection with the Plan or any Award, and against all amounts paid by them in settlement thereof (provided such settlement
is approved by independent legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any such action,
suit or proceeding, except a judgment based upon a finding of bad faith; provided that upon the institution of any such action,
suit or proceeding a Committee or Board member shall, in writing, give the Company notice thereof and an opportunity, at its own
expense, to handle and defend the same before such Committee or Board member undertakes to handle and defend it on such member&rsquo;s
own behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. <U>Eligibility</U>. The Committee may designate any of the
following as a Participant from time to time: (i) any officer or other employee of the Company or any of its Affiliates; (ii) an
individual that the Company or an Affiliate has engaged to become an officer or other employee; (iii) a Non-Employee Director&rsquo;
or (iv) a consultant or advisor who provides bona fide services that are not in connection with the offer or sale of securities
in a capital raising transaction, and does not directly or indirectly promote or maintain a market for the Company&rsquo;s securities
to the Company or an Affiliate as an independent contractor. The Committee&rsquo;s designation of a Participant in any year will
not require the Committee to designate such person to receive an Award in any other year. Notwithstanding the foregoing, each Non-Employee
Director automatically will be a Participant with respect to elections to receive Options in lieu of directors&rsquo; fees pursuant
to Section 12.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5. <U>Types of Awards</U>. Subject to the terms of this Plan,
the Committee may grant any type of Award to any Participant it selects, but only employees of the Company or a Subsidiary may
receive grants of Incentive Stock Options. Awards may be granted alone or in addition to, in tandem with, or in substitution for
any other Award (or any other award granted under another plan of the Company or any Affiliate). Awards granted under the Plan
shall be evidenced by an Award Agreement except to the extent the Committee provides otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6. <U>Shares Reserved under this Plan</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) <U>Plan Reserve</U>. Subject to adjustment
as provided in Section 16, an aggregate of 1,500,000 Shares, plus the number of Shares described in Section 6(c), are reserved
for issuance under this Plan. The number of Shares reserved for issuance under this Plan shall be reduced only by the number of
Shares delivered in payment or settlement of Awards. Notwithstanding the foregoing, the Company may issue only 1,500,000 Shares
upon the exercise of Incentive Stock Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) <U>Replenishment of Shares Under this
Plan</U>. If an Award lapses, expires, terminates or is cancelled without the issuance of Shares under the Award, or if Shares
are forfeited under an Award, then the Shares subject to such Award may again be used for new Awards under this Plan under Section
6(a), including issuance upon the exercise of Incentive Stock Options. If Shares are issued under any Award and the Company subsequently
reacquires them pursuant to rights reserved upon the issuance of the Shares, or if previously owned Shares are delivered to the
Company in payment of the exercise price of an Award or the withholding taxes due as a result of the issuance or receipt of a payment
or Shares under an Award, then such Shares may again be used for new Awards under this Plan under Section 6(a), but such Shares
may not be issued upon the exercise of Incentive Stock Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) <U>Addition of Shares from Predecessor
Plan</U>. After the Effective Date, if any Shares subject to awards granted under the 2010 Plan or 2013 Plan would again become
available for new grants under the terms of such plan, then those Shares will be available for the purpose of granting Awards under
this Plan, thereby increasing the number of Shares available for issuance under this Plan as determined under the first sentence
of Section 6(a), including with respect to the exercise of Incentive Stock Options. Any such Shares will not be available for future
awards under the respective terms of the 2010 Plan and 2013 Plan after the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) <U>Participant Limitations</U>. Subject
to adjustment as provided in Section 16, with respect to Awards that are intended to qualify as &ldquo;performance-based compensation&rdquo;
under Code Section 162(m), no Participant may be granted Awards that could result in such Participant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) receiving in any calendar
year Options for, and/or Stock Appreciation Rights with respect to, more than 500,000 Shares (reduced, in the initial calendar
year in which this Plan is effective, by the number of options granted to a Participant under the 2010 Plan and/or 2013 Plan in
such year, if any), except that Options and/or Stock Appreciation Rights granted to a new employee in the calendar year in which
his or her employment commences may not relate to more than 1,000,000 Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) receiving in any calendar
year Awards of Restricted Stock and/or Restricted Stock Units relating to more than 500,000 Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) receiving in any calendar
year Awards of Performance Shares, and/or Awards of Performance Units (the value of which is based on the Fair Market Value of
a Share), for more than 500,000 Shares; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iv) receiving in any calendar
year Awards of Performance Units (the value of which is not based on the Fair Market Value of a Share) that could result in a payment
of more than $500,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">With respect to Awards that are not intended
to meet the requirements of performance-based compensation under Code Section 162(m), the Committee may grant Awards in excess
of the limits described in this subsection (d), but only if such discretion would not cause Awards that are intended to be performance-based
compensation under Code Section 162(m) from being treated as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">7. <U>Options</U>. Subject to the terms of this Plan, the Committee
shall determine all terms and conditions of each Option, including but not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) Whether the Option is an Incentive Stock
Option, or a &ldquo;nonqualified stock option&rdquo; which does not meet the requirements of Code Section 422; provided that in
the case of an Incentive Stock Option, if the aggregate Fair Market Value (determined at the time of grant) of the Shares with
respect to which all Incentive Stock Options are first exercisable by the Participant during any calendar year (under this Plan
and under all other incentive stock option plans of the Company or any Affiliate that is required to be included under Code Section
422) exceeds $100,000, such Option automatically shall be treated as a nonqualified stock option to the extent this limit is exceeded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b) The number of Shares subject to the Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) The exercise price per Share, which
may not be less than the Fair Market Value of a Share as determined on the date of grant; provided that (i) no Incentive Stock
Option shall be granted to any employee who, at the time the Option is granted, owns (directly or indirectly, within the meaning
of Code Section 424(d)) more than ten percent of the total combined voting power of all classes of stock of the Company or of any
Subsidiary unless the exercise price is at least 110 percent of the Fair Market Value of a Share on the date of grant; and (ii)
the exercise price may vary during the term of the Option if the Committee determines that there should be adjustments to the exercise
price relating to achievement of Performance Goals and/or to changes in an index or indices that the Committee determines is appropriate
(but in no event may the exercise price per Share be less than the Fair Market Value of a Share as determined on the date of grant).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) The terms and conditions of exercise,
which may include a requirement that exercise of the Option is conditioned upon achievement of one or more Performance Goals or
may provide for an acceleration of the exercisability upon the Participant&rsquo;s death, Disability or Retirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e) The termination date, except that each
Option must terminate no later than the tenth (10th) anniversary of the date of grant, and each Incentive Stock Option granted
to any employee who, at the time the Option is granted, owns (directly or indirectly, within the meaning of Code Section 424(d))
more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any Subsidiary must
terminate no later than the fifth (5th) anniversary of the date of grant. Notwithstanding the foregoing, the Committee may extend
the term of an Option for up to six (6) months beyond the tenth (10th) anniversary of the date of grant in the event a Participant
dies prior to the Option&rsquo;s termination date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f) The exercise period following a Participant&rsquo;s
termination of employment or service. In all other respects, the terms of any Incentive Stock Option should comply with the provisions
of Code Section 422 except to the extent the Committee determines otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g) Notwithstanding anything
contained in this Plan to the contrary, the Board as a whole shall pre-approve each option grant to Non-Employee
Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">8. <U>Stock Appreciation Rights</U>. Subject to the terms of
this Plan, the Committee shall determine all terms and conditions of each SAR, including but not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) Whether the SAR is granted independently
of an Option or relates to an Option; provided that if an SAR is granted in relation to an Option, then unless otherwise determined
by the Committee, the SAR shall be exercisable or shall mature at the same time or times, on the same conditions and to the extent
and in the proportion, that the related Option is exercisable and may be exercised or mature for all or part of the Shares subject
to the related Option. Upon exercise of any number of SARs, the number of Shares subject to the related Option shall be reduced
accordingly and such Option may not be exercised with respect to that number of Shares. The exercise of any number of Options that
relate to an SAR shall likewise result in an equivalent reduction in the number of Shares covered by the related SAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) The number of Shares to which the SAR
relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) The grant price, provided that the grant
price shall not be less than the Fair Market Value of the Shares subject to the SAR as determined on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) The terms and conditions of exercise
or maturity, which may include a provision that accelerates the exercisability of the SAR upon the Participant&rsquo;s death, Disability
or Retirement. Notwithstanding the foregoing, unless the Committee determines otherwise in the Award Agreement, if on the date
when the SAR expires or otherwise terminates, the grant price for the SAR is less than the Fair Market Value of a Share, then the
unexercised portion of the SAR that was exercisable immediately prior to such date shall automatically be deemed exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e) The term, provided that an SAR must
terminate no later than 10 years after the date of grant. Notwithstanding the foregoing, the Committee may extend the term of an
SAR for up to six (6) months beyond the tenth (10th) anniversary of the date of grant in the event a Participant dies prior to
the SAR&rsquo;s termination date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f) Whether the SAR will be settled in cash,
Shares or a combination thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g) Notwithstanding anything contained in
this Plan to the contrary, the Board as a whole shall pre-approve each SAR grant to Non-Employee Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">9. <U>Performance Awards</U>. Subject to the terms of this Plan,
the Committee shall determine all terms and conditions of each award of Performance Shares or Performance Units, including but
not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) The number of Shares and/or units to
which such Award relates, and with respect to Performance Units, whether the value of each unit will be based on the Fair Market
Value of one or more Shares, the average of the Fair Market Value of one or more Shares over such period as the Committee specifies,
or such other value as the Committee specifies in the Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) One or more Performance Goals that must
be achieved during such period as the Committee specifies in order for the Participant to realize the benefit of such Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) Whether all or a portion of the Performance
Goals subject to an Award are deemed achieved upon a Participant&rsquo;s death, Disability or Retirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) With respect to Performance Units, whether
to settle such Award in cash, Shares, or a combination of cash and Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e) Notwithstanding anything contained in
this Plan to the contrary, the Board as a whole shall pre-approve each Award grant under this Section 9 to Non-Employee Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise provided by the Committee,
a Participant shall not be entitled to and shall agree to waive or otherwise surrender any rights to receive dividends or dividend
equivalents paid with respect to Performance Shares or Performance Units valued in Shares until after the Performance Shares or
Performance Units have been earned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10. <U>Restricted Stock and Restricted Stock Unit Awards</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the terms of this Plan, the Committee
shall determine all terms and conditions of each award of Restricted Stock or Restricted Stock Units, including but not limited
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) The number of Shares and/or units to
which such Award relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) The period of time over which the restrictions
imposed on Restricted Stock will lapse and the vesting of Restricted Stock Units will occur, and whether, as a condition for the
Participant to realize all or a portion of the benefit provided under the Award, one or more Performance Goals must be achieved
during such period as the Committee specifies; provided that, subject to the provisions of Section 10(c), an Award that is subject
to the achievement of Performance Goals must have a restriction or vesting period of at least one year, and an Award that is not
subject to Performance Goals must have a restriction or vesting period of at least three years. Notwithstanding the foregoing,
if the Committee determines in its sole discretion that an Award of Restricted Stock or Restricted Stock Units is granted to a
Participant in lieu of cash compensation (including without limitation bonus cash compensation), the Committee may impose such
restriction or vesting period on such Award as it determines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) Whether all or any portion of the restrictions
or vesting schedule imposed on the Award will lapse or be accelerated upon a Participant&rsquo;s death, Disability or Retirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) With respect to Restricted Stock Units,
whether to settle such Awards in cash, Shares, or a combination of cash and Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e) With respect to Restricted Stock, the
manner of registration of certificates for such Shares, and whether to hold such Shares in escrow pending lapse of the restrictions
or to issue such Shares with an appropriate legend referring to such restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f) Whether dividends paid with respect
to an Award of Restricted Stock will be immediately paid or held in escrow or otherwise deferred and whether such dividends shall
be subject to the same terms and conditions as the Award to which they relate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g) Notwithstanding anything contained in
this Plan to the contrary, the Board as a whole shall pre-approve each grant under this Section 10 to Non-Employee Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">11. <U>Dividend Equivalent Units</U>. Subject to the terms and
conditions of this Plan, the Committee shall determine all terms and conditions of each award of Dividend Equivalent Units, including
but not limited to whether such Award will be granted in tandem with another Award, and the form, timing and conditions of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">12. <U>Payment of Directors&rsquo; Fees in Options</U>. Subject
to such restrictions as may be imposed by the Board, a Non-Employee Director may elect to receive all or any portion of his or
her annual cash retainer payment from the Company in the form of Options. The number of Options granted as a result of such election
shall be determined by multiplying the amount of foregone cash compensation by four (4), and dividing such product by the Fair
Market Value of a Share on the date the cash compensation would have otherwise been paid to the Non-Employee Director. Such Options
shall be issued under and subject to the terms of this Plan. An election under this Section 12 shall be filed with the Company
on such form and in such manner as the Board determines. The Board as a whole shall pre-approve each option grant under this Section
12.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">13. <U>Transferability</U>. Awards are not transferable other
than by will or the laws of descent and distribution, unless and to the extent the Committee allows a Participant to: (a) designate
in writing a beneficiary to exercise the Award after the Participant&rsquo;s death; or (b) transfer an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">14. <U>Termination and Amendment of Plan; Amendment, Modification
or Cancellation of Awards</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) <U>Term of Plan</U>. This Plan will
terminate on the tenth anniversary of the Effective Date unless the Board or Committee earlier terminates this Plan pursuant to
Section 14(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) <U>Termination and Amendment</U>. The
Board or the Committee may amend, suspend or terminate this Plan at any time, subject to the following limitations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) the Board must approve any
amendment, suspension or termination of this Plan to the extent the Company determines such approval is required by: (A) action
of the Board, (B) applicable corporate law, (C) the listing requirements of any principal securities exchange or market on which
the Shares are then traded, or (D) any other applicable law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) stockholders must approve
any amendment of this Plan to the extent the Company determines such approval is required by: (A) Section 16 of the Exchange Act,
(B) the Code, (C) the listing requirements of any principal securities exchange or market on which the Shares are then traded,
or (D) any other applicable law; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) stockholders must approve
any of the following Plan amendments: (A) an amendment to materially increase any number of Shares specified in Section 6(a) or
6(d) (except as permitted by Section 16); or (B) an amendment to the provisions of Section 14(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) <U>Amendment, Modification or Cancellation
of Awards</U>. Except as provided in Section 14(e) and subject to the requirements of this Plan, the Committee may modify or amend
any Award or waive any restrictions or conditions applicable to any Award or the exercise of the Award, and the terms and conditions
applicable to any Awards may at any time be amended, modified or canceled by mutual agreement between the Committee and the Participant,
so long as any amendment or modification does not increase the number of Shares issuable under this Plan (except as permitted by
Section 16), but the Committee need not obtain Participant (or other interested party) consent for the cancellation of an Award
pursuant to the provisions of Section 16(a) or the modification of an Award to the extent deemed necessary to comply with any applicable
law or the listing requirements of any principal securities exchange or market on which the Shares are then traded, or to preserve
favorable accounting treatment of any Award for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) <U>Survival of Authority and Awards</U>.
Notwithstanding the foregoing, the authority of the Board and the Committee under this Section 14 will extend beyond the date of
this Plan&rsquo;s termination. In addition, termination of this Plan will not affect the rights of Participants with respect to
Awards previously granted to them, and all unexpired Awards will continue in force and effect after termination of this Plan except
as they may lapse or be terminated by their own terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e) <U>Repricing and Backdating Prohibited</U>.
Notwithstanding anything in this Plan to the contrary, and except for the adjustments provided in Section 16, neither the Committee
nor any other person may decrease the exercise or grant price for any outstanding Option or SAR after the date of grant, cancel
an outstanding Option or SAR in exchange for cash or other Awards (other than cash or other Awards with a value equal to the excess
of the Fair Market Value of the Shares subject to such Option or SAR at the time of cancellation over the exercise or grant price
for such Shares) or allow a Participant to surrender an outstanding Option or SAR to the Company as consideration for the grant
of a new Option or SAR with a lower exercise price. In addition, the Committee may not make a grant of an Option or SAR with a
grant date that is effective prior to the date the Committee takes action to approve such Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f) <U>Foreign Participation</U>. To assure
the viability of Awards granted to Participants employed in foreign countries, the Committee may provide for such special terms
as it may consider necessary or appropriate to accommodate differences in local law, tax policy or custom. Moreover, the Committee
may approve such supplements to, or amendments, restatements or alternative versions of, this Plan as it determines is necessary
or appropriate for such purposes. Any such amendment, restatement or alternative versions that the Committee approves for purposes
of using this Plan in a foreign country will not affect the terms of this Plan for any other country. In addition, all such supplements,
amendments, restatements or alternative versions must comply with the provisions of Section 14(b)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g) <U>Recoupment</U>. Any Awards granted
pursuant to the Plan, and any Stock issued or cash paid pursuant to an Award, shall be subject to (A) any recoupment, clawback,
equity holding, stock ownership or similar policies adopted by the Company from time to time and (B) any recoupment, clawback,
equity holding, stock ownership or similar requirements made applicable by law, regulation or listing standards to the Company
from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">15. <U>Taxes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) <U>Withholding Right</U>. The Company
is entitled to withhold the amount of any tax attributable to any amount payable or Shares deliverable under this Plan after giving
the person entitled to receive such amount or Shares notice as far in advance as practicable, and the Company may defer making
payment or delivery if any such tax may be pending unless and until indemnified to its satisfaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) <U>Use of Shares to Satisfy Tax Withholding</U>.
A Participant shall have the right to satisfy all or a portion of the federal, state and local withholding tax obligations arising
in connection with an Award by electing to (i) have the Company withhold Shares otherwise issuable under the Award, (ii) tender
back Shares received in connection with such Award or (iii) deliver other previously owned Shares, in each case having a Fair Market
Value equal to the amount to be withheld. However, the amount to be withheld may not exceed the total minimum federal, state and
local tax withholding obligations associated with the transaction to the extent required to avoid an expense on the Company&rsquo;s
financial statements. The election must be made on or before the date as of which the amount of tax to be withheld is determined
and otherwise as the Committee requires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) <U>No Guarantee of Tax Treatment</U>.
Notwithstanding any provision of the Plan to the contrary, the Company does not guarantee to any Participant or any other person
with an interest in an Award that (i) any Award intended to be exempt from Code Section 409A shall be so exempt, (ii) any Award
intended to comply with Code Section 409A or Code Section 422 shall so comply, or (iii) any Award shall otherwise receive a specific
tax treatment under any other applicable tax law, nor in any such case will the Company or any Affiliate be obligated to indemnify,
defend or hold harmless any individual with respect to the tax consequences of any Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) <U>Participant Responsibility</U>. If
a Participant shall dispose of Stock acquired through exercise of an Incentive Stock Option within either (i) two years after the
date the Option is granted or (ii) one year after the date the Option is exercised (i.e., in a disqualifying disposition), such
Participant shall notify the Company within seven days of the date of such disqualifying disposition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">16. <U>Adjustment Provisions; Change of Control</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) <U>Adjustment of Shares</U>. If the
Committee determines that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property),
recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase,
or exchange of Shares or other securities of the Company, issuance of warrants or other rights to purchase Shares or other securities
of the Company, or other similar corporate transaction or event affects the Shares such that the Committee determines an adjustment
to be appropriate to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under
this Plan, then, subject to Participants&rsquo; rights under Section 16(c), the Committee shall, in such manner as it may deem
equitable, adjust any or all of (i) the number and type of Shares subject to this Plan (including the number and type of Shares
described in Sections 6(a) and 6(d)), and which may after the event be made the subject of Awards under this Plan, (ii) the number
and type of Shares subject to outstanding Awards, and (iii) the grant, purchase, or exercise price with respect to any Award. In
any such case, the Committee may also (or in lieu of the foregoing) make provision for a cash payment to the holder of an outstanding
Award in exchange for the cancellation of all or a portion of the Award (without the consent of the holder of an Award) in an amount
determined by the Committee effective at such time as the Committee specifies (which may be the time such transaction or event
is effective), but if such transaction or event constitutes a Change of Control, then (A) such payment shall be at least as favorable
to the holder as the amount the holder could have received in respect of such Award under Section 16(c) and (b) from and after
the Change of Control, the Committee may make such a provision only if the Committee determines that doing so is necessary to substitute,
for each Share then subject to an Award, the number and kind of shares of stock, other securities, cash or other property to which
holders of Stock are or will be entitled in respect of each Share pursuant to the transaction or event in accordance with the last
sentence of this subsection (a). However, in each case, with respect to Awards of Incentive Stock Options, no such adjustment may
be authorized to the extent that such authority would cause this Plan to violate Code Section 422(b). Further, the number of Shares
subject to any Award payable or denominated in Shares must always be a whole number. Without limitation, subject to Participants&rsquo;
rights under Section 16(c), in the event of any reorganization, merger, consolidation, combination or other similar corporate transaction
or event, whether or not constituting a Change of Control (other than any such transaction in which the Company is the continuing
corporation and in which the outstanding Stock is not being converted into or exchanged for different securities, cash or other
property, or any combination thereof), the Committee may substitute, on an equitable basis as the Committee determines, for each
Share then subject to an Award, the number and kind of shares of stock, other securities, cash or other property to which holders
of Stock are or will be entitled in respect of each Share pursuant to the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) <U>Issuance or Assumption</U>. Notwithstanding
any other provision of this Plan, and without affecting the number of Shares otherwise reserved or available under this Plan, in
connection with any merger, consolidation, acquisition of property or stock, or reorganization, the Committee may authorize the
issuance of substitute awards or assumption of awards under this Plan by another party to any such merger, consolidation, acquisition
or reorganization upon such terms and conditions as it may deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) <U>Change of Control</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) The Committee may specify,
either in an Award Agreement or at the time of a Change of Control, whether an outstanding Award shall become vested and/or payable,
in whole or in part, as a result of a Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) If, in connection with the
Change of Control, the Options and SARs issued under the Plan are not assumed, or if substitute Options and SARs are not issued
by the successor or Affiliate thereof in the Change of Control transaction, or if the assumed or substituted awards fail to contain
similar terms and conditions as the Award prior to the Change of Control or fail to preserve, to the extent applicable, the benefit
to be provided to the Participant as of the date of the Change of Control, including but not limited to the right of the Participant
to receive shares upon exercise of the Option or SAR that are registered for sale to the public pursuant to an effective registration
statement filed with the U.S. Securities and Exchange Commission, then (1) each holder of an Option or SAR that is outstanding
as of the date of the Change of Control who is an employee of the Company or any Subsidiary shall have the right, and (2) the Committee,
in its sole discretion, may grant to a holder of an Option or SAR that is outstanding as of the date of the Change of Control who
is not an employee of the Company or any Subsidiary the right, exercisable by written notice to the Company (or its successor in
the Change of Control transaction) within 30 days after the Change of Control (but not beyond the Option&rsquo;s or SAR&rsquo;s
expiration date), to receive, in exchange for the surrender of the Option or SAR, an amount of cash equal to the excess of the
greater of the Fair Market Value of the Shares determined on the Change of Control date or the Fair Market Value of the Shares
on the date of surrender covered by the Option or SAR (to the extent vested and not yet exercised) that is so surrendered over
the purchase or grant price of such Shares under the Award. If the Committee so determines prior to the Change of Control, any
such Option or SAR that is not exercised or surrendered prior to the end of such 30-day period will be cancelled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) If, in connection with the
Change of Control, the Shares issued to a Participant as a result of the accelerated vesting or payment of a Restricted Stock Award,
Performance Share Award, Restricted Stock Unit Award, Performance Unit Award or Dividend Equivalent Award under this subsection
(c) are not registered for sale to the public pursuant to an effective registration statement filed with the U.S. Securities and
Exchange Commission, then each holder of such Shares shall have the right, exercisable by written notice to the Company (or its
successor in the Change of Control transaction) within 30 days after the Change of Control, to receive, in exchange for the surrender
of such Shares an amount of cash equal to the greater of the Fair Market Value of a Share on the Change of Control date or the
Fair Market Value of such Share on the date of surrender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The provisions of Sections 16(c)(ii) and
(iii) shall govern the treatment of awards made under the 2010 Plan and 2013 Plan in the event of a Change of Control, and the
2010 Plan and 2013 Plan are each deemed amended accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) <U>Parachute Payment Limitation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) <U>Scope of Limitation</U>.
This Section 16(d) shall apply to an Award only if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(A) the independent auditors most
recently selected by the Board (the &ldquo;Auditors&rdquo;) determine that the after-tax value of such Award to the Participant,
taking into account the effect of all federal, state and local income taxes, employment taxes and excise taxes applicable to the
Participant (including the excise tax under Code Section 4999), will be greater after the application of this Section 16(d) than
it was before the application of this Section 16(d); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(B) the Committee, at the time of
making an Award under the Plan or at any time thereafter, specifies in writing that such Award shall be subject to this Section
16(d) (regardless of the after-tax value of such Award to the Participant).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">If this Section 16(d) applies
to an Award, it shall supersede any contrary provision of the Plan or of any Award granted under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii<U>) Basic Rule</U>. Except
as may be set forth in a written agreement by and between the Company and the holder of an Award, in the event that the Auditors
determine that any payment or transfer by the Company under the Plan to or for the benefit of a Participant (a &ldquo;Payment&rdquo;)
would be nondeductible by the Company for federal income tax purposes because of the provisions concerning &ldquo;excess parachute
payments&rdquo; in Code Section 280G, then the aggregate present value of all Payments shall be reduced (but not below zero) to
the Reduced Amount. For purposes of this Section 16(d), the &ldquo;Reduced Amount&rdquo; shall be the amount, expressed as a present
value, which maximizes the aggregate present value of the Payments without causing any Payment to be nondeductible by the Company
because of Code Section 280G.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) <U>Reduction of Payments</U>.
If the Auditors determine that any Payment would be nondeductible by the Company because of Code Section 280G, then the Company
shall promptly give the Participant notice to that effect and a copy of the detailed calculation thereof and of the Reduced Amount,
and the Participant may then elect, in his or her sole discretion, which and how much of the Payments shall be eliminated or reduced
(as long as after such election the aggregate present value of the Payments equals the Reduced Amount) and shall advise the Company
in writing of his or her election within ten (10) days of receipt of notice. If no such election is made by the Participant within
such ten (10) day period, then the Company may elect which and how much of the Payments shall be eliminated or reduced (as long
as after such election the aggregate present value of the Payments equals the Reduced Amount) and shall notify the Participant
promptly of such election. For purposes of this Section 16(d), present value shall be determined in accordance with Code Section
280G(d)(4). All determinations made by the Auditors under this Section 16(d) shall be binding upon the Company and the Participant
and shall be made within sixty (60) days of the date when a Payment becomes payable or transferable. As promptly as practicable
following such determination and the elections hereunder, the Company shall pay or transfer to or for the benefit of the Participant
such amounts as are then due to him or her under the Plan and shall promptly pay or transfer to or for the benefit of the Participant
in the future such amounts as become due to him or her under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iv) <U>Overpayments and Underpayments</U>.
As a result of uncertainty in the application of Code Section 280G at the time of an initial determination by the Auditors hereunder,
it is possible that Payments will have been made by the Company that should not have been made (an &ldquo;Overpayment&rdquo;) or
that additional Payments that will not have been made by the Company could have been made (an &ldquo;Underpayment&rdquo;), consistent
in each case with the calculation of the Reduced Amount hereunder. In the event that the Auditors, based upon the assertion of
a deficiency by the Internal Revenue Service against the Company or the Participant that the Auditors believe has a high probability
of success, determine that an Overpayment has been made, such Overpayment shall be treated for all purposes as a loan to the Participant
which he or she shall repay to the Company, together with interest at the applicable federal rate provided in Code Section 7872(f)(2);
provided, however, that no amount shall be payable by the Participant to the Company if and to the extent that such payment would
not reduce the amount subject to taxation under Code Section 4999. In the event that the Auditors determine that an Underpayment
has occurred, such Underpayment shall promptly be paid or transferred by the Company to or for the benefit of the Participant,
together with interest at the applicable federal rate provided in Code Section 7872(f)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(v) <U>Related Corporations</U>.
For purposes of this Section 16(d), the term &ldquo;Company&rdquo; shall include affiliated corporations to the extent determined
by the Auditors in accordance with Code Section 280G(d)(5).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">17. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) <U>Other Terms and Conditions</U>. The
grant of any Award may also be subject to other provisions (whether or not applicable to the Award granted to any other Participant)
as the Committee determines appropriate, including, without limitation, provisions for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) one or more means to enable
Participants to defer the delivery of Shares or recognition of taxable income relating to Awards or cash payments derived from
the Awards on such terms and conditions as the Committee determines, including, by way of example, the form and manner of the deferral
election, the treatment of dividends paid on the Shares during the deferral period or a means for providing a return to a Participant
on amounts deferred, and the permitted distribution dates or events (provided that if Shares would have otherwise been issued under
an Award but for the deferral described in this paragraph, then such Shares shall be treated as if they were issued for purposes
of Sections 6(a));</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) the payment of the purchase
price of Options by delivery of cash or other Shares or other securities of the Company (including by attestation) having a then
Fair Market Value equal to the purchase price of such Shares, or by delivery (including by fax) to the Company or its designated
agent of an executed irrevocable option exercise form together with irrevocable instructions to a broker dealer to sell or margin
a sufficient portion of the Shares and deliver the sale or margin loan proceeds directly to the Company to pay for the exercise
price;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) conditioning the grant or
benefit of an Award on the Participant&rsquo;s agreement to comply with covenants not to compete, not to solicit employees and
customers and not to disclose confidential information that may be effective during or after the Participant&rsquo;s employment
or service, and/or provisions requiring the Participant to disgorge any profit, gain or other benefit received in connection with
an Award as a result of the breach of such covenant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iv) the automatic grant of a
new Option (the &ldquo;replenishment Option&rdquo;) to a Participant who pays the exercise price of an existing Option in Shares;
provided that the replenishment Option shall cover only that number of Shares that is used to pay the exercise price and shall
expire at the same time as the original Option to which it relates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(v) restrictions on resale or
other disposition of Shares, including imposition of a retention period; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(vi) compliance with federal or
state securities laws and stock exchange requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) <U>Employment or Service</U>. The issuance
of an Award shall not confer upon a Participant any right with respect to continued employment or service with the Company or any
Affiliate, or the right to continue as a Director. Unless determined otherwise by the Committee, for purposes of the Plan and all
Awards, the following rules shall apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) a Participant who transfers
employment between the Corporation and any Affiliate of the Company, or between the Company&rsquo;s Affiliates, will not be considered
to have terminated employment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) a Participant who ceases
to be a Non-Employee Director because he or she becomes an employee of the Company or an Affiliate shall not be considered to have
ceased service as a Director with respect to any Award until such Participant&rsquo;s termination of employment with the Company
and its Affiliates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) a Participant who ceases
to be employed by the Company or an Affiliate of the Company and immediately thereafter becomes a Non-Employee Director, a non-employee
director of any Affiliate, or a consultant to the Company or any Affiliate shall not be considered to have terminated employment
until such Participant&rsquo;s service as a director of, or consultant to, the Company and its Affiliates has ceased; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iv) a Participant employed by
an Affiliate of the Company will be considered to have terminated employment when such entity ceases to be an Affiliate of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding anything herein contained
to the contrary, for purposes of an Award that is subject to Code Section 409A, if a Participant&rsquo;s termination of employment
or service triggers the payment of compensation under such Award, then the Participant will be deemed to have terminated employment
or service upon his or her &ldquo;separation from service&rdquo; within the meaning of Code Section 409A. Notwithstanding any other
provision in this Plan or an Award to the contrary, if any Participant is a &ldquo;specified employee&rdquo; within the meaning
of Code Section 409A as of the date of his or her &ldquo;separation from service&rdquo; within the meaning of Code Section 409A,
then, to the extent required by Code Section 409A, any payment made to the Participant on account of such separation from service
shall not be made before a date that is six months after the date of the separation from service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) <U>No Fractional Shares</U>. No fractional
Shares or other securities may be issued or delivered pursuant to this Plan, and the Committee may determine whether cash, other
securities or other property will be paid or transferred in lieu of any fractional Shares or other securities, or whether such
fractional Shares or other securities or any rights to fractional Shares or other securities will be canceled, terminated or otherwise
eliminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) <U>Unfunded Plan</U>. This Plan is unfunded
and does not create, and should not be construed to create, a trust or separate fund with respect to this Plan&rsquo;s benefits.
This Plan does not establish any fiduciary relationship between the Company and any Participant or other person. To the extent
any person holds any rights by virtue of an Award granted under this Plan, such rights are no greater than the rights of the Company&rsquo;s
general unsecured creditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e) <U>Requirements of Law and Securities
Exchange</U>. The granting of Awards and the issuance of Shares in connection with an Award are subject to all applicable laws,
rules and regulations and to such approvals by any governmental agencies or national securities exchanges as may be required. Notwithstanding
any other provision of this Plan or any Award Agreement, the Company has no liability to deliver any Shares under this Plan or
make any payment unless such delivery or payment would comply with all applicable laws and the applicable requirements of any securities
exchange or similar entity, and unless and until the Participant has taken all actions required by the Company in connection therewith.
The Company may impose such restrictions on any Shares issued under the Plan as the Company determines necessary or desirable to
comply with all applicable laws, rules and regulations or the requirements of any national securities exchanges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f) <U>Governing Law</U>. This Plan, and
all agreements under this Plan, will be construed in accordance with and governed by the laws of the State of Delaware, without
reference to any conflict of law principles. The parties agree that the exclusive venue for any legal action or proceeding with
respect to this Plan, any Award or any Award Agreement, or for recognition and enforcement of any judgment in respect of this Plan,
any Award or any Award Agreement, shall be a court sitting in the County of Los Angeles, or the Federal District Court for the
Central District of California sitting in the County of Los Angeles, in the State of California, and further agree that any such
action may be heard only in a &ldquo;bench&rdquo; trial, and any party to such action or proceeding shall agree to waive its right
to assert a jury trial.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g) <U>Limitations on Actions</U>. Any legal
action or proceeding with respect to this Plan, any Award or any Award Agreement, must be brought within one year (365 days) after
the day the complaining party first knew or should have known of the events giving rise to the complaint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(h) <U>Construction</U>. Whenever any words
are used herein in the masculine, they shall be construed as though they were used in the feminine in all cases where they would
so apply; and wherever any words are used in the singular or plural, they shall be construed as though they were used in the plural
or singular, as the case may be, in all cases where they would so apply. Titles of sections are for general information only, and
this Plan is not to be construed with reference to such titles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(i) <U>Severability</U>. If any provision
of this Plan or any Award Agreement or any Award (i) is or becomes or is deemed to be invalid, illegal or unenforceable in any
jurisdiction, or as to any person or Award, or (ii) would disqualify this Plan, any Award Agreement or any Award under any law
the Committee deems applicable, then such provision should be construed or deemed amended to conform to applicable laws, or if
it cannot be so construed or deemed amended without, in the determination of the Committee, materially altering the intent of
this Plan, Award Agreement or Award, then such provision should be stricken as to such jurisdiction, person or Award, and the
remainder of this Plan, such Award Agreement and such Award will remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ADOPTED BY BOARD OF DIRECTORS: December 15, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="tproxy1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="tproxy2.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 55; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tlogo.jpg
M_]C_X0KA17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    <    <@$R  (    4
M    CH=I  0    !    I    -  "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P($-3-2!7:6YD;W=S #(P,38Z,#<Z,C@@,C$Z,S<Z,#@      Z !
M  ,    !  $  * "  0    !   !5J #  0    !    5P         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
M @$ !     $   $N @( !     $   FK         $@    !    2     '_
MV/_M  Q!9&]B95]#30 !_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)
M#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ *0"@ P$B  (1
M 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M:RVGU?\ MQ:/U>Z%G]/^IN4_)HL9=EY-+JZ2QWJ>E4::F/LICU*][FVV;/\
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M[1(.4&AO=&]S:&]P(#,N,  X0DE-!"4      !
M.$))300Z      "3    $     $       MP<FEN=$]U='!U=     4
M0VQR4V5N=6T     0VQR4P    !21T)#     $EN=&5E;G5M     $EN=&4
M    0VQR;0    !-<$)L8F]O; $    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0   #A"24T$.P     !L@   !     !
M       2<')I;G1/=71P=71/<'1I;VYS    $@    !#<'1N8F]O;
M0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O
M;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
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M9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M %-C;"!5;G1&(U!R8T!9        .$))30/M       0 $@    !  $ 2
M  $  3A"24T$)@      #@             _@   .$))300-       $
M>#A"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-!         (  3A"24T$ @      !      X0DE-!#        (! 3A"
M24T$+0      !@ !     CA"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      -)    !@              5P
M 58    * %4 ;@!T &D = !L &4 9  M #$    !
M      $              58   !7                      $
M                $     $       !N=6QL     @    9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<   !7     %)G:'1L;VYG   !5@    9S;&EC
M97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L
M;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%
M4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%
M4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q
M    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL
M;VYG    5P    !29VAT;&]N9P   58    #=7)L5$585     $       !N
M=6QL5$585     $       !-<V=E5$585     $       9A;'1486=415A4
M     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4
M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!0
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MSF],Z?3U_K.==F.?#"7M<TPX>]S*-KR';6TLK]BL?4O=^T<T/,O%;0X^)#[
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MDI__V0 X0DE-!"$      %4    ! 0    \ 00!D &\ 8@!E "  4 !H &\
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M<&%C:V5T(&5N9#TB=R(_/O_B#%A)0T-?4%)/1DE,10 ! 0  #$A,:6YO A
M &UN=')21T(@6%E:( ?.  ( "0 & #$  &%C<W!-4T94     $E%0R!S4D="
M               !  #VU@ !     -,M2% @(
M                                        $6-P<G0   %0    ,V1E
M<V,   &$    ;'=T<'0   'P    %&)K<'0   ($    %')865H   (8
M%&=865H   (L    %&)865H   )     %&1M;F0   )4    <&1M9&0   +$
M    B'9U960   -,    AG9I97<   /4    )&QU;6D   /X    %&UE87,
M  0,    )'1E8V@   0P    #')44D,   0\   (#&=44D,   0\   (#&)4
M4D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M
M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="($E%0S8Q.38V+3(N
M,0              $G-21T(@245#-C$Y-C8M,BXQ
M                                              !865H@
M\U$  0    $6S%A96B                      6%E:(        &^B   X
M]0   Y!865H@        8ID  +>%   8VEA96B         DH   #X0  +;/
M9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H               6
M245#(&AT=' Z+R]W=W<N:65C+F-H
M                             &1E<V,         +DE%0R V,3DV-BTR
M+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M+DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'
M0@                            !D97-C         "Q2969E<F5N8V4@
M5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ               L
M4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M                                =FEE=P      $Z3^ !1?+@ 0SQ0
M ^W,  03"P #7)X    !6%E:(       3 E6 %    !7'^=M96%S
M  $                        "CP    )S:6<@     $-25"!C=7)V
M    !      %  H #P 4 !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!>
M &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X L@"W +P P0#& ,L
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M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __
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M6&AXB)BHN,C8Z/@Y25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOK_V@ , P$
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MP'A$QE^:GQ7B^W:9)C)WWUB@A>G=XYUE)W-Z##)&RM?])!!^GOW7NC,9C?\
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M+!9E;,Y0,I_;Y# F_P#6_OW7NOI?_+0 _P F7N0%5L?@!D05T@*0>E8 1I
M M_MO?NO=?.X^+5%1K\E?BP5I*52GR#Z&T%:>%633V/MG2494#(1I'((O[]U
M[KZS/OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>X<>O>_=>Z][]U[KWOW#CU[KH^]$ BAZ]]G5;_\ -:1'^%F_U=%=?[R]
M>:@RA@=.\<2?H0?<K>R)(Y_VB)D!!C<9^:G_  4ZC'W=9!R-N[EBM'0U'K4=
M:_7P2AA7YI?&AT@@5U[)G0.L48(4[*W>VD,%O<$\?D?CZ^\H?>2W4^W.\O';
M3J(R,D )\:C&:T],=8X^U9D?G_9F,Y92M:?[4G/6Y#Z;?[#3?_8V_P!O[P&#
M2:2:'5J_E7_-UFUIP(:8IU__T]_5F"*6)L%!)_QL";>]%-; =:!H.JT?YG#U
M%=\8:S(TY!@V]VAL&MK5 U:*2JGJ\/'(_P"52*MRL3$\VL;\ D2][./'9<[P
MK,0#/:/&OS.I6I^P'J-/=)'N>5)3$"?"N$8T\A1A_A(_;U1C@LZP91J)Y( 0
M_D@652+G5S8?X^\HI;(J;A2,$:?LS7J";>[$ETMQJPZT'V_9U>-_+SZCA3:3
M=XY^C,N6W#+D<5L9JA%*4.VJ>9Z6NS=)'J.FJW%6QR1B:P/VD*A;I(2V+GNO
MS#]1NT7+T#_H6_Q4\VXT^P#]I(].I^]OML(L%W&=>]J@5]/,C[3C\C^5F8'U
MO_3ZDW^MR?</B3]=D(P!CJ0Z*&+GRZ1V^]B[7[*VKFMD[UPM'N#:^>I)*/)8
MRM0-'(CKZ)X) HFHJZDD(E@GB9)8955T8$7"K;MRW+:-R2]LY&252"K#RIY'
MR(/ @XITFN[2VW.!K>=0T1X@C]GV$>1_PBHZUR/DG\6*_H#L6?;43Y#+[.S$
M)R^R=P5<2F>MQP/AJ,5E)8HT@?+X20!9V01^=9$G9=4GO,'D/GF+FS;7N;EE
M6_C #**\?4#T/$?L)J#UC?S5R@^Q[@D$()LGR#\B3Q]"//\ S=%];:"E71X=
M2R)I=6A5U=-08Q.&M^U+ILUOZ^QFVZ Q.Z?[DK\(_P -?+]O0>^@)>2 ?#3!
MZM9_E\?(/.X+*8[X_;XKC6[<K()_]&&3KY)'K\-7Q:YYMF25,KWJ,550JSX^
M_KAE5H;E&C @+W3Y-4V\G-6W*#(<S@"@_P!-3U'GZCYC,M>WG,[:UY:N2= !
M"DUQ\L^1S3YGY]7+*00"/I;_ %O]X]P%U,-*8Z#?N'M#9_2/5O8/<78.1&)V
M-U?L[<6^]V9#0\TE/@]L8NIRU?X*>,%ZJJE@IBD,2@M)*RJH)-O?NO=?/%^5
MO\ZWY_?,3?$L>R^S-\?'_K;-9),=U]TIT%6Y' [GJJ3+5T%)@:7<6],(S[\W
MAOG(AHBT5'/2TB54A2GI[$*?=>Z K?':G\USXLUVV=Q=I=G?S ^B:K<%5.^U
M,GV=O7N+ X[<%310Q5$\>/@WO55>VLS4QPLLK134]0Q0'TE5<#W7NMG3^1-_
M."[?^6._,]\2?E9EL1N[M+%[&J]\]6=MT&&I=N9+?N"VK48S%[KVMO3$XV*+
M#3[MPU-DZ7(4^0IHJ;^(4AJ/+%Y:=G?W7ND__P *&OG/\NOB/VQ\8,%\:N\=
MP]2XC>^P>Q\MNRBPN%VGEHLU7X3.[>I\;4S_ -Y<#EY(WIJ6LF11"T0.H$WM
M[N@!J".M=4K;!_GM_P QC#=/]O=9R=L;F[([H[=W+LC#]:=E5^U=IY#*]1[3
MH\9F:?=M+U[M+;VUX$W'V/OC*U=.E'-6TU;!CTIRZ0O(5M4BA(ZWT1.I^:7\
MPCK_ '\^;R_RK^86S^RZ">'+5D&\^S.QZ/)Q-5G53U>0V-NZH.!J<95NI84\
MF-_A\BE@B+<VUU[K=R_DA_S/\]_,"Z<WIL_NF3"Q?);HJJPU-OJLPM%#A\=V
M/LO<<-1_=+L_'8. B#$U5;58ZKH,M2TZ_;4^1I=46B*>)%]U[I(?SJOYNV3^
M .'VETWT)2;8W#\G^TL/7[CBK-RTLV8V]T_U]$SXF#?&:P=-/1#.[DSF8+Q8
M/'3S>!VI)ZBI5J>'QR^Z]UJ&8'Y ?S7_ )C;GW9E]A=O?.KO?/X%8<ONVGZ7
MSW9HPVU:?(M4/1/4[;ZJ;![8VS3U061*: 4X/BC_ &U8:C[]U[H0?C%_.0_F
M&_$3>\<U3W%OCNS:V)RE5CM\='?(O*Y?=Z5O\/K'3/8NAW)N'7V!L'=U%)3R
M0K(U1+!#4*J3TK)J5O=>Z^A'T/WYL#Y0_&S87R ZPK'K-D]K=<P[NPRSD&NQ
MC5V.F&3P&6 )6+-;;RL4]!6(#9*FG=02 #[]U[KY/NX?^ 6Y?^H_<_\ [NLF
M/;U:QG[.M>?7TM?EI_VYF[C_ /% <A_[Y:#VSUOKYX7Q;_[*4^+7_BPG1'_O
MQ]M>W4^'K77T\_E]\GM@_#7XZ=K_ "2[)2HK-L]9;=DR?\#Q]3!!EMUYRMJ(
M,5MC:6&:;]L97<FX*V"CA9M2Q&0R$:5:S5*XZWU\_KY$?S<?YD?S3[*2@P_;
M79?6N-W3EZ?#=>_'SXO5N>VR$EG9FQ6&@S&U4C[&W_N9]3>::6JCCG;7HIX8
M52,6':V1U[H+,Q\E/YJ?P\[!Q$&\^[_FUT3OR6A&=Q.W>Z-P[_GI\WAHJNF2
MKKTV9VQ_&-K[DPXGT03D4TG@$BKJ0L@.W()%.O=;CG\EK^:_7_S#=B;SZY[C
MH,%@?DWTY0XK([M.VHGQNW.SMD9EY*/%]D[<P\TU1)A*NGR=,]%EJ!)9(:>J
M:*6)A#4)'%3(^$=WEU5Z%6#&BTZ"S^8C\O/DQT]\J]S;&ZT[;S&T=G46R^O\
MG18*AQ.W:VGAKLO0Y*?*U)ER6)JZDO630+?4Y5?[('T.5?LUR%R?S%RDE[S#
ML22WIFF&O4X^&E!A@#0D^7V]8R^ZG//-^Q<T2V6P;RL=FL4)TLH)[ER<J>(S
MT7"#^8Y\O]P]6TG4^V]W[FS'8V7W/NC+9SL7$X#&Y'?(VH\6)3 [7V?18;"R
MT^*I\7)#42U^3EHY:C]Y4C:*^L"I_9+E*QWF;>MQ:UBV:/0$A=R$K0ZBQ+58
MDE:"H ID$]!Z+WBYHO=LBVNT$DN[OJU2(M7 P J@+1:4)KQ->(IDKV,^2?R9
MVIN!\UCN]^ZL1N+'5TZSQYG>NYZXQUL$A%509?;>Z*FKH91$S!7@J(/0I T*
M"/8\_J%R%NT (V&R?;=- R*H05\U*T-?,$'H$KSASEM>XNPWF5-Q8]RL6\1J
M>3 X^6<>75@O9/\ -2[W[*ZFZYV'U5CI]L=SY6DS</;.YMH[<J\QD'3&ST]-
MAY>N<:1E%Q@W'CY6JZVH\<[XV=#!$RDB3W$6U^R/+>R;YO>Y\PSB38(I +=6
M8#74FID)IJI@)D CXJG'4JW_ +P;_NFTP6>Q[=HWQ5(G*YH?+0 33U)XUX4'
M5?6/^2/R:VGN%\K3=Z]U8G<^+KG:HCS6]=RY"2GR,1)EI,QMO<LTV/G14===
M-54[*WXTAPXEJ?D'V_W2P2T38[=8Y4&ET5#2H]1D?:*?;U%D7.G-^TRB>;<)
MVND<L06:O&M#4]PQP-0.MG[X'?)O*?*;HBDWIN:BQV.WYMG/Y#9.]X\0DD>+
MK\OBJ>DJZ;/XZCD:26@H\[CZ^*?P%F\,_D12452<+/<KDS^I/,<VTVTQ^D>C
MQD\:'!4^I!X'T(KFO67/M]S9_7+ER/<YE"W2G2X&,C\7RKZ#S!^SH@/\PC^8
MUOOK_?><Z!Z R6/P63VY'2TO8'9L<$67S&.SM53+6R[2VC354;XFBK\90RH:
MZLFCJ9%E<Q1I')'(XECVF]FK3F"QM^:^9:C:96(2+AJTX#'S(-#0"@IG..HU
M]T/=:[V._/*NQ"NZ: 6E_AKY \ 16A/$<!3JJ^EW=\W=W;:R/:]#NOY5;CVA
MCY*JHRG86(W!V3+MBF./+1Y"8Y'#U%/AX*>@=")S$J10.IU"P(]S&=J]F[2X
M;9)OI$W)SI6(K&#CS(IY]1(NX>X5Y:MS#"+AXK45\2KD5/E6OET<OX6_S+.U
M=I[\VEUQWWO!M_\ 6&Z\K18&/>FY3 ^[]D5F6:&EP^1JMP0F+^\&V9ZVHBBJ
M?NHGE@CE\@F(5E(!]QO979WV.YYCY="K?Q=PC0 (]*\%% K4\Q3-*CH=>WWN
M[N4NYV^U;]E)6H2V66OS.:#T-?.E#U?=\@>Y\%\?.G=]=N;B@-=1;.P[55-B
MX9UAJ<[FZN>+'8#!4\\BNJ3Y?*U$4/E*-XU<O8A3[Q?Y8V&^YFWVRV)64F9A
M4T^$<6)'R' 8J: \>LAN8]\M]@V.]WR45\-30?Q'@!7T)\\XK3K5#[5^9_R<
M[@W17[FW#V]O3;<5=6^3&[,Z[W%F]I[6V]!,8UI</B*3!3T=?7R4Y(C%14M5
M5-2X,C$,P"9S<O>UO*.P[<+=]GCN&1/UGE"EM-,G4W ^5%H/(#K#G?/<KF3?
MKOZA=PEMY U8@FH*6\ETBHX5-:5/F>G_ ')\K?D+6]);P^.O=%9O'=>"W6NV
M<WM#)]C4F2H=[[9FV]F:#)RR0Y/+4Z5^ZMNY&DI=&FI,SPS699!KM[2[5R+R
M@G,5IS?RF(XGM59'2,@J25(K05 -#Y4J.->G+_G7FN^Y:ON7^:R[B=U=&8$&
MBFM 33!IP/Y4Z:_@MQ\U/C2/I_QDB6XX/_,$[P)^B1CZ_P!%7_6][]W'9O;K
M?F)-2B?]7$Z<]J#J]PMK-*=I_P".MUN0?D^\!#P3[#_A'6;OEU__U-]?<%>M
M'2VN+NK6%[<6M?\ WCVKM$UR#TKTS*VE:>?16NUMJXON/8'9/3F7E1(^R-I9
M+#8NH:01I1[FIT%9MNIDF/\ FO'EHHV0KZF9=/Y'L8[9=2;)NVR[U'$3';3*
M[TK\%:/P_HUZ#^Z6L>Z[5NFTJP^HFB;2/L&/^- =:N"#.8++9':F=IJK#;IP
M^9EVOF*&JA,%;C=P4^0.(K*=HFY2:EK0S*MB2@5O[2ZLU7N(+_;#N5FX>TF1
MI%89&$K0GR..L2;;Q+>]AVVY4QS03:6+5J:M2E./GUN0=?[5H-D;(V=L_%P)
M2T&V-K8/ TD"VM'!BL;3T: 6O<ZHR6/]HFY/OGUN5T][N-Y>S&L\LC$G[6)_
MS=9H[?;+9[?#;Q\%10/V9_G4]+$*U_U BW(M]3[0J!0J1WCSZ6*1H (SURT\
M?C_;<?[W[\-=,D$]5T@? *=%1^8?6U'V!TMG:EJ=9<OLJ6'=^&F"$S0?8 0Y
M>%2&&F&IPTLP=>02@;\"PNY)W:7:-]M'4E8)#H90:5J:BOY\/MZ#G-.WKN.T
MW,1(^H0:@U/V_M''[.'5,?\ <_@$)<'D$6'X4V)!Y]+#GWDU/>A;ES$:$H""
M?*O'J%8;4-:1KKK,'()^76:FVY7XNII<MC)Y*+)8JLI<KC:R'2)Z+)8V1:JC
MJXY-0=)(Y8E(M8$7O>_MB[N!?6WT,N;9\./X@>-/3IZ" 6K^/!&5N1^+K8AV
M?GO[S;3VSN+2B-G<#B<M)&A)2.2OHH:F6-#876.60K^/I[Q)OX1:7MS;"NE)
M64?8":?RZR M)C/:P3-\3("?MIG^?1:_G;\71\U/B=W)\77WY6=8Q]NX7"X2
M;?-!AX-P5>!@Q>[=O[FFEAP]378V"M-;%@VIBKS(H$Q)O;24W2CR!ZHW^+?\
MA;ISX _)'J;Y==K_ #+Q.Y=L=.Y;<.<I=L]E;#V=U[MFMW+D-FY[;NWLS_>C
M([O>*BRFU:K*_P 0IC'$SM) H%K CW7N@*_X4#?S'/AKWU\6L3\9NCNVMJ=V
M=I5O<.P-Z5E9U])_>';.P\)LNIR%9E*K*[NAB_@B9;-0,:&GHJ:JDJI8YI)&
M7Q(P>X2N:XZ]U3E_(9=X_P";9\4@DDB"3'=^Q2!'91+$>A=_OXY +:X]<:M8
M\:E!^H]Z9=(K7KW5F7_"J,6[L^&H_IUEV[]/I_Q\.U?Z\^[IP/V]:/0"?\)F
M^F=N=A_.CM'LW<6.BR-1T'T1#E=F&I@6>GQ>\>U]V2;:.<A65'CCRF/VMM/(
M00,O*QY%WL&-S5UXFO7NK"_^%2_2^WZGIOXP_(:EPM/'O;:_;>0ZFS6X8(HH
MJNMV3OG:><S5'B<K41J)<A!B]T[;@>B21F2G>IG9 IE:].M]5<?\)M=XUFW/
MYE$FVH)VCH^R/CIVA@\C3B<QI6-MC,[/W;C-<(*^>2C>DG,9_P!UB60BVH^_
M=>Z*/_.9W_7=D_S1?F!D*VJDJ5VGO? =98PEO(E+B=@;-PF/AHHG/I$4>0R%
M7($Y"2RO_JC[]U[K;V_X3T=4;>Z^_E@]1;IQN-IJ7.=T[E[&[5W9EHHX5K,S
MD:_=N5VWAY:NKB*SO#B-K[=I*2G4M>.*'CU%B?=>ZU6_Y]O6F#ZR_FD][+MV
M#[.C[(V?U/V_7T\02*!=Q[MP62P>X9X4ABB4#(9'9QJY3ZGDGJ'9V);W95U5
MSU[K8'_X3+]@Y/<GP$[NZ\KZE)*7JGY =A46W:9>&H<#OG:.W=\- U[V@EW'
ME\C*H%E!8V''O3  D=>ZT7]PBU%N4<G_ "_<XN?J;9K)CGZ<^WC\)^SK77TM
M?EI_VYF[C_\ % <A_P"^6@]L=;Z^>%\6S_SDI\6O_%A.B/\ WX^VO=U:@I3K
MW6W3_P *GNS<KB.@_BMT[25GAQ'8W=6YM[[DI #X\A3=3;.:7!Q5,Q32E/29
M_=T-5H)TF:FC)Y (J#0@]>ZJN_X36==8C>G\QG/[LR])2U<G4/QTWIN?;@J3
M,)J'<N[MT;<V4F5IX?']O/X]O5-?"&UEHQ4A@ 2"+,VKRZ]U=O\ \*<NKL'N
M3X';#[0GH()=V]1?(38)P>7,,0J:; ]@46:V7NG$M+PYHLHM;2R,A)3STT+E
M2T:D545)%>O=:_/_  GJWG5[3_FF]48B">00=F=8]T[&RB*7*U=/C=G#?].6
M"(XTI7;3B9BQ +J" #>]BF#GKU>KD?YKO'S7WB+G_F7/6-_]JMC\SIO_ %LX
M!(_-O>;?L.?^8=(="&EU.*D9SIZPW]Z HY\NGT#^P@_XZ>CZ_P EO8V"CV%W
M3V0:6&7<^0WY0;.BR$L$35>/V_@L'19$8^EJ;:XZ>OK\N\\ZKI\DBKJN%6T4
M?>+NYANVS;?#(R0+;ZF )TLQ>FJGJ!CJ3O8:SC7;-XO)(HC<&<*K!:,JE<BO
M'CGTZ([_ #:L#B\)\Q*ZKQM)#2U&Y^K]D9S-- BQI69>GK,_B$KY(U 0U#46
M/B#ORTC1IJ)"@>Y.]@KIKGDPVUS62W2[= K&H H'Q]E33J.?>NVAAYN#PP1I
M<O;JYD5:-7"G(]3FO1Q_Y*.V,))@._=Y/CZ5]R)NK:NV:;*R1))64N!CP$N4
M?'T]0X,L,-56U1DE5"JLR+QZ?<>?>.W&[.^;;M0G9=M%OK" T[JTU'R)'EZ9
MZ'GL#MNWIMV][D(6;<3/H9V(-12N/0'S]:#HIO\ -ZP^-QGRXQ]704<%+4YW
MI_:F0S$\,:1OD:ZDSNY<;#5U14*))UH:>./5:Y5 /Q['GW?F>7DEXS.YN!=E
M0S'4 H"T 'EDDG[>'0)][B;;G.VDC1! ;:K*!0L3BI/RIT<K^3-D?X;T_P#(
M6MG(^TQ.^L7E3'^D6AV=YIV=N>76E )_HH]Q_P#>+MX;[FCEPE"'DB()KYJX
M4&G[<=#KV)G,'+_,9)[(Y0P'IV%NJ!=TYW*;LS6[=TUU6U1FMU;CW/N&LKW\
M;RR93/Y>MR4U;(TBLLBR5%<TC%@2+6'IX]Y2[38PV-IM5N(J006HT1K@5T\?
M3K'&^N[B[NX[B4ZG>X?7(<DKK./E3'6TSU%\R/@;UQU-U]UK2=_=64F.VEL?
M [;EQ'WE2T(>#$T]-EON:>2@=I36UCRO4%]6II&+?4^\$]WY(Y]W#?=QW9MA
MNWG>Y<JX%*]U1IR.&"*?+K,G:^;^0]OV2SVN/=[=($A4%"&/$48,*&M23JKQ
M)/6KKV11;>H=W=D8[960I\ELZGW?ONGV;E:28U%)DMKQY[+_ -U<C3S21H:B
M*3$_;R*Y4 _4<@$9Q\MPW!V39XMS@9)C&OBA\D&@J&'KQK\^L.>8)88]\OKW
M:FU(6.C3C3G%.KT/YA_9%9GOY>7QAGEJ:N2M[)R/4M;F*BJ/DGK_ .#[!R&7
MK&K&)O))/EHHIM1O=U!]XQ>T.TVL/NQS-,%U+:^.RCUI+0?90=9$^ZFYW#^V
M&PBNE[A8J_E&*_;T1G^5SL7$;X^8>T)<Y0TV2H]D;5W;O>EI*R%9X!FJ""CQ
M>'KC$X*//C*G*F:$V)250PY ]RG[X[O>V?(\T<4[(]Q=JE4.GM(J0?4$"G4=
M^T6WQ7W.=L94C>"VMF>C+6K< 17A0GJV#^;[L/'9[XP8[>DE%#-G=@=A[7J*
M'*&*/[FDQFX7J=OY.D%1;RK25<U;3LZJ;%XU-N/<%>PVYWEOSNFW03L+.ZC8
M,IR*H-0-.'RZF3WJVZVNN4&W":)?JK:12"!FCG217C0<?RZH_P#@HH'S2^-%
MN O9,J!; 6MLC>%@+6' ]Y&>\3 ^WF_.!AM(IZ4D3J!O:@:?<+:E_HG_ (ZW
M6Y#_ %/^^_'O ,BH'R-/Y]9N^@Z__]7>=[&KS224\9_0]$6%S^1,]^>238#V
M=[/$)26\Z]%E\Y05KT57<F;DCD,T$S0SP2>6":,GR0SKS'.EF"_M6N?S^1]/
M8_M;;5%)1-0/;I]:]!:>=VE1X7TS)FOJOI^?1$_EE\<H_D77GN?J"EQE)\@<
M%%CI]^=<"2*AB[GQNW&I9Z//[0J)&AITWW1XN#P-!(5-=3QK&"LD<3L..5.;
M)^2K*_Y:W-R_+=VC:914FV=@0$;T0M3N'PZN[' $\W<KP<V7UIS!LX$>[P.O
MB1$@>*H(J1PJP'E^( 4[A0WLX6MDK\5B:R:GGHYJW%T%5-154+4]71RU%'%.
M]+54\C-)!/3EBKHQ)5Q8GWCA.-,Q%?Q-^>>->IOBS"I_HC_!T[CVT/B;\NK#
M@.N_=NM] YOC?FQII-T=7U.XL5+O6MZZW/N1]IQSK/EDVW3T@I*C*U=/%Y/L
MJ-IJV)$,S1F4MZ ;&QEM]AN!-C?-&1!XZKJIVEBV /4CY8Z+;F]M%GN;*5AX
MGADD>= ,DTX8X5SYTH16K2+9X6&)=!4A$N"@Y'C01D\CFP/^O[GUMQ!$2@_J
M*@!]>HP7;X5:5DX%CUD_N@H4L8V;@DV3@A0?Q]#P/>AN#5\^K&S2AZMBZDHY
M<?UCL2BG6TM/MG%1D'C2BTRF/_;1D>\?]Y8/N5V0W&4]2EMXTV4  P$'1-_Y
MI/S5G^ _PV[%[\PF&H=Q;_2IPFP^J\+E?+_!:SL?>]8<7@)\[X"*B3"X5%FR
M%3%&5>H2E\(:/R>1$-#6OETM' =?/BVM@OF#_-2^4VU>OLSO?<O??>?9^2R$
MR9KLG<5=!LG9&V\?%'D=R9V7%11RX+8>P-J8A"QHL10 O)XZ:*":JG!/NO=6
MH?S!_P"2%M'^77\%<UWYN/N_/=O]OOV5TWLRDI,/MFAV!UEM>CWEN%<9NL4F
M#7(YS/;LJWATQ4M355E(D6D2BE5BR^WE:M ?3K716/Y#G_;VSXG\?\H7?G^P
M_P",!]A?X#WJ3@/MZ\.K-/\ A5)_S.[X;?\ B,NW?_>AVK[]&,$UZ\>HG_"5
MW+4D7?GS+V^_E%97=/=,YV'F/PO246]>P\35#1<R&6*6HAMI]*QNNKDCWM^
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M:P..F;_CAZF;WC=?ZB;H?Z47_'^J O@I_P!EI?&D7O;LB4\?2_\ <G> N/\
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M3C&S6)PTA734S;1V;1N,B48I3ODH5-I'<#WEDXZ]T>3^:Z1_LZ^\A=;CKKK
M$7%Q?'Y@+JN>+D^\X?N_FX7D!$M[?4GU$]?/^'_)UAC[W_4#GJ<AU$7@P?\
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M<8<V\]\R\YB*/==R:.V1PPCB ""A!R&U5_.M/*G4@\M<C\N<JF23;+!3</\
M$[Y:GR( IQ\AGS-.C</3B>&2EJ((YX)H'@FBGCCD@FAEO%)%-$VN.2-XF(9&
M!##@WO[!X.EQ**^,O USZC/K\^A;I765"@6Y&5IY_P";Y=59=E_R@_C3O?<5
M7N#:N7[!ZF&2K*BMK<!LFNP%1M>.>KE,]0,7BMR8+,'#0-*S$14[K @(54"
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M_P"0 #Q[T7H14]; IUS]^K7(ZWU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:WO\
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>Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tsig.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tsig.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ , #E P$1  (1 0,1 ?_$ &P  0 " P " P
M       ("08'"@$$ @,% 0$                     $   !@(" @(" @$%
M 0     " P0%!@<!"  )$1(3%!46(1<Q02(C- H8$0$
M    _]H # ,!  (1 Q$ /P#MAU,VNK#<RH07/4R*<-,?*F]AUP\Q^R(BO@TX
MC,WJV8N\%FD=D<:<!FG-[@U2!E.+R'!@\>/'G.!X$ (27X#@. X'C(@XR'&1
M8QD>?4.,YQC(A8"(7J'&?\Y]0YSXQ_IC/ \\!P' <!P' <#3I5^U0;L MU<#
M*@8O)!3K9?AT(&V.X#!U0ZS5VKQ-*B'D2##">6"7LQJ0U,%5E85D18Q%8+,
M/(>[>5S0/7:G+-O6SW3\-7]30F0SN5K@ P<JPTQUN/<#D;:D]@C<'ES&2%,A
M2E^35:PXLDO&1C#C(5R],R2YW#6FWK2V(7(2KLOK</9*X;#@#:]XDJ2CG9WE
MB2+H:%$^EJ%*5:YU(PQ%(T.)1 LE('(A0CQD8DPC!A;?P' <!P' <!P' <!P
M' <!P*G.O%X>"-L.X6OS$A#;%(MO-!Y1&&TEM WA LLS3W7*1R]T+$ !6%)<
MADI!RTPS ?!BPY0;D0C#3!9"V/@1NW%F$WK_ %0V/FE:&'IK"CE*62YPES(.
M;TV6&4$Q-TPR2<]0ZD*FPA#%G 1;BH&>484%.E'D0!8QG&0U/UC2RR)[U[:;
MSJW'J522Q9KK[7$NDLCFZ@2J72$^2L"5Z0OL@/,Q@X;F\-2TA29\F,&AR;X'
MC \9QP)T\"@ZSA2W9?NUUA@?W'(V+:;5Y8.R\C;H_)7<AC@L>F$3?*<JQ+-V
MU/EIR3:-[SB5NKEAJ<4YWT8C 4IR48RWE=Z!?CP' <!P' <!P*9(JM')_P#T
M"6^H:&]Q.;JKZFZBA<S=C" %-R"26)M98LUB+82<([)JHQUC\?7FX$$'H'*0
MP.<^<8\AE&\#JR;+;5:W:*"? (X%61K+V"[CCPX@1-@*?H^5"_H*LI0(PL:4
MQLM?8)L3O2H@T9>!,L$78'Y =C @V;U"B>W3KHUGGLH<X\^2JZ(U)M@)*^1=
ML"TL[J[7Y/I7;PSTR? SAG82))D2EP>,PT1P4^!^XL9QG@63<!P' <!P' <!
MP' <!P' <"HGK\+;0[V]T9C,X.:I(/;/7X+FD=F]*F-0RD&EE%B><-JQ*N4_
M>8#D)B'"?!I1!Q9H#LBP+ P^ MVX%%O>JFEMTUCJ-H#!9!^ONG8)MM$Z5L-4
MF6I4[L7K?%H=,+'V'4("1IUJT(1P>/!194DDB"0>N) ,9>3P"X%WS&RMD;96
M>.LJ4*%F86MO96E$$PTT*-L:TA*% E":>8:>8%.E( # AB$//CSG.<_SP,>L
MFQ(945>SBU+%?T,6@-<1-_F\SDCD9@I"QQB,-:IY>W-2/_/QHV]&8/UQC(A9
MQZAQG.<8X$ >L>HWE#7EH[B6;"LP>_\ L)L!%LI9$:6F95O4 @ID59XGKW3C
MBX&(6Q0<?6E.-#=A<48E3B*D#BZ9R7C(\\"S/@. X#@. X#@5":9,226]GW;
MQ>Y+\C?$3._:?:L,P4KJYJ,L/]2:_I+4F;*L;U1 6Y$-/*[W&+ DY@L9-^;W
M  7D1H0P4SQ$IZP>XOL]<R)+$9%N-6VRTFK5\(9CH],V;7^I*HDVOFH*E$44
MO,>VW$@8V@,V+,,,3&$*98>>$HO&<"&%U>D<!555IIJ96B]A01=R@.M='1%V
MCK6% % RO$?K.,MCPW)?Q0A-HRTSFF-#[D9$4/./8.<XSYR$G^ X#@. X#@.
M X#@. X#@.!3UUT8SC>3NS\XSC.=U:2%C&?XSD.=(-<\8%C&?Y]19#GQG_&?
M&>!<+P.86/WV_P"V7_I0@3:V-C1)-?=+=8]L*ZKB0-BL#BJ17\D<:2C6PTT7
MHTYN%;.@;S["30)(K4E?14N+0[)TIAAY2H)0=/7 I.VY=,]@NZ$)ZX(J0F>]
M>-<EL V4[&'PMR<@-CJ,8E[OK?J"XHD*I&D>3;0?$ 9A(TJC["=.PL20L8,&
M+0> G?NQO1KOH%3RRX-@I6:VIE)BAH@$!CJ(V069;DU^MDUK@-8PU%Y<9))G
M=2(H@'C!:1,(\ U1Q!6?DP$(HGNYL1K'J7=>\_9L*'U0"?O*%PUBTJB+&(=E
M01O<P*FFHZ-D,F;\R)]LC8^YGAQ;P/)*9*)KCRL6?4!"8I9\ 2<_^N)KK7UY
M*-Q.PY@AE16#!JF>+2N*MZ\<1+VZ./:LYP<XG3457/+TO!*+#,3K&R.8$4KR
MF=9((8DWQD'%  &P["W@H6@M=JIV-VME:+6"/6FBJQ&1&K//%F4L5@6H@:E#
M?6*AJ8"'1<[RQB6N)A#B%"2>4D*1*59HBTA!IP F!P' <!P.3&NKKFT)ZR-O
M3JW<65%LCVE]M^Z6N%"-*HUU;FR$V-?>Q4MH)R>3'U"[(GC*>M*VK5[EY2X
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M'WU(N:UX4;DB)4%?*4+XSR@##X$$.<!FQ98"@ **  LLL 2RRRPX  L ,8"
M  !Q@(0!#CQC&/XQC@?/@. X#@11VUT<U.WH@7]<;64;![ACR?YC&-:_(#$<
MOART\&2Q.T#GC*>V32#/&,9_[+4O2&BQCP+(@^<9"#";H;Z^T2-.WHR]N4C>
MD3$HDB%+V ;ND(TJ-.4$A.D3IBK["22E((!@ "PAP$(,8QC'C' D?KSU2=<6
MJSFVR*C--:(B,S:"S (;%7PE!-;0+R<)(,XT5FSO]EGAAQIB$L61"<,YP(/\
*>/.?(6#<!P/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tproxy1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tproxy1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@$,P,T P$1  (1 0,1 ?_$ +,  0 " P$  P$
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M]0_EW]9<_P#TD.G_ .&? ?4/Y=_67/\ ])#I_P#AGP'U#^7?UES_ /20Z?\
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MN9-$A8$7-EG29(W.;!/+$E#$I DD#,D5E&;3>U*/3@$ 0?E\0ZUX# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M0O 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M2[@,!@,!@1%;7_.::_=Y@GZDRW EW 8# 8# AGHC]@ZSO\6__P!IMV!-RO\
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MT7>\5IIN6L=.P2WXY(J=DLZ>42U%*YQ84)7,STBG$6CBE*I0J80$XHTC9H3
MGB"((?)K8PNQ@,!@,!@,!@,");]_8)NK]R6Q_P#J<\X$"\S?Y-'-O\7FCOWK
M8G@39@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"
MN6O\H3OW]V^F/\T'G_ O+@,!@,!@,#2K*_8ZGW^)4J_4)?@5#X__ ,D3D[^+
M!SW^]##L"Q. P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M4=A;?R90BF3R666M61-TP24Q]I!3&SW2I7NHA'R/YW%^,?3MB%8(Y468E/+
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MX#ZLG3'Y^MB_H^\M_P %> ^K)TQ^?K8OZ/O+?\%> ^K)TQ^?K8OZ/O+?\%>
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M4SBG2+TY2M < 80'E%FAUOP$'6_'6!=/ 8# 8# 8%<H+_I!9W_$FI_\ ?_Z
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M!P3Z"+:(Z\[@0\^U\\3VYT:.(,;-R55ME7O,^=9*_OD"=K%J)QF]S7-/B/G
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M"4>:QNR&/KG LDQG7')]!LJ7MCO".1.L3K8E\-AK9;M5<W71)+D2<LSIX;J
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M*_R]\>G*Q9$>Z3V12*;4?82ISG8R3DR5\4I97SC#5) @DD;T)HWL>Q[5+-J
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ML,.0@\J8T0-A9' 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MX# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MQW[9:7H11ZU,CBRNKTCLXIK;2>GB=2;Y*$,L3%>X"7D4H2VG)EZ>0_*@"Z:
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MX_RUTEUS3\-Z9J>-*&QUD"$^DJ*5%NC+M4K-2+_FZ^E"5)DP=:UH)T]5;U!
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ME^D $90?;K4WB&4(]27C\UU@3,HL-X:GB=N86+W!^KFPV);7STHM5YHU&SW
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M-JL*!#MKTLCW<M1M+\F$]*'M*G,VH2!(^''"1Z#[-WIV\^1&[(#>+[9-FO\
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M.</Z16?UL=_P,!\.</Z16?UL=_P,!\.</Z16?UL=_P # ?#G#^D5G];'?\#
M?#G#^D5G];'?\# ?#G#^D5G];'?\# ?#G#^D5G];'?\  P'PYP_I%9_6QW_
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M6ND2N-D64J<D26\Y7$7A1[=W>'5Y;BA.1B;2\2IOT$Q0K@+LQ=7JEK?G^TF
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M#<X)PJ4IAI.ST+@D-(.!H7F*.*& 6M"#O6@XGSNV+<YNOSNR<*[VMJT(;SY
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M2\M\34TE:N4[HEO.'$]U<>3.!WN&:!I5OD-RQJ"M*2^:LVF@$Q>Q26 *80)
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M=_Q)J?\ W_\ H# OK@,!@,!@,!@,");]_8)NK]R6Q_\ J<\X$"\S?Y-'-O\
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MSSPQGD\H:V"9MYJ2%R*4M$#BLNE1->16PI](&IJ6H:XC$EF"KX6D<%8RA#,
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M P& P& P& P& P& P.>',_\ A5VA_'9L3]YR@L"T^ P& P& P*Y07_2"SO\
MB34_^_\ ] 8%]<!@,!@,!@,!@1+?O[!-U?N2V/\ ]3GG @7F;_)HYM_B\T=^
M];$\";,!@<]SH?26O4I1V(+M9>1TA] 8J[)XL^<E$>P5TS[<<X.=M0TR$BO(
M2$4I3_.+;D!WT'1I7LM#TA\R;82'&N':RB4KKN:H7Z?&KZVZIZ1ZY8B5JMF$
MW++%ZC8+'8)TQ.6BV,DTV(,Z*SUYC424,I86843LY0>'0]##V4]Q/55(=-=
M=415PFBZ;7X$C3C%9 O;5< K/XHZ()-8HJP9TS0B<&'=S39I1/LF]Z5K/?7-
M(6,KV(-;!L-,Y*]/:H^+W:7*ZJ>7P<=D3.XQV(1YQ@5',+E7L9<Y(KE"EJ;[
M3@M4Q*X;!$F<%)9"15*W]\.3(TB<&]F'%[4"#.<E\-0SD6:VC/XU.9Q.YA<2
M>%HI&JD,6J6"-BTJ#K9&N9Y X12DZXK*,RVSWQ3*%&GN7N214_/0"DY9Q^BR
M0AV&N0+ARH <J6?RG]*5@6ASE:2V:@AR,3S />ZC9WV=O$U/C]83J$1-M4O
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M9XDH$:<_1OLCE0U0!%Z+#O8]F:V'P\=>&!Z52Q&A 68M5)DA9IY"4HQ4>4G
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MZ[C=)5XK<;6D:>;0QOE\'D,S8YW*H0RQLQM;7 A0:%W$,8P$%FBT%.W>FNP
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MDX)IM%D$4>%+?#+9@U?U:S2Z IV>2HA)?;L#6Z-ZXQ8C6D%GD"#H+VX# 8#
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MTKB, FD,BT\L=I432%Z=P&GM\?4FQ]7H>DVG( 6PT--H'U/KHF,)I"%37FY
M[])W7!*3E=:-S9:D?C->6*U6A&+ZDCE*Y ^C8GP^IPM#;S=(%6F@">1*CBU;
M<648(TU6!$'L3^LI%/FRIMIQY[G#=0+2FVW/\^U,XNX3%!.P\@/?81\30UJA
M3':>4**+QA>R&NI3P%.-UVE-3@4(CS5*8+N\G=5/_3<)L)[<Z2F523"OWY,Q
MF1>8I9DTM$FT\0MBFT?=(R_SJNJZ?UK6H2OX$*TXQB*+2N"8\)(E:;1"H\*:
M<Q>J'.;1BG/3A:5"(F04_#S3!;>FD.L%M5M,,NOJ2!$V#6K-#X&YMX9'*H$8
MR/++IU=!K2#VM2[^S)3N)*%>K("7ND^W+:H;J!+4$?IF.65"GJIZ0<(X?J>?
M,V3J[AO3ILF@(\T.RM<S/+8V0-I2JBW%8L+3J5@ @,T42>/R%;"&M^KJ4HM"
M15$R<]J)-*S'>&M%9*V&U$:F(3<V3=/,?*SB-TG2F")(>W CLVD*=>>*/+9<
M2!N >2H,2NA(F[8?"CU?VQH"SK)5SM*(FRGU!:DV=7IXG"(+2JM&HT?0.Y+2
MU?R(J*CA4RD W?GIP3)P*W9D?EJ=S2+4;*J1EKC4@>25>J?.V1BL,$TYK?*F
M,C""RF,N5-UFPFR3D5@0[F:'];M#8FC7PAC(<FQQIN:)]*59IY0$<C),0!*5
M)/(Y""V%0=3VU).4+PZ$GU/MRJ6U/9'73*T5K7$F,=54TB'.MRV7 V,ML<'-
MM)T7,7QB@>P"(V6(I2XA\P/8@/"42$"+/5CB+F8_R.M*A=+'IZ&H':P9/:R.
M?QQD0N="M5FH*:W:]9,2YO/4V&J66(@DI1+1[=N]HW1L9X5FU*]O1'AE'CU0
MT0@5:U0FC'B636WU*=NB<=7V"QQIN3N2OIUQYE3[?WT3*[G-K4!W;#7<Y04B
M4FA1@$2 @U1KR["R?5?8C'R>7#39=!WF0!L5@G2&"_!G5$1J27:QE1<==T2B
M$M3@U\Z+A&\KP-"KY2BQ-!^C"_MP8%-IOZGMD#2QTJM>=VSWFRK0BK!3#Q,;
M/;AMT[@4=[<I_C^\G24,S(S;=ZVDC<YVHE61Q.:)S)6)C]'*QIE28YK&&NQW
MU>$[+&$LOFE+2UXJR/(F1+.K9222*(Y("3RFE+,O1A;6:J$:41;DC+8JX&W+
M56W9(%.K7I3"RU!7O8DH7WY3Z<DW0BRY(Y.:C#3TWI65P:-2!B2V(R6<TN15
MA5% [C87-KDC&U,A?E*89\G2J234Q8@*TYNR]FIQ$'FA1BM/5<?WV)Q20JN=
MIE+XFM88VPCG3=,X.V2R6V\_\/F=O-,39ZRV2G0)$CU#F]0RB7&/!)2=\,3@
M 2:F,,/3AK(/5OL5Q=H<Z,7.C YQY;7LY3S6":L]P9[(C-[)NF>7* @,'=2)
MI7\/>8<VJ$W1Z%S=R)#'VEZ2$'@- D&2 @2\+"2GU,6Z+-\.0G4L[N5ASR?7
M[4$;AZ&>,134IM6D.GZAY/)9E,N<FI 2AB<NL2X$BK3R:C")O:TI@QI#5 RD
MPP@N;^J/9E66=8!%T4XV0*M:M::]7/*"OYY$K9F"^4JJH[CG-B1!:Z)#VV-:
M: J^6B M2PLQ XIC!A+=4J,9RLA &[3OU2)W7BJ;PY^Y*6&VU4<5N"QK?AS7
M>D36QJ,UM3]4T]=+B_1J>?-,HJ8OK]"KA3)TC5MO;Q >D9A)QY: TAS,"RO.
MG<"&_+]M^BU59.];+:\2.SW#ELK>QE/MFP]AE9<.<YPR1I5'FI"MB)CFL1C(
M<6!UDJ).%:2F=#FQSWMOT$/W/ZHL3J!IFJ[=0R64N,1L;HBMD[*CEL<:%#\[
M<^@K_2Q2F5NY9*%O22I1824LD:@8"D7DV(\>@BUO03U&.P_?^=^E[HE]9KHK
M*^4%5U,UJ5NWRMNE")1(J:AH)^H20Z=D-K6D?&B311P0')E1[>B.2GJAIU*8
MLY.8' KI<GJ?F5W(II%H5SX\62ZU_'IW-I3L=E1Z((DD+K3FFENFY8X)E"MD
M>#5;X9&+G2MC:@]F *MR3Z$<H2I3=J"0A=J]2:[9%937%#XC%XFD>^L3JKB?
MNN@R!#(J22=6<PTL*0/VSSD;I';*5QNZE7] (&I;RS?Z)_OB@ &'0+JBXK?J
M:;\CH:_10(<%MCI6-5/;;C)AO:J6$,$DBLO<6E% 6E 00T%KE3NQ!,6.*Y9O
M21,1[(E&H&I]NC#!U#=]\RCH3KZLIC&JW5,5.3^BT5<HHL]/*)8BJZR(MMX?
M9)-) ^-6BWF9HB4RAQVVHT*5&4'V: M4>((EYH<XHGVKW*I8&F+609N"VM/)
M55,[=#8G043OM!5/-]J,W0SA$)15<>H.]K)=K[^,S.I$$><U:G3>K8V\Y0^#
M0&-^AJ4@3OZ8-NNE_P!*6I>+XQ%QAYMN_P!98#M'R0G 3M3C): YX<%9"0M0
MH5J"D)AQNS4X!G'#"08#0C#-ZV,0=(@C&#?B 0@;\/#Q"+8=^'\[QUO6_# _
M3WA1_P"?._\ 2C_X6 ]X4?\ GSO_ $H_^%@? CSA:V$1QH@[^SH1@]ZW_MZW
MOPW@?E@,"N4%_P!(+._XDU/_ +__ $!@7UP& P& P& P&!$M^_L$W5^Y+8__
M %.><"!>9O\ )HYM_B\T=^];$\";,!@4NFL$X_A?9]%V _T;%3>O[Y;;0CU>
MWHBB2-3+4K-3U:$N\J:'Z7F.)"]L;!PA;I(C)*3J 'CWL ]%_(9@;K&0\;*K
ME!4T27\]FWY7,VG-W?1TR/<./M&$6%:#<N2V79ID42+S)&T2>8,\Y4:>E8B-
M'F)7;8CM! H#L01-Q]>?&-\6%?-B44W5-%.F7N9RR&](,+8ZP3?0;P1SA9LU
MH2*RBU&R..*J1[C8SHH:8P'+@!V4W+D^A^4PP.MAL',B7T]'"=V](N/5?*SU
M8DG*3N5V*Z&D,#D+XL22-W<W<"B6MT5=' MK:I!(U*U2> !"=*K<QG&'!&IV
M/>!)4!H_F#C^,6--ZMJ>O:0CJ6-*Y78CQ!XT)$=\TZ[:WF0 )$!"!8Y:C\2;
MC%QS<T(@A1I-G&Z2)@"-%H05RY2E_'5DTC>4TA_,:OFZE;.2:MBX4E[5E$*]
MK>XX%;L+43$-PJ7!+)I?5$F@4RASDH4.^M+RC6H\U04[HT2H8PC#:8EKTUXK
MRI,?F>Z<G-7&<N?EC'8CFDE,*-IB42MY4M#(K9IY)EKNH0O,G7J$S>A"G<E9
MBW8"TB<L.B]$ T$W)^M>5UM:+KI2]+4,JI]MD:>'N5JD6U!C:[0RU66E.1QA
M7,@/>V!._K25Q R$@C]'G /+V6$6C >(:'=U^\]1^DZ^ZW,11B_(-$K&JQ54
M,SKYSC,N(02J[+ 9>:&Z<P.2 <#&0![:7;*M(O4$G;/ WC6IPZ]J+9>P^G0U
M2\&0ZG$L?ZAAW-D1H.+V2Y2UH(MWYJ12OF2TYJ]R5[>'MB6/RML3MTJF3O)'
MA0L"E- 8X%KEH3@&$&'AV&=D7('&UM5/5-:2/GJB[ I2M&5-]"L2-B; \P&(
M15U8P-Q*6 %(O.W)X>^QH\!!B5,,;:XH=@"86:5H&M!,;75%8L:VNG%F@$4:
MU]00QSKFJEB%G3)U%=P%Y11EM=X;$# !T)FCKDWPMH).3%>!8RVQ,'>O H.!
MJ5F\U<^71*X+.[;IBNK&FM9* *8!*I7'$CF^Q81;JA?BT[>X#T XUM+?FQ,O
M"C4;.1A7)RU&BM' "/0?G,.9N>+!M./7A.:5KJ6V_$_@.X_8C]'4J^2(!Q1>
MM=8D>8H,W[NY*X@ZN2A4SG*RE!S2I/,-2")&+8MA\./,G.SQ<:+H5UI2N7&\
M6TQM4(K25QU,=+"%[*T*H^R/.U0M^ZGR)CCZTY A<S"1N*-":).2> K?DP)R
MP*T,'&7)D4NAPZ-C'.U51^^G9]D$G=;;:8V6BFSC))8C4M\G?EKF2<$*AV?T
M*PTI6>(&QG!,%YM^._' FQ%!(4W2693-!%6)'+;$;HVSSV2)V\DMYF+5#D3N
MVQ-ND2T.O:N2..-[^N)1@,\=$%JS0A^0>\#78E2M00%1&54(K*$Q51"ZO1TE
M$C6-@1(A1RG6]<D<T-7M/D+V%+!TC@@(. WZULC1A0=^'R8&"ICF^@.<TDD0
M4)3E?U AF#BE=9,C@,?3,*9X6H"E!#;[<A/O99"%J(5F@1HR-%(T8#1A(*+T
M,6MAOL\@<-M&&26NK$CC=+X+,FHYCE47=PGB:WYG4B+&>W+PICTR@28T90=[
MT P&_D^S@>>NJUKNH(8R5S4\$B5:P"-E'DL$+@S VQF--(%:DY<L&C:6I.F2
M@4KUR@P]2=L(CE)Y@C#1C,$(6PW7 8# 8# 8# 8# 8# 8%2J$_RBN^_W:Z._
MS0Z.P+:X# 8# 8'SK[.O]O7_ '\"$N#?V'K$_C==O_YW-S8%6>>)5Z=-YV9(
MDL3Y"2P61]>P*XW$J8V+1$08X_TU (U,&=ONHAM=&]=( +$;E(WEO<W9 ZD-
M:AZV<6O$2I&4884&F--X^DX&"TS:#;2,8 WP7MQ7PW4X-TL09+8MT@KMPQ$L
M&!*868M%&3)NE!*QORDT\G01E.WCI2((L"__ %Q67*S[6,MN3J:G8-:D/H:M
MK+F[D.5PAKFZYO@[9&QR.>-C<U.)!H75,[-T8)-&WF>8A2K1IA[#[4DD8 JY
M.1\F6_S=8S;<<&?.$JMF48F-6+;"N=#1%/KI%".G78N=W9$89(G]]G\?2E7,
M-D,%(MF%IW(X\SWLC8%A):H@)MO>^^ X+25B5U==CT$JJ"#U1&55@U6X2.)2
M0IJJ!]'&8_#UKE!$RY:Z B+B*0-!;>KVGTGWI4E,+,UYRQ[#6'N!^EVG'T4"
M0(>-DA[F.,F]/"='JJTBI">JE*&11-1:)RAR*41E6XST"9S1FJ]I353][-8'
M8UOE-P/?":4],RU)(CC%;P;CVPY53T2>XT3&(,35LI=J^ADR=9@4\MBN/Q\Y
M:>QL[J]RF0!UH\D  *W-QT7L)BE3YP\<KZ*I6I;XDW.N^7;8'(K)A3C.)1)X
M]7%=_1I.:SKE@KRNI%+W^0N,[:]KHQ V>5L3 J"O2 .+(V$HHDQ,4(80TQN9
M_23CZLE2N3\30J4'5-%JV<V"4R.EFV5LU9R./1R(1^"2%M5OR@:5(MC:MK8@
M%B$/WA![JA 88FT07@3P^51PG>]D2*'OD2YNM2VJ\EF[&F<3,!!)1/HI*GUK
MB;*?(IE'R#E3\WFOS1#6).?IQ)T2M*:T(3 CTG(\@1E>_5_IZJ[51TMT+,J?
M63"IK(1-RX-GF1E)':GG,KH6;3UN52)^EBI$TQXJ74V>[HM&#&(A<4N,0&:%
M[89>!M<9HKT[$JQPYKBT!Y9->UD.D#LYTPWDUZX2I3!)_J$*7QY61#VZF1&1
MQ_+A4;$%6,G9&BFEL]D,($J7R!#EA4OZ:W-%[4S.IE&JB8+<4IJ4I3GNK#"(
M(<^,2IPO>3BC<VK. J"D\M,<U-JW<<ND#Z4)4$HQ,2N'H"E.,X82NEC'ILWA
M&3H U Y%LV,,K<PUL*.1][J^1IF)OILJ132.P],4RN*@YE^C9&_NSDG3%;*&
MV)EBL[6@%&G;V&4M);PW0U:P*=3B)4HP4_-)Y6C)&)21'H0&M$[K*ZR'2,!D
MZQV'[O$VZ)%4T;\W"G$1GN94<-"D#O:4>@;#-UM)N%>9XTSPRK)AS?4D=G4:
M=;ICT=BLN@C+\^H@ACXESE9;$@2.GOTOCB")QO[5R3!4IB&QN" L84Z8(0!7
M3FR0^EM.T5'7G5\6YLK>8AIQQM:G&^2'5)&+6B=%'&2]W*L!#'4,C<U\9A.F
M5[=UR56(1>F=L<E9(_<O.L3 "RXW?A^\K8KE[!)N;K4NDJ(IY/5JE%*J_ED^
M4P9KEK=+D4BB)")S6O#E&&F;1!.XIUB<!J9,X(/;%C 8 0L"M=DOGI:<IW<)
MEF4'H*O+L>3:WLUR6?,^*-3XU-5E=!M+)$K =7U<6B(8XJAOA$0[*3]' 3MC
MB6)R$ !H]FC"4Q5SZ:<HF5:+?@G(;[.+5A4G+J0!2VL%[S9T#F9DU<9,J@R
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M5DMN1!)JQC$?LN:2&&PNTC&&'3PMY*9YBI5M\K;5#J6WG;,.=2]B5!&>5HS
MCJQ(5Z4G3F[K!(7/GABF]D6[*N6[*G>U-;P^RI;;$,6P9'8%6-SK+D9Q\@>W
MI"RLK6[IB$Z@QV;0IR3/:EZ3B"%^BX#2-!TC+(TR5U$HI2\8BTX?Y)!H]%VW
MYOK6-4C=G^;Z51T!&DCT?(0'*S%@3PF"7&'#]KL6Q[\0I9!%7IF5\TQ*.LE8
M4K4<,LKF%[Z*+=Y+"XE!8251UCHZIJ>0[FDD>1I6UN5RYE>(RR*4:PW>U:%&
M0EV(1:<LO03G$X;P*[.!=E0E!S"[+Y-)H+)$DRCCA7;GIVEK^LA[O7+LW.R!
M8>0<]R-SJYD5M1A O:N"IC3'$^T,3A$$)NCLCHCHME999#Y'5MW1V%3<#JPR
M2*OL8L%EC-AQI,<G K;W=E6.J%LE3*C>1A\0F 4D%*OY@3->(1W*IYQK'$KQ
M:4RL#G>/(9*&M;'?; ?IQ &9"^D1IY$U5-,W*3+'=*F<4+:_-HDC*M,.&3[T
M0(D@6QA$'01<MYU]-E% 9=&E]9\F-]<2>9MLNER Y)6[?&U4U:8(XV4SN*H[
MVQ"5 X-=6NJY\2EEC*"GC:U4J+ % I/&8$<\6OD'DA'53U6CQ%7ZOE784Z)A
MSM!E[0Z0Y2PMM-T&U(BHRN8#3V0YG0!0[3$Z2BV05HGV8?#0?#072P& P& P
M&!7*"_Z06=_Q)J?_ '_^@,"^N P& P& P& P(EOW]@FZOW);'_ZG/.! O,W^
M31S;_%YH[]ZV)X$V8# H@NYMN-^[F@-^3N^H3(*=J8NVY91M.?,<35:T9=;<
MJ>"T_,X\NEJ9]*9I)4[&JCJY^2*!M1CR%W?AI#U6DB=.'81%5_%3I%^GHVZ;
MNRHG^N:1ZFZ,[5C4'86 X/3/TA=61R?QQ\B5L2/4K6MP*P8=V@YC0J2VLE:\
MIT;.D.T2%O$:I#T<P\6QFG+GJR>,ES5=+G>L=>HL*4Q^(I6HJ2255VWT]%K]
M;U+F) ]K5Q)E6)(V%F7;5EFB5J! ,+V0$/L\#*<A\#@YB?>7%:2Q8A(3.9N+
MYWR?*FZ-QG;&IEL@L*UJWMTJ?*"RW%08T)]BAJL8D:P!JE2>ZB5!,^4S9@=%
M9,W.SQ&9(SL+^.*/SM'GMK8Y26TMS^.,/+BUJD;5(@L+P QH?=L:\XM5[DK#
MM,K]E[(W7LQBP.5]-^G5=U9\X]CTZ3>%6UO->HD"$,*2\]5%(X10-)R=/%-L
M,FL&&4]*9K) 1R0W:Z#$Y2A&P'-#8D/]F8WE>^EC6GAKT(]+ZPFVDK5K276Y
M#U4CMCO:CNU#E;2BMN9,<>;*;)H].?68'ZXI]-[,F3FZ$TT((7MT<AB\ZP.]
MIRBR@D!""57I;7O17,5?5)4$EKRVYXD[,]-6W@KI'!CR:^BT8Y*J6BZ>ELLF
M<572ML7R*.'J*9&]FIVY84Y%D.  )]&J2/,,+I&\"3-SXON#GQVM&'(;>N*_
MWKK)PF[! 7LNG8A<*_H>)=&M##&ZX4RLN2#JANDT*0H598W8AS<0GK%PC"E*
MG8 AF>T>*;-[#A7-B]TFL"9[NY_FKU83HB3*;ZA]+SEYG%7R2L9HA)6U%:$"
MO&)MR1-)A+&8\E\/,#H!B1:4H3JS?*%Q:$J%LHVE*FI*,MK8B9:FKR)P!N;H
MV5)M,*)/&VE.W:3,1,PDDSEQ#*6:2+2,IR=W-:4G\@#5)PP['L)7 2:9YO9E
M&#\N]:%Y0B%Y=[\?#6_#7R;WX8'Y8'Z!)-$ 1@2C!%A\?,,(!; 'RZT(7B+6
MO#7E#O6]_P [6\#YT0=L'M=%&;+UK>]CT 7D\->.M[\WAX>&MZP'L3M%^VV4
M9[+Y->U\@O9_+O8=?;^'EUX[UX:_GX 1)H0:,$49HO>M;T/81:#O6_L;T+P\
M/#> $2< .AC*," 7AY1" +6M^;7CKPWO7AOQU@#"#BM:$8487K>_#6Q@$'6]
M_P [6]ZUXX'Y8# 8# 8# 8# 8# _)0(0$ZD8-Z","90, M^'@$821B"+?C\G
MVHM>.!S=JR=$/\FAR*2N_:+JB<^=X#,G=.S(;H.&LG;N\+"'R1-P6A%HXR,.
M"<L(4IJ?_P!6B#K^@Z\WC@89)8.S*3CDG-?.U!RQ9;++'EST6BN+;,HC2GH(
M$05M)!X$/P83P="=[0  7KWK;AO0 _\ *OEP)13R6/CNUQBXU/<FXD35C&_$
M,OPZ]OC1<B53*0-RQT.( B^-!:SVM&04 8M^Z[&6/0?Z+H6!%R*PMFTI%).<
M^=ICEB^V(_'W%Z*17%MF51M7?Q<26M*<X"'X,)X40L6T!8"M>];7[T /_*L"
MT7/+;&TDNZ/<HX@L)'I]LR%*W4^U$\I33IQ7(:7KYI(4.Q<R"!]VF(;D))*3
M8PZ+]@7KR>.OEP+/8# 8# 8'SK[.O]O7_?P(2X-_8>L3^-UV_P#YW-S8&K<I
M\ UAR#7[0FK1K@BV]$3.[L#K>D@A2]8[O;1))^=.)(W?#-2[X@RMKP8:'1J5
M YITQJM,G4&@,T0 K053:O1W;&V7MLAW?3B>R-<[CUL)8C]'Z8MM!;;5V(W=
M$NMD:/\ G8,>I"]TXR(JUWOV?D)1$B<=>81@D>!TNNFH'Z].:+FH:5RMH;'R
MY:=M&J'*9,,85EM#-NQ8H_Q,E[1Q1QDJ]6I+9TCR P:4QTUM2,H6O:E:'KR!
MSI<O3*LE94#=4T9L;F:D4"*6-[XY#YQYGG],))H@'54UJMV%,UL4Z733PV0)
MD<J(6HE#4_M*90%*:WNA#@@6&E!".&CT;)+'H\ZQ1BZ/96QC5\WPRFC4Z:IY
M![G,9I!:PI"O&">6/%5=Q+H$M+1K:,0. SV!JCLI<4YY;<XO:U(@3:$&]1'T
MC$+%8RF8O-JM#ZV-USH;>BA2N,V:\2,H#AV'!.Q9I$) .7WM**VTU.$JA!;4
MC.88LP&Z*]@N7:6JR-[."V]"\3-%%V7%;';Y:C=%,>C_ &$R+42:'I&0U\.Z
MQZH8>FC7!6XD.RHWVL(.91-&M# ;MP]MM5L2?>MDB#?;=YE!:EL@M$4Q$R;!
MROT)S-\%TQA7AV"]Y)44@%,??]NJ3?FC.ZKT5I#[+P5^^^;VY7LO P*-)_2+
MCI4)=XH=:C:K6NE>=10?3^HJYO,5IUO27.=,<];D6@&2@9QBJ'M5/EJ= ]L$
M2XA7I)LP@!&C!A*W+GIRI.;>A)1<N[#3S5J./O=9"$CDCL_<W9S^BK+9;1G:
M-]=7NZ))5QK4@>F?1"73'#6!4L("F&O/4'I?:GAF)]Z?P)_TU*[X<I^P_-^1
MO(983#55>!<7=%)U'*ED<IN6S9.?*0HE3..,S5.XD%Z;"U!9Q"E.(T92H(B
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M& P& P& P& P&!SPYG_PJ[0_CLV)^\Y06!:? 8# 8# 8%<H+_I!9W_$FI_\
M?_Z P+ZX# 8# 8# 8# B6_?V";J_<EL?_J<\X%;.?Y U,'-/*FG50)/N04US
MW%FKRD''^\/CO5<<$WI!>Q /V #M)#/$P?@6#P^7>O'6!87 _%0>4E3J%1XM
M@(2ISU1X]!V+824Q0SCA:"'6Q"V$L&]^&OEW@:RV3B,O!L/);UYAQD\BBF;1
M<(D:HKXA&T9,=4*%QFS2@Z1& *E2'?L3?(;OVN]:#]H/P#;,## D#49(U43
MH%M]1,*"3*$GL#M  S.;DY-")5I3L'NXQFKVA0#9>A><.@:%O6M"UO8#Y U)
MI U1<Y0(+V]-+V^-R71)P@'MD=5,B-W/$H"#9!0DRB1)-: (6AF:,WL.MZ"+
MP#,X&&3/[4K?WB,)U AO3"VL;NZ)=D'! G020UX)9S@J! T0<)28PJM;" 6Q
M%^SUYM:\P?$,S@89UD#4R*8^C<E B%$H? QQD $@X[2IX&U.SV%,,10!A3 V
MVLBD?M#/*#Q+T'Q\P@ZV!F?VJ0?&-M2@2CX#('2+.GF(.(]W>V41(7%('VP
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M;/2#75UJG3J33VJY8\SM'9\2Y!Z(6-PYO"4J-D6'.:2Y&)M93 KT^]/!P@
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M#0M:T'U^<+U"(3U%+69(6:[L-JRET;"5J10H2GGEPRLB@>U3E#)-4$[\PM>
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M+4P?J&K9QRXU]?EFR*,T\OJ-;=BPZ5,1R&41^#M<>5R9W&^QQO-=%*=Y:FM
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M.9_\*NT/X[-B?O.4%@6GP& P& P&!7*"_P"D%G?\2:G_ -__ * P+ZX# 8#
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M4T(F!KVO?Y9:+P[GE-K*VD)2"]G>S*)*T$(=8&0_^6YQ=^TV/\I%M?CY@/\
MY;G%W[38_P I%M?CY@/_ );G%W[38_RD6U^/F _^6YQ=^TV/\I%M?CY@/_EN
M<7?M-C_*1;7X^8#_ .6[Q?\ M-C_ "D6U^/F!9VJ*DKFCH.V5M5,50PR$LZQ
M\<4#$WFKE)1;A)GUQDTA<#E;DJ7."U>\R!W5+%)QYQAIIYXQ"%O>\#FO6M3>
MFMTV&$,=4Q^R5A-10R.,]<SYB;>L*I9V.'4N^6+'&PB%78Y((?''L*%3:TE0
M'FH'E4I<T3BIT(1Y!(1$A+5;\6^GQ*6I;\P:ZCL@:F"C)5Z>ZP!THGBT*:GJ
MQFRM))*EUI\?]J52^(3%K$4%]![1Y*$E*]BX;++)WH-VLGB:K;$YIG/+S=-+
M"11R;SF&2V82Z2V;85H6.M=XA/X#/EA:J=S*;K9RB<7%N@R5O(/(<TYK20(L
M]+H R@>(9!/PERBVQJ41,<+<#"K"96V,RA]=+,L5=.Y*N;;-D-XM$F53]PEY
MTV/LQOM*0JI ED0%VGXA860,M2$"1,$D/V9>'.4&-YJN2DP7;C+J 77*[P^8
M2&>S>12Y%(>B&TY-<4FFTA>Y0N=9M)ITC6C,-7/QBY2FV/0T@R-:#X!"\*X'
M]/2SHXAG$/@I\JKM.Q3&NT+*"R+?^C8LV/0%;RM.W8FOUDL3QPN?_,>'?-];
M(@H=/1XVPI4%6)4 *H00 _Q;TC[-I6JY_)[<?Y]5EK0VPI5&[8<^@>E7YQM&
ML%UBU'!;'26?8>IB;)'^LH[9J^()G!KDZK34PK20&#(2A*7#T%UYI4W(72MM
MRJ72,T<HG'.;C#87:P6N;6!&(0%1%%#5?$'@UQ-3,\LM=6BA@3@_)9*0UO1;
MJ2S'./G-+)TK- :&ML$MX#4\_P#+$<C]@U^LH>2VM6;!RC[M-GI4CG5HUC8'
MQBO$$#<A.1C]-SV>9PL2KS;,5HU"=(,X\1B/8AB"OC<B],)5*[XANIM-H6MA
M:9[O:P6.7S3I^JZ]J!OKF^V&U9/9=6AG*N+UK7+21?[.B=U:V*"3IERT(M:V
M8E&:6(/I$XSZ6].6I2"QB42U/-;17TY)>?7-R5=132#>[S1QLQYI.-0%]=BW
MVL(5&SEEP20]MCP%"!*C*<A;,3%E%$>R#H! .6J,J\H@B$0KX,4FJ!IH<@/Q
MZ2+O)5;&\R>0-D8\7%W5[%I,[3%Q-][WXK1>\>41VP@!H(:TP\7\[QFM[<J!
MEAKFDK.\85'Z_L6';FTX4-3C'(S4$?H=L"T>\2$U5%G8=6Q-K;5*]L,2+58F
M\A2<:-6#V^P_2MN-Z#JBRU%N1&.R3<V,3RD*-3([%L&7,3"Y6 I9E]ER:*Q"
M3R9UB44F%HNC E6R5V;D29P>ENC3U1IABE2(X/VD7&O-$MFU[6+)*J9GB8=+
M5NP5+=+NL7OPMS&"1I&M;VEJ"D Z@11Y:4C5%@-<&LM$XJ/<$&S3QB;T.TX1
MJJ].+D]R; -[S#YK(%9OS[->93(;EN![GDK<;#.K%6]/LPGKE.%$PDLD:'&E
M(>K87%6M,6QM5&6TUJ-1B2E[T$SH^8JA3UBS5$O:Y/*(BRV%%+7+.FMA3Z9R
MMQL6%66S6_'94^S>2R1SESXN0V#'T:[V:I:8F$ @*;97NFO88&5LOG6FKA<7
MATLJ$(I8ID%2S6C7@+@N=RDRVL+"=(\]2R."2(G!*G),<'6*-YY:XL('!&:F
M").>5OQWL(%_^7-RJ/34H51BP7!\2/3V]2&8N5XW6OG5FZD9T)/>V"Y)JIGQ
MDFMZ&K]UM'B]LLB5.+46G9DQ!9 " B+$'[$^GCS(CC;[$6MJM-C8'=P;5K6W
ML70-ZLY$ 2-2N3+$L:JLM!89!=8PH8YDZ%',C(%$U*$BOW8T@:8E.42'G1>F
M]QZW.["Z)*Q<BTT18XM'X1&#+&LM5"($AB&ZUTV'0.%JY<?&H<XK":?C93@I
M;TR<YS+;-:5"-VH5;/#5+E].BL9="(>RTLM34G-Z^)A31"IX8&QI2LC\5A,C
MFDJ0L34IC5M5C.X\N->+ =![=V:1M;L(E28C.//;CE"(X)<H#CZ!T70S1SH>
M_26RZS0T;!:&<(Q.5FU\:=(O$XJ[15]5!CPC#4;>JL%(]G;> EB%I2 !(1[%
MLO8QAKC'Z>7*K)'9Q'!0R72(%B1UEBLHD,VM^WIQ.36:+.C(\P\MHGLKG#O,
M(VMA;E%F@YG5MRU*K;36A$80: Q,6/0;@=QA0"BCW#GPV/RK<"=YRWVB\N0;
M,L@NRWBT6NP6FTT5E.MNERH-G+IT5/F)&X:<C'42C0DQ1.A:3E@)T&':.#.6
MVIMEC:HKM=*!V!$[1A5A/<[GEA3R53YDN7Z.P6'N92Z72EXDL@=G9+4L;3)E
MZA4-:TI&9,0@-2DEZ!@1M)/2YXVF+<H0RV%V%)53PBF#9-)*\WU>JR;V<U3D
M,+"_-%J3D=B:EMC-.M5Q'PI$KNL5$(2V=,4G"62 18@WAM]/GE-JL,VSTL!?
M1R<$B+E#,G6V99[A%(@ZZN6*]"J]02#+9@?#8.W.UUPQ!(UJ-J0I$JQ> ?M2
MQ%&F%"#QNWIV<G.LC9Y5N /2!U9I0GG 4K98UD(8N_31KM*8W3&I/.H01*P0
MVQ7&'V78+TXM07Y XD(@.)J4!?N>@$ "N-!^DI6E9HY:=9]E3:R)4[+*G#")
M9!)/<%*O53,M,PF>U[$FVNG]NNJ93J(EK8C9[XVN"!J>VZ,[:U8$2)G1)BO(
M(+]I>?("&"V%5;P*1R>KK"CK?"U,#D<ID#HTQZ%(:[8ZX'&8PX*7(<A:2'!L
M9MK5"DM9[Z8Z*CEGMM*1B-V&MQCD>C(M#D\)(C\B?D +=B=\N#Y-;!G\YG$D
MMV#.\9>8E-Y;/I9)7>8RIR8CH8TIR +UIZ<"!M3H_9^ZE!*T'XW7QSSCT2]&
M2"Y*W235T-:("Q&'K'J2("]M596DV7-#4FDS0\-Z8(6ZP6DI2=O0="6I1&HE
M.SD1YR<P-60\&<S-,L:IDPQ*5QMU0.3@ZN:2,VO:L=CLV5K;.G5RIM63%V>9
MHH_8R5@LRS'UU:R'I,M);AN1I) 0)O*2$/.Y>G_RF[FP<"ZN7 UF@=:P6HDL
M0!/[$(@<LKVKFMY9ZTC]HP8B5%Q6V2X AD3AII.D:1S4)!K#!A'YO+L(:TZ^
MFSRF_0,JNWUCM5Z92#7HDEU=>B;_ %LX)C4D@Y%:2"O2+".LH4W(K)[@*4EK
M5QT"\+0I*(+-,($I $_0; 1Z?_,:)1+!M4;GC$WS%F4-;A'(Y=5RQR)-3@M1
M1I X32)19CG;>PPRR'(J'MQA\B:R$CR8J($HVH]X4*C#PV1PXFYK>.9I+R$]
M0 ]YH>:#?E4QC#E+9DH>I2\2J;*+)DLE>YU\?!.5DH?)ZJ,=E#C\1TK$L'L6
MAAUK0=!X)_PER[94EGDTD-;C23.QV2D6&12V+2N8PZ0)TG.,L7SBEE4:<(P_
MM1D1=X-)W#:@E8V:2J5(2$Y2D9Q*8@LL(XB7IUTU KCI2QH7K<=BW.M:=!Q&
MGXD5N4/,K89MU%-P3*X;&>+6E$T?I-(CUXM'EM:(TDL3:>ZN1^E)OO1128+Q
M1%@%%(I&(L-Z?)(*-1YE8!2*3+S'62/PF9M3-VWJ0NANM&N3XZ;3>W5J!?;'
M*#!CW\N\"B/,_P#A5VA_'9L3]YR@L"T^ P& P& P*Y07_2"SO^)-3_[_ /T!
M@7UP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P&!PEK;TY.C(AS6_P#.[J@JY>#1+4J^.O'7G4UD
M5W:R2,=%L-U&U;*N=IK7)595'7EMQAM51V0'1P2XU"C7'% 2.",X]*,*D/G
MU[59:U30=%SU7\S4S*_ZKM>/2& 1J8N=8\:Q9L]1R;=0SUFHRPE$8:FJ-+%M
M4R8A#)"'A+$R'(#,@*;"W@L>FE $KQ7T:+U:H3,6=1;D5;;"6ND*CVK-*F#P
MZ#MB%/;K:\&Z*F\\C;#4-<G1RTK"Y^NM]2MZA<YS=U)D8R1'OPD2<C0 SX/2
M,OM+$&UO>9A1UK3=V8+,KXV9SQ=/$1M!IRY!5$/YUZ!H\LF+ORURO*K^=*38
M6I868?'C3W\H1Z9Z*2C4EJ@V4_TL;P^,N3F;KG=_3LTK<'^7(WAZFA9GJ!I'
M#J9JOM(G[-'NN7%&R*XE$FXQG;=Z3STCXBL-,]F4U>#5L.A'#]$6;S;S_'>:
M9?'H C;(?%)6[-\GKM]>5,/*DEF7!<4N6U_'620M#?(4T<KZ+O#(6G7*/ 2K
M:D982@:3^884MY-])=[YULJI#GN65]*^?$O$,SHV[Z%&V.BZ.N_1%F,] Q*X
M;'@9;@V)D6JWNZ+4N6;)&E:6G&:^!$X +$:YK]!#H#Q3R\GYBY'J[G25!8)8
M],414H;3>@'.TF063,Y&:K63R3O[I,BS9!+%4N<5YPU:AUT8H4 'Y#/M-:#H
M(08N&I$U4'S95YSA7IDMHCJQ'>6I"4B7>ZD0?72,BN5TBT55"9@N3>XN$:<$
M2(PGR$(S%2701C]D L>!.*3F]T>7GKV26,=$Y6[] +F:-P4A82L=FF(5)!:[
M:&FO8HY(G= ,E.K;K27R63'^Z@.+"L>?: %L98= #4JIY=G,35<2H)E(XT\Q
M+DCFD4%$SM:E[WI[Z ^9==UFAL9(G5H$Z0]CCL :Y4A0C4>S6 ^<I@ME:WKQ
M"%TV Q].8V@V4(VEODAC:C&_(&!R6/#(C=Q)R]N"9H=G!J8U[DW$JMB"2><B
M2FFEZT(11>][#H,O@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<
M\.9_\*NT/X[-B?O.4%@6GP& P& P&!7*"_Z06=_Q)J?_ '_^@,"^N P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P&!SPYG_ ,*NT/X[-B?O.4%@6GP& P& P&!7*"_Z06=_Q)J?
M_?\ ^@,"^N P& P&! /4]R.G/G/%MW0QQUNECW7L06OS/&W=V4L+4\.@32$C
M>B<WE$V/2QM;S%:H&SCBDBDT!>M["6,7AK80<=-_4$)--)' .*M#*,&4/7TR
M7W\@BQ;"+7VO/P@_9U_,WO7^S@?G\_/4"_6!Q5^62_/Y/F ^?GJ!?K XJ_+)
M?G\GS ?/SU OU@<5?EDOS^3Y@/GYZ@7ZP.*ORR7Y_)\P'S\]0+]8'%7Y9+\_
MD^8#Y^>H%^L#BK\LE^?R?,!\_/4"_6!Q5^62_/Y/F ^?GJ!?K XJ_+)?G\GS
M ?/SU OU@<5?EDOS^3Y@/GYZ@7ZP.*ORR7Y_)\P'S\]0+]8'%7Y9+\_D^8#Y
M^>H%^L#BK\LE^?R?,!\_/4"_6!Q5^62_/Y/F ^?GJ!?K XJ_+)?G\GS ?/SU
M OU@<5?EDOS^3Y@/GYZ@7ZP.*ORR7Y_)\P'S\]0+]8'%7Y9+\_D^8#Y^>H%^
ML#BK\LE^?R?,!\_/4"_6!Q5^62_/Y/F ^?GJ!?K XJ_+)?G\GS ?/SU OU@<
M5?EDOS^3Y@/GYZ@7ZP.*ORR7Y_)\P'S\]0+]8'%7Y9+\_D^8#Y^>H%^L#BK\
MLE^?R?,!\_/4"_6!Q5^62_/Y/F ^?GJ!?K XJ_+)?G\GS ?/SU OU@<5?EDO
MS^3Y@/GYZ@7ZP.*ORR7Y_)\P'S\]0+]8'%7Y9+\_D^8#Y^>H%^L#BK\LE^?R
M?,!\_/4"_6!Q5^62_/Y/F ^?GJ!?K XJ_+)?G\GS ?/SU OU@<5?EDOS^3Y@
M/GYZ@7ZP.*ORR7Y_)\P'S\]0+]8'%7Y9+\_D^8#Y^>H%^L#BK\LE^?R?,!\_
M/4"_6!Q5^62_/Y/F ^?GJ!?K XJ_+)?G\GS ?/SU OU@<5?EDOS^3Y@/GYZ@
M7ZP.*ORR7Y_)\P'S\]0+]8'%7Y9+\_D^8#Y^>H%^L#BK\LE^?R?,!\_/4"_6
M!Q5^62_/Y/F ^?GJ!?K XJ_+)?G\GS ?/SU OU@<5?EDOS^3Y@/GYZ@7ZP.*
MORR7Y_)\P'S\]0+]8'%7Y9+\_D^8#Y^>H%^L#BK\LE^?R?,",+5Z-[QJAMA3
MFYU3QX\ES>W*JI]"2V75>!)B)XMB8MT,:795M;0)8!MS6L<@G*  W[090-Z!
M]MO6!)_S\]0+]8'%7Y9+\_D^8#Y^>H%^L#BK\LE^?R?,!\_/4"_6!Q5^62_/
MY/F ^?GJ!?K XJ_+)?G\GS ?/SU OU@<5?EDOS^3Y@/GYZ@7ZP.*ORR7Y_)\
MP'S\]0+]8'%7Y9+\_D^8#Y^>H%^L#BK\LE^?R?,!\_/4"_6!Q5^62_/Y/F ^
M?GJ!?K XJ_+)?G\GS ?/SU OU@<5?EDOS^3Y@/GYZ@7ZP.*ORR7Y_)\P'S\]
M0+]8'%7Y9+\_D^8#Y^>H%^L#BK\LE^?R?,!\_/4"_6!Q5^62_/Y/F ^?GJ!?
MK XJ_+)?G\GS ?/SU OU@<5?EDOS^3Y@/GYZ@7ZP.*ORR7Y_)\P'S\]0+]8'
M%7Y9+\_D^8#Y^>H%^L#BK\LE^?R?,!\_/4"_6!Q5^62_/Y/F ^?GJ!?K XJ_
M+)?G\GS ?/SU OU@<5?EDOS^3Y@/GYZ@7ZP.*ORR7Y_)\P'S\]0+]8'%7Y9+
M\_D^8#Y^>H%^L#BK\LE^?R?,!\_/4"_6!Q5^62_/Y/F ^?GJ!?K XJ_+)?G\
MGS ?/SU OU@<5?EDOS^3Y@/GYZ@7ZP.*ORR7Y_)\P'S\]0+]8'%7Y9+\_D^8
M#Y^>H%^L#BK\LE^?R?,!\_/4"_6!Q5^62_/Y/F ^?GJ!?K XJ_+)?G\GS ?/
MSU OU@<5?EDOS^3Y@/GYZ@7ZP.*ORR7Y_)\P'S\]0+]8'%7Y9+\_D^8#Y^>H
M%^L#BK\LE^?R?,!\_/4"_6!Q5^62_/Y/F!5J&0#U+Z\D=S.L:0>GTO;;>N)[
MN :*2S;IPU?'US[$8/%%+(!:SUDV)G),2"$EG!/V02+>S]AV#7E\P@W_ -\]
M4_\ 6YZ;7_MKUG^(. ]\]4_];GIM?^VO6?X@X#WSU3_UN>FU_P"VO6?X@X#W
MSU3_ -;GIM?^VO6?X@X#WSU3_P!;GIM?^VO6?X@X#WSU3_UN>FU_[:]9_B#@
M:QR7)^B'3U%K^B_2+31;;*XSQ3S:Z1\Z@GBQGB,JX[++SZ?![-Y'9;(QO"=[
M2.4:.WH) #$XB#@[\^A:V'0=@,!@,!@,"D/J1_Y#/27[GX_U::,"P;E_TBO_
M *M5?\>9@>+ 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8%2NP_\%N?_ .._QE^_M&,"VN P& P& P& P& P
M& P& P/L$(A[\ !$+?AX^ =;%OPU]G?AKQWX:P/O[ __ ,R;_P"C'_N8#V!_
M_F3?_1C_ -S >P/_ /,F_P#HQ_[F ]@?_P"9-_\ 1C_W,![ _P#\R;_Z,?\
MN8#V!_\ YDW_ -&/_<P'L#__ #)O_HQ_[F ]@?\ ^9-_]&/_ ',![ __ ,R;
M_P"C'_N8#V!__F3?_1C_ -S >P/_ /,F_P#HQ_[F ]@?_P"9-_\ 1C_W,![
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M_P#.#[0P.HN P& P&!2'U(_\AGI+]S\?ZM-&!8-R_P"D5_\ 5JK_ (\S \6
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M:XL^=JV,^O>A)92*=M2+2'5#&H+ )@5(E"@\DU*M5G31M7GH#&\HL18 )]A
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M:K_YTI_J@[_C!8'GP& P& P& P& P& P& P& P& P*15'_I9.DO_ *?''?\
MG!]H8'47 8# 8# I#ZD?^0STE^Y^/]6FC L&Y?\ 2*_^K57_ !YF!XL!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@5*[#_P6Y__ ([_ !E^_M&,"VN!]=@ (9)HBRAFI]BVG-&6 9J?8]>
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M4?\ I9.DO_I\<=_YP?:&!U%P& P& P*0^I'_ )#/27[GX_U::,"P;E_TBO\
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M P& P& P& P& P& P& P& P& P& P*15'_I9.DO_ *?''?\ G!]H8'47 8#
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M12"H87$[.16HT^S85#BI:R'5W?%T7 L8E7D$K$((P#)+'HO[;8=X%A[HMZV
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MN-#.M9J()7*.JIE,6)_D_LA2V=.$4GK/#S).THD+B<0SP19M8?I"!47[XN"
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MUQD>I%YR=A*/ 'W79.]Z$+8]X&"C5+55#I_+[4C$(:6:Q)\ TN92Q*:Y"<I
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M-UHTNXMC-(CG58S"KIE(5-45/8(PI2@;5:=R7)]C 8'^A"%[,L.O. P& P&
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M=;3[UX:+^T\-8%M@UY"=35HL<E@1E3!CA:BOF1Y2*%9!*"$K%Z5V,84;6F5
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MIXY%/41Y_L*.L#J)ZL."]&.<_E"E0\O!9BM%&(@V1MI]Z5F*&^.LZ%-HW2%
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M'8'1TP<Z*5Q1]2,].,<CBVT2?HH-DF(BQR$B;>[ &4A4+#VK8UP@)" #+#O
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MKY>D&YSDIS;GY,J,AB<Z0D)"23$NP.)A"8(]&A\->(?HLY0L^Z6WDUCZ*C[
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M4%E85ST<::<84T-X0E[ A;R3 )@&"" :CV7M1 !L?ET&_8# 8# 8# 8# 8#
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MJ&JYZBS9)7B9W3)6AZ8FJ2KG%#35>S!PE4P;VUA<0MB@$C;*Y;4Y*8WSB2)
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M(/O4\?M^9Q*MJR%$V.S(G,[.KR4JG0=]1!V3EHZ?9%4"<O>5S$* #*+<% W
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M%\@OD"6^7+LGG2CM.[F1ECCG-ZOX;%Z3C3JP)D<MD[BTE %.K"?'0S0G AL
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MN1??U"U]:KPTI&-_?T;L@DS4W#.,:TLEB[\YQA]$TC4;$?MJ5.+0,Y/H8A#
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MIK?EV1ZIT<U>F(J4IH6T'-#N_/S\FCJI2D1/#J6@:-$I2E!FB-#-V(6M^&O
M(-C_ $O?T@Y EEC1J&168W-!97<]<RI[-5DQ6#,_T1*),2OM54S';6J5J<Y
MS)QELB38A'N*@)>A 3Z'L(2&=/KHE?*E(6DR6?7%5J7N 0RPKRMR<Q\AR31:
M(J8:6]R)WB<1\$T<5/:MV.+" E6<0F*)$()7F,V .!)?)MBV%;7/E;6):32G
M9YC)V]Q6*?=6M0PD/+.4].*2-2L# J,-4,6I7'R$SA[H(6_9:/\ M? .PZT$
M7Q:ZKN=.V%E.3&+LL'J@5,S:9P]K*7-T@E<K'&K&9(FCGKTXI2@ACJ5Y3*3Q
M(F@!@Q@3" 8IW[86@@#5VZU>CX]UU JFEDOK29LU@G67(9+5<$BJCWRE*;8D
MFMUM8#[8"DPAR4/\L=O*C4(EJ8"<\X>])/$.M#T'MAMK7\R=B):/LR709_C4
MM@D]G)34W059!V^(%M+LB'!F2OYL]JBUUNO)D:5Z.DQ021::A^)GB67Y=;#\
M*LZLE5L]BGUPQI&Q-SP;4TUD$+D9B4DQXL=^@T[9X=()JU+]C]NGA9;LH6(&
MX 0>5P"C$KUO8!@P(^Y1Z9MVV+H4,UH3]#&FF1D6D\P"EWV@)+ 7UYC$;E*M
MJ8W:.6L\#(:YD8Q,Q)2AR3D$Z,\#_EWOV8]Z#IY@,!@,!@,!@,"D51_Z63I+
M_P"GQQW_ )P?:&!U%P& P& P*0^I'_D,])?N?C_5IHP+!N7_ $BO_JU5_P >
M9@>+ 8&->6PI[97ID/-,((>V=U9CSR?)LX@EU0*&\TXG1FME[-*+4[$'0M;U
ML6M>/R8%8'#D6(N'+<*Y3,F$H*BL((@)"&6%IV;<E7:KZ4H94W"6)]I_A)8G
M!4A"4?[,O7E+%O8/ 7AO WJ9T$Q3:VW^X'"1OR9YD%!RGGP]H(+;S6Q-'I6\
MFO:N0$&J"Q+=O:0\W8"@"%M-L&OM@[W@:#2G,\\I-/ (ZAZIMN65K7C8D8VR
ML7Z+5:FCZUC;VXUO;&M:Z-,7320)*#8RS0& 5:-$,H.A"V'>];#<[FY[:K9?
M89/VF>3>H;2KE.]((M9]>J&<#PDC\D"0%^C+TVR)N=H^_1UR-3EF^P4D;]D>
M'0P"UO>];#0A\3UNHIDRH%4ILI8[G6+]- +A4R(L^U2+D]^TYE60C=-HOA29
M>49_0PI"TH46TNQ \GB+8\#TP[D].W/<XGECW!8%UV7-ZT>J@23R6HXLTEPR
M!/1:@+FU0Z-19M0,"%4N6GZ4JU(PF&J30!T+RAV+0@A<_P!,NH3RW3QFTV+6
M.G,35S$:O"DCFS"69L1-31J>E%B1>QW,%C(T%(S ;_Y)[+Q\ ^.!:^'4,PQ"
MX91<B)Z=W!\EE75M5)[,L3MOPQ$V5H);MK=T1I1.E_Q5SVM%[P$0ME!\NO)K
M6!'\DXOI*PK3LNV+=CB.W7N?-T78VMLG#4WJVRMV.+M2MN*;85[((%*<US4+
M#%BE0<(9VU/AL.]:UX8'XP/D**PS?/05<TE,S3<YPBSJ[CR23(6,XF51&S$A
M+6H:Y9HA,'VY4?92 (T_LM T<0'P.T+ V#FCEN#<LQ2<P>O79]71V:SIZFY"
M%[VA&9&@NS<B:R8ZU')2B3%;6THD!821J/.?O6OMQ;^S@;Q0]/,] 5+#JA87
MIUD#1#R7@E"\/A:(AU7!=Y ZR$\2DIO+)1A]@I=QEA]F'6O(#7C]MO>!"UB<
M1UA:$=Z2CLM=Y K2])32,6 O5@(:0K:[ED/C+?&61TA9PDX]"-)2H?.9[WHS
MVH3S2A?T,>]8'U+X:IAXD\-?K,1?3$V5Y2D-I.%PV?M#0MC#"VQ0\H]3+4Z5
M,44,R4R8TH.E0Q;]D67KR%!UK Q#-PA730P5S#_GA+5T/JR6WI((C&UB9D$D
M1L-\1EYB[S Q':3>W%'8LF?E)K:+7@H\XM!-$(.M:P/RIS@RNJ4(@I4<F<P<
MMPBJ+=JD)SJF8PG/Z:XW\M]?9.["3)2]A>VH1!:=* OP(V26'VFM[UXX&RTC
MRY.:-0U[%V?JRWI%65=)4K6W5@]1:JR8^XL:,@\I.S+W5NBY$E"F+,.T9HPM
M5H_S UKS^7QU@2K*Z08Y;<D'NE6^.Z-Z@E<V/6J!D2DH!-*]MLK2#3FYK#3B
MQ+@.#9[@'W<)8M%"\V_/K?R8%?1>GY4VV7E5 *02?3_R6XMJF'3 "9D+>9:R
MM[[N3:C$M*"E]T&TFO'E. )-HLT@7G]GO7M1^(9ZQN*8W.I+8SFPV]<=5QF\
ME1*RZ:YKYX8D<8LQ>4C);7!PT8ZLCB\QAT?&H@"=R.:SR=JR]?;:UO>]["QS
M)!#X[)T#DTR^1)H4T5ZSP%GJK86\Z(MIK*LT8EEY2XY..1GR,3466WC]JJ&0
M).7H6P^UWL>P]I%<5ZFFJJRD\%B">Q5R+;:MGI,=:2IBK;]IDZ/:%3) )=.Y
MZ/:1(45[,1NP>S+"'P\ ZUH(*M/E9#/9XZ6A"[>M2B9M+8LA@4^=ZP71\LBP
M(TV>\:9T;RWR5G=TJ=]9R%9I2-R2>Q6$DC\NM[\-;T&M2/BZ/C3<_DUC:=AT
MTMYNCDNBT%>&!/&9:\*T$V2MR-_.?SYTV/!*UP5@0#$,S16OMU ]AT#6@:"'
MM>^.HU8[M5KC?L\D?0B6K$,^*1L%AQV&I6"2NTY-2Z!()&UQMJ:D1SA%6M&!
M(WA*+ #0-;,,\YGRX&*)X:@#/$K"A,$FT\K-ADUML-WP)/ SVYEU24[CZ!(C
M$9!P:3F)UL;<QH]&JVUQ >F%X[UKRZ\-A#]VOBQA6L=V@L:V+.LZ?=!-L4:I
M=:AA['#),V-\$'L^$EPQ)#&] T,PF!Q_H_GV _:D>O(;XE[$#8;35',ZJ#V:
MJNFP+IL&][(W!=5@PR.:((FR)HY"].I+PM;DC=$&QO3N#HXN"<L:E8I&8:+P
MWX!#YMX&)L'E)TEUP2^Y8=T':=//D]@L6KR5-\$:8$J)<(_%-N(D.TSC*6!Y
M<6M>8-T-%[9/L RQ>&P[^36!/E65G$J:KR)5=!$9Z&*0MI TM)2M2-<O/ULX
MY6L<'-<9H(USHZ."DU2I.WK7M#C1;UK6O#6@W_ 8# 8# 8# 8# 8# 8# 8#
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M/(I2V3&O^CC8W"U!"-KBM?,+)&8F2F:VA$AUHUW=7%:K/4KG)8(:@[>RB@Z
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M'<AE\XZ-Z:C=E7"P6NTS)BMJO ,+F_,T45PMMD#BNC9E1 (1EG%+4"+32L"
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M#DNIE:VMBR(KZ)K]37S<-E55Q+44&9SGN2EI*[)9VIQBZ5,N+^<Y -IA(P'
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M@1TKF_*#@CZC:5VX"M2PHTU?U<S*HTH4;,&G8M#$YS=L-;!FRHL#&UZ+ H(
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MB]XO&=):=*JP-[JPOXI@\1J*":7Z1@9G0M%+A-LI&T)&N4::GL(2W;;8I/\
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M&AC+C4\[I-<Q43''5/'#0F-^Y>;7C4J2-4?&FW[@<>Z"T8<$L(A&;%H.!/\
M>FI%5G6%1]*+(!/+%K-JIB=U*[CK:,J9O*ZVE#Y)FZ1-\I+BC>/XNH:9"@3"
M;U"I($9A&P:T/P +6MA$5IMT\L"H:CN5NY<>88SUSUZAO*444U-3<.P[#KA
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MS]:) #R[T(81@%L+NX# 8# 8# 8# I%4?^EDZ2_^GQQW_G!]H8'47 8# 8#
MI#ZD?^0STE^Y^/\ 5IHP+!N7_2*_^K57_'F8'BP&!A9*VGO49DK*F&46I>HX
M_,Z8P_8@D%J'5I6("##Q ",>B2S5&MCV$(A:#K?AK>_DP*)OO)$[=^ H+R;M
MZAHYM&F&L6=U=U)[L.&K?F9.&F2/0"#?A W0Y,N;$)A16C$@?.8+6AZ"'>]Z
M#<R>2V:+=%+K4JZ,5C7D$<N:YQ42Z-15A31=:MF\FD)3D@D*MN8F9.U*&U.V
M$A)-/&;M5KRZ"$L0=:W@1%RIRQ<-" J1D?:AXL4%P1 !E?K@C"66?3:XHC$B
MY,O=T3HJ@[<0H?5Q*OV!GME0 &)]B"(7A\F!8N^J7L"63RI+NIB0Q!EMJGRI
M@RHVNPTCPI@LUA4]1)$LCC3TICXOC;*L*/0$J4:Q. W99FA:&#>MZWH(YEG-
M=YVS1\IC=L7,P*+D76Q'KGKATCL?4_1I4;]!W)"YP^&LJ%:61)7Z*!-2&Z7'
MK!B5&"5#$6'6@:",,E%:<Z"L"[X/=G1KA4;-]$,2G+#74'J ^5NR)QD]AMQ+
M-(YO)GN5HD"A*6!H(]BC;DY9FBO/L0S-[UOSA31C],FRF\=<C63:";31NA9]
M#)6TI5L@VWO5N'MMO,572U.$;"7[9ICS-:/D4G&Z I*$2+111FO+O86/*X6:
MI;-^>G&YV: V%!*@Y.:J1>XTM/?C1+;$:US.:3(V@HI,VEGL!:-(I+",\XH[
M?MM:V1X;\=!L%@<7?2+<,,="Y6NJ*CZCIYPKZJHI2CDGBLE0/<R7&DV :O)6
MQEQ84,;<XMY&\)9&S#U.O-LW8-"%H8:S%./K*:ZPY?JJ2R*$29AYOZ*<Y<G.
M6GNRD4EH8IMF35&XPN2G,@"#):F;)4%&I3"\J 2<G[4[P\ X&W<@<BO?+-BW
MVX E2.05Q.%,)1U,WC5N2F2Q"'Q04C.1Q5ZVK2%)0I8^%^TD0"(/.\Z8G6Q:
M+W]KH)2YGHMQHX-[!<OFOOZ5.@Y_;#/J,$FE:2QJ3Z;M,K6\>V;T'E=&[W<[
MS%E^U(*]KOV8]^86!&MS\?[N^VK3E<E=6Q%$YMSW$*WBBQ :MU,X7:,)G[G.
M8W/F_7NI:-.4R+%! RAE*?;F;":5L 0#V+80O&>%[;4T]RW2<ZL]N:8_4-AV
M%;%G2>N'IS22]^FZMX?7NLU<,5O$8,1D;9G1^-6+3U901%G^'L0#WK0]!E#.
M(;,9:RN>F8Y/VF0PB7]!U+>M>.T^=G)5+D2AHE<:EEN()BH;(T4@/6OSJP"4
M(#4H-@../%[8).]B%L-2KWT])U!+)33+4OB+BV,G6<2M.*)#53UM8QT-$-V4
MXML&3@$SZ()D9;Y8IIFDX1^Y:"#8O;^/AK S[)R/<D.L2V92AJ+BBSR)Y>DN
MMJ/2ZV4LN5V+'$$@=DJ]K:"%B2#+R41C)[IH\G12@02E9@A!%_\ ?8%N.FZ>
MDMV1FL6>..+*WK(7?=2VL[&OARXHA4R0)Z.<WE"A&B1+C3'9649X)@F! 4(7
M^_,!KY<"IUW<"R*W&WJE>GE$=CT_LNY";4HV5)5#J6=&4:JLVBN)7%IJ:2V;
M4$M,R:$ZI,L*2:6%[*$29O0A V# E!?SA<L+>*-M.E9)6>K4KB@&+GR>QFQR
M),;7DYC#44UKTRYN>(X47(F9S8Y(B-.3CVGV!2F-\A@2]^/B$T0&+]'Q"$0I
MNE%A0BT9VOLA2^6L_/K<Z,;(T5\\J5ZQ;%:H0M"?2H:F+AVF3M0G<0M&E>UV
M>/7]#"$-SM&HF2V QD+S++0BNHHZFNZ+=:6(_5^)T/-TEUM))=L9@/C[6#W0
M/E3G^)8?./P_W^\#1NA^=R+^U"EOTD3VNGJN%\E?XJHA)[ 6C.D;ZP',!"YX
M22!A?TI@FU$I/*3G%E!/2EJSA%"T/>MZ"IT6XWO&L*QY3.A4UA,ON3G%NLUC
M4-\^<7A)7RZ/6M'!,#@P1E[8XV6^(6R'J$Z=8WZ5(C#E']%*-,UX@W@2NZ\F
M2!)P(HY!C,F954J'7*.+[E+L%>W1U;(SI2FE;VXFE)4S@XI6LU>-0%.'11AF
M@>S\VM;\W@%DK;@KM/J.L:LV=4WI'Z7U9(X.V+G$:@MJ3.SQ%U#(E5+3$Z=2
MJ"@*5G:$/8"AF:+UXZ#O?R8%2*?XU?\ G6;45+Z64PN/-Z6KVFK^HX8)8]D,
MUC'-J4M:DLF+'Z;5AA\Y;).I5F:,6@3:5(C-%"$7K>]:#H;@,!@,!@,!@,!@
M,!@,!@,!@,!@,"I78?\ @MS_ /QW^,OW]HQ@6UP& P& P& P& P& P& P& P
M& P& P*]3:I)%)NE:#N9&XM!4:JF%7+&GUM5'+-/:Q78R!A2LYK.26D,0F)4
MAK69M3LT\D0="#Y CWO?@$ ):/ZC/Z^47W*#Z"ED&1.&HQ7[>^.MA'RFI:J/
M-V4^[@;,F:$<5(L>7)=:&XN*D9XA"W[ !H2->&PS#C05^R_I&O;$FLEJ8N%U
M18LDF,9G<1:71BN23P%V9%C6S4;+T9"$ID.BS4L<#%"Q6-<I"MV$(PIRS=[W
MH-JDM43+IJ-F-]IOTHJ(VM>B'V25LZ5@62WJI''H4;[I ).^-=@L[XG6*2%J
MH]04(:0"8:Q*6J3:V5LDP01!77(]O5ASC$ZY ^53;LWB5T.=I!C-RLI<FK)<
MT+'A]/W'6%T^:H'F(/:\EUTXF.GN*P9+H<I+!KW8T.@A@DG#<V::;KEO3FU,
M]V;7G3,JZ825\ZHW8JA]BFASB4ZU(UAVV+'1OC+:@6%F(U@D @Z7E;'M/H O
MD"8:4K.V^9JKI*L&5+%9@OD=WR9RM4#4AD6XQ 81.W"53)Y(@)P0I2FUJAJD
M29*E&Y:**4^802B=G&EEX$M0:II"R]&WA>$H7,KFEFT:K"!UNB2&K#7&.0F&
MI'%QD3>Z 4HR$R0U_F3F-7L*8PX)@  V/>A:T'053@/&UL1?HIBL9SDE?FQZ
M.7A:5R++2;3Y &\[(C]A-)C<UTQ-"S6T#8&'1?8BPAW\04I?8I2?=TQ(];W@
M>^%\621-U2VW5)VJFV".0^RK!LEE=JX%-T4JGB^9LQS(RH9/#GQ8K@\,4,A:
MTY6[+FD?G?EX2C#  "'Y WJ<P&]KOB5=SO;;!HO;U!].O]@ULS/I<J9(9.(/
M%US[%&<I^.4)5\G854MC*\1^E7N@@:.+"863H@T L#::FYVE%?\ +E@4\Z/K
M$X6'9R>[7^2.S?[^3$TLUN4]^7')$!AR?XH9'60UT((T:,G1QH"1&>SUL6@8
M$?6ESYT4Z<D4[SG54O@#$[L<3A4)N%W=GN6LR.2Q.+QQ&VO$7BSS'V4]^0M\
MN7)]DK%.@HU6F_S  ( C1> 3O64;NR&0:F8B;'J#C*6-N*YDL-@@>YH1%F2N
MV]$N)B26J2G$G2LR0 ."E]^^*>! @[.$$0A[UO8?=;4<A5]91F^MN+3J(LW/
MTAJ14UB-6;D0WQWG[5*TZY,1[IMNVT%-Z$98A"4!-T=O6M%[#XBT%?JMH[J-
MFZFDUZ6D?04O9Y.M<8^@<RG:PEDZK&HRPJS&:"5DVJ6=NB308O6@3GO*HS0E
M#@;LW8C1!T$&!DXUS_T Z=%Q6VK0E=5)45=(K3:$,WJYJ=8Y8]NQ^=) -D,8
M+(:!(26)O0UDA  Y/X*G'VJ\D!I>BM;'O UFH>%'RE>@*_L"-W=.W^M876,U
MBIK-*UD?42=>]S"6F25:UJ=-L.0)'*'N:]6:[+CSU7Q4YX 7O9@B=C#L/33?
M*=F1>\:YL>:HJ!BC1344LZ*LRZC(PKB+U<'TBKBQD.%@Q\#2VL\<1QY&5HW2
M(A0XZ-<1"- 8 &_D#H?@,!@,!@,!@,"D51_Z63I+_P"GQQW_ )P?:&!U%P&
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M7XJ8#ZAO#WYG'+7Y *J_%3 ?4-X>_,XY:_(!57XJ8#ZAO#WYG'+7Y *J_%3
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MY:_(!57XJ8#ZAO#WYG'+7Y *J_%3 ?4-X>_,XY:_(!57XJ8#ZAO#WYG'+7Y
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MX*H@(U$ P1IAY)GGWX!\@AA>G 8# 8# I'W8865!Z$,-& LL';'&HAF&""
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M_%3 ?4$X7_,SY7_1_JG\5,!]03A?\S/E?]'^J?Q4P'U!.%_S,^5_T?ZI_%3
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MAD=C4AB\@8YH6D0)'E&^>R2;<BBQ+ AT)M2YNI* Z.HB#RJXH=9%=:Y ZXZ
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MW$K90/U6Q-W->*IMHFLX]+[M:P.]21&5747"#:AB4FL)(/RM2)T>TARM1_0
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M5C/-K'FRAX;[BMNB%S+!:*O.T'Q+8U$0J)V+;B(;'6U=2IX&QP6$3=N<EKL
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MGUB:N^^R_P# Z_[E@/K$U=]]E_X'7_<L!]8FKOOLO_ Z_P"Y8#ZQ-7??9?\
M@=?]RP'UB:N^^R_\#K_N6 ^L35WWV7_@=?\ <L!]8FKOOLO_  .O^Y8#ZQ-7
M??9?^!U_W+ ?6)J[[[+_ ,#K_N6 ^L35WWV7_@=?]RP'UB:N^^R_\#K_ +E@
M/K$U=]]E_P"!U_W+ ?6)J[[[+_P.O^Y8#ZQ-7??9?^!U_P!RP'UB:N^^R_\
M Z_[E@/K$U=]]E_X'7_<L!]8FKOOLO\ P.O^Y8#ZQ-7??9?^!U_W+ ?6)J[[
M[+_P.O\ N6 ^L35WWV7_ ('7_<L!]8FKOOLO_ Z_[E@/K$U=]]E_X'7_ '+
M?6)J[[[+_P #K_N6 ^L35WWV7_@=?]RP'UB:N^^R_P# Z_[E@/K$U=]]E_X'
M7_<L!]8FKOOLO_ Z_P"Y8#ZQ-7??9?\ @=?]RP'UB:N^^R_\#K_N6 ^L35WW
MV7_@=?\ <L!]8FKOOLO_  .O^Y8#ZQ-7??9?^!U_W+ ?6)J[[[+_ ,#K_N6
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M"V*"26:.$1=$C4T/JEM='!:WJ$Q"<9Y0R]!JZCL7F-QJ9[N.!$&SJ'M#Y$&
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MI#J_Q5P'U0&K\Y3M+](=7^*N ^J U?G*=I?I#J_Q5P'U0&K\Y3M+](=7^*N
M^J U?G*=I?I#J_Q5P'U0&K\Y3M+](=7^*N ^J U?G*=I?I#J_P 5<!]4!J_.
M4[2_2'5_BK@?8/'#,K%I(;TGVB(I3_0#-;Z'6>&P&_:"UOPBP=_8W_,WK?\
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MFU 6-/I?U4DBD!0N#C!YGZ@,EY6D\?(?H@T_&UR%"\+:&;OA9!8UGD1NQP5
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MB+?WIP'T=UU^UW7_ /[$1;^]. ^CNNOVNZ__ /8B+?WIP*Q,T?C\?[_7%L#
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M&:..ZU]FD:B^DKPY-"56ZMJ?1+X(?M2B#AEC#K>RQZUL&PYX6IZC/5//W5M
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MH8?T^O5&O*52O@BC[9=*YF3#T!3S&\/EGE/BB?6-*K*FQ'0LM;B1)V25)95
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M"/HI)"XW&E?O4G8"XG"$V]. #'(1H4YH@GA3%E$)PQ75%94?#U<EZDN.</\
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M&A*Y5)%RV'Q98MF+60QR]8JC[2H52IE2D'I4S/)%!J09KXUITRDPLM.JV:4
MLP0=!UH6];#,-3.T,*(IL8VIN9FXG8]DM[4A3-R(K9@MB'LI*C*)(+V,6_'?
M@'7CO Q;G"X<]M3NQ/,3C3NQR!9\0?F9S8FM>U/;A[1,=[\[MRI*:D<EGM41
M(O:G &/S% WX^(0^ ?LIBL76O;3)5D;8%<C8$BYO8G]2SMQ[VRH'0L!3FB:7
M4U.-<VI'$HH(3RR3  ."'6AZWK6L#]8_&X[$FI.PQ5A98RQI!J#$C-'VM"S-
M28:M0:L5C3MS<0F1DC5*SQFF;"#6QF#$+?B+>]X'X.41BCRPN\6=XQ'G6,2
M+B!^CCDRMJYA>P/!QJEW [M"I,:WN0750H,,4Z.+'H\8Q"'YM[WO ^@8;$ )
M"$ (K&P(4J6/H$R(+&V!2)T,34;5Q9&0GTET22EC2L6S6\L.M 1F;\Q.@;^7
M V3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8%7NDN7H[TD*&[?Y L8_F8SW0TH@I
MFIO= J/IHI>:4LZ*A:7[U[ YH99JH4%>3_RP@[*'O18Q8%39!Z7D>DI[BV.5
MON8H08\NDU9V(N!,&I"CG\GA%85Y+G!ZF)CD:=(X<X1RM=;1LHD:<212N\35
MBM.B0)DP2G1OI_PNBX;7T,89LZKV^O>@&:_V\8V!H;0JG9HHM/1^X^-*C,V0
ME0K4)(G(P\O^B[4F"!X;#O8MA'$L]+Z%2)G]S1V8^-+HB<G.1LZ\MC&F2@E"
MCLAT[,;5SV7%Y)$Y"YMJ28.IK6>2D=6U8<D%M22L2K?(< /)!O2VA,%LFHK
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M5A?,6O7AZ(BS\THND:H^=4ILZ,L1.S);'JVAI#DZ% 6F?#&T81KSBAFIDYI
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MK$(0ZJ8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M7 _HGP(6Z"_8L?OZI9OU61X$DQ/_  5C/^+[-^IR; V# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M *8[7_)\P'SV[9_,LK_],=K_ )/F ^>W;/YEE?\ Z8[7_)\P'SV[9_,LK_\
M3':_Y/F ^>W;/YEE?_ICM?\ )\P/T*G7;11A9H>+*^WLL81ZUOL=KWK>P[UO
M7CKZOP?'['\_6!3JLJSO.F.5HI4HBTI+O7B*NHMT,1 W&L'IY(BS>U2[XTFK
M9UO9 TUHZGD2TQ  :AU2IC#D 31)BP*-@UH/IX="_,#P\DX^J;\X?'_R7"GT
M]>^_ O'S>R\?H#^9GSC_ /\ :/'_ /(?)@=R,"%N@OV+'[^J6;]5D>!),3_P
M5C/^+[-^IR; V# 8# QSNM$VM+HX@"$8T#<M6A"/S; (25,:>$(_+O0O+O9?
MAOPWX^&!_.YQYZ]'TX15G4V50$M76HLJBCU9]"T QAE-HK;EF3?TO/K,2LZ.
M<S.,QT-9,M#TJS39I5*W$A6I;'\H@L2U8>E3C"WM<^M-RE;]_-?.]6PV_9Q*
MI2W^^P&4MD$C#?7]A*E%(O-],K+&I!(9ZRJDCO(H@Q')4H79(V$ENO\ 0%)J
M<L!IQ8>)@]7:MX_2="V1:5;6X[O%OUK85Q23585ZSZ9ZHK:N+NB=*RZ2V&AD
M-H*EC4"&OUA-!;@0V+'U2J\BHY"6H 6$&!EUWK1\<HQ7H0 V;*UE)RQMA:-,
M4?5B8%L/SG>:SFT!,#<G*T4#-%R$MR(1MIYDZ4PW0$6P.NO,U& 6[#?JJ]5G
MF6Y[DH2DX$AL)?(^AJJ;K:B+FY(H.Q-3<QN&K#).;5C<[SU',94OC[O5[JW/
M*N*-4B969?[J6L7$A6)QF!TOP& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M&!SN[RH:WK= P+ZDCT>EBMVI'J#FU];7^3IXJ",(^G(S!F5%:852Q&L+=6^
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M'TC+(JD2W<]UL]7PEZ6[%I/J4+$CD41+;)/6[_4[76"E$6:M5$(G1Y+;R_;
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M$#OI/))L>F<4RI6E;_AR)6 Y((1!@4MNQTZE!Q90%5*"+JAY$KH24D/"&M*
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M:$I2')$IJ<[8BQDEB#L 0S^ P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP&!7:J/V4;J_NRC_ ++=L"Q. P(6Z"_8L?OZI9OU61X$DQ/_  5C/^+[-^IR
M; V# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8%=JH_91NK^[*/^RW; L3@,"%N@OV+'
M[^J6;]5D>!),3_P5C/\ B^S?J<FP-@P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!7:J
M/V4;J_NRC_LMVP+$X# A;H+]BQ^_JEF_59'@23$_\%8S_B^S?J<FP-@P*8]?
M]FH>/D]8*W;GSH:[DMK3EFK-C/HMHJMV U3Z5N[4PP:,R#5CVS61B17-WAT]
M@A.("I2EB(,VJ-3!\FQA]:I]0'E6U&ZVS]6S"Z\?J$=K*;KJ@MFSBOXU.*M;
MZIG#M7DKELY8DTN==QN$ADK,:!,ZJC"TAY8BQ:%KV@=;"TT,G,+L:(L4_KZ6
M1R<P>4-9+U&I?$'IND<:D#0H#L9#DRO;0H5MKDC.T'?E,),&'>];UX^.MX'/
M'G[U:>3+P@,OLR6.3_RU"XDVU+(-2+JMSJ^L(_(XG>P)7NI9+'90V65+8H83
M,QPAU 2VK%R-]3B2;VH0D@&4,87%6]/<VMLY=ZR<+_IA#8L?@A]H/T&66=#$
MTK9:W2M@7Q5/75A.>0.3?$$S&,*TQQ-+ E B%H\0]%;T/80/;GJ6<15!3SK=
MB_HZH)M%4;G)8\R-M;VE6LJDL[E\-4,R>5P>OVP,O1$2N:1[<A1#6-J<_:E.
M6J)$8$.C2_.%M;&LJO*?A3_9-KSJ(5I7L52%KI-.)Y(VB)1-@1FJ2$1*AXD#
MZK0M3<4>M5%$E[--#[0XP  ^(A!UL*L2GU!^9V#H?F;F-DG#'85E]51%_L>N
MPP:;5>N9DM8LK8A<4-A.2IXGC(O>H_,A. 2V$N/)GM>[!(5J2$^T:%8I(#T]
MD=R5YQ4BKA9.:XNBS#+(73P*-KI.*,$P>V".U= 'FS[$FCXT/4NBJU4P12%,
M"I6:0U <W=3LO125$H-$$&PVR,=H\X3"53V.L-HPI4TUC4-;W9/9X9.($EAT
M1AMJIG=VA_SL&IE14EAZQ?%6TEZT-W;4"$QK<4II*DT0C2R0SK+U_P H23Z.
M-Q[I>A'W5P2:10NJ-L]MP-RU94OB*TMME,7@NT;\=J4R"/.1Q:9:D1>V/3*#
M2RQA",P 1!&UL^HIQ/3-=6=:,OZ5IU1%::GL5JZSQQNQ(;('&$6',Y(5%6*'
M25O0/@SF1_-<_>!&IU7L3"$R!:<9H):-0(L)CUTWS?N;HZUU?U,"L-QKW=MM
M\'#9T+W*UU6:1"<_I'2,.GK;FI@VVP E.G4!>T.TP=FZ,]GK8M!II'</&"IH
M0R!)UGS<K87.=?1BW/:2[*X5-"VQ-)&U?N$I7(B1F(CI/I"\HSMH@CV?HI60
M/R^4XO8@GV8S2'5W&W293^61J#1!D+(->I5,'UKC4;:"E2M.@3&N;X\JD38@
M+4+E91(!&F@T,TP(->(A:UL(ACO6O+,O6U<VQ3H^C)*XW>F?U=-H6&UH.[*[
M53158L;I,?7J= ^'FS M@<6Y0G6;0:/]W/3FEF>498PA# J.WN,TD.DEAJNL
M>;TT"ATZ3UA+)HHNNN"8K&K&5B,TE@KX_F2,+6URQ3H@P1: XT"D998QA!L(
M1;T'[OO:W',7DLHADEZMYQC\O@Z98MF<7>[KKAKD$21MR(+FX*I(SKI(0X,B
M="W&!4'#4EE!+)%H8MZ#O6\#UM/8W)+^D@2]BZ>Y_>D-J3137%9K&FX( XI;
M L!$!N,60F&J$;^<5))6E"\(]&($>SE0!+" [!K9Q6A!^(.SN01H+ =0]3<[
M[:ZG5L*&T'/Z9Z[TVUTME#ZIBT;2SA?N1:2190^R9$<W) +AD"/7$F$ \30"
M!H-8H3NOF#HIEJ%9";5B+7*;TB#A/:RJN62N'M5K2>'MSC(6\R1-<)1R)T7N
MC0I!%ERHA0C$I).1)C#@B\A1OD"PTLLRN($I3HYS/H9#5:R.R^7I$TIDS*P'
MJ8I7R)"Y3R2IRG5:D&<PPMN<TZAU5AULAO(/+,/$6$8=[".".K>8%4DE<.3]
M%4<=+8*U0Y\FL8+M2#BD$29K"6,C?!'22,^GSX@R-\Q7R9M(;#5)98%ISBE
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MG+Y_3,%;ZUZ'2$VZ?6$?<IFY0>(IXK35FV];-TT3"Z@N(DJPCY>R3Y1;W/\
M)F)3MJ:7EG2J4@#3%^DIH5&!T&MR^*1H!B1R>]+?K*FXXXJSF]N?;1G49@;0
MX+TR%0YJ$*%PD[FV)5BQ.VHSE RBQ"& @H9F]:  6]!K;AU5S"T3%PKMUZ+H
MQMGK3$W>>.L+7VQ!$DI;(0P1MOF;Y+W%A/?BW-#&6B'NR5V4KC2@)B6P\"H8
M]$"T9@8))VCQ^O15>XH>IN>%:&[3BD].JT]RUZ:1:9Y\B%$"R:^,!(=ZEYNY
M:';5L*#V^].7_)=^!^]%X'L5=@<H(F^U'57TM0Q#;1DC10^YUH[9@ON]4RUR
M5'(&Z+V$9I\WJ(2%P<$QJ8A$N]@H.4DF% !LPL80AE1=/<]G2V)UTSW55$CL
M^PX&&S*RK%CLN"*9W9L(4M2YZ:Y- F$^1)CI&POC:VJ#D:\D7N!Y)!INCO8E
M&F ")ZZ[UYVEM*1.\;$EC?S2PRZQ;#J-)'>CY57%?29%9=76)+*OF$./.0SB
M11%R=$,HA:[0-MKLN)-2@"=H?E%\@6!N:T4-+5C+K/<8E/YZ1%$!"DF$U9%5
M4UL*5N*YP1M#3'XG&TIJ;2]U=75P))",\],B3!&(]4H3IBC3BPUWG2^HOTM4
M[-;,38Y9%4;@^3F(O,1G2)J03"'S6LIU(ZUG\1D)+ ]22.G.49FT37HAJ&UQ
M<&Y5['1R92>0,!@@JDF]6+A)=%VN>-][PE;7BKIB<<I2"PPRR%)(17UF0.+V
ME+7!?8,B<90B0QF%/C54;D)G<C-CT[:4(S4Y8TZC1P0M IZLY?1RYI@*KHVB
MDTY?HTHFC)#SK9@9<F=H>DB>IXIE3>R#?M.2N.$P;?QG:T!>TWPK6U?G]WUL
MS0?6.=7\O2^%H['BG1E&R.OW&,3":H9LR6K!W.**X?7KLTL,]E*=_1OAS69'
MX2^/Z%&[+-&^[MRI:04H$6,TL(@BZU?4(Y J,B2"?+VK-\<(':%>519[!$["
M@+O(*E?;&LN,U0D=[1:C92B40>+QB62Q*!Z6+M%_#P><.P#.UHD06FA$YA5F
M1&/3^N9=&I[!9:UIGN+3*'/C;)8O(V=8'SI'1C?F=2L:W1 H#\H#2#1@%_,W
M@0?S?UM3G5RN^2::<G5\;^>+UD?/$TD"IO+2,+S/XE&HE(Y"="EX%BG<BC#?
MN7%(=.&@$E'K4BC1.C"0%G&A9K 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M1-LLASXOOL-2RVPH3.FZ(EO;6^U8W(W6;@1L;NVNC\D9F]4Q2(]6)8P)5(#
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MH#%K*^(FYZ:%8TJD&S$JQ.0J('O8#2P#"(.@S> P& P& P& P& P& P& P&
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MC>D9*]L6[0+DSFBVI2'A&4;M*X(RC@>.OM3"PBU\NM8&Q8# 8# 8# 8# 8#
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M]V4?]ENV!8G 8$+=!?L6/W]4LWZK(\"28G_@K&?\7V;]3DV!L& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M&1( EB7,#R:QKEQ;8](PFAV:E/V \O0M;$'7CK W; 8# 8# 8# 8# 8# 8#
M8# 8# 8# _(\XI,2<H/'HLA.48<<8+Q\I910-C,&+PUO?@  =[W@<38;ZHO8
M-QU>EZ/Y_P#2LL"SN8)*RNTYKBR73K+GBOYS/JO;#%QB29HZD?%*IQ8UDC:V
MX:QN:E[D2I&4:2%0),8,82PZL\_W=!^E:,I_H6LSG$^O;NK6%VI"QO"+;:\:
MC4ZCR"2-!3LW;,.TA=$Z-Q 6H*T,P)9P1!T,6M:%L)>P&!4OLSJUOY#JEAG
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MST9[76O)KR^.P];K40W'HR#7N%V2E$1&D[7J-2P;;MC5N9MD3FF)@E=_BFE
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M6RA;'H-O]/\ MZL^G/4?]23I+G^9,UM4$^4YP?5,?N&&&F.M>2.PZ[3=)O\
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MD!Q;[('1]);3E#,SL3>)MCQ#D%N;PZ3!,+;TI #1G&A&<8&U8# 8# 8# 8#
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MB3JD;61*!LLC;'5CTB=D11BP\@"%R:SE1I6B$J]"::4K)#6^"F"\HOSV2P]
ME2LB9H+/N<3 5-G0QWD957+[3E;I5!"Y8LLVYWHLM+ %R HE,YRM_=$)  )E
M2PTTH6\#G=&Z-[;B$3C^YN+J*?Q1];:!EW0L2CO1;BHM>3/Z>9]6E6?'JJE"
MNV6)5!"T*%UJ]0Y((^\,"->PM8TZ8PU7M66>$J\[TIV\QV;3MA7'*;;<GALE
M=51:>H7&Y#'JO U85PS+D4Y4.=?-TI!#'V0_6F+8].3J4W"=%3NG&J1F ;CC
MC!A^79-+==RY?0<J2H)38MP0VK>NHHS6!RJ_*>>XI![:LQ13PN?Y!.(Y-+N<
MI(]5TSK(D8<_IA.3ZVJ!H1&JFH\@9:3 DNQ:'Z%4R;J=+$':U$+';<[X+<VA
M\CEPR%L<2VEFN-HWU>&O7)RFAK]63!]%Q!X3VUL&VIQIC30-Y0E!H_,%8%_/
M?7;E,J!89[&>@IY'H%>%)OD#=RKQ0+8;!854?;MP2R7OE\H7ZS@+[2>GGG7<
M",8UBU!(W@6V[80F(W M:8J"69!S5TNIAAE<L[Q>C3%@];]63+WMBZ%E[3,W
M&HWFB+=%1X'2QRK#!8CBP[NMQ8#4J$]S&>G/)3^\EA1$C!H(DH2?W@+OJI*W
MLN96F\V4D;9&MN-H;[K:':KF6#-_(5+&M,9E]&L<[6? )>TW:_+U^Y .-ID#
M@J=-C3NRP"A,E2!97U$(YUW)9A2(.:([9*E&PGER%RD4"G9S$@3R!NM2I%JI
MEE4<#;U1LRE"MK-#(1 6O:>:-AA7O#>!C]Z6DJ=!5QMI+N1AGM_W1'X3<SS>
M4+KAB7,3A,+M9=UYT5/Z[ZKL:U-U753>HGKCJN:DM&E7A*RZ1JT4?9T0EB3V
MJ4*YO5'B"\44HB\(5/: >ULNLJ;N[1QI<U=W-,E5FKUC:[W6M>J1?86[M<5E
M3LZ15HD"]XU+1(G1.SC]BA*)2KC3$Y",G0<_&:JO4%3\^LT<?6'J-Z5M+_<2
M1G''[O/@]UO=C/-(URW4E9UA'/72=BIFFO(5<J62@>6M!,7&..K@:0]@CY#2
M:%M3A:*<5M<-=U+W+?EM7E8L L*.[6/E22IRO"3M-+-$<A53T3+$>VBO@28$
M(88Q++WA[\D.]];@/)K>[K46M^YJBD^PO!R*59QW/5=26Z-O":U;&0N=L3B.
MO:]:O4U^[VJ]N5@@JE,-:8,2=LJ1OD1$92E%Z 6$EJ#O0?$6][#BW6%"]N5[
MS<BK2/5GTK'FA(V4-#);&'R]CGZ1(YXT+[S7VA853)X+TE7KHGJ)8C=8*V 8
MFJ80E( 1>U0DHRVYS(= LOSG6W;A%]4HKN]/=CK%7KEFM8I>:V0VB<VQB(SE
M+SVQ-$Y<(FXU[>)S2_2QWN9*I+6D&PPI]2."@YZ;I:8W>Q;,#7)K3G:\7I#C
MYA@J&ZWF9UM/[?U+8NEM97IMD36LN).MK#=N6*BO"&30.R:[(-,2/RSY_-A(
M#51#W'G%0K3FI@[',$RV^RN>1;YMR-J#!5L?1Z?W1*E*893M^CZ1^V=&%1"Q
M0H5E-'O>DJOVQ1 RU(=Z#H0-A'L*37+2T@/[EJ"]VR&VA*697S;==)+':*6,
M^HH5#9:^R6OY+%55A5VHL./QMQBKTTM;L4)06SNVA.1*,2DH)A"$XH.;1'+_
M 'S5?.U;U9 5-\D1&-QGEP<PCK;:KS/+#*?&SD>;0NQ&>!N.^F:7>F:/1SH-
M'%EBMJ;Y>UL!(R?>$J)6VA6I#P[@$PN623FY) +%<7UWG;O2Z*+3AU;'PZ(2
M-UF*F%$MLB7)9!!'5I''W1P?-G#T>U+" $&#\2#0@T'>!16A^1[%B\<]/NMG
MUTO*&5K2G(Z\JU(['^A; 0$!Z):U7-JB'LTO<FFP%$AF32R!;)B0D;@JE<9*
M0^T1B*VD$D(P*RQ2I/4/3O%I*;477],8NHM^.N%GQ2 3<$'5V5""[HL]V /G
MB7G=-.CK&4Z"OG&+@<4K.EJY(J8$8F\250Z@4;$&#H==ZA$ZK+GI?!E%UO()
M]5U'S=%:\YLB,O$6BB]BY?O^'2AHMH"^6;?Y))%U[N,/7NQ")G<4+N/RK_:&
M!2FA+#R1KGCU"Y!3.FI[DW3[8]M+!T.^LK6?<#I7DD!;2/F.OFNJS%SRBZ>N
M202B+NO1R1V<D2=QDGP03B X[X8A9%!"8P)PGZ7H2OV+KZQK+?KMK.01>+6S
M9+/>[[?C6T<TF-<:E]>3SFZ Q&KRY6OTS.@FV-FQR1#(:63:@*AW)6'/&G=#
MO0=(>4T]FBY\KY^MXQV3VM/VUSM&:,<@6+7$^"/]I/+E8&ZP*]Z/V,EHJA/(
MRHVD)*V66%*U \NM;WO>PY-%\L]3W#1<YKJVV+H89ISCPZY2QMF?1+P!?-N@
M:\Z+-D745I56^0NW-J(Q23I7(FY6U,NCV=O"<WDC0,R1>DT,P.NO0[=8Z/F^
MU8[1C>XNUI*JQ?8?6&CGK1BY%*GIF'&8Y(G)]DCJ4>M!&5BXMS6'*%FU2DI*
M9X#&>/7B'#'5(=3<\JJSXOAJ*U5_S,B_8[OR^\\Y33Z&*J*/=)-QW+JCL"RX
M6ZW"K<%M=T?.[+ES&M:'=6_:/1>UV!N6)U980!;>.U'UV]BZVCLQ9[77@F="
M]<0]^.FMEM<BK&V+.G%A/AO-*R@HDMF[ZGK:,QZDUIK2Z$^Y1I/[52B*6E+%
MB4]9H+&NU.W'N9<:/D79TK8YU1S#>\&?GYS4M2EMAMB2N"4HUPM.Z(P*CE+L
MC.?XDK]KM&4J)T!(+S[UH9?G#D]8'I^='=71.'Q"[(;T(1#(C&9<X&I+)NZ/
M2JQC;V7\L2.OK?6-LK.F\T&51_0<L>_FZ-G(4D(36Y:[C3HVA&L*'@2NAH[U
M)6B06$WM+M;#.VI*1;6**M$9DC2U0Q1!D--T4QD5G#WY=?ZQAB5T(94Q2XIL
M=&^",JM(\*!JU<D-;3TFM!T,X8HM1$JS<%=C5I-8H\H.I>C;GJMLN&5I+ M"
M+LEF26;((^^/LL32N;J53^ZU_,E:47OKLX.)")9LA6<-0$P6!@N%HETM$;!Z
M63W>DLU7$G66D.T#E%J3 QU>%RY7-;04N;*RQY#;%H0[<<98FJ8/='MB0P1"
MX(S4Z0V.)UK<K4G!CY= >CU_J%-+\C(MQSYTD,#U&I.9](;M$*[B#497<_2N
M+S"S83<30H-E:Z<*FE.>W.<&/>RE)A#NURE&F1G-NPI6Q4!U977'W.].UW7?
M4[&^536MZUNZL4=Z"VA?2.G],,(0\^7,IF#U=:DV1\R,KVF?3=M0UIS:5M40
M8KCAY0-E%AO=NT1V78[3?T-1MUOIK@?[&CCU';ID%A,4PY>2QMHZQY^G=.NE
M><Z.UB(R3'FIJOB[HK<T^D\:.4*&UP(6*78QV0FEA^[!S9UL?8%?6PK0VU'+
M4KVO^0ZI>WT5\.;M&[#=83V9;BCI2:2EN)ER$BPX/,:;E Y(UM[XA%\):7P"
M%N1HW%+[NG#\HW177DMY>Z.KZ9Q:XUTBD]3\[,@H_<UJ,$]<)ITU&)4_N?1M
MC5DXJ9[)FV)5'+"/@)C0@]LSH C0FB1M:#Q&$X/OTK1O9TSZ4F\LK5DMD<SC
MI/1KK05KCLYC)Y_A,>FW$2NMJD9$%9.M@I](+2;.AU#B<I<@,!!VBUVSE3B:
M@,((3!LW/_/'44J=Z8;[DEO4#%4S'(^C9,XM2VVI-6<G0Z-1<[!I=HF!L8Z3
MN^R),SII:S35Q;TSK,WL/LU!A*LLIN.3(,"?.1XITS&.E>IS[6166NJR12!X
M>8))[&F)JPHI4HLB:*V2-0N,(;6L*'K8BC@+@@$B=6MBK\]*WEI&QT:W!Q3'
MN.!&/5L4[AD/8E:.U!MLZ8H$P)801\\T\U./JXY"[,ET-DY,FD(-MB,1PDJ/
MR)VBYZE.IA$R>'8D))Z!:V@0'%B"KL$Y][NCT,M::U5&KY@MIS&Q:,C#BFNN
M]6>7R65,TEYK;.=[JM4Q\U8TQ*4LM)V4[:GS"B4+"C3A1U06TI""'!.EP+U6
MK1]UL[OV*.JGB[]M]@<B4O&:XD+-:6GZ9ZN:*.M[L\K4U^19$V1M,3E H<JB
MYZG1*B.-[JM-V<%8G7F*5Q053:*Z[Y/;J  K8;L;75K3MC;"US-<;RWQB"OS
M=UFO?97.^DXM,;MGLLDT8G'+?N9#;&W1[LDUB 6K:@*MN)I"P0;E:#+>7,/*
M,LOL,\M9RZ?UTBY/40K6R;YDTACENI'/HVRHI3E#Q^,+I4ZPYM+FU-3Y D0-
M[2E*5J5B%M.6Z,5HA&@#INQ57(DO.[;2[Y9DR72_Z("JZ>[B3/3B">JI0HB'
MS?=;(0OAJGXDDDYCP:8YIS@F!$G4>7R>700ZT')25UWZBLDIR*2:<MMW#MZ8
MH>A!*H+2]U,<625->J*+596/)TU?7$B?QEH>:2 &NWZ6O[2 YS0?%9=YW!H7
M[+$ H-UFM ]&0XKU%DU,L-R-5I7E9E)6W&+*169(9!")9!28GSG&;MB59L+Y
M?$6/@UG*4L+FB-O(3#B1A" YM3HWE&04AVC#H!QU';2CO.<*8[G7S)=-@+)R
M8,4[& J:H(HXSR3K8&SOIR:R+;6@7,L'4MZ4 E4J?G4!10-+EZA:$\S8<T&#
MG^\*JHY-549K7K-1&XCUUTS)K39H'T0])9]:D&LATOV34;*ZAL:2WTD?6^&,
MTDET27R!!MS8%!SF4<I7(UN@.(%0='I @Z';>(%32<F53CJ5)S0F:74J,RI#
M#U\ENL%<$(7T^/3 HI$@8URZ7^W-1K"M)  -V 18TWVIA8<:&AB[C1R"NJA=
M0]0:L5>V]:3BCDZ*VUT;9X2@3W=R2&F[(O1H?^C[4>957<1:Y-)$XF%^DDX<
M"&M6K1'(AB.2@3A)-21/K>Z(O:#K#'WIYCBTJMDZ.2R5/]ZFZ73 4;]2Y2C?
M7JASA3UT=:NAD0Y*8WUE<DR8B/&*T1B!.2F5KTNU&!9.84?TNU]-1.+PAPZ$
M/J) ?5#!$K"^GY_<8'%:(20ZQ&J_XW9:*2V JF\VNN0R!W0G,4A7-ST[DF[:
MCDSFE V+=8%9)]3_ *I#K1L55/DDL[Y]"LZ<QF81^LYKMWEFXU65.!IJ@K/9
M3&V_J$;DB"T++CJRQGI,9(3"4RV4("WEJ7I6Q0G(#O5%"'Q-%XVFDZSXC)4[
M SD2%P]BD3^_/A3<G+=EGL$ 0(2/>EX3!^0G6B@^;P!K0=:P,_@,!@,!@,!@
M,!@<F.9/#?J\^JKL7ALS5#^FP$&Q>&S-$_!>J1;"#>_M]$^UWO?AK[7S^._L
M^.!^?(GAKU5_6$T'PT';7Z=XAZ#X>&SMT/8 1"'K7R;.V2 O6][^V\F@:^QH
M.!UKP&!B)!YO@+WY?'S?"'+R^7QT+S>YG>'E\/E\?'[&!R(])4!._0]X_!L)
M/L1<3MGM0["#V0MF0]TVH]J'P\F]C&(6Q^/V=[WX_+XX$R>C7YO_ )3GIP^;
MQ\?J6\Z:^7Q_WNJOCF@ZUX__ 'N@^'A_,\/L?)@=*L!@<EO5J_Z)].G6_P#>
M;]6GA7S:W_O-^6:OXR_/K?VN_*>$.P^/V!Z#O7VWA@?/JK?]/^EJ+7^_UZM'
M,V@;U_O]>:MK]";Y-Z^VUYB-CT+P^R#8M;^3QP.M& P&!R8J#0=^M?W&(6M;
M,#Z?O P2MBUKSA)%<O;0C E;W]MHH1H=;%K7VNQ:^7Y<#XYSUK7K%>IUY-:U
MH7+WIN"-\GAK0CO>^P@A$;Y?D$;[$(=:V+[;R:UK['A@=:,!@5VJC]E&ZO[L
MH_[+=L"Q. P(6Z"_8L?OZI9OU61X$DQ/_!6,_P"+[-^IR; V# 8# QKR[MT?
M9W5^=U(432R-JYW=%@PC&!(W-J4U8M4C 6$9@@D)B1"WH.MBWK7R:WO _FZJ
MSL+I:GXP9'[DL3ZN;ST??;/T-'[(Z01DVXTP^F.AJ+Z'M B#0ML9YVB;XNV1
M:UZ,2-#<T.2M,I:T#V%.)&6<>D\ N13?6U[7;=<'J:UFB,15+9[2WQ6QN;$<
M3ES)9<#@,AX^C5U.G01M@%RA.\-D56W%(#X$26)$F+3*3"TP56GE&J+V&,KA
M+*#>;/2LE2QYLDZ8,M^QB(.CHLF<_.='&'/4=MIM>&R>A4/0Q3%O4)F!NT(;
M\%;LLPDLP(@F[\^PKE</278'0&OHQKVS6> 6&+H:LG) &*0Z3M"GE^:P;K]1
M!X335_'HY L.L*)W/"(WIT>41Y+88XLB=P4)RQ-CB@$4'@YMZZZ\J<SGOG\8
M1VP)B@IY:LVTW0U;;O2[RKFO3Y4PD4<=%SH?,C%T*-J]F)"%*TK&I"%89IT4
MHR%;8,L+9\(2R>=3+NB7N>WVLG)2:P^.[ ;'NJDTDKV,QIV8*SK>SY?3Z1E<
M9!(BTR F7)%+-*$91X#3R#CD+B6!P+6:P)FJ+J&TI-W[>/.,M7QQ?!HTPO;K
M!FR(1D"E9'4,>05&<6HLMX<),W3>(/[TLG:_:7:F-J8M(T@2!LSQ[P@<DI@;
M%T7T//Z[Z7J"L$D\A=4061L48?42J6UQ); =;\F#U;T<@+W3,"W'GAL5,TAC
M<2=PNAIJ5.XJB/B1#B>3II;'/V@<TIGZCO9A$#<72".-5/4M4J(H_2=*.G94
MN3\^RM5%NJ)%+^69LVIIVE6/4[CVZ18PG+SC4*\@I>>I,2:(<6G8 V2O/4=Z
MK=WYQ1;.K.RK#BD45)5G,D7K:0L=A2O;9RK8-O'7&4\#E[HK:(^Z6Q"FUB)0
M%HCDI07T*+W@Q>H;_,'G9>]^UY-5*B6QZ14PXFPV!])VVNDK- #9XAL1)2%9
M\U3]NK$&X;/QQ2,."Z4VR_,:Q0@<79<G2(B23BDSPE7E!"6Y7WW=42L'M:)O
MLBB)"*J%S>GKAQBD!8I"S0)H<+LA%3(%5DN\NMRN%D&E1K5,O?U.YHB98H>0
MF.?VMX7L*-45@?KSCTM?%M7!PQ8=HW6Q5U"[7I;K&(/=;;B2-MBMOVY5G0\/
M@D5,8GA;)=IR)U*X(B,>4*5%I;H"-&Y#0>T1J3!DA]GKI2^:?K*1)WRRX9!U
M1_:'2M?2KHJ?U_)WN',D?@L&EDZ@"(4)7S_2)G6V3(&-!'TFDSDG;3!C&G;D
MH7%:C!H)!Y]Z>Z;GW14)W8L8B40A5BOJRM76M]5L\MDX@3FR<=4=TF<XO-B+
MI ,]S/06'8#]'Q-YS8004G+*UXZ6$G[-#?.XNIKDH>Q8%'J\41-I0KH&YS1A
M8Y-$763.O1]C([+KN&(N<Z_7H'EKU'I8X1N5JG#1A!#BX>(B5@4^V]N<]##9
M>,HC8X;R[OL"R[%=IVI4](FU]"$C@T/#&CBE>QJLJTD+&Q,:(R4.4=,:$ADL
M,+]JC;D9AZTM4I.,-,4C 4$ES5?92;M&K8^@DY08),>9NAE;:W;C[L/4/G<1
MFO/Z1(_K%J63)6"3%/2*8BT!$X-VU*73</W-44!2L 8'*MK[+Z2I/ACGB8K;
MVB%KV.19MCQ&^7210YL46DV.L+;9"[_1&CA[W/XI%WBTT[DA*]O'7"1L<K?&
MX[2=@3J%VB2C Z[]?V+/*ZYOF4WJU,RBG(5U;-,<#,8NY29F0G36RX7$5+@]
M11(XL;DXA9VV0'*=I_>4P@F$Z\XPZ"+ YBSCO_HZNI31D%<W6*/,H^G&05G/
MRC:U0QE%:D/:^YW/E8,O8OBEE:D21W1U^V[?UJ&,-+VG:5(RU[FI1M2A,G."
MO$%]2_O)5"7==/":K1@=W*B@F6*77'T<QRF(Y/F>2/TI?Y0LLFRRH:L(->=M
M4=2*75Q;$2)0I*,.V8<=HO86:J_JJ_+FZHXZ8;$FD5KY2?*4#E(^>HA&9HC<
M9A%I+Z>LPLU1=:F4.KLC4KJJ.N"4JF1 WN30 A*Y,2< CQ.A PX%A_43ZNOC
MF]^I1IIUJA1*&:M=G/KG(9\%-MED$O@ZNN$T'I1$8<]-:_3U9Y,P<SRB6=.Z
M2126S#TUH5(RSPZ" ;'[UZ:C,C[-9&=MAAS!2TQKZ,TU,E4)=&)OF$*F-ZQJ
MN+SMA>[RR3-45,:^-SWM5&7H6U!#:L<4&WI::D;1^ST&PU-VS?<UE5*-$ZG=
M2P)7)X+#G>-Q-OK25SE3U@OE-EW9"'ERK-_8Y(23&$\-B=>Q][6J4)#PR-^W
MX2U4K&Q&H%AH0<\=PWG>U116:QN[(K3++6MD^F^X739#!#5"B+QY3;C22JZ*
MAT[7O<E0M;)&H/-UJ5,\$GJ2_A 2C6YR&$SVVRPOK-YAT"VWSU.55SNQS-P1
M\:U9:=#-;BPOOP#YV!E-R)3X4M$CEP(Y( 3-;%B3 .!*1&YI .0 &&J$Y"8
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MO_GJF^I*M?J8OF"MUA5Q(SVA<O8ERMU:E*5VCSJD?8[(&"0QYP:)+%9/'7I
M2K;W-L6)'!$I*"82< 6O' J=3'I1<,T/:42NB#UA-7>R( <YK(&_6MT#T1>:
M>%.SRU*V)RD,58+HM6>1MAE"AD<%"/3HF1EN!250:46<$!IFA!T7P& P*3]-
M>G?R/UY,8Y8MWUP^N%AQ:-'PMJGU?VQ<-*30R&'N8WOYH/4FI>>P!XDT72O1
MIBQ,@<CE:5(K---( 68::(8;IR]Q?S=QLSS%HY[KY1$S+#>T$AGTED,UGUG3
MV;.K0VA9V0V56+:4HF<Z?$D?:0^[-R50XC2-Y(QA3EEZ,,\P6DP&!7:J/V4;
MJ_NRC_LMVP+$X# A;H+]BQ^_JEF_59'@23$_\%8S_B^S?J<FP-@P& P&!JT@
MA,5E3K"WR0,R9T=:[DBF7PI:>,\)L?DBR+22%*79)HDXHLQ0;%I<Y(]Z-T8#
MV:L6]!\^@B"&T^'\W^;]CQP& \-?+OP^S]G_ &?YGR__ &L#X\->.M^&O'7C
MK6_YNO'P\?#?^SX8'SX>'V/D^SO_ .[\N_\ [N\!X:\?'P^7?AK>_P";X:\?
M#7C_ +'C@/#['^Q\NO\ 8_F?)_\ :W@/#6O'PUX>._'?^SO^?O\ V<#4V."Q
M.-2*:RQC9$K=(K&<F=XFSJ2-0(^0.3!'6R)LZM8$TXPD!B&.LR9*#102P[+)
MUO>MB\1;#:]:UKY-:UK7R[\-?)]G?CO_ .[O >4._-XAUOS:\!?)K[;7AX>
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M7R:UK^9@?&M:UX^&M:\=^._#^;O^?O\ V<#YP& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M-V'/GQTBY=V1Z82Z-(&6#VS+RFN)0271J'2Z42\]/6K4Z0-AB;K-F8IX4R%
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M4FA83 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# KM5'[*-U?W91_V6[8%B<!@0MT%^Q8_?U2S?JLCP))B?\ @K&?\7V;]3DV
M!L&!1+MOT]**[Y8#(U>"N9%-?T-753*0$3<6=N.;45U.M3/ZN:MI[FQ/)B2=
M0:0TRSKF)3K_ ),0?H[2@A2 >@!"-:U]+:HJVE%C.J>TKDD<0D\"Z%KRL:RD
M"Z!BB7/C1UE)&N;]%JZO4M<$;9.M<K$FS*E<"Q2!>]%- "Q)4("4I@RA!N+3
MZ?[=#K;IFV*RZ0ONLQU10M&<VOT+8$M'O44N*KJ!?Y-((@VV&=.*;E4J;7!R
M-F#@0X*HRY1\TT@_^A;)&  PA=N*1QSCH9%ISF4DF6WN5O4C0"DA<>+W%VQU
M,*&CAK%\WF)BT.-L 2]A2"6Z5N&PC%[=4=OPWH*:71P'#[[FLJ?+&N6['6!R
M)OGYK540G6$*(K )E95+N]"2B8U_)7.#.-EQXH^!/RTTN/Z>S8N%Y5&K]MPC
M!>7 QK%Z?K='W,$M;ND>@DEEN\HL1\L2RVY55K-)K!8[665<Y3:$G@:*R1-,
M-8CUU/LVV]5'T[8\-96E("%@?>1BP)GJ/D^OJ:FZ>>1EXEBUU31BT8H6D>%;
M0<VZ;K8O20W^_F^R1,R%1[RAETD.2H]Z,\@&X  &!,.T(X08>9<=PB9WLANU
M9,IXW$"DE9SJ5U@VJ8X&!SBPJ83O2:K9F^'*HZJF2-=%RWD AI6]U1H%YC8@
M$I),]@9H\- (]/NO-P=NKIULBSGB)Q@SHA' T1QL*1JX;$^D8A(XA*H@G<$$
M.3J'Q#&R98N4M"IQ]Y<"SA%Z5'JBR_)L-*/]+6@S)-<K^G?)6W$797TO@\D1
M-S#5"9W1+9_#8G!I?+4-@?1N.R5K@XM,/).(;E[NL8T2U:L,)1! 806F#I;@
M<UHWZ:4+BC2UDM5\7B9*H4[5ZIJ*>.6JG<7ZJ&"MY+8<I9HBR-YU8:C$C:%J
MRU7M.L.?$#DN-1FI2]'A&C),P-IJOT[JLJ2T:*M!CG%@NR_GRHXY3\)2/J6N
M1.2UAC=?+*W*#)9VSP%GL1X8G9L7#=%L<$ZABXY* IV*;R51018&?>^"*E?H
M-J *I+8)+1J ]<5UI2F<H^!P^#=DSM!8%DJO:CC9B?XDPN[< IE'[+V9"?>]
M*0*A^ ]!H2CTS*9U)+]D;-)7QA'?@9N<\-Z:OZ#="&M?9MB,%I6)\37R&H'A
M\M*.2N5Q_0#6.9*Y S$M:Y:A)3%ISBPD!ZF#TVJGCSWR^[I9Y89Y7*R5&7!T
MBE'6VUARA#)9#*@@02LB $3:OHTYJY*8WN4>B[DS1YRCZ- TGHA(41)6!-'7
M'),,["@K!7\YE$GCC*QR%>^F$L*"$OS>] =8=*(.M1/D7L:)S>'.@T;9+#UC
M6J/;C%30\)TJY*,!I&O,&BU;P76U4WG%+W9YE-W.0PNI&"GF1N<$=?H-'1QA
M@\.@1),DE4;A+%/9DSZ0PLEQ3,SLZK65M?5JU<B2D&'@T4'IZ<X,J;JR6-\P
MG\CG[.XML*<(*2FBCBP)$!C2Y-TV;3SSR7>./)HUP2)XKV'?GT7YBRO$&]:'
MH859L?TJV5/"^G0U1.)&\V9TY'28"MD\_>HW%S:];7*Z7.VR;50RZ!UC](,^
MM>I'V2J7*/*G]>L5+1M3:@-7)"2MJ@ATED=6(2J$?J3@*9O9&PNH72K(6C5#
M.*:VA""&'Q*.)E TI1J@MO0)]$A'LL AZ+!ORAWOPU@5>YTX1:*C0TS*)U94
M[LBXJX41)]>Y>[*HJ6C>W:,\YN7.3;&=)&"$Q5*.&1N,R%R5(1!2IG-2XJAJ
M5AYVQ[*T$=WUZ<89VW62XUK;LYC\EDTG>Y?7+$]+8P7#*=EUHV]6-F7;.8>I
M30-RDR^128Z &J&].]GO#8@6N"HLM.6G4["2&PB],>ECI_6EI.$JESY8,*DB
MZ52Z62*,4U('FT7=?<Z^^S5#JK=JM5BKPT-@.JHL)D+^;9WP52)!L>P%IAD!
M8$SD^ &\QR7E0;W+]P*4MDX:W![]]:/G:41/I8^3%V&E6_!=M(#DSD_&EI]B
M1CT$D(-#T,6MBV&LL_-J\[N6:=7/R=C;VM'1,5IBOVQL>U[HL?G$V0NDGFEB
M2MD4L+6UQF1($IJ*/-@TJIS4*FHM1L\XD RDP WB[.<TUP2B%S=JM*S:?F$1
M8)C!CI+5RV,(7=_KBPW"'.TSA:M7)8Q)AL^G)T@#2H3.K7[B\MIR;8DJHKVI
MGF"M$R],6H9\8^)9+9%N*HR-VGKI7T3(70=(UU,&V;237-:;?$E9$&"\.R29
M6 A(/V)\4NI[>C("D1F$$[%H0?C$?2WH2#V57%GL+[*A/L!=4SNK$]QZHY(X
M2@]EM6QKBBA0Y8_5HX32$IV"6VBYEF:C+BRB=&\"8A:(_P!CH8@L[T3SH1T"
MFKTPFS[#J20UI)Y#)H[*:XU"S7,8I96\VJJ0M;BDG41F;*I;U<4GRX16PI@'
MIEY:=069K9/E$$$5CZ;5!4];KC:L &ZL@%L6,CJ>* 8*U/ WJU%81*GU#P78
M1\$,N%:6*$PM($#8JD)[.6N.4JM)?.:'109"3>GS6$B8:?BI4\LUCCE9TU7W
M/<H:FM=%!%W/3U:.\8D,:B5AJ%\36*T(]/48\QZV/C959J9R7I_/HL\OV ;-
M97#E4V?2!](/KB\FM15XRSH=B?G1I@TN5,EDRZW)C<2TTV,3.(O\!DD=(>IT
MXMX6]T:5A8FLW01"VI"!4$+$4_6##2U7P6J8P>K5L4"CC?'&Y8O3,B):N+0E
M>4U>K11IH8(ZB4KE AFC)0(4:(H0]A)(*+T$ 0J0G]/2O!UG'ZG>[,M)_BD*
M@/0%30+WDR"H7.*UAT##$4&=(F%:UPE&%['"F=)YFA>N+/7".'L2TQ7K0=:#
M9Z8X2J.C+YG-]0Q8Y:>9ON8JSV%3&:R3DM[W8KI'7R=/ YJTP-MM21:>'B-@
M4)D+L_+FYL$L5!2D%E#( F#\KQX-J:_;A:KIE\CGS?)6E%6B AM8'%@3L1I%
M6R6:2AB]X3KXZXKA"7+IRK+5^50'0R2RM%^S%H0AA7Q)Z0/.+9"UT,:'=S1)
M4<RB4NK]0?5_.#L1! 0MJLA@96=:PNU*+([:X11VV'A">XS5+(7@TKW0W2L"
MI*!0(+AUSS Q518,8FT&G4R;6QFHNMJ$D$'/1PA3'9K'*>%+QUK('4\N(I7M
MDDK .?.^S=,ZEN;EGO(-&)/ D&M!&RW@.I%U=L=:&2>Q"V1@IJ\J01K"7./!
M=3(O?MA5_9$M<CSAQD:03\UO5<HBFXS1(4Y28TX)I)PQ & -#YDY)M:I.FK*
MM*5R5N*JM/&K.A=.0!KEH)2C:VZUKX=+MD#RG1F5=!G>'EC4FIBC&]P>I@:%
M28:6E6ID"=*0()LG/'T*G=X-]TJYE/&DD;U4\KF-:M"F. @U@3*B7)]=ZAE$
M@.6QQ;,$"R(N3[[8PAL=$*-R$WH=*BC0D"":$UTS5K#2%35S3T76.SC'*RAL
M?A#&O?3DJAY6-<<;4[6B4.AZ%&WHSEQI"<.S1%$$@V/>_  =?)@4@G_I@T[9
M5S67=4DL"SAOMEM<R:%J%,"NO:M#?.V2OF9Z;$,O6P%;82U@;=5J@/9FI:[*
M6IF-/6>[IPA4:T6&2DW"C8Z7W0$S;S G0&KKUOSJ"6.+U*%>Y0]V%:XR'%EK
M1#%6N,(V1;6S;/=-\M]Z6N.U:)VB#2 !"G9ABA.%ENE>>8_TS7B*O)+(WV-M
MZ"91::@.:$$4?D#HLBJT2Q,RRR(3R.RR$S.++1&;V<W.C<J3;4%DJ A"<04,
M(5CKCTZ(11RJHG&L['M1:TT8EA[]'JM>W: -\/L6R:TH23\Z0N73Y^05D?)6
MQ8?63\0A6%,XT;5M2VHUFD&S2C 'ABVG@APGM.1N/6O.W^L[!4N77I4XU2CZ
MROS0MJ_LVW7VR[.IH;[/Z\&:XH=H#VE*!_2-;.[IUK9M0C&G":, @V%R]-^L
M75_L)<KLZW Q.:MEFMC+7255 DT6KT-QV93]NV,KBZH$$^<ZY4\S6E6LQ/\
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M$(_>TF]$.6AM@FT8EZ8OS;VGV8G&$IX# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8%=JH_91NK^[*/^RW; L3@,"%N@OV+'[^
MJ6;]5D>!),3_ ,%8S_B^S?J<FP-@P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!7:J/V
M4;J_NRC_ ++=L"Q. P(6Z"_8L?OZI9OU61X$DQ/_  5C/^+[-^IR; V# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8%=JH_91NK^[*/^RW; L3@,"%N@OV+'[^J6;]5D
M>!),3_P5C/\ B^S?J<FP-@P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!7:J/V4;J_NR
MC_LMVP+$X# A;H+]BQ^_JEF_59'@23$_\%8S_B^S?J<FP-@P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P&!7:J/V4;J_NRC_LMVP+$X# A;H+]BQ^_JEF_59'@23$_P#!
M6,_XOLWZG)L#8,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@5VJC]E&ZO[LH_P"RW; L
M3@,"%N@OV+'[^J6;]5D>!),3_P %8S_B^S?J<FP-@P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P&!7:J/V4;J_NRC_LMVP+$X%/.E.R8+S4]HXI)$*5?+91 '235JQ+)=
M'(H;8DP*G<%KMDKIB-?CRAFNKJ_6 B-4'DEJ?<4(3#Q$F>70!!BW*UI!9U/6
MXWS2$HH!/:LLQ'6\V8&66[GD6$[ ;(-.FMTB<Q-CD.7/K([1&=-I_F5M#6L3
M*1G)S4X1%><86WB?^"L9_P 7V;]3DV!L& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P*
M[51^RC=7]V4?]ENV!8G JQ>E6739T]@Q<%MIQJ*%1J(S5Z->(_&*WEJQPM8+
MM#28(CF#'8<3D9SM7Y3()X,4)696R+CC]:UM>2/28PL(;8'RZWRH^A]WL5!D
M<K:+P;&%K;J[E#7)XPD86J 4Z2-:B"FT&11@,IDVW)[ S/\ H3TVD.991AB@
MCW=2<%ZXG_@K&?\ %]F_4Y-@;!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"NU4?LHW
M5_=E'_9;M@6)P(%MULZ7<Y+!"*-FE.0R(B32D-D+[)KB66)(2UNB&LZ%G1%O
MC]G5LW^XC.*7$.0%1XC=>U3FDB\"S2S CR4:E1-*3QOG-@5O8LQ:YDC12)VK
M.%*( VMBP0HVL2L3]&EMBV<O329*UJTYQIA[B PU*H3BT06#RB&%G8G_ (*Q
MG_%]F_4Y-@;!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"NU4?LHW5_=E'_ &6[8%B<
M"E/5C1<[G(Z]%%4EZO%/D,\NU.F3F675S";8.FQBJ-?,A>YNMAO\2.5P!(U
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M@56/:2D<P9BP@*7#,=/.$/LBA$%;+WK86\B?^"L9_P 7V;]3DV!L& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M$&M&?55,HW/&9\JR&/$AL(Q/N#OQT9E$=I1NO]]K]4PL,S<)*:Y(X Z$EEO
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MZAU9VIS5M+BP*G)M0KU+$[B;Q.S*H6)2E!S2Z":%[JU"<6XPS9)^TJI2GV:
M7LS3 > ]A5WH;KZ&<ZR!I87V&SN8^2%/=J6 YPU/'#$%5U%&Y'&HJ]6+*@O\
MB85SHWI':4E"T@9B7-U-2(UAP$PM$:"8&STCT*9>+_9")IJ.S(E$*^G-@UPD
MLB7F0 B-3>6U78<DK.<HHPU,DX>YJ0B;Y!&C1I5;DUH$ZY,+SE"\P1 T&ES?
MLJ&PJ[OH7,@=AOGNC] H+(+":"(J"$QRS[88WN05?7;AIUE#;)E#M+T;,67[
MZF;SFEO4.K>!6J)">:-.%+47J;VF@ICF*[IES-)4+;:Z?I%]LN"QIVK]]E3'
M!Z)@T@FQDVBCJHM1NBWPLI''CBU*98J,<U:@.BDR4/M2S-A,#_ZJG/#'*[SC
M2=CL&3DT1#9_+'MSBJ:(.A\B458R0Z03N.,\9-EZ.5,[DB;ING W*7Q&T-KT
ML1KDR)2::G!HX+]US*I#,XFA?Y37,IJA\4*'%.LA$R<88[/K9I"X*4:=2<XU
M_*9E%E25U3$@5$;(7F#T2<$)H2S=#+"'--!VYT&13_<%ZRNGU#!&*"MF<5Q7
MD:3-, ?'1MC=9*U3/+;'E*Y-T*B)G12,\CX@K:$^HXJ+3["F0C<#=C-"$C7[
MWUNH+93Q%IJR82"N8!++!8KVM M+&SV-L70;C6RNN!P*%)13ALD9TX41N/L9
MFEBMLVQ""N-1[4@5ZWLD-\>NYHN5-%]<P>G[AM2=L[P\EO46A2*#EN:*(1:M
MJ'LR5SI/\YYO'4CJWM+?T9&V\EN3&F/+BZ&'E)4AI1(CMA]7CL$<+?NN?GO"
MW-M9>;#*E"WMZI?7$:')&NS0K$[;+MS^26PFA3=&7!>#0C!/GS;/9TR4X9X#
M_.5@:]4GJ$12]G>KF>I:2N.:BL*N]V<].R!14R5@KF-$V5.:?6BD3LYV>B*?
ME*6?P%82'3 %V J;]Z6IQ&E:%K03?SEU-7_3Z!W=:Z;9.2V,$>K1T>5SZA0(
MR6V16-$"9N=7BK21R7C*G$!97!#I_2[U[-$I7E$A,-&$W1866P& P& P& P&
M P& P& P& P& P& P&!7:J/V4;J_NRC_ ++=L"Q.!RE]19SBC*]MBU=,I;7T
MG=>?+CAI:QI2UB>V6; IM,ZBBTQJQO<+12+&N(R@Q>[-;D-]) 84SLZ=6K6)
M%Q)  %!LM9*V%52'1I;9%RX3(&V_TS-8<5:)HU6+!VJ<,\!IMN5&P&;MC'&S
MI$SOC"F;W)S/<$"1UU)ECH%86$\(\#HK$_\ !6,_XOLWZG)L#8,"L-ZV=R_3
M$\JBQ;XFT8@LW):K&BM7.\A<W5*/X(_[A+E9VRD2(1C>)G0$1MG5.;BM*]W:
M4A&SS#DY.SA[""9*]\[S.:]PQF^JY'7+;$8Y0*FS['=I^H*;9U!B%4T?:3EL
M67Q5[2OT$ED2EK4N$WZ1 1O1;M[H8F,-/]WV -"10GTUULRY_<BYPI<YA(ET
M*<:S.<;DNU>IG,J@UUS&;U\Z6P%QE1B>3SAFOMSD9;9J;:,7CD)S@VE &>68
ME+#!)(UZ7X:TE\K:['7:C26Q8:B,L)HNN^AV*R21BB<T:J\8JNFZ&5CLY'"D
M5<2V2DLZ>-*1,1D;7.HR/.A][&$.@STWTD5STY-CPY1U+SH33QZ-<\:E"A+%
MDM.$P[90W0F:I74M8E94\-![8MU)7!.+)#I0 _0]:,P*5P*6\((6"@HU5;B"
MQ$<RZP?'&*O3M.9RY2H71S)&7IRF4CG\JL)TU*'ZPV9E<O8GM#TI,<CB30 *
M2C"EV$D(@KBE.1*WM"S[ZL&^X3-6-R$1,H-$8^5/&%M@R*#]A/4R2. (R784
MR0'2M-TT[)F,#=%V>--[N^I32S&=6O6*/ .F%.M5)I*1CR.H-,3M2#DQO+JQ
M:0*U<G8W-CDR]U?'W0AN9SDL7%+%[HK]X3'[&,L8AD"+#L.RPARMH1'Z<5\T
MI(3'F%N3112&QKI8JY!<]N6G(E,D;*(K>55K)Y,QL\RD*EY@[#5=8I'(R-(@
M'>:,(30N",*!RV9[$)./ICG2:7)U$W)N;Y5-9@V4HUVDP&*[\D0H-<D3Z?2.
MK%(7F'-!\QVP55-93(.<TIS@["0HW 2] B="505 A&Z"Q7/U*T#:-,<KW/$X
MM847$G9T?0$"<'2U; 564E=+R:VV;S5OLJ;)YDN=;++E:E<3I\1NZUT;5YB4
MG6RQ%D$: %/+UL[D'I#CSL=1&GA1%ZT?>AUD8Z@-E<-DA:V<R"O7^*US)&V-
M.4E>62/5^JG++4;:W-LE4#$UL!0 KU:,M1Y]A"]DLO&BK#M2W.#G%D7RF:%<
M_I)+*H I975HA\GK^S$DUBVH<1*R2"6Q&>M;(\<4I_HA)9)"TK11@S0'ED!1
MN&Q#T^7;G>$R^YFN8U VVM9-FHI-%;+Z(MN52*62^"J&B@[2:+*E+;/W;=@U
M8!DHAE3NNG4TR+$-K<B.5@3[%XB#H5V.RL$HY=N^'RR>QRL8M.H&Z5_)9M*(
MRIF3<T1^?")ASR0BBZ)Y8E;U)WIM>S$#(26<8/;RJ2[TF6>'NAX5F8VOTZ)/
M,>90,<M87.2%0.LV*EF1MFT\0,<GBU-/<G3TVDL&)-KB@ASZZU[.&-]U&"98
MCVN1R%$X 0@TM3* %!LJZA>$N+F^/3Z2E#@21-.86KA[O,+$M:;JD+_6M=V5
M'(*Q1=$]R24+DD4K6J)3)0)VM*2%G9V(L]2:440C]L2$WVQ9?+<ZA-@5K:U@
MP97"G5OF<4L!M<)0-H0@;HU6S7;$V2.#TA6(3&TAEJY[2/BI0!25HEM4 .]I
MH._' Y\6!)/2YGUK5FAE*T8"[G,M>=MD\;K%L^$Q=_FZ6[Z'9I;7]E-37(V)
MP(5BMLZ*+RVV0(R6EO7I2/$)(U8 *0N@5Z>W)20MTVUUDK8U[II&9I]89]8S
M+)&9P;7: /K4^1B1-TL3O$6D+2[U<QGIE[><G5%;1;#H?LSU #0P4^KZI:%G
MG*YZ%(Y-\<>FZQ^1C6Q<N42!(X0B90!^NU<ZSF62R0&2 T;(JH=0::YGGKEB
M@QU5;4;%LX9Y85W;57$#=65;$478PY%"9OV7SJ3)U:V8S&>R2Q)_'55>!J*,
MR.P;8>7)Z;&5C;FB'.S(!8J$0\Q]K3(VD)XG-.88$X]-]2<1OU7]+5[:L^2S
M-!2<(D\]MV!P5PDQ,_9@4ZYQB2+S(NX1D]H<T\X@LI6,"CS-Z\I4RK%S<H4C
M3%'DFB#5JAXBYBF<GK/HR#*ILZ5P.!MSK#H0]3"W )WB7N-]RGIAPL6QC)'-
M-.ECNBNV)+\7+025(O(1.B4*HCR[%K6@KY34"],BNZ.W!'/HIME:ZO5$51O]
MRF73:4/E[(]5AN>+(T\5E*B9X-XK.&H399*OAI43<2(^ITO>""-GA&M+T$H-
M$4]+%UML]@:IS%CIVPQ>1$*XL*Y[.*B#8DCW/3C34L?'%G62X$ W.=<UEGHE
MCFIT-]/CZ$2[VH@IC%0 WZP+UXJ=:ZYT6-'0<1@K57=M19;2YP]/2US.=:L9
MD,>EL,'%UY),L.)54W89R=:>H+")$S/13P,0T@=&C#)-U6<J6?,.I8I25@[3
M7M*(E8-8V$\F2N>3H=:--@REU^DY)6L=EDA,B,:3GV&2L-=T\<]D@32E+H"X
MO2A/M/H+&O5K4)5SK%N<5<E9&F3+((G1P^LRC%GQ!1%43,^H&%L I++$C:C7
MMOAKF0TEJU"<YR$UJPI='"3'^S#G'"YEZ5EI\VP:W4\I)KB&F,%","-0T6E:
MT+LNO%C)SZ]$5_#D[_"9,BF:8QLY_E3XG<5S:H-;W..Z<%2E2H2$'*"@N&J;
MN3G"&V[4T#:X+8RJZT[W''VJ44T/(*L^0P.@ZW82HJ@?%C@H2Q\]#3#?%M 6
M)#20IDPTZX(_;B$<(*/ODL]/A@H'EV\K%C$[+DEFIH5,H/74PN>Q)?:DZ,M*
MX:IVH:;>>5D\=$ELQ..VP[QY1HB4*W!C N3ITZ('G/ F-"_\LJ/E3G^&2:72
M-,.NHXZ1 ^IG1]0RZP4SZJ9)U8TCF),7C9S$]'RLV3O]CV$O.0_"=;>!JEH2
M4PO*$HL 9B3="<H640DI>06E!Y"AO:LUZE(S =U06B6UW-(7*'8T.Y.@]BTM
M@Y% V!Y7I2#%J9>H;FY8I(!LM*<86'.Q=-/2+@">(IV5NA2.L[P(N"O'R=1]
MZE[7$68+#RY3U7R9OEA(7)*ZMZ20\PQB,A2NH$^DP6)&%Y]Y 6>->:%X)]S1
MQ_7;;8]PV$@-CD0<=(I-,#'>R[%+KQL<2YI YJ9((]!RY4.*L4JF$[@# I6G
MM" IP?W!,6 WW@U4<!0&:KN[>>(T_P!1UG4*Q$N3](2*[+281I7!P()5.BY[
MFEDVF]^64"*6J'D^P%#@6L8R-Z7M1QAOG2$)DINB@JFTR[TJ8M!;Q9B;4C3M
M$IFZ06O;0 ]67:LX=%B1 ;9LBJJ Q%8[/+W)005$&)2Y9&T,<'MH]W1N(T>M
ME!,WH,]:W(5)V):$G[-M&VHLKYD5UA.[!DC*VFRQBBKU%)KS,LI>83R53!GM
M'5?.L>,I5<K/+?4L9228*3:8G;T-O1)DV@D,5H>GLL9F*?&V!!@M,ZZ+^E5M
M<U#_ "I(89?,!8XM#U4G>6T\XE=%TD782V4M:)Q(1L:8A8C4'ZUI:0:<$-6\
MW<'2>-VY%J_MBO839%..[@5))(,^S9D" RN2=9,5K2B-^Z0^:1"3[G[YT<!,
M4F*C3VAEK*\N"$#<8GV:D(."8N:I;R=0],4/R<EO>(SL^65N>]1L;FJ6B,L5
MFL)7-)4M=1A7K7TYM3S)<F?OA:%U<CW1:4VJR@FK5"-69H*T,T6](K5&2%T8
M;/-5U&X/L0CD@D39>_0;BZKT3'2+VVQB-B=$TP43!94^^;7A:$1!.Q1<^(%#
M6&^9.D]Y*"W<UE$2N'Z?N/UU%FRF)QF@:TGL)0,M@LC!&[8@DX53)GB:&)2)
MA<$3I7#FPR6L#2TJP9A6B-!3*TQWAK[0(=II!PXMJ?GFR0*9#4SP8UM_9<71
M2BZ;$':+4X=%/C0W2U=,)<3-7%UGS;8$^DR9L>FY2L<6ES<E! !)]^=/K M6
M]<=42^D3],I9I@B)L2QVNX7$+':-F1\<7M9J.4J/I"K$YEEB$^J94[J5AQCF
MJCHFT3J(\WWO1VC3=#" "!<N5K?;OPW%:>=$KE:G("%$Y*D3PM3P5X@=>[ET
M-A-(*GA3(#G1JGCU%GZ3NI*@!8%"EO2+%BE4,X)8MA!#PAYXGU3TK:3[S'8,
M>36QTQJ@9\7%KT>XI+:VE9<B9^%UZ-WD,-F[,LG5928FH&9H=6I JVC<FU&G
M6J4IBDO8M!/EFQ"MN/FWLCKRSW?W@^_W^DX+*WJ",FX6K@U8DK(U0=:(RSS)
M"ZK'5]AJFPEKLXO!)R0Y6 8"DJ(GW5.4()I@W5'+2%II"",U\QI^56''VMDK
M0QX?%:^02X#2Y'5\F,?UBU.%0VR%VF+&I9]!=O<U2Z0)U"$L UI9A 0HK&V/
M@UHH>UUM\56X5E :\OIXJ!YJVUK:F-KQ55(ZKBLI^94/@#(.52)G^CEFB,]<
MW9EC:)(0V, PF+_=$YC86I3!ND&4>G#8")HF#\]Z:G6Q.6F.Q9M7%A6[8CE'
M@5Q)>;F!$[O5CL*J7KZU?K:0\WB2IG5V/]ZE XT4%6,X2385&PQ)\-]*ZP(G
M6:5?8*F6L\PFDT8XU(7.[;]7O]FN;P^5""5)+!F"J7?.*?5\ID#) -$J)$J4
MQSVA;"!,;Y%",)P61Z'K+C*IHO:MI7])#ZOA=J3NOY3,)"OM:QHE'VNVXL-F
M#";#A!+')4B>N+,+W$D&S7EA WKE8&\&U1A@-&>8/O0LLX1AR./R.BYO7Z9(
M\0:K*J9W9!+7AS^*Q@Z970[5TVK3WMP5F+'M[G9LW4'N"OS.C@X 6C6GF#+\
M0AKR7MWDZGJW@\C;;4DMC0^V.CW&MF&1-[=*YDI0SJXWAYME$C5[/0[=$$$0
M1^3$GLI@ &)C& U")![=*,D>!L=G<A\9QHRW+TM5B$R-+TP66YV(]2"S;$0P
MEA06,DB([,D+)&M2TN,0V0R=77S(M-<FE(E=/BS8F4IS0*]:&(*[M]'>G"]O
ME!Q=BB:J?N5\R.T#(F_2&R+:52%T=8UJ\K#LYXD+M-Y.7('N9)IM)I,2Z-BH
MT3XG5+U S$X$[>;[J$I.EZ^G%\8F\I76C 3WJ(=!0ZU94>D?I:M5ZOA3$GJC
M8*]M+:W"/')3GI@J=R8FY.U$JVQP5LBL)19JLD[>@L/7M&\W/4!K-VKMC9WV
MO$_/"JG:S=F>2OKJRK>?;&10YU-9VMRT\G?%6F1-\4:#BG 9ABWV1(=EGAT8
M/SA53H2JZ<YM@=)Q6-TI;=G!L3KZMS$\K8NAY:PVG%;;EL?%6C):;_;$RL1+
M8$A2(H(A#'%24MR5#-8?^1[(,(\P<#+PY^YLZ&MGKCC*/5W)"V"OY]'K(N:8
MIY5,8@N-Z"=7:$V@W.4'6HE3?*&IQC+D@9W0AW;5Z,@AQ2Z"F*$7KVPPW ZO
MN):(L3GNL!R%7 +'CBV?;J9F^DVTMNKX5?T[62V8L%@O!DB6DS-CMFSF<Q6E
M;Y<I5)W5\;_(A 8>GV (?+W2'#O'D=89]+RBH$R,,\@ZZ&/$NG=DRU6T/T&B
M,^C]<0F$I'1_D3N5#J_A,NDFVJ,-Y0F9H;SURH"0HLHTX ;R9T3RRV7)+GQ3
MT5&@21KHUO?'Z.FS40X*TUU&&U?;BN<$_P!$%%MO0(),TSPM,(.$O#&C$BPT
M'N(B3L"$;;L[TW.@'"G939EGQ-Y/?ULGB5?*2)?/8@AG3&@FM< E<7F2%B5L
M2"9U&9.U,3-4DR(M1&5"E6W&>(P+"MGA,L5Z2XMJUEM]!'K?KZ-,=:V')I%;
M(E<@7;2,4\MVWY"ED*XU<[#."NU([O=W%HUI 8>C(?\ VC47HM05[J (Z7OW
M 4[OVK;752MI<KBF+%&YM!$Q+Y8J%DE1T?CUC#K^1R*OR#DL'<K+9(REE08[
MM[;]R,"=&M"B!O:'_DX0)74J]/>P><:NL:(1N7N56V];LYI^MXK/9193*&/O
MW3+L74MF1..AE,@&TPB+.[(^*3T34D4IV\!I^T[2 MQ/ 3L)&F3-Z9S!+^AV
MN:SB--#@W0!^0WO$W.V+&106/1YW0UK&YV\EQ@,E+@C)-5J#YIII(Y-));\5
M[XB$O,+&X^94'0JM[,@EO0]LGU;25#+(B['NR-&[H J2@Z<&!X7QY^:UJ-<0
ME<&QX8GYK4HEJ-222I2*TYA)I8# "#H*4.-O>G8LI_H&,KK.KPZI);/7YMN]
M.&4R/:5\G%W.[VVJ$[<M(5?%W$5D2-C<$#.)B,,2N+DC/1MVQJ"AE!"5%G+W
M+%]21!T.HC1LV'8,;.>"%14UGZ6 RQ#-ZA>:>42UQKE/(D,)<90\TK+%,>&Z
M*FS;H%H&6GV8'V!.BPP1'IX\K$Q\$=W$9NI),D+Y(GAZ775="^7RL<IB,$@,
ML8)I-5<_.E<O@\KAM81UN<F!Q6*&9:G9DGM4PA$A%H)>G?,E,V/](!LEC*_3
MC9BRK724/C%*Y9&)!IZI-Y+D54OT??(Z]MCG$WV$/I(%:-6V&)#_ &P-;,$/
M6O# 5'S)2U$F)5-6Q$V/KD425PE.N72672=8..KI]+[15)%RR4/SNM<E"F>3
MQV<#51YABPPQ6( C=EA+" (XICD-BJFE'^K!RA2%_G]TR?H.S)M72!;687^S
M)G;I5NR(;$S)G^0+(W%SU24AF+0#<5N]LA.DYYIWF,V,+AX# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# KM5'[*-U?W91_P!ENV!8G Y<^I9"K#LR/1BN&QGD4B@T
MSBM@M+*Q0AKYE>GYRZ"&4Q?1("4-O3R)T8SZ]*;1/0ENV-,:X!%X^\>"?PT(
M-]B,'EM6<WS^J)**+*&NMYTRL$&<8PT02.:7Q5S8*^F"G3U&ZX9XQ&6=T9YC
M)W9M*$%H:%#@W(DJ\Y+HQ7LXX+TQ/_!6,_XOLWZG)L#8,#G_ -D<NV7TA85/
M$Q*=H*[@*:L>F:NM]^,C[/*7M7$;QC]>QHQBC+6[JD8&][<D3*L&F=="4%MR
MD@K9R1628,@096W.%(1;#+?; IESLT(KHB?-S D2@;DSFFAR[F"5.4VKUQ-)
M4+"5$F;G"0GIOB:,XY.)2D3#* >4,WVQ85H#Z<\0065SE'EG12=(ZUV\M5[H
M*K:H(E9&N1OM5]*&7A-)E!(PEFIC5$VI^DUK-S$_+G)+)7\U&6U[^+!4B7FN
M(?8/I.LQ<(<(R&ZM&J6ZXVNW8$W'5H0GJ2).R2OK*K)\-.IIDG++'$S].XY:
MBY2^'1I1$V=2\(D"M.TI0EJR%H74LSGA OXRDW,$62&/"9%06ZHB"4EP8H$>
MM4QR&D,45,*6MD7<(K%S=KFU,9K1;*:U)Q> -HQ)M;)P*GT#0TN4:B\<Z0GY
M+1?LCZNGG=[1$4#5'-.3A#86V1JI2V=[*B:UXA;3[B3,6@:D"!V=1DB6$@TJ
M6#">?H/;(O3UJ"PGKK9"UV+)/G+8EY4M;Q2"1QI6XQ"GI#7CP@O%LAS*@T?%
MA3. 3NTI1()2_$)G8A1M;*5912Q(H3IS" O3SW3;7S_3<&J%G7)G1)#T"XLU
MS11]HBB-R='IY<I&^+TD=8P!;VA*L>G=0863H:@[0!:V>H4G[,/,"H-F^GJ7
M,:9B-6Q:ZWB"NT5?NH5 )L?"F>4#5QKK0%K)+!9 Q]8[-J1,\LJ2TM[9G'9Y
MI9"IN*&H2*BC34^PENIH_5B;H.W62-3A\<K'A/.O.%-S>&NT.D,?):(I%G>\
MG:"SAH>WEJ;VJ6I9@IESNE,-:CUJ-,H9AE"-"=HPL(3M1]9(:2IBI*;;WA0_
MH*KK>$UR@?%I!"-8]I87&FZ/)W-2D3C,(3J5Y#;HX998A!!L6]:WO6O' KRH
MY"4KJBZQH]QM0Y17O2#];C^R>QAZ--)JP67@O?Y!8"<][^/'()JC!)I&<H:P
MF(6TQ$ET%.<-5O\ HV@EXRFWE-TH._V2<E(&Q_J6.U//8 OBI3GI^1P:26!*
MX*]QZ5%O;:HBRYM=;-= N!9J-S*<$^B  TE&4,PT**7OZ==82> T]&7^S%"
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M-5US>[K$YM 8#4E;1Z4ND 894V%L-<\_2WG-ZVNBREY;4JMPE,:EVW)./W@
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MG;!J1T<T*$J?PYUBBUT7Q*-3)K+^*(A)C3G&%S!$[QN0-9HA>!Z%47L)Q A
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M_=63]V2SQ=5,9LB85?S8F=X\^QU0E89C*SKOZ%4Z:9-ML$Z-)5\RY3'V=S3
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M_P!^^N,":C/_ "AG_P".+_QMX'TP& P& P& P& P& P& P& P& P& P& P&
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MMJ+T>E.^+$) ..C"!'[("%]/;F_^'O\ [G^Y@/;F_P#A[_[G^Y@/;F_^'O\
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MT\M)4A-= -*_^B(]$>.]8$JO+/S#(*Z<JE=H8 ^O766N<^/CZ<A_;1I9X[V
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M;E^##?NF ^F:"?TVY?@PW[I@?45SP4(1""H<S-ZUO>@!;1A$/>M>.@Z$,T(
M[%]CQWO6L#:^?4REQ.G4W-*TF2R5X**1)MCT,P(4>U*DT0]Z_F:TX #K?V!;
M"+>OD\,"R> P,*__ /1PO^A/_+$_]/\ _1W^^_\ OO\ \M_X'^S@:;^3/ ?D
MSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^
M3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'
MY,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/
M?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\
M!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DS
MP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3
M/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y,\!^3/ ?DSP'Y
D,\#<F'_F._\ H7_RYO\ T#_S'[ ?L_\ Y?\ \+_[6!FL#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tproxy2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tproxy2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@$,P,T P$1  (1 0,1 ?_$ ,X  0 !!0$! 0$
M       (!08'"0H$ P(! 0$  @(# 0$              0,"!@0%!P@)$
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M]9#I_P#3. ?,/Y=_ N?_ %D.G_TS@'S#^7?P+G_UD.G_ -,X!\P_EW\"Y_\
M60Z?_3. O_Q^(=6.G;&BB5>_+F6$=5]:0F+:2232.7N35%(OT#/FF.L>'^6.
MKW(%B%F;$Y:=/A0J.R43IKIKG&NNN,!.8
M                                                     !!:[/\
M&_R9]'SM+_[GY$ 2!
M          8/X4_L!>/TU.TO\R-B )L
M                                                    (+79_C?Y
M,^CYVE_]S\B ) @
M       ,'\*?V O'Z:G:7^9&Q $V
M                                                 $%KL_QO\F?1
M\[2_^Y^1 $@0
M    &#^%/[ 7C]-3M+_,C8@";
M                                              ""UV?XW^3/H^=I
M?_<_(@"0(
M #!_"G]@+Q^FIVE_F1L0!-@
M                                 0GO6[[]9+[@]%41%J9<5KW3DYM^
M22*XI+.F9$B116<5_"$+,RHH/%I$H5*5RF:['&FGY*U+U(UUUUV]?.=0M[[\
M/(7_ /0>(/\ ?;H/]%X!]^'D+_\ H/$'^^W0?Z+P#[\/(7_]!X@_WVZ#_1>
M??AY"_\ Z#Q!_OMT'^B\ ^_#R%__ $'B#_?;H/\ 1> ??AY"_P#Z#Q!_OMT'
M^B\!1<WUU[ +*H5BN"'\R+8-<EO%U$L75=,K:4RQ@<%]:V5/FUX3H9A F=G7
MH\&UYLF.*V4%[XU4^OKG.=/5V"ZKL_QO\F?1\[2_^Y^1 $@0
M                                        &#^%/[ 7C]-3M+_,C8@"
M;
M            @3.OV@\'^A+;GR_T( D<       "+71_]ON'_IJQG_+ETV N
M2[/\;_)GT?.TO_N?D0!($
M             !@_A3^P%X_34[2_S(V( FP
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MK;8LW3/IUSG'W0$\
M                          ! F=?M!X/]"6W/E_H0!(X       $6NC_[
M?</_ $U8S_ERZ; ;#0
M
M                       ! F=?M!X/]"6W/E_H0!(X       $6NC_ .WW
M#_TU8S_ERZ; ;#0
M
M                    ! F=?M!X/]"6W/E_H0!(X       $6NC_P"WW#_T
MU8S_ )<NFP&PT
M
M                   0)G7[0>#_ $);<^7^A $C@       1:Z/_M]P_P#3
M5C/^7+IL!L-
M
M                 $"9U^T'@_T);<^7^A $C@       1:Z/_M]P_\ 35C/
M^7+IL!L-
M
M              $"9U^T'@_T);<^7^A $C@       1:Z/\ [?</_35C/^7+
MIL!L-
M
M           $"9U^T'@_T);<^7^A $C@       1:Z/_ +?</_35C/\ ERZ;
M ;#0
M
M         ! F=?M!X/\ 0EMSY?Z$ 2.       !%KH_^WW#_ --6,_Y<NFP&
MPT
M
M        0)G7[0>#_0EMSY?Z$ 2.       !%KH_^WW#_P!-6,_Y<NFP&PT
M
M
M     0)G7[0>#_0EMSY?Z$ 2.       !%KH_P#M]P_]-6,_Y<NFP&PT
M
M
M  0)G7[0>#_0EMSY?Z$ 2.       !%KH_\ M]P_]-6,_P"7+IL!L-
M
M
M$"9U^T'@_P!"6W/E_H0!(X       $6NC_[?</\ TU8S_ERZ; ;#0
M
M                                                          !
MF=?M!X/]"6W/E_H0!(X       $6NC_[?</_ $U8S_ERZ; ;#0
M
M                                                       ! F=?
MM!X/]"6W/E_H0!(X       $6NC_ .WW#_TU8S_ERZ; ;#0
M
M                                                    ! F=?M!X
M/]"6W/E_H0!(X       $6NC_P"WW#_TU8S_ )<NFP&PT
M
M                                                   0)G7[0>#_
M $);<^7^A $C@       1:Z/_M]P_P#35C/^7+IL!L-
M
M                                                 $"9U^T'@_T)
M;<^7^A $C@       1:Z/_M]P_\ 35C/^7+IL!L-
M
M                                              $"9U^T'@_T);<^
M7^A $C@       1:Z/\ [?</_35C/^7+IL!L-
M
M                                           $"9U^T'@_T);<^7^A
M $C@       1:Z/_ +?</_35C/\ ERZ; ;#0
M
M                                         ! F=?M!X/\ 0EMSY?Z$
M 2.       !%KH_^WW#_ --6,_Y<NFP&PT
M
M                                        0)G7[0>#_0EMSY?Z$ 2.
M       !%KH_^WW#_P!-6,_Y<NFP&PT
M
M                                     0)G7[0>#_0EMSY?Z$ 2.
M    !%KH_P#M]P_]-6,_Y<NFP&PT
M
M                                  0)G7[0>#_0EMSY?Z$ 2.
M !%KH_\ M]P_]-6,_P"7+IL!L-
M
M                                $"9U^T'@_P!"6W/E_H0!(X
M $6NC_[?</\ TU8S_ERZ; ;#0
M
M                              ! F=?M!X/]"6W/E_H0!(X       $6
MNC_[?</_ $U8S_ERZ; ;#0
M
M                           ! F=?M!X/]"6W/E_H0!(X       $6NC_
M .WW#_TU8S_ERZ; ;#0
M
M                        ! F=?M!X/]"6W/E_H0!(X       $6NC_P"W
MW#_TU8S_ )<NFP&PT
M
M                       0)G7[0>#_ $);<^7^A $C@       1:Z/_M]P
M_P#35C/^7+IL!L-
M
M                     $"9U^T'@_T);<^7^A $C@       1:Z/_M]P_\
M35C/^7+IL!L-
M
M                  $"9U^T'@_T);<^7^A $C@       1:Z/\ [?</_35C
M/^7+IL!L-
M
M               $"9U^T'@_T);<^7^A $C@       1:Z/_ +?</_35C/\
MERZ; ;#0
M
M             ! F=?M!X/\ 0EMSY?Z$ 2.       !%KH_^WW#_ --6,_Y<
MNFP&PT
M
M            0)G7[0>#_0EMSY?Z$ 2.       !%KH_^WW#_P!-6,_Y<NFP
M&PT
M
M         0)G7[0>#_0EMSY?Z$ 2.       !%KH_P#M]P_]-6,_Y<NFP&PT
M
M
M      0)G7[0>#_0EMSY?Z$ 2.       !%KH_\ M]P_]-6,_P"7+IL!L-
M
M
M    $"9U^T'@_P!"6W/E_H0!(X       $6NC_[?</\ TU8S_ERZ; ;#0
M
M
M  !K2O*S:TK#ONMG"S+&@-;M[OQC<+>TN%@3.-PM YKR+WH56<B;ULE<VM,L
M5DIM<F;%E[;;ZZ?=SCT9P R1\[#E/]:/FSX^JG_&X ^=ARG^M'S9\?53_C<
M?.PY3_6CYL^/JI_QN /G8<I_K1\V?'U4_P"-P!\[#E/]:/FSX^JG_&X ^=AR
MG^M'S9\?53_C< P%;U[T78EL<.QJO+MIZP)'MV0R.6(_!;0@TP?/>Y#SGTKA
M:O\ >F./SDX81),J"_:F^S]33U\>G./2 VQ
M
M                                         "W'^'1&5Y39E$6CDDRB
M]K[CR_LC8\92>W]3VWN;WQ2J/8>V]GKZWJ>CUO5QZ?\ 1@!;OY'ZE_-=77^Y
M,:^# #\C]2_FNKK_ ')C7P8 ?D?J7\UU=?[DQKX, /R/U+^:ZNO]R8U\& 'Y
M'ZE_-=77^Y,:^# #\C]2_FNKK_<F-?!@"HM-;UXPKR75B@4+97--[3"=Q:8L
MQMR]/[4O8HWV*Q&A)4%>T*WSKMZNV/3KG.,_<R O0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M+X AK?$T2M\C7SAL<5#0JB* AT+0D+I'[ZI3$Q2,HS<]0?KZA6N^V<8R&PX
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MUTCSHB>&XM\BSVX1J3-&RUO/4)L.<>D34J0+2/6]HE6)C23,:F%[ZX"O@
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MZMJ]EEH5U L2G$'6($\92N2LU/HU-RA5N4%;YKC]U]"+N+*IF72M_37F^:=
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M,\QMFK:4:#6-'L]FZS^X9XQ5O#FY>2CWVV0I]I1(TQ:PW?T82%9VWWQZ-<X
M9<*<$!ZM4@(7)#EZ'4C=:B*4DF*T>BG7;=-LJ3:;Y.3ZJ-=,YTSOKC&^,9]'
MI ?A6YMJ U&0N<$*(YQ482-Y*M60F-7*LX];"9&6<9INJ49U^[ZFF-MO1_J
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MP$327,\(VGJ-/H5'I1,(.S/*"*S]SA:K3"UBV>DB[5F<L85I-2E.,&8#-X
M      "E/K&T2=D>(W(&],[L,@:W!D>VI:7[5&YM#JD-0N3<L*SG&#4JU&?N
M49IG[FVFV<9_T@/>F3)T:<A(D()2I$I)29,F3E:$ITZ<C34HD@@DO74LHDDO
M7&NNNN,:ZZXQC&/0 ^P                    ""/DQ8YW)^(+VC==4_F^9
M _M<4:5E7ZZRE=N^Q%;/HJ3/%VD6A4\J^36/][$)V7NFT12R%HS+M$66;<_V
M2[?3<-!/-_*G6%50_K*^ZVYQG$?D5(]0<P=C\CT^R<_U_P =,UUM#53#M2_4
M%?0#GF%SF<,]0K;6K9Q?6XU Z*RWE<[:M+BYD:G;E>H%"[%X9Z+WJFFJ3=^6
M#+ZL*5\?W/*))<OS<6CJM<N[;Z8L>66A=D*:<V->$ I7DM8TS!\1JVZT'%F<
MG8]KU*0(UB;5I+2*0D15G,_81%D478$GIRQGEX9+4\;,_D!LH=,(U:ARJ_Q7
M]"5C:*F02)4K6*VM0UW5*&]C=W#.AIR=R7ZF^@ST9V :Y(KQ5UO((K?JF$\5
M3BKE-F^*7LRB9U"XCS,T<W)7KI25J*7DL(K!\L>2WU<%R=72U*XM\A);;3E2
MS"1P/,,4H5&35JLLH-A44Y6E#Q8ALHY;X?M?DF@&ZW/%2BF523.&,,&63:YZ
M&[+16!<]]HX8TR9[(?4-;TWA.A?YP9O[:;&::F%'.1:#55D+/\;?'72%;]ET
MY);@A?03%=M>2CH9SZ9N,OF2BH'6MN)9>@FJ8E;.>PD,R5V?UC$+$D#TT.\<
M:#$J]SCRM$E,6$,^K=DK8*MYO.<NA.B+8N9AK?D-UL.0J^0&R/<Y7 P<[MO0
MLB=K((<+1D#LS1BW[(O*%UIPB_0!]]YUFCXVQM1*Y/E65ND7*#VY$A+#99P+
M2B>I>P_(K*WCGQ]KJ07J^<RVRDN)= $[4R6<QJ>8ZRCTV:3)V1Z_OA,6&\F2
M5K7QJ4Y+4DJW+*W?7?"S!F9B)F8BG7NUZ#1-/&^7L4YDK=6UX4YHQ5@YS/QU
M4B[D=)U3J@,XGZN=;BE<VZ"S@Z>%;::\\$R^!-6<XU]T8-A9NNFN?]&?W>X[
MD[)N''\3*Y3Q_?)W#=K6+S3=;<['N'?'*>/6]MQ\79^F).OXS.-N^1X]G;NE
M$S/S>8WHN47:J;%VUV6YJQZ)]Y1_0NS7-5S_ )?V];<?P,H]&.".J;UD3[R]
M95'RRI>0I>V]H\D12.]'U,G:K'MJT]:;J6T>>B2%$\3ZE:,,#BEAO.==]<:Z
MXFA.<;9V]'IU+RPQK_,?+W%V_P V]JY!A\SYKA5\8Y%D7MDW&;F%MVW_ (GN
M.!O,S&)5K-[+R-FQM8G6?PRN--%^;5&/EU5X%=JK'QJHO68BY1I577V456_^
M7R4Q<J_CA0KPJJ,Q1EK:C::Z6HU_A3Q2%9]#6G8;#TA59>-^[.-H%8SG#"5V
M#YRGR:LZ-N26Q!=OMG&VIF(D=G;/H].1V' .8;MO.?NOF!SGBO(,;?K&_P"=
MLVWX5[9-PG3B?)LS"MY4T:8E6E.R;9C;E:B.DQ^(T:1JQRL>W;IHQ<:_:FU-
MJFY75%RC^O9IJFG][^Y7-$_P2G@U]24I#_&YT$R3ZV*M;.ANK**[AZ.LYO9K
MDJZ0(*UM*THS()$Q4_(7!%.%#B3*X]'),TQ=E2HTZOW7F-*-==M,EZ8,^=\O
MRCYYO?\ E)QK/XYLV[W?+3A_(>*[)@5W=LS[->=@8%^S9N[E9HJQ(HG'O7[&
M1GY5RY7;]W\=;F8F*JII[:G/Q;>R7J;URW&9D6K]RJ(KIGMKJB9BB?6UUB)B
MFF(B=>V6NE"MYLL.FG)BHF+0_G:(OG*G+]4=!Q"77-3L)?>A;F;^H^=)P[R\
MLMHM):OLYVK.I&&;;O,\4F8/=4LA+(+5*=B#2DWT[D6/-/C/.;6X>869G<GW
MK'YAOVX;-DXVV;EE6MFVRO8-ZQ+>-,W-OIHP+>=N-[:XQMHHCLQ[F'5<JLVH
MN45W>EB<*]C31B4TV;<X]JBY$UT4S<K][;JF>E?K331%?=<GQBK36=.F:^H5
M'(K3/^FH-7$4I&53B9L=(L_C7O"I++H-IJ_CQ)$(NR$JT+1+4EA,VG,">N;K
M+>9L\^X$J766H'34@OWP.]9$7H?E):\Z<WC?$^0<HS-_P^/X.1NMWG&U;C@[
MO<S^2U9.1=FFNYCU8=V=^G-VN<;:\;WURY.W7<>;E7PUO2_5RL^=NIO7[5FF
MU5=JBB,:NBJW%-G2(\)[H]UVU]U=6D1WQ.GK3T9-2O7/4T[IL&8V1-*H6<06
MM*[LA3)7"CI:I]2H3?LPJ\F$63W(ZUN3*]]F" = 1TEZC+1MJJ4G-2]5F0;(
M4QLD5'I]3O8/F7L7^/>V['Q; WFCS^V?#VO*NYM.Q[CKE;/C9\Y6#Q2WFSCQ
M[[,V>].+G9,3;HIR+-N-MC(NT;7:MW+XJP[NZUW;]5N=KN55TQ3[VCU;DT]M
M5^:=>E-R.ZF.LZ3/?I'?,QCBF9ZQ6Y1U]V=9/2G/NG4'*2NH.>>2SG6^:X3K
M+$6>.N;K9AFS6T]=+4Z?*/L2;G*VM>:9G8M0U^SUWV]EC7(VCG7'=PX7Y@<<
MXGQ;BO)9\I>8T;EO/(HM[1FS3A4\TQ:<;X&N*,>J>[C6+%O(LTQI51D=TTQW
MZJ<:]1D8MZ_?OV?C\?LMV=;E/K?#U:]T=?[U6L3]"IN4\YH+UH.\.O&NKNFX
M3;9W6=V="<W1JS:4NAWJ7I+H1]JY11QDNJ=TL0EOEY5.<_P\ZMDSB1JMTC;E
MK[JQE.6J,5E<7%X[YJU3R/@'DK>W?B>_;+3QW:]FWN_@;IM=O<=DV:SGQNL8
MVX6\*:\:=SWC)IWNNQ5-J<ZQ/N9BY79HLUS5>P?Y.5N,6[]JY[VNY;BJBN:+
MER:>S6B:NO9;CW<3U[9Z]-=4;'9D86F%R)(CGE.I^B9_XV*NJUHLIGNVBY?)
MF1)7W5\TE]B<P2:WE=C%-IUHO'(KS'X4EV='8ELDV6W*39SRG)V-QZGA9^XY
MF^XUZ_MV^5>66V^:>?GW,&YM>[8UB[5F<>Q<;"WZQMM.%-<8%OD=K,W2Y%C'
MJOX/OXO1B1=KBB>%5313:JB*[?QM>#31%45VYF.V[5-5J:^[3NFS--$:SI5I
MIW:0V%>-+H3F/GM3=TG*M=!'X!9\QHR*L$ 7Q+DOEJ+-;^7[_,<QM".<^US:
M>=HDP,2%W;B9=(U21#[[%-91R4A=A)D\SYH_RJ\M?-CS*M;!M->S7,GDFTX.
M[9%[,HR.1;_D7+,^YNXV!?WC-V__ -B]>KMWJMNPK=R[\/5?KHNW,>;T6Z>X
MV/,P<.;MR+D19N56XBG2S:B)ZQ-46Z:^D1K'?5,1KIK$3IJBD7+Z4WA5NP*'
ML5>M7D,=VSM\J6=]F]*U!6L2EJ.U2K%-KIU:+L06:8NMY/8C,OCK)'(NN)TT
MKX\KW;L4U;LZ<P[V*K9>>4[]LO(][R-SO?XT6+O%9Q^(1L>Y9V3CU;?.%&;;
MN;77@11MM6%=HS<K-S[54SO%%7N(KS*<ZY3;X'O,7W5RS;BB-YF+^N1[VBF)
M[^[MF*^[U^Z.VFFF?Z?CZO;&OQ>'7DNRVRT6GG"'0'E7G27QO@Z"6)2,GLZF
MZF<[+L6O.U:RFMG3AOAT;M)6:OS65!-SLBD$UP84;)M%&,$J7#1'@_6S!P_.
M;BF7M&9YH9VY<P\SL+*Y;EX6ZV,#<]QMX.%F\7SL7 Q*\F_@4Q1\?O%>/=P]
MKTJIP9HF;EK&JOS;F*JMNOTW*<*FC'PJJ;%-5$U443553?IJJJB(J_=MQ,55
M_O?)-6FK+Z&NN-H5:4IF-0N/+,8D47\KG,\SH1QAEJ4VV'PKF!8PT01=NM2(
MVR7E%PJK9%(7R;9D#0TE)$CLL/5;GIC]_9[8TG(Y/YY;]Q'#V/FMKE^7MF7Y
M.[[B[O1E;?N=R,K?J;V[3M?XC5<QIG*S[-FUM?P>3D57+F/;HLTV[MNGNB>3
M%G;;615=QIQZ:Z=PM56YIKHCMM:6^_LTGU:)F:^Z(TB9UUB74X/R&;Z
M
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MWU='LQZ#\C=0_FKK?_<>,?!8?KCFOYQNGWN_]H?#8WU='LQZ#\C=0_FKK?\
MW'C'P6'ZXYK^<;I][O\ VA\-C?5T>S'H/R-U#^:NM_\ <>,?!8?KCFOYQNGW
MN_\ :'PV-]71[,>A^]*?J0K?0TNK:Z+,*WT,+,TA$9TW+,+VQN69IOJV8VTW
MTWUQG&<?=QG'IP,:N;<SKIFBK=]TFF8F)B<J_I,3TF)_F>$QXI^&Q_JZ/9CT
M,BC6%P
M                                                   PCT-.+JKN
MKG>4\_46DZ.LY&O9$[35*VU8_3"=Y0KG1,E>G#:?2=F?V=MRQM9IBO!.Z;?9
M5DKV6F==ML9P&O/YW_EK_P"3?&_WD=(?HI 3*Y<MGJFTV.:KNG>16[E)Z9')
MO30QB;^AX7?VDX;E" Y0X.9KK#XO&D\6V;E^FB?!"C0[<[&_M-<XQKG "'!O
M7WEHU--T*\.<;-*T--T*-_\ 4@I$OVQ6AFVI1WL\U5G8O)I>,;>KG.<Z^GT?
MZ@&7Z#Z.\AL_M2.12]_&NR<^5<XDO6\AME'VO5MOJ(T<B9UJQF(TKZ-5^QO+
MW[]NY)*+.Q2HO"7!_MM_6UTSKD/3T)T3Y!*\M)WBM >.%EZ,K!&VLBEIM=;V
MA5],J'AQ7(-#WILV@$G@+\\-NK$NSE/@_=3OHJQCVFF-<9] #">>P/+9Z/N>
M&^-YS_[/_4CI#'__ "D!,[I:V.IZSAL)>>;^1V[I^8/;KA+-(4NZ%AE%E09K
MRS'+,NQ4GED8D2"4[8>--$7N=.23OG&_MO6]7&=0$,OG?^6O_DWQO]Y'2'Z*
M0$S:XM?J:2<Z2NQK%Y(;JSZ&:44T/BW-A'0L,FZ*6K&4@XR&H3+K:HPWQ:/8
MFY^FA>YIS>;JU^OZQN#,8S@!#''8'EL]&/3X;XWC/H^[C_U(Z0SZ,_\ L]/Y
M*?N^@!)CEV\^VK2F4A9NF^#VGE2'MT9]\X_-4'5]>7X;(Y+[ZH4OWK[QF'PN
M-+V8OWK//5^[S3C"?21[+U/6WQM@,06;U'Y-8Q8LWCE:^*I@M&O6.3.S9"K)
M/[XJ""'SN-)%.Q35*384[ULXND4,=TV,&Y0*%!QR?T^KMOMG'I >&"]5>4-]
MFT/9)OXFX_ H6\2=B:Y=.2O('3DL-AD97N:9,^2DJ*MU9(G"2F,#::8JP@(.
M).5Y*]EIOKMMC. SSU-=O9]5R*)MW,'#;7U?'G9E<%LJDCAU+ * WB+RG7%$
M(&,MEF,.DRJ1:N*'?=1E428463G3V>VN<YQD!%SYW_EK_P"3?&_WD=(?HI 3
M,E%L=3M?,3-9\8Y';I7TNM:XPJ>.63.AH8P(&1S='1(EDS5K?*R+J8BZ:Q5L
M.-5ZJ"VW31?DGV1>NFV^-L!#/YW_ ):_^3?&_P!Y'2'Z*0$R>6+:ZJM1JFJO
MJ#D-NY/=&1P:D\,:6_HB%] :SAO5HU1SHXFN$.B\9)BVS0L**(P2HU.V48-]
M?7.N-,XR$.U'7OEF+4*"R/#K&U"<M0>6G49\C](DY4IRS=]"%&2=JJVV)RH*
MQC?U,YSG3UO1G.<X 9:H?I#R(3VU(S%+T\:;)0%7.>KQF26RC[:JNW5$7V1L
MRY:T:EU]'*_8WE]]^7@@A%G)*HOW-A1[;;UM2\ZY#W]#]$>0&N[1<XMS[XY&
M;H^L4K4R*VVUEO9U84NH='1:ER:\M.T!E$"?WA!JQJL8)PHW4[:*L9]?377'
MW &#]NP/+;C7;.OAMC>VV,9SC7_U)*/U];/^K'IS5/HQZ0$S^D;7ZFK:"0E^
MYTY(;^F9P]NB=+-("NZ%AE(%09L,9%*X]U*ELKC$A;I3LG>BRT/N=.03OO@W
MV^-L::YUR$,OG?\ EK_Y-\;_ 'D=(?HI 3.K"U^II1SS+K$LSDEOJOH%H2S4
MV)\XI^A(9/44Q4LB+<^&)3+G:(PVQ>.8G"W74C<P] ;AKQMZYN#,8] "&&.P
M/+9G&,Y\-T;QG.,>G'_J1T?GT9_UX]/Y*?N^@!)3E^]>W;1FS\R=-<%M/*L,
M01<QT8YR@ZQKN^S7^3:NK<D+BN\6B$*C;@T%F-:A0K]WF';DZY38*]3UC-=L
M!B>T.HO)G%K&F\;K+Q6L%JUVQR1Q;8592CO6H8$?.HZF-]5NDQL)>*V<G6*F
M.17\[*%0H.-(_P!&V^0%*A75GE'>YE$F:9^)>/P>'N\F8FR5S4KR"TW*#8?&
MU[FE2ODH+C*"LD:^1[L#8::JP@(.*.5Y*]EIOKMMC. D!U-=?9E5OT10<O\
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MF8)T%F<JEYKMH^I#4L-B48,BV(^4D2;X,4;'86>[,XTQK[';U@F.
M
M
M
M
M                             \+FYMK*VN#R\N"%I:&E"K<W5U<U9"!M
M;&U 08J7.#@N5&%)42%$E*V,--,VU+++USMMG&,9R Y[;%_BG?"S74R?869T
MO(ILHCZTUN62&NJ>LV6PU8K3[Y+/PQ2E-'"6N1(M-]?1HL0[J$1^/YQ)QFF<
M; +)^UI^%?\ /7;'U?K0^! #[6GX5_SUVQ]7ZT/@0 ^UI^%?\]=L?5^M#X$
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MT/@0 ^UI^%?\]=L?5^M#X$ /M:?A7_/7;'U?K0^! #[6GX5_SUVQ]7ZT/@0
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M/=Z'^?O_ /&)O_PL_P!=I_T@(Z^-_P#P;55_YO;ORV6, G&
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ML&>*F5LC2Y7LE]TN:H]*8;@-WP
M                 .1?P3_MM_XC3Z0D'^4B_P !UT  #G,_BM_V(O3G]]>=
M/E^KL!LIX<_P1\9?1+YN^1F%@)1                         /8W?^((?
M_G$W_OM $>/&_P#X-JJ_\WMWY;+& 3C                       !JP[[\
MG##PY<7,=7'UJKL5OMA\UD5]RQ#(2FA+S+SIFPZWIC:^Y6CW;5^[LPZVY<+
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M'*LM+#K%5RJ&M>E>2]3 %)+H6D><(M3"SRR-3,K-L)@&QD
M                                      !R+^"?]MO_ !&GTA(/\I%_
M@.N@  <YG\5O^Q%Z<_OKSI\OU=@-E/#G^"/C+Z)?-WR,PL!*(
M             ![&[_Q!#_\ .)O_ 'V@"/'C?_P;55_YO;ORV6, G&
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M*'P^;=,\MR#DBXEL2US7QDA3-S]6C_E60E7.*Y.WO"4@Y/KHGP:E-".O07C
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M;P_9VWRN]Z_='\\!L9
M           <B_@G_;;_ ,1I](2#_*1?X#KH  '.9_%;_L1>G/[Z\Z?+]78#
M93PY_@CXR^B7S=\C,+ 2B                         >QN_\ $$/_ ,XF
M_P#?: (\>-__  ;55_YO;ORV6, G&                         Y+Y+R9
MU%%?*%+;,Y]Y'G*>2R'K>S[C62V_*VY_L7GMG;)+2+["VWIJG^T8XHA/3%?/
MSWDAL0'5 [DREH3'GJD^I&B/4I66&!&ZP?*O45#U-MTS8G<C$LM/MW@BI)Q&
M6Y,R,EWOTJD4)O!5V%'J F3A84AW?(++UC<T91(D"5FCR8]#KO%=\;&[Z$A4
MW.A_+\VN1%],;5U\KZ1E'CEF535S)7B2QAR=H]'X]WP_29OB-PHT;TGB#7U*
MZ<%.*)2C4;9UW7SXO.^BG#H3G?4,GRNMO,S):2<%42LKMIK<8;R]VQ8-$$E;
MH(+8KK;S+T91AG)%=7&ADTML*03Y?^3W>6G(])*I(=7AAUT(?"M3=3=#PJ]]
M\V]QI;,KA;-T7D'MVM.<N[.V55>VI3\KCKMU4V\XV9P77*" NL4F*M:PK'"/
MNG2,DD#65J5@M:0C+-2$Z:HR-"P%Q4RR^<_/2] ;=!2&Y4.R2JN>C)/O"&>/
M2"@GB+)N6'G7HYBM(QIG<9A;#=[AT/MZ=70IL<WDIRU0;,.F['E87J&T3C[E
M2VIGXLX93/:EF=.3^Z;RJ.-2OHO[_P"UG:/6DQ3J11>++9I3K%+*W-BKQ$8$
MF<V8QJ/;T*SVJA(K6EG*C<JSMM@TC6IPEY17O@[Q!UY"Z5BK[$N28IPM*)31
M+[;<JK>R&#IV%7["#Y7*+&CC#7TRC,PK.MJG9SDFGK.Y1C/E[=G7W YJD+:1
M@.@'IFT8KT3P=U.XD<CV;TXWLKG;%1&\KK=$T=>;XF-2V<J@&6=N=&:1'ICJ
MNDTRCNJO=Q]OG)T=U-W4(MM_:H-@Y?9/X_.C)/048T9>$KL>)?<E,=G0>(PU
MWJ"J*LC?&GD Z+Z7H*XVR\:WKG6TI*V4#S;%HK%CT$;E32N/?""8R;E600J=
M\EFAL=[=\<?0[Y:7EK<^>XQ9LC7]7\'\K9TFD@F"F78LZV8?TU=,IN>GX4GL
M.3;1YG1&T62VLC9%/6;(MJC<4Z3?70H]29D)[>,;G6=*.#[6I"[:VF= Q"Q+
MJO[[P&]BC$)Y0OAVHN<2$M<RS&PXIS$HCD,IBW)0<K<M%6L3*8]RT6J93J0D
M5FF>J&B>P?'+TZT\+\HU$JXQGUL*6+CWR<\MU-72!NASZX<K]27[U+'I1RWT
M1(C)G*D>\-8F>NXV<=B9HCU;FR%::>OG7=9_/#8%Y(><[?M)' 7UUYMZ>[.K
MVL[?ZUB]FTS.FBN)N0^6);W#;'4U)V]0,.DLD:FS?G2)V<N5%IUR\S1YCSX\
MNSI@K0DG!NH82Y1X.Z[K'MOF/%JT5*GBXZ\NNC+FL;O+V</<H>OYEA7B?8^5
MIOSGM9.D@,GJY[7=/(U&^8M[AV;E6NWO]G;.-O:@,F]I<_>1NR/(VO\ (55%
M%-;Q!N#[#H*NZ$C+I/Y/';KM.GR"5Z_M993]9-T7=H!-&R\8_<Q[&G5OS\RJ
MM-X$GW2DF9VUP8&HSJOQ-^0"=R#N.*PBA9TY4OTY?_8/9+XU::I"7&07)15P
M='1[E)O;TNSMJ263<D*O2//I1.^2\':Q738W&-BML ._%!IN6A1EF:YTW+2)
M]-]<_P"G7?0G37;7/H]./3C. 'K
M                    <B_@G_;;_P 1I](2#_*1?X#KH  '.9_%;_L1>G/[
MZ\Z?+]78#93PY_@CXR^B7S=\C,+ 2B                         >QN_\
M00__ #B;_P!]H CQXW_\&U5?^;V[\MEC )Q@                ,?VFFM-9
M7TH34F\P&/6H<WZZ0MZM&-R&7P!N=?=*?.Q\GC44E,)D+PW^X\&XP4E=4)GM
M<ZY]IZN,XR'/?3OE:[N)I[BB[;=JJD[G1=B=3W51C74G+U?RR+V<TQNBX9U8
M8_+&AUNCH?2"NLCD,PH5O6E'+EC4WMK&<L+.]LH]B=H&7Y+YYJ A36Z7 YL,
M\D]'26F.(;/K5M9X-&(5*6'?L!MOAY;E-N6E9MU1JGHBRH4M.;I#=W,UB2-[
MGC5.6O=-UZ?4D)_6GY!JMJ[FCG[IW:O[;F\>Z9FM"5W5U?PAJA+C8ZZ9=&KT
M+57S*X)G*=M,+3;ENCB60O4%O9R-/GUC-#C2<>T 1,SYR^92%+*0Y4_TRU%H
M*FZ(N6]5JJ%P,]%RU$N4K+D]/WOI=YK?9BTWWTB-C1C9M3$QC228>-EB4U#L
M>29MN6%0F?FTY\J>L[-LV\**ZGII-2#W2I=V1*50.#/\SJZ ])1M^>J#M]_;
MZXLN;M;C +&?F':->JV+%SRS24[5&Z($>NAIQ89IC'E!J1\N"$<\/=37I!;\
MG,_IN$(ZCEC!"=):TH+DY\EW1R:P7C5EGKPVZ0" 12OWUIDBU.H4&()(U'(2
MRE&-B3C P/UGY8J>Y+M_H.+WQ"W:>Q6C))R.@AJ2+0>',Q\6G'0$.N^5))--
M+CMZX(K4D<9BD=5GDHG%PVBWN):?HB+/<3UQ>"0D/TMY.J,Y?Y*IOL.9Q*RW
MFNKR6URW1)K9RZ\:5S$ILR+.$N9CK'F<VL**4]7C0A0-AB92Y.4F*;=G'<E*
MG/4&*"?7#'3WYAN=&=UBVI5=7L\P@V$\L3JY[39XY!%<%YD;>SGHJ/<_(;D/
MQ8VKZO<I*Z'EY<,Q!#*4K,C-+5JSBTV^IN0BK4?FJ5^@I9>L-3JG-P8K4116
MJZ5@BM9,Y]8R'R;6-P#2<5BDLFEMH8P4ZSI1&VWW:C<4R)"E5FJ7$QW3(M/<
MA87!UMYBK YX;G=]8^8K',DK?S/$+B,YLM&*QZ#VZPR"2]LP_D94LDLZ37(Y
MP0Z/)%$D]UMR%J1N&CUHH1+B'C1 <9L2%[N7GOXF899?,5D;5;;-O0S'<BER
M7:MM;R V9S3G]_CD-M6JXO&XE9T@F+5-FJ<R<EF:SI"W,C#)5:=68T.2U(GV
M4Y"]*B\BUOV94GE5L:04IK4,@X3D,X9:]K:R4Z#$MR9$^2*\OLI+;IL%L2<Q
M%S4*9=+%!6JB.._N,]E]S[%F>VSN9D+(H7S8TU)HA3Q'0=56WS]/YE#.;Y+-
MU<LCD,05NPM?2M$61<%>VLE=6:S9DI:ZDG;_ $Y)8ZV:K]\2)$]%I$SF@2Y5
M:F@,TWIY)G6 \\<$=#5GSA94X:NYK_YAJUJA4A70:'3NOX;T80>]-S_(&MVF
MJ5E^^S1@(TU3M_OEA*4K4:^[%)&A>WK!$*E//56Z6FI5-NN*HL"KI!&HQTA8
M<>D43C\9,K"Z(?2/:!W(*1HJ@UTM-TE"68;2R4Q-$LS*"8^UG+G)0J(4ZMZ<
MPTD,^VYY7F5T\775/?/,T7)/E_.Z:>1I3 +9):Y"UM%HP%^96=W9'ERIV>/\
M7GD?,2OB=<B<(K)5R%S2*2=DZO.VVVFH1UY]\R-AMTLO2O\ J"#Z3J5Q9\Y2
MB7/L>J#G&\.4[BO:Q.I'6R&%I@#7SSV?,6R1M[)'E]>&G[SM>]M<1-(PK+R=
MH:@-]<,[33SG<JU^RTR^RNOKN94MI6=(*8E;>[)Z>9I+2EIQ"]6WG*7P:<Q)
MWN%#)ID_1:S733"W6"))<46S:[.>#-D>2S# ]#IYH*S5.\NA\$Y?ZQF,T1W?
MT?S[6Z-#$:F);;;F')FEA_.(F$(4O%UL?NNMJDW@>F%ZI;LVKW)0[(D36E6K
MMCTZ<,BU?Y*-3N#>!^FK+K.0S>[NY8K2S;7U%4&@9_?.97#:%8.5H.<<B)UH
MSB,QJ-1:.1B-/#FK<)#($J9"W-^^35&YN2]# Q?0'E%F/6W>-+4E1E9+VCF6
M1<A3[H6SYG844;TUELUAQ6[IESRYU,I3)[=0ZP9=6]H05>V/1FK')O?!P)VT
M2;EM^='7<,/QWR6=FMTV=+7G,8YE>>1RO*7-O&WO#XK'K1CW1,=+Q>*R@J[M
MS67.<^E%?S?/WX&H5#TRE,+09[W&'&IE.-RL%;!5(#YXZ6;Z?89S;5<W(_Z,
M7)%<]87';=<5G%XQ3L/CUP3"?5]4L7,:I;>4AEK/,[-G\%W9&IORH<TVBM3H
M>J7IT.BE2F#,T*\T]$6DDB+;4%$=+W):3RX7+I,J7JADJ&<SFM(S03Y7K!9<
MZ=7AEN,ZM9_%B%MK,&6?:%/TF62#5?G#>0>8G4EDA:D$\R.7B6717LBY$OEV
MLZ,]D]"\QT=5E6J:FD<QN&*<TU['+ M*S35,IM6'1B)E1%H>TYRY*XKD>3C7
MII0-N7)<:J+3A^'_ ,\?+:)CG,XB%-]1V;5-<\_4'T5+[>A< A&E?QZ*]-$$
M;5 PR);*;*C;Q&)(YJ?=1;KNXHDK5'RVU8H<EJ9,3[78-E_)W34&[!H2"]"U
MRW/#1$IYH]^][:^N<(>W!*;'Y Z1M=_^VZVE\^@;VA4+&G<Y(L:GA>D5)#"S
M=#/YV==0D8                                              .1?P
M3_MM_P"(T^D)!_E(O\!UT  #G,_BM_V(O3G]]>=/E^KL!LIX<_P1\9?1+YN^
M1F%@)1                         /8W?^((?_ )Q-_P"^T 1X\;_^#:JO
M_-[=^6RQ@$XP                 !#R)\&<OPF-\]1*-P!8A8>6K)LVVZ21
M[R^7J]HI.[@;K5:I^[J%*M[.4R IY0W3(]-4SANI3)O=VN2="\D$9+#"Z?Q)
M<2-<1;X=%X38L%2,U>4=5C&]P"]KIA<L9H3SHAL5KJMG1R>/3I [FDM+7;#^
MF6X4&'ZNY*_T+M5&22,E!^>@/&13EJ<O<R\@5DK4T727-%[<YVM&6&(J97[[
M?>M0$R(EI4-8IBW3!AFT8D4@,*SDN2E.1SFB6[>Z_P#;'>G.0OB!^,KBRO&U
M<T,]0^^S>^4/:?-\O)FLQF\ZWG]77A8SA;=Q);"4RV1.ZJ:R>RK$=E;H[OCC
MN>[J3E)FONC!><:8#'FGA]X(5PU7 9?54GM*+O,RBDVEJ*X[@MRVE4_6UW W
MVM:K8+#=K FL@=IO!*DB4C5%Q>/N1ZAG95VVK@G3ZN&N%0#\U)XTX56':\-Z
MRWD:)[::*X]CO&?-D0<&N4/D]B$#3/:9_D<FLZXYK/):_6G+-MDVS6SJ-DC>
M8WLZM66H,7*%.ZC 9;N+QX\Q7A+K*L&7,=@LT_MA15:F83:NKDM>L9(H,IE@
MG<5@A:)=!)>PZHD"6-V6]HUJ373*-S*6^E64=N21N4%4D7 W,SYSG5G*K7%I
M;7E.4B1'D]3M53VE9E92*%$QEF<8\WE(II#96TRMT3JF5X5IUQ+BK6D.6%.^
MZK0XWT;X#%2/Q+<&-2VIC6*FET<9*?B]/0UG@L>LNT&>MYK'^>I(KF=%I;GK
MY%,2HE=Q]3S%>>Z,RB5I'902L-VVWW,U]&N _:WQ.\,KFMU:C:I>2<.<>?H^
M2Z(;.LUND+!L^].O'9'WR1*1(9:G>HI-F/I!\/DK4](#R')L48T(3G%I=-2,
M!YW;Q+<.OL+<X,\UU,G1 \T^[4F[/SC<]P+YTY19\OA/TZZ/BV?+)N?+U5AJ
M;[2%R;[XMUFSN6NTUTT/U3ZX)P'LQXI>)SM[F)=:_FTA8;\C,_C=E0B1W7<K
MU7KB?;*QC=K4FC- ELZ,B<5LVQ)%&T+NZ25M2)7LQY)V7%J2E1QYIH9/JG@G
MFZG*VZ JR*L4W=8[U,I>W"_G.P+9L^S)M9CM)*U9JE?WI]GD]EDAEV'5U@[
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M98P"<8
M                                                Y%_!/^VW_B-/
MI"0?Y2+_  '70  .<S^*W_8B].?WUYT^7ZNP&RGAS_!'QE]$OF[Y&86 E$
M                       ]C=_X@A_^<3?^^T 1X\;_ /@VJK_S>W?ELL8!
M.,
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MWY;+& 3C
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M/ !\P'G+^LZ$^N7V+^G@ ^8#SE_6="?7+[%_3P ?,!YR_K.A/KE]B_IX /F
M\Y?UG0GUR^Q?T\ 'S ><OZSH3ZY?8OZ> #Y@/.7]9T)]<OL7]/ !\P'G+^LZ
M$^N7V+^G@ ^8#SE_6="?7+[%_3P ?,!YR_K.A/KE]B_IX ?K7@/G33;7?0WH
M77;7;&VNVO9G8V-M=M<^G&V,XOCTXSC. $CJJJN"4E7T9JRLV4R/0:'HST+
MT'O#[(5*8E4N5.:LQ6^R=S>9"\+5CBN./.4K%:A0<:9MMOOMG/I 9"
M
M                                    '(OX)_VV_P#$:?2$@_RD7^ Z
MZ  !SF?Q6_[$7IS^^O.GR_5V V_\"_X%.*_HE\Y?(]#0$M      !KIZ*M[L
M&$=3<]U#5;US4FKOH1?/$#:JL&MK1D$UB>U75W]_4C.6KXY;T58GS61&$&ID
M6FB-'[AUVUW-V4YQG7(8,@OF!JYMJMWF_1%=V#5+FW%SI9&W QKBC; [A31;
MIK?F5*EJN02*Q$^$J_69O+"4L-E>T:0:ENGN\I1NUEG*R0EM!>]:&L+D^?\
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M"BO$_P"2:)VK.JH_*["JAF9*N6LL]3SQ9'%:$I620U9:D#LX)FM8YI' _4G
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MS*9Z-8F^0Z4SI*9&^P^"%1^H'/I!VRT\]L5JK&ZS'-0SN]LFJVTU/HWDNA;
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M&@U>200O3*6AX<8X_-*[5&J7MQBUCD3.K1'&I%*I$<81DQ,H/(V+.W"$DO\
M+-SC!K&MZK9#$+C+E]1L3W(3&AL9( ^/DX;X]<%=T<YXBT+9K*76$Q*CIU:;
M)[W%RMHC67MN5>[FWW8FTV,P%F7?Y8XG!*7MR5U]0MZR2X:H@]Y2.<58[Q**
MGG4JJIES)C)SO=BZ.V0M:MH8]29Q2[)38BX25<L:_=*TDCW.C5FD!MN(WV-(
M)-VQKC8PHO?;&N?3KC;?3&V<:Y^[Z=<9S]S(#Z@     #D7\$_[;?^(T^D)!
M_E(O\!UT  #G,_BM_P!B+TY_?7G3Y?J[ ;?^!?\  IQ7]$OG+Y'H: EH
M  ,*/T+J2QKC@TF7N*)UM?F_#R]LS4W2+U7"(DW%%W6)F+9+'DBGUMDLE8FU
M9H@V5E^IMLG,W)].Q>V<!@N0>/+F61Q2/1%9'I4D20YBES-"G=GG4F:)-#5<
MONN)=#GRJ,2% N)<FJ8,=MP9L=&Q?IO[1)JGV3>C9,:<3N&0L4G4%6\^R&H9
M7.YRG@,M.<6.46#.KCEJ6Q'>36U(BF;1?I:VSZUR)AE3[*Y&G2L^&I2@U1*C
M4R9N*(UU)*P&'X?XT^78>P64S%-,W?E]RP.W*]M>6R.<O*Z63UHN[[RBK <7
MMQ2[($A4@7H:[9DQ*M(G3;)R46/5Q[0PTPP*$?XL.2U4OF$Q5M=D*SY>MMI=
MLP'VE+\Q*.&7M+(]/K<Q&(]HNT1(-YO.(LA<SSS?="I.:1@A*:0C_P"[ +TG
M'!/.D@E=M6!(G&R62/VJV6 X6? FZW);&::<7Z?5>LJ>=V8X0I(Z)&))+'*N
M3S$ZA5MG"+51IARRG]\=,+,!19/QCRK><BE$DCDOF;18+6YQ%*_SJD[JD$4G
M$:*S3+!%4<5,?8F[85-+).:<=FH]6CW]&%I)B!S*]144C5EA3YGXO.2I9&W.
M+(62PZX97EF>X@^%U1:TZKM0[UC):EJNE))4CFNC[PG6*JU>X)2<8T.;]M_7
MT6M>JLHTM0:>8:'];_'SRE-T$M?V!VLAUJ^ZHE+=E4#CES3(JEW$VVX83$9G
M8\=B+4ZE,A<HFL8WSN:KUR8DPM4G.)!!2\\U5N%\S[BV-6),KG=7*=V!&8S<
MKO5E@+TE>2QZA,I8+;K>)JZS5RA&^M:K+<^1N95<D9FEP8G9$N;3<M63=RC-
MCL>Q#[TMRI5/,,Q;)!'G!HC,)BU-U?R[1T26+5!)<1B+5(W=^7H#7Q^=E2F3
M3"RIP_)==_\ J[F:-:,LO78W8W.X4 [BKD6[*TBA3:G52R!X07*[P"5Q"QGO
M.4:F_P"ZXKT3*YK#I?'W710G?T%P0=K>6)R2G^T:34>NB?;!6=]-@K"#@'GG
M,>D<?F":P+3^_6L;'J6;OMHV3+9?));$[6D;)*I?[X/"AQ3G-CEEXC:'=N.:
M\-^K-JFTP@T3>C&0&/Y'XW*"<&!H4RNTNFC'V'+9\_9MUPZ7LANL(IKGL2C,
M,G#2YS%.\H2DD16P6&)$6Z4HI.0G]0Q?KG1SWV7@+IY\XYA%6=&VKTS'\00I
MMFM+47S_ $LP5^W.B5HB-$U$TK5;48XN"V0.[;()/*EKLE2F+4!"-/M'XVR$
M9]MNFR8 M6Y_&=0EKS>SK;)4S=ELZ?&2"5HO3-Y.=6[5;KK0[[SJELY?7J5R
M1-[ZXE5B]>]IR12;N@R27DP@DA48:HW#$"'Q(P!K;^<T[5=-ZMTBIYT9EDLL
M]-;MD;6Z]L\2Y[L>CX/"H#8*B3GN\!@D3,LQS7$-7_?4Q^JY7[HP<J/RJU#.
MR;QF<I-KPSJF5@G;%%&9HCR0NJ6JSYN34KE)HA7'Y)(G9K[!3GA0VO=H1^O]
M"D13RIR8>>>E2KE.#W%(F5E!>&W 7,YD'WKHZ*/9\3,D,ADYK>9+I#[0UUE'
M,:[D)YVV6EK=%>I"FCW$U!J7KOK@M7MA9KZ%&,;@/-7_  -2%?V[ KMP]6]-
MYS6+$<U00RRK4D\V:8R[.-?M]7R.8M#8['[%-\DED);M4SCH3DMK-/./5EHR
MUB@Y1N'ZG/$?*=R2?K9WD;!L^2GJ2K8K0/1!C3-G<AQ(BT=C;A][R-L(;'/4
MVN9?M'Y:E5^[T6J1Q4:)6M1G?;W*DWU"U'+QF<KN-D12S"V>>M#C#CJ'<6J-
M,5D2IIA"B0\T(DK/2\D>(TE6ZIW=RAT>2:-Y9)^^[<>3_M34VZK711J%?F7&
M/)D=J"1,,Y1J([5T?YNJFB7E^>+"?(Z5#ZAYL=WN;UB_%S##LWJXS)*ZD#H:
M[DR'122L(5)B3]C?21KG ?+YD7.#'&WE@G$BL"7++1KJX*!D$OM2X)"^S&=,
M/19T553MB*>'5R(++>G8BO6XML(:B4NB A)OA(07ZYVVX28DU/0:72^GIP]H
M%A\AHEZD+_72DER6)B&URE$!D%:/!JY(29J0[%G1.3*R==#\;ZEF[ZFZ^C?7
M&0$6)QXV^99ZZOCLXI+*9#9E([,>+*2P^U)K$T%K,%P21NEUA5I9*5E=$NLG
MK-^D#9H=AKWSIA*6<J((,*3KEI2@*.]^/'F5RLJ8RE9+[@06C83!)M(HM1WQ
M,&^65I%E=C1"R)FDISU77#NR0HVPFYE.6-AOO@QI4^Q+7HF);%&R$T/17_C*
MYBJEZA+Q6^+6@^D4-CJZ0L<7MN:,<;MY[B4VD5CQR0W$RMKBF231X;IO+7%;
MMMZ$Q*HI3[A4EG-I1",H+SCGC_YHBL410MGC,@)86^14_*4Q!LO?CSM7BBX&
MWUM79VRDQ7D[<ENBC822>7G/J*C,9,,QMOG.0%B8\7O*6,G(?>VRLP\Z&J8M
MBL\VM-L5F0]K*,WYL66FGA6KIAH)MI52QF[/N]8U]?US-UV"\.)FZO8,V.5#
M<Z-JNSH$_P"$A2WKF$$UI+HHZS!<C<K"B4#K%5 UC5&DNCDD="36NO5QF%I[
M;MHH+UV]T;;Z[8QO@,:4KXZ.<:*D[3-XJ78[[,FEX9'XN2SFQY%*5RAQC51S
M6BH][1*K/*:$B!GJR=K6LA&D3)DF,:%*,E95:[G;A;M:>/?DMFDE6V#6:^P,
MLM-R*-+XI$&2XYBKJ?>TJ6@2_G))/9%""W<R//ME,L$:MXXXJU&FV3MT&AAY
M>5I.#\!FRZN1JWNJ9MMEGRBWJKLU!%OO"56'1EIRJK)3(8!AS5O9,)E1\?5Z
MMTC8VYX<52MNW5)C%K.I6*3&]0EW5*,FA'(CQ@<2H)_#MV%#+XXZ05NIJ3-=
M:LERS(EI7*Z&>%/Y+;$E,>5/RQ]E;DRK%*E.<K<3U*-R4'&'JRSU_H4ZA79+
MR%5T!N#DN[9%(X9"*+X!H:55U5B60J7!._(7J6,<8K)([SB=O;\6P+(E%:\8
M-$[>0H2;K=GIP,595%^I@LT)3OG.U02JRY-;$NAS=+Y=*JQ9Z>7YE)>K\S)*
M_:7J3R UD:&)QU/;&KW^=)6?NZ'%%ZG.&J=)H=MMHE(UT"'CGXJ^;<-FR2/J
M+#UU;8B4SQB)SBQI[/:?(E[;S<\\GLEA3&JEDH:VR<O^E'.9+"ORH5$;KD:,
MK?!A*WUEF0CS6'CAKZHH[.)5UQTF\:6,]36*VVWV#$;QMV#.\'C525.902[1
M%8MH6=,;'<8V]PNPU:!^T.7EMJ0IY2%%Z:+BBW)0$E''Q4<CO!,9:GAML]WA
M\*JDRI(?7[M;DX<X9%&DZCEO."B21EM7.BA9'YBKIUQ/:SU2-00G4'F[.!A&
M[EGW8 ]C/XR:%B\Y.M6*RJZ4%HICYM)(S+'.U).\$1RT[$IAQHZ96]A@RK1-
MCQ/)'%5^IZD]7@THE>5@U%HC]H=@P)-W/SO#;WA<1BDU?)XUO$!D+/,X19,!
MF#K!+*B,V:61UC6TJ8),PF$[IESM'9"Y-ZX@TL]$L0N*@@XG<LST8#RT3RY3
M?-V';6I6%Q8]7R+P&).OOA(7N0G+VZN29%HQK5JQ]6KUZ^0+U4K<%;HXGFFK
M75<J,4*3##=L[9###WXZ^=9 _P!GNC@;:V(Y;"N<O,CJ]);DW15.AEUGK4KE
M8TWC\$3.A;2URB9N2;94J,S[1,2M5*E24A.I5*#C J>/']SMN3;*58@FSDCN
M1FNF-2=(X3I^/);(U?UG*+DLJ/Q3U3RS(^UN-DKE;FET+VVV0[K#BR-M"<ZE
MZA;3OP+R_&<V++W]VLAIKY<XO=DN,'<[AF"*F*W<#;/8;^G$IB<-V="6"*E/
M5AP\EW6YVP8G1Z[*BD6B-.J5%FAF?H2JJ=O4FLH;.9P_0B;$RA?.*2E%<V.M
MK:UF^2,\2>FJ2.5?/;.L(<EY)L E+@D=DOLE:,YL7&>W*SZ"]] J]'\PTYSI
MESQ4L=61TEVA];098G4OKR]Z&,-4MCRUQ/.YSTM7K%+OL7(%A[@O.--6NBP_
M=0J--.VVWR$9I3QWQ90=;6Q(K)D"V$5A*DJ9IF$BL.U'!M8(RQNW0,CN]@BC
M*\NRY-HR-F+ILE9EL3^T,4;97EH2]MR\$E:AZ]^*.1ZIPZO\@F$Q880>^$V%
M%87,KRDB.J*TV@EG-'5#T;6<.<WI*PQYC2S*O2WU:7ZBC1O:49Z9-E(UY.3Y
M#(*KG&D6UP@[I!9FY0"=/KS=KO6\H:)6<L<73/05OQ'IZ\TT>2*EF4CPGF#E
M --\8Q@W1 T&'Z$XP3MMKD*OU)QE2'66(DLM_,V1F09BLF,)G&#SZ00!6L@E
MM,S4RVA#7ER8%:17F/RYLCZ+52:08F7D82X]SJ2-3#L&A9=/\5<RM%B5GTU7
M[W,IWO'H(D+I-6Y6L_3RMXPP2FNXY"5$KK5&J<%J%&1-( S)-#,)C]V@S!QJ
MM.F*4*3CS PRZ<6<TRCJ&^WZWKB7RJ7WI8;7+F/GXFUGF/QIF7N'*2*EFA\5
M565(]V]^LDJ"U?+G-J>-$9.Q*4O=1J5NI:"5A 9GDW#G,RZRH!)5SG,XX^I&
MVM&]# FJV9"PQ"T7/G,G#I3TGF=>Z.>C78DKIL\LEP0JCB#?1NC2;KM%)2))
MJ0%':_&+QXU1I9"BX ]K(4[J7AWD<3<YS+E[-*9A*Z<G%$S^QI%J>[;+7&RK
M+@$_6XD;][;5R>74I,YJ#=G C12 QQ8/#W(*V-8H>U;[NA>[S)R)/>4T[ZFE
MJB<V+&[#;TM1H:_?VUX>_>]_@TF3,Y34A2ZMVJCWS*W5)C]74T]6:$WF"CHP
MAK6<4]*#U$[K*:$2:-YALBT]JSLU82-A*B^*K0Z:FY4&1-OCVAB4O!AF3=BS
MM_YV/N8P$&(_PCQG81SQ63+<]Q6)/.>I_&E+PY?.;F<MLRFU:BL'B',%:*G#
M=Z6FPYI<JHEBPC8C8DEY4$+,+C%>RW!*S0/1'?'7PP_M^M9P>4S95"T-(PV)
M/M10SHF9G0F1PK2LY'SG6]ES.+M,F-TDDF(KJ)K8^WOJO8S1>8PEFGX5+6L@
M].$_(344(KZ6V5-HRA5I9!;+A$7.:*%#BK6$KE<(A3-7\>W2)5!FY+?JGC3"
MF*WU*QK@TS7)FWIVVSD!!C;QH\!TS&9Q)UL2*@<5-HOH&EY?)'NQ'UN:&6H^
MA['=[5M4H]U=G?"-E,T?GL],W..=M#V5ESJW)3"D6N"0&7M^ >>#U-T'+4,V
M<4]ZQSH"(2]L73M_/;&N,]//<;E%SLL-3^WUVC"*42R,ENFF"-\[(EJE3LGR
M7H;DO 9)OGEFJ>C4$(;K&)DV"H 9,M&4R-2=SCIZEIL*LY74<VCKSNBW]1U8
M9'")DL(.),U]<L[!)Y6Y9Q6F^ Q=//'YS_.G4F4%F65!IZ@T@Q+#8];V/(HA
M.HTE@4"?:P;T+(]HCS,$-KU!9(K0.J8THY.X>DD\S3W4F2GDAG)SY\K-W@%6
M5FO;WI3%*;DU6RZ#%*Y1(')W3OU..K8]0A<]2)T<5S])CT[BT$FJS'!2H-<-
M_6V4;F;;[;9"$]+<(<*KW:4*:NEDILK>JIHS5HK;-KVE4_9Z9=*@G#E9++2S
M*A->UZ2'H*_E$L/SNTY_[T26=HE5;;Z$$EE!DNX>#(K9;9QY#8S8-B51!.1M
MW9'&MZYFDIB=D',6:-D-)1QN:K$8W=$ZH#6YI>\;*]U.JO1<7KMC;3!N=#BP
MJ,6\='+T)G,.E\4CLO962#[Q%S9JC3V',#Z3/FL"KM-4L/LM[K-<ZJF)^L1D
MKE$G;<.2O!NRG*8A8IT.7D$JRPL6'^)KAZ"QUYC$=K%Z2-SW13%SNH4;V!-C
M'A'7\8M5_NR/K&E\]^]79KG;39C[HYDR D[1WT,:VW7V_J($VI82$J'DNLJ=
MDS/.FMYLV:V"U,%C1T^>VA8\DGDF>D%IOM<2"6>^ASNJRWZ8V5U.Q%HR4:9(
MD0D)=]2"=,GG[&!CJ]^/N>9I-'RY)U,[!K&93!VI9H;YG#[;>:Z4LED0Y?+X
M)54AA2A.J+(;+"?6^XG6)F:%X,)?6UW]P*$JCUM/0%[R/C"B9'S,V<F;,T@:
M:E8\Q58Q^],K>\3!LDD,FC;9#!-,S!R5.3P\2\NP6HIY5K'+=;ES7[&;K=5&
MIQNNX0/L/QL<CTX^:VE9MSS.MN=&R"S.$6 R2J\YW'$]FRB_[Y;+&G"*VIVO
MEZ;>;12U9DK)0F1X_7_;'K=TJ38M.I,2F!EN!>*ZCV]IGA=HR&QK&>YA.KYF
M<<,+L:>,$=IE7='1#G?Y;Y1,>1R'8FIYXS.Z5@]9X:MR3O=C-DU-JE)5JR#@
MR_&/'GSA&5D<>LH9W))8P2-MF:R;RZPI+(9A,)HVV_"+Q+EDV>EBOVC^[FSR
MN6;.<;:Z)26Q"4W$$DH=-"-0NR(\Z\_TI=K)8<?>W2)V/8:*WXFWQM?/57O9
M8QU@VG,^GIGH5$G-284]O<9ELED+FA,2ZX.;&Q<K*^ZFQK@L*;,^#N<)XT/;
M+)(V^J&^02V])PYZ$2Q\2;F2#HQG6L=IJ2S256NQ)#JW+S-4Y6OH+1;9]8K&
MN< /73?)E$0BWY#U%"'J83B8V%&I$T,$FDMF/5BQ^-P2Q)<WV3)6"MCW%<X:
M(H=))8WI%Y)'NA6G1%$%)V_*5%KA. P[9?CWY(E-E/<ML>2V/M8%RJY(P5O[
M\7?*DKQ!9,Y25BOV0[<\F*G7#U%7Q-*:?12<E&C.4I&K1E,]QIDR'W208'\/
M\5W+*K9'LH5W>=L:1/FV<9WO:R,[6_';5LHVW+,B=O[8>\;SN-3F=F[*5Z91
MG7_NVYB(K8I$<<G,"WY3PYQ.1>B5-++#FI-_VPIVF=1,SW>;VIL"*-%77!$>
MAGTNE&MU7JGI#!F2S&%I6K$INJ]N0)<%-Q&$R#?5)D/6_<&\7QR2P.NM)Q,J
MPGTL:(/^1^/Q^]'B)3I6X\O*9B_-\VK1$8Y>_2Z31&,W"Z-CZI2Z'D'L#IJ0
MN*VUP29J&%H1SCXN9?-TM$T_T<ETMZN6F/P]AB%=]3;+;:A$JYVE5K.::7M1
M)D@=I499\$VMJ6L[XK485;*6=U5HG<D\KTXU"4G.MO<?1A!/4-2=C02Q(!3-
M;1Y!,69ROEELK\G:6+2*P7B6VQ-9B\2=Z>SEDT<Y1DEU=5BC"+&[065IMK[+
M)988_+\;_$D:M O"Y?+BYI81EI2.$P!YN61>XD[4^735_1%LZU["S70K4QJS
M<,4CSPY*?9JU27VI:7*@M"84FP%B] \W^-27VP[TO:-X(ZYN:]'&:9F%9Q[I
MI;6$[MUEO+=DRZ5[*8ZUR9M>'R(RIWB:92SM>Q>F^RHM5HASDI6X$J VY:::
MEZ:Z:_<UTUUTUQ_[-=<8QC_]6 'Z      '(OX)_VV_\1I](2#_*1?X#KH
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M:EI=PR[GS10;9= V9/SA=JN0K&M,^6]'4T;EQSU7K,OM645*UN$,;=(%LMM
MA[<H4Z/*'<TN/E*H\GU.UW]W&>]VH4NN?*#<"Q%%M9W0BAVM:>3"15Y$JC@L
MOB"2)JE1_7]S<\PN4.-AR W*QKPG:ZS]L\E^R4%X)),4IBMSC=$> R2V^5C=
M]1QIY8N7I^O8&R14A ^@'(RPJZ1'4?8=Z]$._-+!'DS>>OR;:#;'YM'U2QS<
M6K8LO#4<C,3%J3S5*=&$XNCK^>*4)K!@@]9.-Q6O=,]5U_6M?I)2QP5O7N#-
M!IA9<F>)'-9%H>W1YB887!7 [;;1.M5J562$Y*??VNQA01.XQ["MCKCI"XG
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M!^P     !R+^"?\ ;;_Q&GTA(/\ *1?X#KH  '.9_%;_ +$7IS^^O.GR_5V
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M'S9>,@45Q9[K7=&W34SI;K[)SJF*;$4M8YI/6^2-9)[.J4K?0<Z*%!,C+)W
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MF5 Z-N%A>BM<TYPD(4:N6@8JG?$W:$TD#W$-6^L6N 12<]C2J)3\JW)'N]V
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M/-$=G#VLC+OHJ21R&0M8B)RI3G)(JN7[Z(RMB3C]M@Z"&HOV36VE>]Q+/[)
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MTS5*FUW,SG."B_3ZFH5D
M
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M=N:9G;??;.0J@
M
M         #D7\$_[;?\ B-/I"0?Y2+_ ==   YS/XK?]B+TY_?7G3Y?J[ ;?
M^!?\"G%?T2^<OD>AH"6@
M
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MMO2ES>>KQ::FB!UI1W-US"8R9!<C,M,==52B%0I.UF[)BT>[RD4878"U[?\
M*KUS5=Z=GT0W\ZQFP)5Q)5?3O4LQT88]/"DED\Y$5U$GWB=MA+HG=W8K2R+"
MG<E>VZ79+(7ZD):^>-T:$HU6ET*"*3]Y4^NYQ..=F:.= <INU;QCR!<TU;8G
M3%#1&09YYZ!BMZ<EVU=)U -ZV47!)-(].X/-X@F8%>4TE.W<G5_CFQI: [5>
MRK I-.>>#K6S:L4S*0PSEFMDDJLKCZ,++3DR](X0'BY)TI8]DQ*8Q_JR#QCI
M-YF1ZZM$,$2I$[H]KJL,6OKEL0O:FHHG38\,Y5=UY=AW\/IT]UA)[*=[-MB,
MNO=+NTSYDGMB,6KD@B/6=N1V'ZP6;LTA:K&CT.;8PWI4S#E,Y%*T;24G*T.S
MKKZ<AGFF/)'U',N\XU1<ICU&?-_F7;W;/%S"0R1N?I;>:]^6^=6R_(U9#U,G
M*P'.).F9'L6M9UK84PI_N;$JRU6N?73 (A]U]9]KQON3J2C(%TQ$X8SQ^]/"
M>EY]K?=D>6)\1,E]]'+H;:[J\*H]/&A_G55OCF4:V38@M/C5Q3KFQ"6J;?8F
M:K@MZ;><_LJ&J:CB9E4\ZJ)D6]]'QZ;O+RI(KJ"]%3'G_OB0<;'UM1*FS^AH
M@LKB6/$98BY*<2699SHD6.R!/EKV1;'KM V3>5?O#ICD)_@$>YU9Z35&N7)W
M?74LQ6W+&9Q*,;I.+:^K.PF^&QQ-"9Y"/<2N>:2U4W'+%)BG1%ZQ:G0HWV.R
M=0&OVX_-5U;3=4V^WR[',33>\3NRN(W7CB17<TVKB60VR> F;MXJ%*D<[Z*K
M%B:YS&%+V7']G=?-$&7U.7L:TL*ISW+:LA?U7^8GK"RK6I1R+A'/;71TXMWQ
M;U-+(N4P6*OLTU9Y$>36^\9 \QV>9GJ:+MB6IIJX%ITA"F/K#'5OR84;NE/*
MP<<&"&GSG]NL]'$VG-*SYR?5EH<J51T17V8;%)VPLU+)IKW2FX_E;Y;RF:70
MG:9G#HI&7=-*SS\.L,1HSB34:M>0CSET*":?'7D=[9ZNO[E*J2&+EJ-PV84Q
MT?>-WS9 2ZSK:P(+1/4B7G:/.=#KZVO*<P*)K+'3/"5>H3KGF6IV14F5D:*U
M^F"3=PQ;W]Y#;_:.YXGR;$;,K2C8I!.ZO%!"DL0P?,&SI/I.!]#VJQO5I2^$
MNJ.9-L</HIC(3&Q!^;=X\ZDKC27#54XH]L)DBH(WUSY=>X(A1SW+*\KVLK'A
M=#<&6GV/8S+/U5V63<LWD*[M?L+GB*QN/3QWLI4:W0J((ZB;I"\*',IP.2LJ
M!6A2>P*-3'-X9&1>;#II1"(5M*)=PM33>OF'69!G7MFG+)3S/9#9S=!:=F49
MK*.QRA^D[8WA]S68LLYS1Y0))K,5Q:6*J5#8V.JE3AO2AC^S/+KV=SM:784:
M<+"H*784>0%35, 565&4$<C7,%-(^&(5T7""I@CF?0?/Z$U@NUX-V98^N>WE
M@4FO3=(EA6'-3NCCZ,*A8'E=ZFNB_.0:W7R.I^7M5_9WBN9I/0$<DTC<N@+=
MAW2%2(;DL^9Q^;LTY3Q"8<NE/SV9$MBBH\M3.)C4<:H=$ZCV;<8$GO*!VEU?
MR)VE,Y[1\LB*^MZ5\7[]T//:;M%+.7V#352R=<U_#EYL8:XG,HBCB]EN,4>%
M*)-(UFCJ6@3X]EE HT-VR6&#;$\Y?6$5F_D'0M=/4:6U<MP+N9XB, DKHV([
M4A"[DIRBK;74YM..(;Y46-,X#?OO[E1C4F%PY,U$+VW=$ZO))AY^@9/T\J7<
M,2[>BG&-LPOFER=4BNF(E8&L+/,K9^LE+=].S:VGBYN?]+$Z*S8BN'4M[V)F
M12W(HA)\.ZEG>#S7EE4>Y&_ 89YE\L_8BF$<M^XV*GGBK$40\+C%9B>=ZW-/
M;PFJ[R6N\F@DI<&JUY%:BSV;C7#DT)7%.K>F][5NN,F$*=\;[84X#:OY1>C\
ME^+F^+_YBN$S!B557B.(6O44M]0XI0BZ2@=>S-,PREA4;>S/(/)<VA;[+?/J
M[:GD[_Z-L ,(\$VET*Q5!Y=NB+9M0^WY57G9?<#)6;&\GV%B'0N)<S&/[5#(
M9'XH^V/)&*,1/;#<7C*9C3M1YVGIW6*%JG.JC0(?Q/S)]F%0EH3VJ@Y,A3W8
M[#XM)REOTZ'V:ST)S) ?(77-O2V3/UY,K[;WOA*45<R&HM&9J7ZR*)MSBY25
M$6L,1:%;;GA.E-Y&KV=_$18'=K1$Z.2W)$=[#9(TX2=]=XES992:#7ZY4XS7
M7%7J42!F7M]5VI%VW63QS1U?420TM<F(4/)23?+I@(&X\]5E1OGF&6Q.=*$9
MU[QSSY5'Q0_2://,'BLGZ6XATK=72-70KWMNRRH=*<V*@F"WWR2QB7RPAW.0
M&^\SIC!!^-0NBP/*K?<_;.O8*LLWG&C'>)\\7PUPBD4+?:B'LQ]=F+QU,_4[
M+U36$D:Y2ZQIBJTV8RA0C:MW-D1HB4[1Z^D@/==M&[<)Q>)GK+HR[D]F4ETB
MJKZ62NB:'X1L%EL.!M4Q9G"6M737/69XL;9WK-IG,U,@FT=?8VJPJ?23V\AX
MRKP;[@1;8V+R&BR2^6GJ.Y7J>6L[6G"6Q*DX#E$]7\RT5,K>KMWY[L/'D^YO
MI!)";]7--F'/V;]B,"7JTRIQ1EQ8XTA>M1[M>J W4U:$S+K\Q7=57QR53D^,
M<J1^O)3WEV/R?5<XD,=?$3#6L7XZ6765ERN^16/TK3%?N4RO9P@*!O9RTS\P
M%MQ:5P4DIWA6<D:M R2S>6'J.V)O*J^(?N4.8YX;44*)@O/,[:9_:W1-CSFS
MN$U_4)5U4T[PB7Z0Z5T[ [!U-8"\J63WF<2&-PV5/R!<8D;S0BISUY6NE(_6
M5;2Q^MBI;&E%B\G^'=OG/3<[>)TOYNHQYZKEW6#'9]R7'733:R*&M3U!%-;H
MH](5+<XQ'5WF"@C1S5-R-.0E1A?LR\W/:Y%:N-@0J&\MJ6ZJN4.@>FIL_K(G
M:KQ$^@V/GWN=)RTW22@EJ.SV<^)5M?=?F;21B<7+W_RWFF%XTRYI-M3]PV:^
M4;J^R^89GR!(*S(8E3F_HNSI'EKF]ASJ"UFO<ZHXNMFTXJELO$1<"FIXB.LD
MCJ?91LZHEQ+?KK[K(]S*"]%104GQN^1JT>MN0>E[@L9%79]J\\O\U9E>M?QP
MMOKM>8TU%&[-84Z=YBEV]!5],<XW?=BU"N-S=R(V39)P>6WK,FIBP@32OEY[
M]DCQ1KU9+!R4I@LY/\/\EFS/"JZN)HE6(CY7,R*/IX[&7EXN*0MJ&04F[Q8Y
MSW<5"!82]D*=46J-+L5E68&-H/Y_>@9N??Z5H+YB-BK4MY775Q>KU%9-&ZZH
MZ#=!=?RGFJ9S[HB))[_DTR4Q*HF!H0NBS+V;5SWHO7:ZN38UH3DZK<,00;S1
M=C4O!&-M;G.G[[<9ST#Y#)TEM6RY:D;*UN9OK/N@NG8+S=SA*K&ORN_O);M(
M9)-%S'N09/W)O:SFHDIB4I?=*PL.D;L>_GD[@3M^V>4[)C.;4I:E.E"&:2-*
M=%/L0.Y:9A\G-D<77,[:OREWG4.D#*:CV2';':)'333VY!Y>FY!@:'.8/(IV
M4P]#M[\X735G1-+698_ACHF8$*$,V<$6SOV!SFY8F=A4 YMMINT/K\E),RB'
M-Z(4)'_$@7Z*,>NW;::XR'PY,\RG1Z.?>.ZG94FJE35G0+!3;3)%CQ(9C=?1
M#C*[HM>Z(9[9TS*+Y2W.QLS:?#F[WL>"H=/6+*;W9EV=68L@K0L)V^5KRE73
MP_>!5:5N]\P1QL0<07!UFWH;^;9LLDUVV!4]H0.),W-=2GQ>P8>E3SVVFN4'
MIFG.4CNL+<-=#"4*W74P@!BB2>5+M%"\6P^O.G)=&4AIY$R.!HC:5MP^RE2#
MG,EJJS%M2>X>G'#%OP^+.Z5R4JD4)96U*NBR3,E7$G*W'0K<M(8%C1;S9])2
MBR?';"ET=YOAT=[';D!=NSES8+C<&BA"6WH&?U'!K5V/*<DK3BL._P!'$DZ:
MF-7Q8UGI793DQ6H=TNQ?K!L,\;G=?0W8UEWQ!K2KF$0-/R4W-5'7RH8F27(=
MG/L]NL2S4D_9( M?']R1G5.TU#'XD_I/7U5+#-Y@5KE7OJ1MC8-:$V\X':L/
MZ,D_,.O.%:N4QCUYN/#9<S^]NPB(>K[1MF['QRY.SN1M,]51=/R?B]CVFLAW
M]OA1HYF8**6)2L8*V"*$J[CZA=6EJ>&"[;9B*8ZNVS.[:T6A8CJE,>&S^(O:
M>97.0:+Y3(GQ]RJD5,ISF PLQ5N4G856S81@M!H61H&T#R^=K75QSU?S _5M
M?-25#&L\9^0JQWJ,]#*)<II6T)K4A?.LCK^(J8]%9S7VZ^S'XQ2N:(\K,6GG
M(??17E,B<%&^B(\*5ROY?.F>@_(!&>;I/15?5;!GYZ.BK]4\J?(ZS=(P- EY
M2A/0FEQJ$SO<:67RV(.<NE6T>][DU;)&].CR4LTD"E24K0%!(N[?(%T[5_D#
M2\.L%-QN8*IJ5'NAZSDK9&I>M]]..8/5$^7=$(G)6ED>C7I>[??D-98I',9]
MB@W)GC6H/1F^YC\G!J3GGF.[2M?GCW^A5P<I018J:O'3?4_N.J8I+G2*<B-/
M178<;IFSN0NG39;9RPE!8T,85>J]\=ME$47[,3:^$;M31L:@="@R,X^>'K=,
MMZZ5)*@Y_P!VFGBK?0-36Y.B-/)N>RJUZQKCFMFMWH2+L-\R>S933[]$)LJG
M;BI^]6"%MK<B*)2+7-"H]^"@FUP+TW;-H<D>6:U9K=C#?#I5G6'83'6M@UH^
MRI#6!L.@//M5O,934P?O-):_0V!;.RA4L1$-\@<-42M6>8E7G^G13N$8:$\L
M/7"F0\QQK=@IAPIA1+?$)0TU)DJ.V91=\E7>0+DQGLV1S32TWRSEB++A7<P-
M)WU,=&EW6OR8X["I02IU]U'A)WR8^5^QN+^N^?Z$KK6I7ELE*GG)SM*)3R..
M":6KX=?G3*&@SGN&3=PN&O$:?[UV_*M?[%BC,_5D*$^-W<AI;]BU9H1_V\SU
M^EUQ?D^.?.0$TMCDH41LCGM2PV[FUN(64CNA'R(X6CVTXI)BIC;A!8M#%N)H
MZ$Z?>(Y;%E;Z)2CFK!CP0'CO3S/7U5L,C[A%;*X5GF8[SST/>*:V4<?N-'4_
M=4]I#H5=337ROQTD<9\VN+9<,D:$91ZI4E<+%2>^SFBU:2'5LV-7:A=,G\JW
M:;=+;#=77YH-(T9MY)R. HI8UR1*S#4]')V*IS+CDUB=&.Y%R1"*K3Y.H-10
M9D1I%D?3%R)=HH/5[Z[%(C0A!S/YK>C:TJ7QBP-YFE?W))+LWI97?*JT4DB=
M+'DD:Z6[TM3GI!+839<KN6$."EJAD;9-#FXEKB4Z4)M$NA;WAE2Y3G'!(Q!Y
MK.UF"NYA94PK+G63MLCY<ZBO:KFJ(Q:U&+:LU'.'D'A7%SA)+D=%M@RDR75Z
MBA=@ES=^PTHV50W)6-83H=L6;A2G!?7FZZ5J/\E,>KI\XJZ,RXH;[?%M]PG+
MG7M ]#O50W7 *P:Z'IYXM[H2&H(I:"IEF>RIW<&)ZM=.2NRFU;F]P296'I0Z
MG$QIAZ9.<:G,2&G$%&F)3MBMCDQAA>N^Z<W8G<TG8PG;.==LZ;;:YSC[F<X^
MZ ^X      Y%_!/^VW_B-/I"0?Y2+_ ==   YS/XK?\ 8B].?WUYT^7ZNP&W
M_@7_  *<5_1+YR^1Z&@):      ".\IZ?YBBL[+@<QN2K6*Q6JRZWI]/&GZ1
M-"*3(K4O%@<'VK((D1K#-%A<GLR.M:L]J3%_[1P(3'>S];V>^,!"*2^6;@J,
MSJ.P=VE41<V*PK>I^AZQF\5=JYF,8G$PZ(1SIWQL:A99$I?XC%$"ZNUA3FO>
M4:(AR4Y+V186XQOOH&6^%_('R)W6V+)12,@BC7;QK&X.EA5*YKXAB[(E'8S/
MY36B%9.&R/.+H=EKR^1<[4C;"@\M+@\HLWV1N^"P$$*]\J7B6KV\YS94;D2&
M&K>FKVZ2C]U7].79&TPQFM3B6!5%4;X>Y[RB2*%<<9YE7B9GPQ^\Z,DAQ;VX
MU<L*)SG<W8-J9'3?';U<,3YI2W%1SO<YC,TSN$U.FD,6<)'AN.CYDK87B--1
M1AQ12\^'YW=T1:;.%F[/ZRTK3*3TG -8_9WE.Y]JNS^EN79USS>CE%*=555$
M[HN>F;1HNMYE&%O5$7CZIH?*DCN]ZUWT[*I3H@FQ)2M9"6=8[Z'^TPG]J;KC
M78)>UO8WC!J*2Q3F> 6CSM%I;P-6<OUC]<[6*UY=Z$@$8A:!#9#FNW=WL[)2
MZ,P@\K>2+EARAS;DB[<Y>85A:9N<%UF^1?QTNT-BEDK>I>>E,/L:?**2BD@=
M)6Q::2>RFOWF>#*N2$..NC@?+""I"WKBVG<K"C8E:G4Z%Y+.+,V#P4]Y">2>
MANLY'RM1LGBUN2^)52_WC++!@3G$I+"&)QB%F)*4<8NX.C<Y'NN9PF=%&V"C
M]$^Z3=$0;IHISMIL7@+?N?R4>/KGV(=1O!]NU-*)3R/%)M<-PU'6SI$76RD;
MI$C4S<^DM\>T6(4ZV<_?.[H699OL?INWNCBG(<#4VQN & >JNJ:>MODKD*$R
MGCRTK^:O(T\1PBO.=JJL>H(T[EN$1B:[J=O4NUEJ[:KRODB)I0UC[OW.0O\
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MJJ69(YEZV)CZ),WZ'J\MARY4I.-"4T-\6V85Y&'KO1EOE:P-;[))Q+WRG(1
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M9OC7&V0N\
M                                   <B_@G_;;_ ,1I](2#_*1?X#KH
M  '.9_%;_L1>G/[Z\Z?+]78#;_P+_@4XK^B7SE\CT- 2T
M
M                                                       '(OX)
M_P!MO_$:?2$@_P I%_@.N@  <YG\5O\ L1>G/[Z\Z?+]78#;_P "_P"!3BOZ
M)?.7R/0T!+0
M
M                     <B_@G_;;_Q&GTA(/\I%_@.N@  <YG\5O^Q%Z<_O
MKSI\OU=@-O\ P+_@4XK^B7SE\CT- 2T
M
M                                         '(OX)_VV_\ $:?2$@_R
MD7^ ZZ  !SF?Q6_[$7IS^^O.GR_5V V_\"_X%.*_HE\Y?(]#0$M
M
M
M !R+^"?]MO\ Q&GTA(/\I%_@.N@  <YG\5O^Q%Z<_OKSI\OU=@-O_ O^!3BO
MZ)?.7R/0T!+0
M
M                      <B_@G_ &V_\1I](2#_ "D7^ ZZ  !SF?Q6_P"Q
M%Z<_OKSI\OU=@-O_  +_ (%.*_HE\Y?(]#0$M
M
M                                               !R+^"?]MO_$:?
M2$@_RD7^ ZZ  !SF?Q6_[$7IS^^O.GR_5V V_P# O^!3BOZ)?.7R/0T!+0
M
M
M        <B_@G_;;_P 1I](2#_*1?X#KH  '.9_%;_L1>G/[Z\Z?+]78#;_P
M+_@4XK^B7SE\CT- 2T
M
M                            '(OX)_VV_P#$:?2$@_RD7^ ZZ  !SF?Q
M6_[$7IS^^O.GR_5V V_\"_X%.*_HE\Y?(]#0$M
M
M                                                !R+^"?\ ;;_Q
M&GTA(/\ *1?X#KH  '.9_%;_ +$7IS^^O.GR_5V V_\  O\ @4XK^B7SE\CT
M- 2T
M
M              '(OX)_VV_\1I](2#_*1?X#KH  '.9_%;_L1>G/[Z\Z?+]7
M8#;_ ,"_X%.*_HE\Y?(]#0$M
M
M                                  !R+^"?]MO_ !&GTA(/\I%_@.N@
M  <YG\5O^Q%Z<_OKSI\OU=@-O_ O^!3BOZ)?.7R/0T!+0
M
M                                                       <B_@G
M_;;_ ,1I](2#_*1?X#KH  '.9_%;_L1>G/[Z\Z?+]78#;_P+_@4XK^B7SE\C
MT- 2T
M
M               '(OX)_P!MO_$:?2$@_P I%_@.N@  <YG\5O\ L1>G/[Z\
MZ?+]78#;_P "_P"!3BOZ)?.7R/0T!+0
M
M                                         <B_@G_;;_Q&GTA(/\I%
M_@.N@  <YG\5O^Q%Z<_OKSI\OU=@-O\ P+_@4XK^B7SE\CT- 2T
M
M
M '(OX)_VV_\ $:?2$@_RD7^ ZZ  !SF?Q6_[$7IS^^O.GR_5V V_\"_X%.*_
MHE\Y?(]#0$M
M
M                     !R+^"?]MO\ Q&GTA(/\I%_@.N@  <YG\5O^Q%Z<
M_OKSI\OU=@-O_ O^!3BOZ)?.7R/0T!+0
M
M                                          <B_@G_ &V_\1I](2#_
M "D7^ ZZ  !SF?Q6_P"Q%Z<_OKSI\OU=@-O_  +_ (%.*_HE\Y?(]#0$M
M
M
M       !R+^"?]MO_$:?2$@_RD7^ ZZ  !SF?Q6_[$7IS^^O.GR_5V V_P#
MO^!3BOZ)?.7R/0T!+0
M
M                            <B_@G_;;_P 1I](2#_*1?X#KH 0\Z4[)
M@O-3VCBDD0I5\ME$ =)-6K$LET<BAMB3 J=P6NV2NF(U^/*W-=75^L!$:H/)
M+4^X4.IA^Q)GJXTV#1#_ !(]K2"SO!MVTWS2$HH!/:LOB@:WFS RRW,\BVSM
MI:E'3IK=(G,38Y#ESZR.T1G3:?ZRMH:UB93N<G-3Z[%>ON&^W@7_  *<5_1+
MYR^1Z&@):
M
M                   #D7\$_P"VW_B-/I"0?Y2+_ == "+%Z59=-G3V#%P6
MVG&HH5&HC-7HUXC\8K>6K'"UM7:&DP1',&.PXG(SG:ORF39X,4)696R+CC\8
MQE>3OA,86'.C_$+OEUOG@[\@N;V*@R.5M'3G/3"UMU=RAKD\82,+5*.92=UJ
M+5-C611C64R;+D]Z,S_C9Z;2',LHPQ01[G4G!T0\"_X%.*_HE\Y?(]#0$M
M
M
M        !R+^"?\ ;;_Q&GTA(/\ *1?X#KH 8%MULZ7<Y+!"*-FE.0R([)I3
MK9"^R:XEEB2$M;@AK.A9T1;X_9U;-_N'<XI<0Y:*C]C<>U3FD[>@LTLP.?+^
M)=Q*B?!9UTWSFP*WL68M=O4"BD3M6<*40!M;%FUU5&L2L3]&EMBV<O329*UJ
MTYQIA[CH8:E4)]L$%Z>KMN&]/@7_  *<5_1+YR^1Z&@):
M
M                                                       #D7\$
M_P"VW_B-/I"0?Y2+_ == "%/5C1<[G(Z]VBJ2]7BGR&>78G3)S++JYA-L'38
MQ5&OO(7N;K8;_$CE< 2-6COH>G9'5,O]\#4VQY*I+C;W.'/?Y]]+"(\!W;*.
MPELC-.1=%4@GBC58<DKF67)&H=FUZ*4-C'=#Y5BA=%%4ZU7GJE2?7*M<X%1U
M4UZ+5)ZK4W?(=&7 O^!3BOZ)?.7R/0T!+0
M
M                                            <B_@G_;;_P 1I](2
M#_*1?X#KH 1=OV7W)'IK3S#6EH<UULSSM=*HZ[;7FRO\AEC_ "S1&UK80T5;
M'6>UZL+D:A7[)>6Y)<'GJR\;ICB=-M-3M<AS]_Q'4E4RGP-]>K7*S*4MA\17
M92#/(911$>/C43(>FR]*G3*F%X0*K'M)3O,&8O70I=N8Z>OKK[(K8@K)><9#
M?EP+_@4XK^B7SE\CT- 2T
M
M                               '(OX)_P!MO_$:?2$@_P I%_@.N@!!
MSK_B%DZZRGU=K1EM>D;UM-JJ>DS!%:RE9+K%9R_0N1N6Z7%BPV5YCSXG<X*B
MR6L09)WVTQZ#,;YT*V+#2M_$F5JZ5)X".C8*Y33>;D,\]Y[T9%F(1 :]1LK%
MF^JTT01MJB]:QZ,1=$V-?L]\E9T2X,S[3.-MLXQKZ WL<"_X%.*_HE\Y?(]#
M0$M
M
M             !R+^"?]MO\ Q&GTA(/\I%_@.N@  <YG\5O^Q%Z<_OKSI\OU
M=@-O_ O^!3BOZ)?.7R/0T!+0
M
M                                  <B_@G_ &V_\1I](2#_ "D7^ ZZ
M $7[K9>G9+/X4UTE/H]5\/;8?,I*_P C?8*SV$W2:>M[S#4<-K^5-*Q\8G]M
MACLRN#NJ4J&0]*X[FI=,:K4N"\%+ YS?XB>QK?FOA/[X:+VB"*MYS'+QYGUC
ML%2O\?D9&*XVL.AVLJ9QQZ9_<SB_0.6VBU2DQH7.J)N=<IR_8*DB8PGV.H=#
MW O^!3BOZ)?.7R/0T!+0
M
M                              <B_@G_ &V_\1I](2#_ "D7^ ZZ $6K
MTZ#?JUGM>U7"XM WN:6%'YI*T3A;%J_D=@:5F@ZJ,H7-$DD*>%6"\R.6J5$K
M3F%-B)KWP6C*/4*#R==2M3@YM?XB&<Z7/X;^\;97(&IBE<;GG,?.<M9(G,&^
MR*].=:XZ,AT_Q(8-8R%M8#)2V+DEK%)%6BAL;E3:Y(52(\C4].8 Z.^!?\"G
M%?T2^<OD>AH"6@
M
M                        Y%_!/^VW_B-/I"0?Y2+_  '70 UJ>1_WH;XQ
M7,DF_0%/U;63,[O.\PK:X$7-R4BT_6*;34RZ"S'I*$3Z)Q^<PI(4IRF3FHBT
M#CHX;%*UC?KC166&ASS0MCRV_P +Y+MGR=GS]:Y+N<W7+@:3491+'A9T- <F
MQ)+M1[4VUZ=K'599I)VR7=9OA7[;392;C77U0Z6N!?\  IQ7]$OG+Y'H: EH
M
M
M          .1?P3_ +;?^(T^D)!_E(O\!UT -4OD6<XHRO;8M73*6U])W7GR
MXX:6L:4M8GMEFP*;3.HHM,:L;W"T4BQKB,H,7NS6Y;OI.AA3.SIU:M8D7$D:
M:%!I:\]"MA5>"GR&%MD7+A,@;>JZ$9K#BK1-&JQ8.U3AGE7,;<J-@,W;&.-G
M2)G?&%,WN3F>X($CKB3+'3587J?KN Z2^!?\"G%?T2^<OD>AH"6@
M
M
M  Y%_!/^VW_B-/I"0?Y2+_ == #5SY+(58=F1Z,5PV,\BD4&F<5L%I96*$-?
M,KT_.706Y3%^2324-O3R)T8SZ]*;=GK9;EC3&N&NWI]T>A/Z,;!IR_B"(/+:
ML\!'7M427:+*&NM[FYS8(,XQAH@D<POBKG9%#3!3AZC=<,\8C+.Z,\QD[LVE
M;:M#0H<&Y$E7G)<&*\G'!T/\"_X%.*_HE\Y?(]#0$M
M
M                                                    !R+^"?\
M;;_Q&GTA(/\ *1?X#KH :Z.NHC 9S=]4Q=SH=DZ0L)XIVY$C'7]@O\/BE>L4
M-^^FIC9/-T<EDK0_R!JL!$ZE-B5#O'41RW4E08<H-2ZD)C=@Y[_-XVFM/@8\
MBC<[/4^=9BW]=T8U3A#8LEBT^>HJ\L,EY;C[+$TEGQ3;!-H-+3!&IGR6]N91
M$A.,-,)>"_?,A5ON'3GP+_@4XK^B7SE\CT- 2T
M
M                                                '(OX)_VV_P#$
M:?2$@_RD7^ ZZ &K+R5)X>>35V]ZE'E\XDE2W9]<XNV\X.4Z16IN;'-(467\
MXQ(O(1Q95&_?O!^\8(V>=E>I.%&Y:'VN# T=^;<A0F_AR>GBFQ,F3U=BZZ4W
MHLW=!2S9(5U5G7E41Q"Z8H^?-2ZH+D!TXW?,%[("R59C9JDW<B]7/99@!TN\
M"_X%.*_HE\Y?(]#0$M
M
M                            !R+^"?\ ;;_Q&GTA(/\ *1?X#KH :Y.O
MTTT-O*E5=#-&91T6VUO;1S1'Y'&H'(ZY3U4I?ZS2S)[>MYM.J^=&20%R7=E3
M(CX\L4*SBSCBUR;=+[,TD-!'G-1EHO EY "WA*ZM=J&=94XJO-B5,,%C+$Q6
MBML?G=88BA+/7$AEL5)B:N#*&-:6=AT7.2I8K4'N9FKD8K)*#I>X%_P*<5_1
M+YR^1Z&@):
M
M                    #D7\$_[;?^(T^D)!_E(O\!UT ,7VC2=0W8W-C5;=
M;0VQ$3(L-<&/26,#>\',:Y03A.I6,JM43NL:%*I-CV1NZ<PK8TK^9MG.OW '
M/5_$]5W JK\#W1T+K6&QF!1)MG//QR*.1)E;V!G(4+NAJ_5KU>J!M(3I]EK@
ML-W.4';8R:>=OMN9MMOMG.0W8\"_X%.*_HE\Y?(]#0$M
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M^T@5LY$7<LNYC0?_ -W1K5"E/C7&3BR\;Z9V#.X
M                     Y%_!/\ MM_XC3Z0D'^4B_P'70  .<S^*W_8B].?
MWUYT^7ZNP&W_ (%_P*<5_1+YR^1Z&@):
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MVRZ3&"O$Y:6R6V0:N5L$I<]G)*XR2-(5&$;(XJ]/0E2&*=BLAG#R-L+)5O\
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MY'H: EH
M
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MB0_" !]KO\-?X=7Y\1$A^$ #[7?X:_PZOSXB)#\( 'VN_P -?X=7Y\1$A^$
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MQ$2'X0 /M=_AK_#J_/B(D/P@ ?:[_#7^'5^?$1(?A  ^UW^&O\.K\^(B0_"
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MB)#\( 'VN_PU_AU?GQ$2'X0 /M=_AK_#J_/B(D/P@ ?:[_#7^'5^?$1(?A
M^UW^&O\ #J_/B(D/P@ ?:[_#7^'5^?$1(?A  ^UW^&O\.K\^(B0_" !]KO\
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MS#_XZR_L8?\ Q5O_ / ?_'?_ (HK_P %_P#ZK_\ D_\ ^-]4!N93_P#8$_\
@8_\ 8E__  __ &'_ %-?^Q__ !/_ /#_ -'H ?4!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
